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Abstract
Acute changes in cerebral blood flow and oxygen delivery directly affect
brain tissue metabolism, often leading to severe life-long disabilities or death.
These events can occur during birth with dire consequences to the infant. In
order to identify and monitor these events in the neonatal brain clinicians of-
ten use non-invasive techniques such as near-infrared spectroscopy (NIRS)
and magnetic resonance spectroscopy (MRS). However, clinical interpreta-
tion of these signals is challenging.
This thesis describes a number of mathematical and computational models
of cerebral blood flow, oxygenation and metabolism regulation to assist sig-
nals integration from multimodal measurements and to investigate brain tis-
sue metabolic activity in neonatal preclinical and clinical studies. The scope
of this work is to construct a set of useful computational tools that will il-
luminate brain tissue and cellular physiology that give rise to changes in
clinical measurements, and hence offer information of clinical significance.
The models are composed of differential equations and algebraic relations
that mimic the network regulating cellular metabolism. They integrate NIRS
and MRS measurements that offer insights into oxygenation and a variety
of metabolic products such as ATP and pH. These models are thus able
to explore the relation between measured signals and the physiology and
biochemistry of the brain.
The first three models presented in this thesis focus on the piglet brain – a
preclinical animal model of the human neonatal brain. Previously published
models are extended to simulate intracellular pH and used to investigate
hypoxia-ischaemia experiments conducted in piglets, predicting NIRS and
MRS measurements. The fourth model is an adaptation of the piglet model
to the human term neonate, to investigate data from bedside NIRS monitor-
ing of patients with birth asphyxia. Finally a previously published, simpler
adult model is adapted to the preterm neonate, simulating data from func-
tional response studies and a functional NIRS study in neonates using a
visual stimulus.
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Chapter 1
Introduction
Neonatal death accounts for approximately 40% of mortality during the first
5 years of life (Lawn et al. 2009). One third of early neonatal deaths, an esti-
mated 904,000 lives, result from birth asphyxia (Lawn et al. 2005). In 2005, a
World Health Report estimated that an annual 1 million who survive birth
asphyxia may develop cerebral palsy, learning difficulties or other disabili-
ties (WHO 2005). Indeed, the development of neonatal encephalopathy - the
disturbance of neurological function - in these infants is strongly predictive
of neurodevelopmental disability (Lawn et al. 2009).
Neonatal intensive care is typically informed by a vast array of clinical mon-
itoring measurements, creating the potential for information overload and
making it difficult for clinicians to translate relevant information into ac-
tionable insights (Ellsworth et al. 2014). Mathematical and computational
methods have long been successful in deciphering and solving challenges
in the medical domain. In particular, the application of mathematical and
computational models provide a powerful mechanism for investigating and
understanding biological scenarios. As our knowledge of biology expands
and the prevalence of clinical data increases, models will become crucial not
only for investigations of elaborate biological dynamics, but also, and per-
haps more importantly, for translations and interpretations of value from
the abundance of information – to detect the signal from the noise and the
light in the data mire.
The work presented in this thesis covers the development of a number of
such models, focused on cerebral metabolism in the neonate. Understand-
ing metabolic activity in the brain suffering from neonatal encephalopathy is
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vital for the development of neuroprotective strategies that can be used clin-
ically in these circumstances and for identifying patients that are at risk of
long-term damage in order to improve outcome. Near infrared spectroscopy
(NIRS) and magnetic resonance spectroscopy (MRS) are used to monitor the
progress of patients by measuring cerebral oxygenation and the concentra-
tions of certain metabolites such as ATP. These techniques are prominent in
neonatal care due to their non-invasive characteristic. Newborn piglets are
a common preclinical model of the human neonate. NIRS and MRS have
also been employed in investigating cerebral activity in such experimental
studies (Springett et al. 2000; Bainbridge et al. 2013; Cooper and Springett
1997).
The Multi-modal Spectroscopy group at University College London com-
bine NIRS and MRS to provide a detailed overview of the metabolic and
haemodynamic changes that occur in the brain. The models enable the in-
vestigation of cerebral physiology that give rise to these changes, by inte-
grating measurement data from different sources coupled with the known
physiology of the brain. The models also provide a predictive capability for
entities of clinical significance.
The models are here applied to two clinical scenarios – functional activation
and hypoxia-ischaemia. The former refers to the cerebral metabolic changes
that occur when the patient is subjected to a stimulus such as sound, light
or touch. Hypoxia-ischaemia is the loss of cerebral blood flow and oxygena-
tion, and as a result of birth asphyxia is a major cause of cerebral injury
in neonates. Although the numbers are more severe in developing coun-
tries, in the developed world asphyxial hypoxic-ischaemic encephalopathy
occurs in 1-2 for every 1000 live births (Shah et al. 2007). It is believed that
the predominant cause of cerebral damage stems from the deterioration of
metabolic processes during the recovery period. Brain activity is often ob-
served to return in the immediate aftermath of the event, only to worsen
after several hours (Thoresen et al. 1995; Robertson et al. 2002). The severity
of this phenomenon, known as a secondary energy failure, has been found
to correlate with outcome (Roth et al. 1992).
The aims and objectives of the work presented in this thesis are to:
• Develop and expand a pre-existing model metabolism in the piglet
brain to better simulate intracellular pH
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• Simulate hypoxia-ischaemia experiments in piglets
• Adapt a pre-existing model of adult cerebral metabolism to the preterm
neonatal brain, and use the model to simulate functional activation
studies
• Adapt the model of piglet cerebral metabolism to the human term
neonatal brain, and apply the model to monitoring data from acute
brain injury patients
• Use sensitivity analysis and parameter optimisation in the applications
above to gain further insight into physiological changes
In this thesis, Chapter 2 provides an overview of brain anatomy and phys-
iology, with a look at cellular metabolism and pH, and differences between
human adult, neonate and piglet brains. Clinical measurement techniques
are introduced in Chapter 3. This includes the capacity of NIRS and MRS
measurements to detect changes in the brain, and a brief summary of their
applications and findings from hypoxia-ischaemia and functional activation
studies. Chapter 4 is dedicated to the study of mathematical models, look-
ing at a number of published models of cerebral metabolism and blood flow.
Among them are the models produced at UCL, with specific emphasis and
detail on the two main models – BrainSignals and BrainPiglet – that were
further developed in this thesis. This chapter also describes the model pa-
rameter optimisation techniques that were used. Chapter 5 focuses on the
development of the BrainPiglet model, completed in three phases, to bet-
ter simulate intracellular pH. The model is then applied in Chapter 6 to
measurement data from hypoxia-ischaemia piglet experiments conducted at
UCL. The BrainPiglet model is adapted to the term neonatal brain in Chap-
ter 7, and used to investigate monitoring data from neonates suffering from
hypoxic-ischaemic encephalopathy. Chapter 8 outlines the adaptation of the
BrainSignals model to the human preterm neonatal brain, and its applica-
tion to data from functional activation experiments. The final chapter covers
conclusions and future work – both a look back at the progress that has been
made and a look forward at the challenges and opportunities to come.
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1.1. Personal statement
1.1 Personal statement
A number of research collaborations have made the work presented in this
thesis possible. This section aims to make those collaborations and the au-
thor’s contributions clear.
The BrainPiglet model was originally developed by Moroz et al. (2012). In
this thesis, it is further extended in Chapter 5 to simulate intracellular pH.
The hypoxia-ischaemia experiments in piglets, covered in Chapter 6, were
carried out by the Preclinical Neonatal Neuroprotection research group, lead
by Professor Nicola Robertson at the Institute of Neurology, Queen Square,
London. Measurement data from this study was used in this thesis to help
build and validate the extended BrainPiglet model.
The development of the human term neonate model in Chapter 7 is followed
by its application to monitoring data from neonates suffering from hypoxic-
ischaemic encephalopathy at the Neonatal Intensive Care Unit, University
College Hospital (UCLH). This data was collected by Gemma Bale of the
Multi-modal Spectroscopy group.
Chapter 8 focuses on the adaptation of the BrainSignals model, which was
originally developed by Banaji et al. (2005), to the preterm neonate. The
model was then applied to data collected during a functional activation
study in neonates. This study was conducted by the Biomedical Optics
Research Laboratory at University Hospital Zurich and measurement data
was subsequently provided to the author.
The computational models developed by the author were complied and ex-
ecuted in the Brain/Circulation Model Developer (BCMD) interface built by
another member of the group – Dr. Matthew Caldwell. The functionality
of this interface also enables the creation of the schematic graphs of model
variables and parameters presented at the end of Chapter 5.
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Chapter 2
The Brain
This work attempts to simulate the behaviour of perhaps the most complex
organ of the human body. The brain is a powerhouse, controlling the ma-
jority of functions of the body, from hormones to movement and memory to
vision - responsible for the existence of life, in both a physical and mental
sense.
Any attempt, therefore, to amalgamate every known function of the brain
in a single detailed investigation is a near impossible task. Moreover, at-
tempts at creating an all-encompassing computational model, based on the
foundations of current knowledge of the brain, would be at best unreliable.
The sheer size of such a model involving an infinite number of parameters
and variables (with various error margins) would be devoid of accuracy and
perhaps also of translatability.
As a consequence, models of the brain must necessarily be focused and lim-
ited in scope. With this in mind, this chapter explores those areas and func-
tions of the brain immediately relevant to cerebral oxygenation and cellular
metabolism.
2.1 Anatomy
The central nervous system (CNS) consists of the brain, the brainstem and
the spinal cord. The cerebral hemispheres are made up of four major lobes:
the occipital, pariental, temporal and frontal lobes. The cerebral cortex forms
the outer layer of the cerebral hemisphere, and is interconnected over long
distances via subcortical pathways. These pathways and those connecting
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2.1. Anatomy
the cerebral cortex to the spinal cord, brainstem and nuclei deep within the
cerebral hemisphere make up the white matter of the cerebral hemisphere.
At the base of the brain, the brainstem is composed of the medulla, pons
and midbrain. Also connected to the brainstem is the cerebellum, associated
with coordination and movement.
Copyright material removed.
Figure 2.1: Anatomy of the brain (Thompson 2000).
The CNS is surrounded by a series of membranes known as the meninges:
the dura mater, the arachnoid mater and the pia mater. Between the lat-
ter two lies the subarachnoid space, which is filled with a fluid called the
cerebrospinal fluid (CSF) and contains the major arteries. The subarachnoid
space expands at specific sites to form cisterns, the largest of which is the
cisterna magna found between the cerebellum and medulla.
The blood-brain barrier (BBB) was originally thought of as a single phys-
ical barrier stopping the movement of molecules and cells into the brain.
However it is now known to be composed of a series of different trans-
port systems selectively facilitating the movement of molecules between the
CSF and the blood. This barrier allows small molecules like glucose, al-
though not lipid soluble, to pass through to the CSF but prevents larger
protein molecules from entering the brain. The barrier effectively maintains
a constant intracerebral chemical environment, and protects against osmotic
challenges. By preventing the entrance of cells, it also provides immunolog-
ical protection. However, this also makes the administration of drugs for the
treatment of CNS disorders difficult (Barker and Cicchetti 2012).
Copyright material removed.
Figure 2.2: The blood-brain barrier (Thompson 2000).
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2.2. Blood flow
Recently, it has been shown that arterial pulsation results in exchanges be-
tween the CSF and interstitial fluid (ISF, fluid surround the tissues), in an
organised system called the glymphatic system (Iliff et al. 2013). The sys-
tem uses a network of perivascular tunnels to clear macroscopic waste and
facilitate the distribution of compounds such as glucose, lipids and amino
acids (Jessen et al. 2015). Experiments in mice have suggested that this
glymphatic pathway is also used to clear endogenously produced proteins,
including biomarkers of traumatic brain injury (Plog et al. 2015).
2.2 Blood flow
The brain is supplied by four major arteries - the internal carotid and ver-
tebral arteries - that coalesce to form the circle of Willis. This arrangement
ensures an adequate distribution of blood to all parts of the brain, even if
flow in any one of the arteries is obstructed. This is especially important
in the case of the carotid arteries, as they carry approximately 40% each of
total blood flow to the brain (Edvinsson et al. 1992). The major branches of
the internal carotid arteries form the middle cerebral arteries, which supply
the lateral sections of the cerebral hemispheres. The vertebral arteries unite
to form the basilar artery, which runs through the pons and connects to the
circle of Willis (Edvinsson et al. 1992).
The distribution of capillaries in the brain is heterogeneous, and varies with
the number of synapses in the region (Edvinsson et al. 1992). Cerebral grey
matter has more than twice the capillary density of white matter. Areas
with higher basal levels of glucose use and blood flow such as the cochlear
nucleus and cerebral cortex have higher density of capillaries (Edvinsson
et al. 1992; Cavaglia et al. 2001). Prolonged periods of hypoxia can also lead
to an increase in capillary density (Edvinsson et al. 1992). Ischaemic insults
have resulted in more extensive blood-brain barrier leakage in areas of low
capillary density (Cavaglia et al. 2001).
The cardiovascular system regulates oxygen transport, vital for cellular metabolism.
Blood haemoglobin increases this transport capability approximately 70-fold
by binding to oxygen at one of the haemoglobin molecule’s 4 binding sites
(Polin et al. 2010). The affinity of haemoglobin to oxygen is often described
by a sigmoidal equilibrium curve. This shape results from the effect of each
haeme group binding to oxygen making it progressively easier for the next,
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and is often expressed by the value of P50 – the oxygen tension at which 50%
of the haemoglobin in blood is saturated (Polin et al. 2010). In both adult
and fetal blood, the curve shifts to the right in the event of an increase in the
partial pressure of oxygen, or a decrease in pH, or both. This phenomenon
is known as the Bohr effect, and can also be induced by CO2, either due to
pH changes caused by CO2 or due to CO2 binding reversibly to amino acid
groups in the haemoglobin molecule (Polin et al. 2010).
2.2.1 Autoregulation
Cerebral autoregulation is the function of the brain to maintain constant
blood flow despite changes in perfusion pressure (Edvinsson et al. 1992;
Polin et al. 2010) - the difference in intravascular pressure between the arte-
rial inflow and the venous outflow (Siesjo 1978). Cerebral blood flow (CBF)
is maintained between mean arterial pressures of 60 - 140 mmHg in the adult
human, however neither of these limits are fixed points and can change with
a variety of intrinsic and extrinsic factors such as arterial carbon dioxide ten-
sion and chronic arterial hypertension (Edvinsson et al. 1992). In newborns,
this range is less well defined but the lower threshold is known to be ap-
proximately 30mmHg (Greisen 2005).
There are three mechanisms by which autoregulation occurs (Edvinsson
et al. 1992; Siesjo 1978). The myogenic mechanism suggests that the smooth
muscle cells of cerebral vessels respond to changes in transmural pressure by
contracting or dilating the vessel wall (Edvinsson et al. 1992). The metabolic
hypothesis is that the high neuronal activity causing variations in concentra-
tions of oxygen, carbon dioxide and other metabolites induce an increase in
CBF. The third mechanism, described as the neurogenic hypothesis, implies
that blood vessel walls are controlled by nerves connected to them (Edvins-
son et al. 1992).
Brain injuries, such as those that result from hypercapnia, cranial trauma
or hypoxia-ischaemia (see Section 2.6), can impair autoregulation (Greisen
2005; Polin et al. 2010). This is evident in the measurements of the patient’s
blood pressure, and is a clinical marker of the state of brain.
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Figure 2.3: Autoregulation curve for the human adult. The flat section represents
the autoregulatory plateau (Edvinsson et al. 1992).
2.3 Brain cells
Neuroglial cells and neurons are the two major types of cells in the ner-
vous system. The adult human brain contains approximately 100 billion
nerve cells, however neurons only account for 10-20% of the total popula-
tion (Barker and Cicchetti 2012).
2.3.1 Neurons
The part of the neuron containing the nucleus and surrounding cytoplasm
is called the cell body of soma. It encompasses most of the intracellular
organelles such as the mitochondria. Structures called dendrites extend out-
wards from the soma, increasing the surface area for synapse formation
and hence the accumulation of inputs. The axon originates from the soma
and conducts information away towards the nerve terminal, and is often
insulated by a layer of lipid known as a myelin sheath allowing rapid prop-
agation of signals. The junctions between cells are called synapses.
2.3.2 Neuroglial cells
There are four main types of neuroglial cells in the CNS: oligodendrocytes,
astrocytes, microglia and ependymal cells. A large number of oligoden-
drocytes are found in white matter as they form the myelin insulation of
neurons in the CNS.
Microglial cells are the macrophages of the brain, found in both white and
grey matter, responsible for mediating immune responses.
Astrocytes are small stellate cells which perform a number of functions
throughout the CNS, and account for almost half of the volume of the adult
mammalian brain (Agulhon et al. 2008). They form a structural supporting
framework for neuronal cells and capillaries (Agulhon et al. 2008). They pro-
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mote the formation of high-resistance junctions between capillary endothe-
lial cells to maintain the integrity of the blood-brain barrier (BBB). They also
store neurotransmitters and can dispel excessive ion concentrations in the
extracellular fluid. Astrocytes may also be involved in response to injury
(Barker and Cicchetti 2012).
Ependymal cells are involved in the movement of CBF and work with astro-
cytes in the blood-brain barrier (Barker and Cicchetti 2012).
2.4 Metabolism
The major metabolic processes of the cell concern the production and use of
adenosine triphosphate (ATP) - the energy molecule of the cell. In respira-
tion, glucose and oxygen are converted to carbon dioxide and ATP (Siesjo
1978). Thus measurements of cerebral oxygen consumption can provide an
estimate of energy production in the brain (see Chapter 3 for such meth-
ods). The cerebral metabolic rate of oxygen consumption CMRO2 can be
calculated in vivo using the Fick principle:
CMRO2 = CBF(AO2 −VO2) (2.1)
where AO2 and VO2 are the arterial and venous concentrations of oxygen
across the brain (Polin et al. 2010). Oxygen consumption is varied across the
regions of the brain (Polin et al. 2010).
A regional coupling of CBF to metabolism exists in both adult and immature
brains – when the rate of cerebral oxidative metabolism is high, so is CBF
and vice versa (Polin et al. 2010).
2.4.1 Glycolysis
Glucose can be metabolised either anaerobically or aerobically for the pur-
pose of energy production and is transported from the blood into the cell
by GLUT transporters (Siesjo 1978). Figure 2.2 illustrates the many enzyme-
driven steps of glycolysis, which are summarised by the equation below
(Siesjo 1978). These reactions take place in the cell cytoplasm.
Glucose + 2Pi + 2ADP + 2NAD+ → 2Pyruvate + 2ATP + 2NADH (2.2)
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Under aerobic conditions, pyruvate is then oxidised to CO2 and water by
mitochondrial enzymes (Section 2.4.2). The NADH formed is also reoxidised
to NAD+, through the malate-aspartate shuttle (Section 2.4.4).
In the absence of oxygen, pyruvate is reduced to lactate. This reversible
reaction creates two molecules of lactic acid at the end of glycolysis, but still
allows the reoxidation of NADH so that the process may continue (Siesjo
1978). The movement of lactate out of the cell into the blood is facilitated by
monocarboxylate transporters (Simpson et al. 2007) (see Section 2.5.1).
Glucose + 2Pi + 2ADP + 2NAD+ → 2Lactate + 2ATP + 2NADH (2.3)
2.4.2 Tricarboxylic acid cycle
In the mitochondrial matrix, the pyruvate produced by glycolysis is oxidised
to carbon dioxide and water. These reactions form the tricarboxylic acid
cycle (also known as the citric acid cycle), displayed in Figure 2.3.
Pyruvate+ 4NAD++ FAD+GDP+ Pi→ 3CO2+ 4NADH+ FADH2+GTP
(2.4)
2.4.3 Oxidative phosphorylation
Oxidative phosphorylation is the process by which oxygen is used as the
final electron acceptor in mitochondria, so that free energy of the pyruvate
molecule can be used to phosphorylate adenosine diphosphate (ADP) to
ATP (Siesjo 1978). This occurs in the electron transport chain, illustrated
in Figure 2.6. The terminal electron acceptor in this series is cytochrome c
oxidase (CCO). During the oxidisation of reduced cytochrome c, oxygen is
converted to water (Cooper 2002). CCO has three redox centres: the CuA,
haeme a and haeme a3-CuB centres. Electrons pass through these centres in
succession before being passed on to oxygen.
As NADH is oxidised, there is a large decrease in energy. This is used to
pump protons from the mitochondria into the intermembrane space. The
resulting electrochemical gradient creates a proton motive force which in
turn drives ATP synthesis.
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2.4.4 Malate-aspartate shuttle
As mentioned above, it is important that cytoplasmic NADH is reoxidised
in order for respiration to occur repeatedly. However, NADH cannot cross
the mitochondrial membrane. The cell instead employs a shuttle system
to move other metabolites across as depicted in Figure 2.7, which in turn
reduces mitochondrial NAD+.
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Figure 2.4: Glycolysis.
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Figure 2.5: The tricarboxylic acid cycle.
Figure 2.6: Oxidative phosphorylation.
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Figure 2.7: The malate-aspartate shuttle.
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2.5 Brain pH
pH plays an important role in cellular function, as it maintains the structure
(and therefore function) of proteins. Compartmentalisation in eukaryotic
cells separates specific functions in membrane-bound organelles, which al-
lows energy to be stored as electrochemical gradients (Casey et al. 2010).
The protonation or deprotonation of biological surfaces results in changes
in charge, crucial for many metabolic reactions (Casey et al. 2010). The
generation of energy in the cell is also dependent on the driving force for
proton movement - the proton-motive force (Casey et al. 2010). Intracellu-
lar pH is therefore strictly controlled and maintained at approximately 7.03
but varies among different organelles (Kendall et al. 2011; Casey et al. 2010).
Extracellular pH lies approximately 0.3-0.4 units above (Kendall et al. 2011).
The immature brain is particularly sensitive to shifts in pH, with changes
of 0.05pH units significantly affecting network activity (Helmy et al. 2012).
Seizures following increases of 0.2pH units have also been observed (Helmy
et al. 2012).
Figure 2.8: Differences in pH among different organelles of the cell. Adapted from
Casey et al. (2010) and Uria-Avellanal and Robertson (2014).
2.5.1 Regulators of intracellular pH
A number of different reactions in the cell are known to affect pH. The cell’s
cytoplasm acidifies due to the actions of a number of metabolic pathways
such as glycolysis generating lactate and oxidative phosphorylation in the
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mitochondria producing CO2. The following are considered to play an im-
portant role is regulating pH levels by making the cytoplasm more alkaline.
Figure 2.9: Processes regulating intracellular pH. The main transporters on the
plasma membrane responsible for alkalinisation are the Na+/H+ exchangers
(NHEs) and Na+-HCO3 transporters (NBCs). Some cell types also have Na
+-
dependant CL−-HCO3 exchangers (NDCBEs). These transporters use the poten-
tial energy stored by the Na+ gradient facilitated by the Na+-K+-ATPase pumps
(NKAs) to drive solute transport. These mechanisms are counterbalanced by
the acidifying processes such as the CL−-HCO3 anion exchangers (AEs) and
plasma membrane Ca2+-ATPases (PMCAs), which transport Ca2+ out of the cell
in response to stimuli that increase intracellular concentrations. In anaerobic
metabolism, monocarboxylate transporters (MCTs) move lactate across the mem-
brane. pHc cytosolic pH; pHo extracellular pH. Adapted from Casey et al. (2010).
Sodium/hydrogen exchanger The Na+/H+ exchangers (NHEs) are a family
of ion integrate membrane transport proteins that maintain intracellular pH
in many mammalian cells by transferring Na+ ions into cells and H+ ions
out in a 1:1 ratio. They are thought to play crucial role in protecting cells
from internal acidification(Uria-Avellanal and Robertson 2014).
Sodium-bicarbonate cotransporter As an end product of the process of mi-
tochondrial energy production, eukaryotic cells constantly produce CO2. In
water, this is a conjugate acid :
CO2 + H2O↔ H2CO3 ↔ HCO3 + H+ (2.5)
Transport proteins on the plasma membrane transfer HCO3 across. Of these,
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the Na+-HCO3 transporters (NBCs) are predominant, moving both ions in
the same direction, although the stoichiometry is different among its iso-
forms (Casey et al. 2010).
Sodium-potassium ATPase pump The above sodium transporters use en-
ergy stored by the inwardly directed electrochemical Na+ gradient that is
established by Na+-K+-ATPase pumps (NKAs) to drive solute transport.
Lactate-H+ cotransporter Monocarboxylate transporters (MCTs) enable the
cotransportation of monocarboxylic acids (mainly lactate) and protons out
of the cell (Casey et al. 2010). Lactate accumulates in the cytosol following
anaerobic respiration (see Section 2.4.1).
Another process known to contribute to alkalinization of the cell is Na+-
dependent Cl−/HCO−3 exchangers (NDCBEs). Acidification occurs due to
Cl−/HCO−3 or anion exchangers on the plasma membrane as well as calcium-
ATPases, exchanging cytosolic Ca2+ for extracellular H+ in response to stim-
uli that increase intracellular Ca2+ (Casey et al. 2010).
Mitochondrial pH is decidedly more alkaline (pH~8) than the cytoplasm,
due to the workings of the electron transport chain (see Figure 2.6). In the
event of mitochondrial-dependent apoptosis, early changes in mitochondrial
pH have been deemed indicative (Casey et al. 2010).
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Figure 2.10: Sodium-potassium ATPase pump (Thompson 2000).
2.6 Hypoxia-ischaemia
Asphyxia indicates a global or local decrease in oxygen supply and a con-
current accumulation of end products of energy metabolism such as carbon
dioxide and lactate (Helmy et al. 2011). Continued asphyxia, known as intra-
partum asphyxia, leads to hypoxic and hypercapnic conditions characterised
by acidosis (Helmy et al. 2011). Hypoxia describes an environment of low
oxygen - the extreme case, the absence of oxygen is referred to as anoxia. Hy-
percapnia implies a high carbon dioxide environment. In preterm neonates,
42
2.6. Hypoxia-ischaemia
poor cerebral oxygenation saturation in the first few weeks after birth is
associated with neurodevelopmental outcome (Verhagen et al. 2014).
Ischaemia is a decrease in blood supply to tissue, which then often leads to
hypoxic conditions. Ischaemia may be local, affecting part of the brain as in
the case of arterial or venous stroke, or global, as in the case of cardiac arrest
(Lee et al. 2000).
2.6.1 pH and hypoxia-ischaemia
pH is vital for neuronal survival after trauma (Helmy et al. 2011). Perinatal
asphyxia is often characterised by profound acidosis (pH<7) (Helmy et al.
2011, 2012; Rehncrona et al. 1980). Acidosis in these cases acts as a protec-
tive mechanism, and suppresses neuronal activity. Alkalosis, on the other
hand, increases the excitability of brain tissue (Helmy et al. 2011). Human
infants often display normal cerebral energetics shortly after intrapartum
hypoxia-ischemia. Intracellular brain pH neutralises within 5 to 15 min-
utes of reperfusion (Robertson et al. 2002). However, in those with adverse
outcome, even with adequate oxygenation and circulation, phosphocreatine
(PCr) and nucleotide triphosphate (NTP, mainly ATP) decrease and Pi rises
in the first days of life (Uria-Avellanal and Robertson 2014). An alkaline
rise in cerebral intracellular pH has also been observed during this phase.
These metabolic changes - called secondary energy failure (SEF) - have been
linked to severe neurodevelopmental outcomes in human neonates, with
more extensive cerebral injuries exhibiting a more alkaline intracellular pH
(Robertson et al. 2002; Uria-Avellanal and Robertson 2014).
Studies using magnetic resonance imaging (MRI) methods found that intra-
cellular brain pH during the first 2 weeks after birth in infants with severely
abnormal MRI versus normal MRI was 7.24 versus 7.04. In those infants
who died or had a severe neurodevelopmental impairment compared to
those with normal outcome was 7.28 to 7.11. In fact, an intracellular pH
greater than 7.15 in the first 2 weeks was highly indicative of abnormal
(mild, moderate, and severe/dead) neurodevelopmental outcome (Robert-
son et al. 2002). Brain alkalosis continued for up to 20 weeks in neonates
with severe outcome .
There is increasing evidence that following ischaemia, high levels of lac-
tate aid neuronal survival. Lactate takes approximately 30 mins of reperfu-
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sion to clear. After 12-24 hours a secondary rise in lactate occurs. Lactate
and N-acetyl-aspartate (NAA) – an amino acid found mostly in neurons in
the CNS – provide a useful marker of cerebral health in the aftermath of
hypoxia-ischaemia. During transient hypoxia-ischaemia, lactate concentra-
tion rises whilst NAA falls. After successful resuscitation both return to
almost baseline levels, followed however by a secondary increase in lactate
and slower decrease in NAA in the next few hours. The Lac/NAA peak
area ratio obtained between days 5 and 14 after birth is thought to be an
accurate biomarker of long-term neurodevelopmental outcome in patients
with neonatal encephalopathy (Uria-Avellanal and Robertson 2014). Brain
alkalosis has also been associated with increased cerebral lactate/creatine
ratio(Robertson et al. 2002).
Activation of the Na+/H+ exchangers (NHEs) results in a rapid normali-
sation of intracellular pH (Wakabayashi et al. 1992). Helmy et al. showed
that the alkaline pH does not extend to the blood or body, and suggest that
alkalosis may be caused by the movement of acid equivalents across the
blood-brain barrier (Helmy et al. 2012). Their experiments inhibiting NHEs
did not result in brain alkalosis after asphyxia, which supports this hypoth-
esis. Robertson et al. (2013) also conducted a study using NHE inhibitors
in piglets which showed a decrease in both Lac/NAA and lactate/creatine
48 hours after the hypoxic-ischaemic insult. A separate study conducted in
mice found that areas of the brain that inhibited severe alkalosis did not
necessarily correspond to those areas with the most acidic response during
hypoxia-ischaemia, nor the worst tissue damage (Kendall et al. 2011).
Studies in rats have also shown that fast restoration of normal carbon diox-
ide conditions - normocapnia - leads to brain alkalosis and seizures. How-
ever, graduated restoration of normocapnia after asphyxia did not result in
alkalosis and nearly no seizures were triggered (Helmy et al. 2011), suggest-
ing a link to pH (Uria-Avellanal and Robertson 2014).
Clinical monitoring and manipulation of intracellular brain pH, especially
in preventing rebound brain alkalosis, has been suggested as a potential
neuroprotective strategy (Robertson et al. 2002).
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2.7 Adult, neonate and piglet brains
There are numerous differences in brain anatomy and function in the vari-
ous stages of its development, which is also dependant on gestational age.
Preterm birth occurs before 37 weeks of gestation and accounts for 6% to
10% of births in the Western world (Polin et al. 2010). The most notable
changes in preterm brain development are increases in overall size and cor-
tical folding. The brain has a smooth appearance during early gestation
but develops the typical convoluted pattern, increasing the surface area of
the brain. From 29 weeks’ gestation until term, cortical grey matter volume
expands from 60ml to 160ml (Rutherford 2002). The continued process of
cortical folding can be observed in the postnatal phase using various imag-
ing techniques (Rutherford 2002).
Development of vascular complexity continues to increase through the post-
natal phase (Polin et al. 2010) and variations in the vascular arrangement
described in Section 2.2 exist in both humans and animals (Edvinsson et al.
1992). Studies of neonatal preterm brains have discovered variations the
development of the circle of Willis at term equivalent age (Malamateniou
et al. 2009; van Kooij et al. 2010) (Figure 2.11). The newborn piglet brain has
an intact circle of Willis and a blood vessel plexus at the base of the brain.
This makes the piglet brain unsuitable for investigating complete cerebral
ischaemia, but nevertheless suitable for the study of hypoxia-ischaemia as
discussed in Chapter 3, Section 3.3 (Cady et al. 2008).
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Figure 2.11: Variations in the circle of Willis in preterm neonates. (a) Normal type,
(b) dominant segment on the right indicated with a white arrow and (c) double-
sided fetal type posterior cerebral arteries(van Kooij et al. 2010).
Oxygen tension in adult blood is approximately 4 to 5 times that found in
fetal blood, however fetal arterial blood oxygen content at term are not much
lower than that in the adult. This is due to the higher oxygen affinity of fetal
haemoglobin (HbF). Maternal blood is slightly hypocarbic (PCO2 32mmHg)
and alkalotic (pH 7.42). On the other hand fetal blood is slightly hypercarbic
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(PCO2 45mmHg) and acidotic (pH 7.34). Fetal blood releases H
+ and CO2 as
it runs through the exchange vessels causing an increase in pH and decrease
in PCO2 while the opposite occurs in maternal exchange vessels (Polin et al.
2010). When pH decreases below 7.2, the Bohr effect is greater for fetal
blood than maternal blood. In human neonates, as the dissociation curve
also shifts toward the right as the concentration of HbF falls.
Although the higher oxygen affinity of HbF is well adapted for oxygen up-
take in the placenta, it is disadvantageous in postnatal life. With adequate
lung function, the high oxygen affinity at low oxygen tensions has no ben-
efit as the pulmonary circulation is exposed to oxygen tension around 80
mmHg or higher. At the tissues a lower P50 means a lower driving poten-
tial for oxygen diffusion, a force of vital importance as oxygen consumption
increases by 100-150% in the first few days of life. Thus fetal haemoglobin
is gradually replaced by adult haemoglobin, with P50 increasing to reach
normal adult values in the first 4-6 months of life (Polin et al. 2010).
The autoregulative capacity of the human neonatal brain is unclear at present,
mainly due to the difficulty in conducting experimental studies (Vutskits
2014; Greisen 2005). Verma et al. (2000) found a significant relationship with
gestational age but not postnatal age. Observations during preterm neona-
tal intensive care have been inconclusive, with some studies showing a lin-
ear relationship between CBF and arterial blood pressure (Lou et al. 1979),
while others found no correlation (Tyszczuk et al. 1998). Increasing periods
of impaired autoregulation have been linked to bad neurological outcome.
Low gestational age and birth weight have also been shown to be a factor
(Vutskits 2014). Wong et al. (2008) found that a coherence between cere-
bral oxygen saturation and mean arterial blood pressure indicated impaired
autoregulation in clinically ill preterm infants, and was strongly associated
with mortality.
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Figure 2.12: Autoregulation curve for neonates. The flat section represents the
autoregulatory plateau. The upper threshold is not well estimated (Greisen 2005).
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A range of CBF values have been reported in literature of preterm and
term neonates, with term neonates thought to have double the CBF of the
preterm. These values are presented in Table 2.1 along with piglet and adult
values for comparison. Also included in the table are measurements of CCO,
which is an invasive procedure and so very little is known about the true
concentrations in human neonates. CMRO2 and blood pressure values vary
in literature as well. Mean arterial blood pressure as low as 23 mmHg has
been recorded in preterm neonate, while adult healthy human values range
close to 100 mmHg. Haemoglobin concentration in blood has been found
to increase after birth (Jopling et al. 2009), and subsequently decrease with
age. Intracranial pressure is relatively similar in both preterm and term
infants, at approximately 5 mmHg, with higher values recorded in adults
(7-15 mmHg).
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Table 2.1: A comparison of physiological measurements in healthy preterm, term and adult patients.
Piglet Preterm neonate Term neonate Adult
CBF (ml 100 g−1
min−1)
39.7 ± 4.6 – 75.4 ±
15.2 (Springett et al.
2001)
4.9 – 23 (Altman et al.
1988), 12.2 (Meek
et al. 1999), 19.8 ±
5.3 (Greisen 1986), 11
– 26 (Edwards et al.
1988)
9.0 – 73 (Altman et al.
1988)
59 ± 21 and 11 ±
4 in high and low
compartments (Elwell
et al. 1994),
Concentration of
cytochrome-c-oxidase
(CCO) in tissue (µM)
2.21 ± 0.16 (Springett
et al. 2000)
unknown, presumed
equivalent to piglet
unknown, presumed
equivalent to piglet
approximately 5.5
within rage of nor-
mal range of HbO2
(Cooper et al. 1997)
Cerebral metabolic rate
of oxygen consumption
(CMRO2) (µmol 100
g−1 min−1)
89.32 – 134.0 (Brown
et al. 2003), 113 ± 12
– 122 ± 19 (Springett
et al. 2001)
30.82–68.33 (Elwell
et al. 2005)
64.13 (Polin et al.
2010)
142.91 – 147.38 (Polin
et al. 2010), 147.38
(Chudler)
Mean arterial blood
pressure (mmHg)
50.9 ± 4.4 (Springett
et al. 2001)
23.7 – 39.3 (Tyszczuk
et al. 1998), 28 – 45
(Pejovic et al. 2007)
45 – 55 (Pejovic et al.
2007), 56.5 – 60.8
(Nascimento et al.
2002)
80 – 100 mmHg (El-
well et al. 1996), 95
(Babbs 2012)
Concentration of
haemoglobin in blood
(mM)
5.59 – 6.21 (Lossec
et al. 1998)
9.75 (Jopling et al.
2009)
11.17 (Jopling et al.
2009)
7.45 – 9.31 (Beutler
and Waalen 2006)
Intracranial pressure
(mmHg)
4.5 (Soul et al. 2000) 5.1 ± 0.9 (Easa 1983) 5.3 ± 1.3 (Easa 1983),
1.5 – 6 (Steiner and
Andrews 2006)
7 – 15 (Steiner and
Andrews 2006)
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Chapter 3
Clinical Measurements
One of the primary aims of the models presented in this thesis is to aid in
the interpretation of clinical measurements. There exist various technologies
to examine a living body, via the quantification of specific chemicals or its
translation to imagery. However, the fundamental biological processes and
structure that give rise to the changes observed in these signals is not always
clear. The technology is often limited in the detail it can offer – namely it
can indicate when a change occurs but not necessarily how or why. Therefore
in order to maintain clinical utility of these signals, it is important to be able
to obtain meaningful inferences beyond simple correlations with outcome.
3.1 Methods of measurement
The data used in this thesis has been obtained largely from non-invasive
techniques employed to monitor subjects in neonatal intensive care and in
experiments conducted in piglets. Non-invasive methods are advantageous
both in the clinic and in experimentation as results are less subject to external
noise and unwanted side effects. These methods and the quantities they
monitor are briefly described below.
3.1.1 Near-infrared spectroscopy
Colour-inducing compounds called chromophores in tissue absorb light as
it passes through the body. Visible light has high absorption and scattering
in the body, making it unsuitable for measurement. However, near-infrared
light (wavelength 650 - 1000nm) is less absorbed by water and so penetrates
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further. In addition, the only compounds in the mammalian brain that affect
absorption signals with changes in oxygen concentration are cytochrome aa3
and haemoglobin. For these reasons near-infrared spectroscopy is a good
method for the measurement of cerebral haemodynamics and oxygenation
(Wray et al. 1988). NIRS is often used to investigate task-evoked responses in
the brain, using for example somatosensory or visual stimuli. This technique
is known as functional NIRS (fNIRS).
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Figure 3.1: Absorption spectra for different chromophores in human tissue. CtOx
is cytochrome oxidase (Scholkmann et al. 2014).
Haemoglobin
NIRS can be used to estimate changes in the concentrations of oxygenated
haemoglobin (∆HbO2) and deoxygenated haemoglobin (∆HHb) (see Section
2.2). The total haemoglobin concentration (∆HbT) gained by adding the two
can reflect changes in cerebral blood volume. The difference between the
two values (∆Hbdi f f ) may however be a more reliable measurement, as some
of the signal noise is removed in the subtraction.
Cytochrome-C-Oxidase, CCO
The difference spectrum between oxidised and reduced CCO can be de-
tected in-vivo using NIRS (Tisdall et al. 2007; Cooper et al. 1997) (see Section
2.4.3 for explanation of CCO). The enzyme contains four redox active metal
centres, one of which – the binuclear CuA centre – absorbs near-infrared
light well. However, the concentration of this centre is less than 10% that of
haemoglobin, making detection quite difficult (Cooper and Springett 1997).
Given that the total concentration of CCO in tissue remains constant, the
NIRS CCO signal represents changes in the redox state of CCO (∆oxCCO).
The importance of this signal lies in its mitochondrial origin, giving a valu-
able measure of cellular mitochondrial oxygen consumption in comparison
with ∆HbO2 and ∆HHb which are intravascular concentrations. In par-
ticular, in the observation of the brain, the haemoglobin signal is prone to
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detecting concentrations in skin as well, while concentrations of CCO in skin
are lower than in the brain and nonexistent in red blood cells (Tisdall et al.
2007).
Tissue Oxygenation Index, TOI
A measure of oxygen saturation recorded by NIRS, TOI is calculated as a
ratio of oxyhaemglobin to the total haemoglobin concentration:
TOI =
[HbO2]
[HbO2] + [HHb]
× 100% (3.1)
TOI is sometimes referred to as the tissue oxygen saturation (TOS), depend-
ing on the instrumentation used.
3.1.2 Magnetic resonance spectroscopy, MRS
This technique uses the principle of nuclear magnetic resonance (NMR). Nu-
clei with an odd number of protons and/or neutrons have magnetic prop-
erties (eg. 1H, 31P, 13C), and when placed in a magnetic field tend to align
and rotate - ’precess’ - to be parallel with the field. This precession occurs
at a frequency known as the Larmor frequency. If a pulse of radiofrequency
(RF) energy is applied at the Larmor frequency, the alignment of the nu-
clei is disrupted. When the pulse is removed the nuclei move back into
alignment, emitting a RF signal at the Larmor frequency. By measuring this
emitted frequency it is possible to determine the the type of atom present in
a sample. In the case of a biological sample, composed of various different
atoms, it is possible to use a Fourier transform to analyse the contributing
compounds. MRS has been invaluable in investigating neonatal cerebral
disorders (Robertson and Wyatt 2004).
A more popular use of this technique is in imaging. MRI can provide a
valuable visual indication of the state of the brain, especially in neonatal de-
velopment. The maturation of white matter and the progression of cortical
folding can be observed and quantified by this method (Rutherford 2002;
Paus et al. 2001). Functional MRI (fMRI) is often used to detect regional ac-
tivation of the brain, mapping brain function in both the developing young
and in adults (Robertson and Wyatt 2004; Logothetis 2008; DeCharms 2008).
The blood-oxygenation level dependent (BOLD) fMRI signal detects changes
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in blood oxygenation, where an increase in BOLD is consistent with a drop
in venous deoxyhemoglobin concentration (Hyder et al. 2001).
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Figure 3.2: MRI images of healthy infants at (A) 30 weeks gestation, (B) term, (C) 6
months and (D) 1 year (Robertson and Wyatt 2004).
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Figure 3.3: MRI images of (A) focal injury in an infant aged 11 days with Sarnat
stage II neonatal encephalopathy and (B) global injury in an infant aged 12 days
with Sarnat stage III (Robertson and Wyatt 2004).
Lactate
Found in almost undetectable concentrations in normal healthy tissue, the
presence of lactate implies the failure of aerobic respiration, and the occur-
rence anaerobic glycolysis (Gujar 2005; Bertholdo et al. 1980; Soares and Law
2009) (see Section 2.4.1). Therefore, lactate is expected to rise under anoxic
and hypoxic conditions. However, a small peak may be seen in the newborn
brain during the first few hours of life (Bertholdo et al. 1980). Acute inflam-
mation leading to activation of macrophages may also cause an increase in
lactate (Soares and Law 2009; Currie et al. 2013).
Creatine, Cr
The peak associated with creatine originates from at least two compounds:
creatine (Cr) and phosphocreatine (PCr). Since both these molecules are as-
sociated with ATP, the creatine peak is viewed as a marker of brain energy
metabolism (Gujar 2005; Bertholdo et al. 1980; Soares and Law 2009; Currie
et al. 2013). Cr concentration is relatively stable, and often used as an inter-
nal reference for calculating metabolite ratios (Gujar 2005; Bertholdo et al.
1980; Soares and Law 2009; Currie et al. 2013). However, variation has been
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observed between individuals and regions of the brain (Bertholdo et al. 1980;
Soares and Law 2009; Currie et al. 2013). Also, as Cr does not originate in
the brain, the concentration can be affected by systemic diseases (Bertholdo
et al. 1980; Soares and Law 2009; Currie et al. 2013). Tissue death may also
cause a loss of Cr (Gujar 2005; Currie et al. 2013).
N-acetyl Aspartate, NAA
Specific to the brain, NAA is produced in neuron mitochondria before being
transported to the neuronal cytoplasm and along axons (Bertholdo et al.
1980; Soares and Law 2009). NAA is thus present in both white and grey
matter and is used as a marker of neuronal and axonal viability and density
(Bertholdo et al. 1980; Soares and Law 2009). The role of NAA has not
yet been clearly deciphered, however a loss of NAA is seen in many white
matter diseases such as hypoxic encephalopathy and is generally a sign of
neuronal loss (Gujar 2005; Bertholdo et al. 1980; Soares and Law 2009). The
lactate/NAA peak area ratio is an accurate magnetic resonance biomarker
of outcome after neonatal encephalopathy (Thayyil et al. 2010). There is
a natural rise in NAA in the developing brain, and concentrations in grey
matter and have been found to be higher than in white matter in the adult
brain (Currie et al. 2013).
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Figure 3.4: MRS spectra from a piglet during a hypoxia-ischaemia experiment that
subsequently developed severe secondary energy failure; (a) before HI, (b) 1.6 h
after HI, and (c) during secondary energy failiure 23.4 h after HI. (Cady et al. 2008)
Nucleotide triphosphate, NTP
The nucleotide triphosphate (NTP) measurement arises predominantly from
ATP, which accounts for approximately 70% of the signal (Bainbridge et al.
2013). Hence, changes in the NTP signal can be used to indicate changes
in ATP. NTP is often compared against the exchangeable phosphate pool
(EPP), as the ratio is considered as a more stable indicator of ATP, where
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EPP = Pi + PCr + 2γ-NTP + β-NTP (3.2)
as in Cady et al. (2008). α−, β− and γ−NTP peaks can be viewed on the
MRS spectrum, which can be used also to calculate pH (see below).
Intracellular pH
Two methods of estimating the value of intracellular pH in the brain have
been used here. The first is based on inorganic phosphate (Pi) and phospho-
ethanolamine (PEt), and the second on ATP shifts.
Pi-Pet Measurement Petroff et al. used the chemical shift difference between
the Pi resonance and, as a reference, PCr resonance to determine intracellu-
lar pH (Petroff et al. 1985). This was done using the Henderson-Hasselbalch
equation and a suitable calibration curve:
pHPi = 6.77+ log10
(
δPi − 3.29
5.68− δPi
)
(3.3)
where δPi is the amplitude weighted mean of the Pi components (Cady et al.
2008).
Phosphoethanolamine (PEt) is a compound involved in the construction of
cell membranes (Azzopardi et al. 1989). Together with phosphocholine,
forms the majority of the phosphomonoester (PME) peak in the MRS spec-
trum. PEt has been also been used to estimate intracellular pH (Corbett et al.
1987; Pettegrew and Withers 1988), using the following titration curve:
pHPEt = 5.625+ log10
(
δPEt − 3.190
6.946− δPEt
)
(3.4)
where we used the PME peak for δPEt. The average of the two measures can
be used to obtain a Pi-Pet measurement (pHPi−Pet).
ATP Measurement Williams and Smith presented a method for assessing in-
tracellular pH from ATP shifts, via a software named MAGPAC (MAGnesium
and PH from ATP Calculation) (Williams and Smith 1995). This tool was
created by numerically modelling the three MRS shift differences of NTP
(mainly ATP) (δ(γ − α), δ(α − β), δ(γ − β)) using model calibration solu-
tions, prepared as a function of total [Mg]/[ATP] and pH. To obtain pH
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estimates from our experiments, the mean of each of the three α−, β− and
γ−NTP shifts are input into the MAGPAC program.
Comparisons Differences have been detected in the pH measurement tech-
niques above. Even with similar titration conditions, in one case, the base-
line value of pHPEt was observed to be more acidic than pHPi and pHATP,
with the former slightly more alkaline than the latter (Cady et al. 2008).
However, baseline values of pHPEt below pHPi and pHATP have also been
reported. These results may arise because pHPi originates from not only in-
tracellular Pi but extracellular Pi as well. Also PEt may be more prominent
in more acid intracellular compartments or tissues, such as in immature
cerebral tissue (Cady et al. 2008).
Pi is also present in dead cells. On the other hand, pHATP is particular to
the intracellular space of viable cells. PEt is also thought to be essentially
intracellular.
In the aftermath of hypoxia, pHPi and pHPEt were observed to attain base-
line values in piglets after approximately 2 hours (Cady et al. 2008). How-
ever, in newborn infants more than 48h old with very severe injuries, pHPi
was more alkaline (Robertson et al. 2002). Similarly, in both piglet and rat
brains pHATP and other intracellular pH measures have indicated alkalo-
sis after hypoxia-ischaemia and ischaemia (Cady et al. 2008; Williams and
Smith 1995) (see Section 2.6.1).
3.1.3 Systemic measurements
As part of normal clinical practice, systemic measurements are often recorded
simultaneously with other measurements. A sample of piglet arterial oxy-
gen saturation and blood pressure during a hypoxic-ischemic phase is illus-
trated in Figure 3.5.
Arterial Oxygen Saturation
Pulse oximetry, like NIRS, uses light to measure blood oxygenation. Two
wavelengths of light are used to calculate the oxygen concentration of haemoglobin
in pulsating blood (SpO2) and non pulsating blood separately (Aoyagi 2003).
The pulsatile volume changes are assumed to be caused by changes in arte-
rial volume. Hence, SpO2 is a measure of arterial oxygen saturation (SaO2).
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Figure 3.5: Sample arterial oxygen saturation and blood pressure from a hypoxia-
ischaemia experiment in a piglet.
Blood Pressure
A sphgmomanometer is the most common device for measuring blood pres-
sure. It consists on an inflatable cuff, usually placed on the upper arm. Mea-
surements are quoted as the diastolic (maximum) and systolic (minimum)
arterial pressures, and are for a normal patient on average 120 and 80mmHg
respectively.
Partial Pressure of Carbon Dioxide
End tidal CO2 (EtCO2) is the partial pressure of carbon dioxide (PCO2)
breathed out during respiration. This carbon dioxide diffuses out of the
blood in the capillaries to the air in the alveoli of the lungs. Under normal
conditions there is an equilibrium between the blood and the air, and so
EtCO2 is equivalent to the arterial partial pressure of carbon dioxide, PaCO2
(Ward and Yealy 1998).
An infrared capnometer, often used to measure ventilation during anaesthe-
sia, can be used to measure EtCO2 (Kodali 2013). The normal measurement
is approximately 35-40mmHg.
3.1.4 Multimodal measurements
Recent studies have utilised combinations of the above measurement tech-
niques to provide a comprehensive approach to investigating changes in the
living body (Tachtsidis et al. 2012; Worley et al. 2012; Tisdall and Smith 2007;
Bainbridge et al. 2013). This has facilitated the focus away from rigid phys-
iological target setting to the possibilities of more individual and patient-
specific approaches (Tisdall and Smith 2007). Section 3.3 details some of the
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multimodal hypoxia-ischaemia and functional studies conducted in animals
and neonates.
3.2 Interpreting measurements
”But there are also unknown unknowns – the ones we
don’t know we don’t know.”
— Donald Rumsfeld
Measurements from clinical instrumentation and patient history provide us
with a wealth of information, that much is true, and as technologies advance
we will doubtless be, if not already, in the midst of a clinical data quagmire.
However, we are still far from gaining the complete knowledge of the hu-
man body at every possible scale. The are thus ”unknown unknowns”, things
that we do not yet know exist. While methods of mathematical modelling
may facilitate suggestions of the existence of such structures/processes, it is
impossible to model the unknown outright. Hence it is important to bear in
mind that the picture painted by measurements available (and therefore the
model) is far from complete.
3.2.1 Quality of signals
The measurement techniques above carry a varying degree of instrumen-
tational noise, apart from that gained from the handling probes or due to
patient movement. The NIRS signals obtained for this thesis did not exhibit
much noise, whereas the MRS signals did, especially those measuring NTP.
Most of the signals have been preprocessed and smoothed, either using an
algorithm or manually. Where this has been done, it has been indicated in
the accompanying text.
It is often difficult to ascertain whether an abrupt change in the signal is
the result of unwanted noise or that of a ’valid’ physiological change that
has been recorded. While time periods and concurrence with simultaneous
recordings in other signals can provide clues, the end decision is clearly
subjective. Therefore, I have made a particular effort to keep the use of
smoothing methods at a minimum.
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3.2.2 Region and frequency of measurement
The measurements are limited by the region of the brain that they cover.
Near infrared can penetrate biological tissue relatively well, but is hampered
by extracerebral structures such as the skull and scalp which detract light
(Brown et al. 2003). Hence it is more effective in younger subjects such as
in neonates and piglets, where the skull is not as thick. Indeed in piglet
experiments the NIRS source and detector probes can be placed of either
side of the head, thus enabling a measurement of the region in between.
However, in adult patients, this is not possible and instead the probes are
often placed a few centimetres apart from each other. It must also be noted
that measurements gained from examining a single voxel of the cerebral
space is not necessarily reflective of the brain as a whole.
Superficial fluctuations in oxygenation and blood flow in the skin are also
known to contribute to noise. This is especially problematic in fNIRS exper-
iments investigating task-evoked responses, where the emotional response
of ’blushing’ can often cause false positives (Kirilina et al. 2012).
NIRS instrumentation however does have the advantage of being a portable
device that can be installed at the bedside and hence provide continuous
commentary on the clinical state of patient. MRS on the other hand requires
the patient to be exposed to an electromagnetic field, at present produced by
a bulky expensive device. The effects of long term exposure to such fields
is also unclear (Hartwig et al. 2009). It is therefore not feasible at present to
record MRS at the bedside. While continuous recordings are obtained in the
case of animal experimentation, long term MRS recordings of the human
neonatal brain are rare.
Systemic measurement techniques such as the pulse oximeter are often ap-
plied far from the brain, and are employed in determining an overall mea-
surement for the body. Thus they are not necessarily reflective of the exact
values in the brain itself, but are assumed to provide an good indication.
The frequency of the various measurement techniques and instrumentation
varies greatly. Some measurements are recorded per minute, and others
per second. Higher frequencies naturally facilitate better resolution, but are
more prone to noise.
58
3.3. Animal experiments and neonatal studies
3.3 Animal experiments and neonatal studies
Animal models are a vital resource of clinical knowledge, especially in the
investigation of life-threatening events and conditions, such as hypoxia-
ischaemia (HI), where carrying out controlled experiments on human sub-
jects is not feasible. Several species have been used for both in-vivo and in-
vitro experiments, including rats, mice, sheep, lambs, monkeys and piglets
(Lodygensky et al. 2008; Yager and Ashwal 2009; Northington 2006; Longo
and Packianathan 1997). The use of piglet in particular has increased in
recent decades (Lind et al. 2007). However, animal experiments have the
disadvantages of first, the possibility that findings in animals may not be
applicable to humans, and second, the unwanted effects of the anaesthetics
used. These can often interact with the body, and sometimes with each other
if used in association. Anaesthetics can have different effects on different or-
gans and thus influence the results (Bazin et al. 2004).
3.3.1 Hypoxia-ischaemia studies
Numerous groups have conducted hypoxia-ischaemia studies in piglets.
Lorek et al. (1994) used 31P-MRS to investigate secondary energy failure fol-
lowing HI in twelve piglets, induced by temporary hypoxemia (low blood
oxygen) and occlusion of the carotid arteries. [PCr]/Pi and NTP/EPP ratios
dropped to near zero during the HI phase and returned to baseline follow-
ing reperfusion and reoxygenation. At 24 hours, although blood oxygen,
glucose and pressure were normal, both ratios were observed to decrease
again, while intracellular pH remained unchanged. The severity of the sec-
ondary energy failure was directly related to the magnitude of the energy
depletion. Mehmet et al. (1994) used the same technique to observe that
the extent of cell death due to apoptosis was directly related to the de-
gree of high-energy phosphate depletion during HI. Penrice et al. (1997)
employed both 31P and 1H-MRS alternately to detect the Lac/Cr ratio rise
during HI, fall towards baseline, and then rise again by the 48 hour mark.
Cady et al. (2008) used 31P-MRS to determine early injury-severity biomark-
ers. NTP/EPP correlated linearly with severity, and alkaline intracellular
pH approximately 2 hours after the insult indicated a severe injury as well.
Bainbridge et al. (2013) using both 31P-MRS and NIRS found oxidised CCO,
PCr/EPP and NTP/EPP dropped during HI, and significant correlations
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between oxidised CCO and 31P-MRS ratios. Figure 3.7 shows the correla-
tion between MRS-measured NTP/EPP and NIRS-measured oxidised CCO.
Double-linear model was fitted, meeting at a threshold point, to show the
change in the relationship. However, it is likely that in reality this change
is more gradual. A study in neonatal rats found brain alkalosis following
recovery form birth asphyxia to play a role in triggering seizures (Helmy
et al. 2011). Another study in mice recorded the distribution of pH changes
in the brain following the insult (Kendall et al. 2011) (Figure 3.8).
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Figure 3.6: MRS NTP measurements during hypoxia-ischaemia in piglets. Top -
representative polynomial fit to NTP/EPP from 6 h after HI. NTPmin is the mini-
mum and used as the secondary energy failure index. Bottom - Linear regression
of NTP/EPP at approximately 2 h after HI against NTPmin (Cady et al. 2008).
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Figure 3.7: Correlation between MRS-measured NTP/EPP and NIRS-measured
oxidised CCO measurements during hypoxia-ischaemia in piglets. Relationship
changes significantly at a threshold point during HI (Bainbridge et al. 2013).
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Figure 3.8: pH maps (a-n) from 5 coronal brain sections from nave mice (b) or
mice exposed to 60 min of 8% O2 (hypoxia alone, H, c), carotid occlusion alone
(CROC, d), carotid occlusion with additional 15- to 90-min hypoxia (e-h), and re-
exposure (Reox) to normal room air after carotid occlusion and 90 min of hypoxia
(i-n). Carotid occlusion with additional hypoxia (e-h) results in rapid onset of brain
acidosis. Re-exposure to normal room air after occlusion and hypoxia results in
rapid disappearance of acidosis and culminates with a global alkaline overshoot at
4-6 h. OB = Olfactory bulb; Ctx = cortex; Str = striatum; Hip = hippocampus; Thal
= thalamus (Kendall et al. 2011).
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These studies paved the way for neuroprotective strategies to be adminis-
tered within hours of a perinatal insult to stop the cascade of irreversible
injury (Robertson and Wyatt 2004). In particular, hypothermia – cooling the
brain by 3-4°C was found to be effective in inhibiting apoptosis (Edwards
et al. 1995; Trescher et al. 1997; Edwards et al. 1998) and reduced lactate
accumulation (Amess et al. 1997). Drugs such as melatonin have been sug-
gested as additional therapies that could further improve outcome (Levene
2010).
One of the first studies using MRS to investigate cerebral metabolism in
neonates was conducted by Cady et al. (1983). Since then many have fol-
lowed, involving both preterm and term infants. Azzopardi et al. (1989)
investigated in both preterm and term infants (27-42 weeks) using 31P-MRS
and found reduced values of the PCr/Pi ratio correlated with unfavourable
outcome (severe impairments or death). Where losses in NTP/EPP were
recorded, ’death was almost inevitable’. Robertson et al. (1999) studied
persistent lactate after neonatal encephalopathy in infants aged less than 2
weeks to over 30 weeks. Increased Lac/Cr ratio and PCr was associated with
an alkaline intracellular pH and increased Pi/PCr. This was found to be ir-
respective of outcome or age. A follow up studies of 78 infants (151 studies
in total) found intracellular pH more alkaline in those with unfavourable
outcome during the first 2 weeks after birth. In infants with severely ab-
normal versus normal MRI pH was recorded to be 7.24 versus 7.04 and in
those who subsequently developed cerebral atrophy versus those who did
not, 7.23 versus 7.06. Infants who died or had a severe neurodevelopmental
impairment versus normal outcome, pH was recorded at 7.28 versus 7.11.
Alkalosis was associated with higher Lac/Cr, and intracellular pH remained
more alkaline in the severe outcome group up to 20 weeks after birth.
Studies in the effectiveness of hypothermia in treating hypoxic-ischaemic
encephalopathy have been conducted in neonates following the animal ex-
periments detailed above. In a randomised trial, Azzopardi et al. (2009)
found in infants who had perinatal asphyxia, moderate hypothermia for 72
hours did not reduce the combined rate of death or severe disability sig-
nificantly but improved neurologic outcomes in infants who did survive.
Another study by Shah et al. (2007) found systemic or selective head cooling
reduced death and moderate to severe neurodevelopmental disability.
NIRS and 31P-MRS were combined in Tsuji et al. (1995), investigating corre-
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lations of cerebral changes in HbO2, HHb and oxCCO with PCr and NTP
depletion during HI in four-week old piglets. The animals were subjected
to brief sequential episodes of increasingly severe hypoxia, with inspired
oxygen reduced to 12, 8 , 6 , 4 and 0%. An HbO2 decrease and HHb in-
crease were observed at all levels of hypoxia, however a loss in PCr and
NTP was only observed when inspired oxygen was less than 12% and was
increasingly severe. Intracellular acidosis also increased similarly at lower
oxygen levels. The main finding of this study was a high correlation between
∆oxCCO and NTP and PCr, suggesting decreases in ∆oxCCO as a marker
for brain energy depletion. No correlation was observed however between
∆HHb or ∆HbO2 and NTP or PCr, which may be, as the authors suggest,
due to changes in blood pressure, affecting CBF.
Tichauer et al. (2006) used NIRS to follow changes in CBF and CMRO2 dur-
ing an HI study in newborn piglets. They observed that CBF increased
approximately 70% immediately after HI while CMRO2 decreased approxi-
mately 30% and remained lower than baseline throughout the 6 hour period
post-insult. A follow-up study by the same group using 31P-MRS and 1H-
MRS in conjunction with NIRS periodically before and after HI. While they
detected a significant decrease in CMRO2, it did not correlate with other
metabolite concentrations during the last 3 hours of the recovery period and
no significant changes were observed in PCr and lactate concentrations. The
authors thus conclude that the fall in CMRO2 may be due to mitochondrial
dysfunction and reduced energy demands during the acute phase. Simi-
lar studies in neonatal animals also observed decreased CMRO2 after HI
(Shadid et al. 1998; Rosenberg 1986), however others reported no changes
in CMRO2 (Solas et al. 2004). CMRO2 has also been quantified in human
neonates using NIRS (Elwell et al. 2005), and increased values have been
observed in infants with brain injuries (such as HI) compared to healthy
subjects in the first days of life (Grant et al. 2009).
Bale et al. (2014) used NIRS to monitor changes in haemodynamics and
CCO in newborn infants with encephalopathy during the first few days
of life. Spontaneous oxygen desaturations lead to consistent decreases in
∆HbDiff ( = HbO2 - HHb) and ∆oxCCO, and increases in ∆HbT. Mitra et al.
(2015) also used NIRS to investigate cerebral changes following neonatal
stroke in a term infant at 24 hours of life. During a 3-hour period, repeated
transient changes were recorded, with decreases in HbO2, HHb and oxCCO
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Figure 3.9: NIRS measurements of CBF and CMRO2 during hypoxia-ischaemia in
18 piglets. Solid line - control, dotted line - HI. Grey area represents the HI insult
(Tichauer et al. 2006).
in both cerebral hemispheres without significant changes in systemic vari-
ables. However, changes in HbDiff and oxCCO in the injured hemisphere
were highly coupled (Figure 3.10).
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Figure 3.10: Linear regression analysis between ∆oxCCO with ∆HbDiff on the two
cerebral hemispheres a neonatal stroke patient in the first 24 hours of life. Point
colours and shapes represent different events (Mitra et al. 2015).
3.3.2 Functional studies
Brain activation in the young is of considerable interest in developmental
science. Numerous studies have been conducted in the awareness and pro-
cessing of auditory, visual, olfactory and somatosensory stimuli and both
fNIRS and fMRI have been informative in mapping the onset of autism
(Lloyd-Fox et al. 2013; Courchesne et al. 2007). However, functional stud-
ies in current literature report disparate results in the haemodynamic re-
sponses observed, most notably in the characteristics – magnitude and sign
– of stimulus-evoked changes in HbO2 and HHb. In particular, some stud-
ies have reported a increase in HHb, while others report an decrease as is
typically observed in adults, resulting from an increase in CBF that over-
compensates for the increased CMRO2.
Anderson et al. (2001) used fMRI to to investigate responses to an auditory
stimulus in healthy preterm and term neonates, and observed decreases in
the BOLD signal in 9 of the 14 neonates with BOLD response. A fNIRS study
also in preterm and term infants, aged between 1 and 49 days, observed var-
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Figure 3.11: Summary of haemodynamic and oxygenation changes typical of a
matured brain, stimulated by both neural and systemic activity (Scholkmann 2014).
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Figure 3.12: fNIRS technique applied to infants. (a) typical haemodynamic re-
sponse from cortical activation showing an increase in HbO2 and a decrease in
HHb (b) NIRS probes arranged in headgear on an infant (c) spatial changes in
HbO2 in response to an experimental stimulus and (d) the corresponding NIRS
source-detector arrangement (Lloyd-Fox et al. 2010).
ied reponses in ∆CBV, ∆HbO2 and ∆HHb to an auditory stimulus(Zaramella
et al. 2001). Of those infants that responded with an increase in ∆CBV and
∆HbO2, approximately 60% also showed an increase in ∆HHb while 40%
showed a decrease. In yet another auditory study, Zimmermann et al. (2012)
found a correlation between total haemoglobin concentration and the nega-
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tive BOLD response in preterm neonates, suggesting that the period of low
haematocrit during the transition from fetal to adult haemoglobin may be
responsible.
Bartocci et al. (2000) investigated the response to olfactory stimuli in new-
born infants using NIRS. In neonates 6 hours to 8 days after birth, an in-
crease in HbO2 was observed in the left orbito-frontal region in response to
vanilla scent, with the magnitude of the increase inversely related to post-
natal age.
Meek et al. (1998) conducted an fNIRS study to observe regional haemo-
dynamic responses to a visual stimulus in infants ages 3 days to 14 weeks.
They observed out of 10 infants, 9 showed an ∆HbO2 increase and 9 showed
a ∆HHb increase. A similar study in newborn term infants by Biallas et al.
(2012) concluded that the sensitivity of NIRS to detect haemodynamic re-
sponses and their reproducibility on an individual level needed to be im-
proved for clinical applications. Seghier et al. (2004) used fMRI in a 3-month
old infant with ischaemic brain injury. A negative BOLD response was ob-
served in the visual cortex of the intact right hemisphere, while no activa-
tion was observed in the injured hemisphere. Another fNIRS study in term
neonates, conducted in the first 10 days of life, a marked increase in HbO2
and/or marked decrease in HHb was detected in the occipital cortex (Karen
et al. 2008).
Heep et al. (2009) used fMRI to observe responses in preterm neonates to a
somatosensory stimulation of each forearm at term-equivalent age (median
gestational age: 26.5 weeks; median postconceptional age: 39 weeks). In 7
of the 10 experiments, a negative BOLD signal was recorded. The 3 experi-
ments which saw positive BOLD responses were observed in patients with
aberrant structural and behavioural indices, and is thought likely to be an
early indicator of abnormal development. Kozberg et al. (2013) also demon-
strated a negative BOLD response in postnatal rats, age equivalent to human
newborns, and development of the positive BOLD response with maturation
towards adulthood. The authors also noted that increases in blood pressure
lead to hyperemia resembling the adult positive BOLD responses, which
may account for the variability observed in studies. Another fNIRS study
by Roche-Labarbe et al. (2014) also in preterm neonates using stimulation of
the hand was first to report local increases in CBF and CMRO2, in addition
to increases in HbO2 and decreases in HHb.
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Both the Kozberg et al. (2013) and Roche-Labarbe et al. (2014) studies are
investigated in more detail in this thesis in Chapter 7, where the BrainSignals
model is used to simulate these observations.
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Chapter 4
Mathematical Models of the
Brain
Mathematical models have been used in scientific research for centuries.
Current literature provides a number of models of cellular metabolism, in-
cluding several produced at UCL. This chapter offers an overview of the
nature of mathematical modelling, a brief look at a few models published
by external groups and a more detailed look at two recent models developed
at UCL that are used in this thesis.
4.1 Mathematical modelling
Essentially, all models are wrong, but some are useful.
— Box and Draper (1987), Empirical Model-Building
and Response Surfaces
The first models are thought to have been created around 30,000BC; num-
bers – counting and writing or marking them – were followed by models in
astronomy and architecture several millennia later. In that sense, mathemat-
ical models have a great history, and have been very effective torches in the
journey of scientific understanding. Yet it seems in many ways as though
the field is still in its infancy, especially in its application to biology.
In 1960, Eugene Wigner expressed his apprehension of the use of mathe-
matics in other disciplines in his essay titled The Unreasonable Effectiveness
of Mathematics in the Natural Sciences (Wigner 1960). More than half a cen-
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tury later, his ideas still resonate. Granted Wigner was concerned about
application of mathematics to physics, and this was back in the day when
disciplines were thought of in the traditional sense as having quite strict
boundaries. Wigner was scratching the tip of a largely ignored iceberg of
the inability to comprehend how interdisciplinary science could possibly
work.
The understanding of the associations between disciplines has since ad-
vanced to become more acceptable, and more recently trendy. Mathematics
in particular is considered vital for the advancement of other sciences – an
acknowledgement of the power of quantitative evidence and proof. Mathe-
matical models are used in various fields from architecture and astrophysics
to finance and security. Its application in the the field of biology, although
hardly new, is still a prime candidate for Wigner’s concerns. Mathematics
prides itself on its undoubtable shatter-proof theorems, established on clear
foundations that hold true for all time. It’s a discipline where rigorousness
and exactness are basic standards of working. Biology on the other hand
stands on ever changing foundations that alter with frequent acquisitions
of new knowledge. The nature of this alliance is conflicting. The function
and authority of a mathematical model is undermined by what biological
knowledge is considered to be known and is purported to be true.
Regardless, this alliance is perceived to be mutually beneficial by some. Biol-
ogy can influence and inspire new mathematical theorems (Sturmfels 2005).
However it cannot be denied that the lion’s share of work conducted in
mathematical biology is in applying predetermined mathematical concepts
to biological problems. This work spans from nanoscale processes to phe-
nomena that occur across the globe. Recent work has focused on amalga-
mating multiscale models. For example, the Virtual Physiological Human
(VPH) initiative aims to provide a framework for developing computational
models of the human body, integrating protein, cellular, tissue, organ and
organ-system scales (Hunter and Borg 2003; Gavaghan et al. 2009). This field
of work is often referred to as being a part of systems biology. While the exact
definition of the term is still contested, it is generally thought to encompass
mathematical and computational models of biological systems.
Mathematical models encompass a wide range of different methods, from
purely statistical approaches to dynamic time dependent models. Certain
approaches can provide an analytical insight, not accessible through merely
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computational or experimental methods. Many models are built upon oth-
ers, expanding and refining to suit the needs of the biological problem at
hand. Different logical strategies can be employed in the building of a
model. They can be mechanistic, simulating the specific biological processes
being investigated, or phenomenological, starting with the data in order to
recreate the relationships that gave rise to it. Many other terms are used to
describe these two basic ideas: bottom-up and top-down approaches, white-
box and black-box modelling and forward and reverse modelling (Gunawar-
dena 2014). Regardless of the strategy chosen, the fundamental structure of
a model remains the same. Any mathematical model consists of a set of
assumptions from which a set of conclusions can be derived.
However, in some cases biology offers no realistic justifications for the as-
sumptions being made, making so-called mechanistic models less purely so.
For example in the modelling of biochemistry, the equations which are often
used to represent reactions (such as the law of mass action or the Hill func-
tion) don’t follow a chemist’s or physicist’s rationale. They are formulations
based on phenomenology, not on fundamental laws (Gunawardena 2014):
The point here is not that we should not guess; we often have
no choice but to do so. The point is to acknowledge the conse-
quences of phenomenology and guessing for the kinds of models
we make. They are no longer objective descriptions of reality.
The title for Gunwardena’s article Models in biology: ’accurate descriptions of
our pathetic thinking’ comes from the Nobel Prize lecture delivered by the
pharmacologist James Black (Black 2005), who argued:
Models in analytical pharmacology are not meant to be descrip-
tions, pathetic descriptions, of nature; they are designed to be ac-
curate descriptions of our pathetic thinking about nature...They
are meant to expose assumptions, define expectations and help
us to devise new tests.
Gunawardena goes on to say that in forward models based on such guess-
work, if the model is not predictive and assumptions not certain, its only
raison d’eˆtre is to test those pathetic assumptions by being falsifiable.
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An initial impulse of modelling a biological problem is often to include as
much detail as possible in order to produce the most accurate predictions.
This may be because of the historical paucity of information in biology.
However, as the number of model parameters increases so does the com-
plexity and the uncertainty. The model exists in a multidimensional space,
determined by the number of parameters it carries, and the range of val-
ues deemed plausible for each parameter. Each range of biological values is
burdened with uncertainty, and through the model’s relationships translate
into uncertainties in model output that are difficult to disentangle. The use-
fulness of a model is therefore governed as much by what is left out as it is
by what is included.
With four parameters I can fit an elephant, and with
five I can make him wiggle his trunk
— John von Neumann
Many systems biology models call for a large number of free parameters
due to the nature of what is being simulated. Waterfall et al. (2006) iden-
tify what they call ’sloppy’ models, where behaviour is mainly determined
by a small number ’stiff’ parameter combinations which translate into con-
strained directions in the model space. Other directions of model behaviour
are less constrained or ’sloppy’. In effect, the model behaviour space has
fewer dimensions than that of the parameter space it is mapped from, and
therefore changes in single parameters can have very little effect (Transtrum
et al. 2010, 2011). Gutenkunst et al. (2007) found that the 17 systems biol-
ogy models they studied had the characteristic sloppy pattern, concluding
that ’these results argue that focusing on parameter values may be a very
inefficient route to useful models’ (Gutenkunst et al. 2007).
Biological models, especially mechanistic models which emanate from bio-
logical structure, with very accurate and efficient parameters is not a realistic
enterprise. First, because the underlying biological foundation is often rid-
den with uncertainty the model applied on top is poorly supported. Second,
it is often quite difficult to determine what biological structures or activity,
translated into parameters, will be more influential in a model before it is
actually built. Thus, it is usually an exercise of trial and error, where de-
tail is added and tested for efficacy (if at all). Gunawardena also discusses
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this, noting that model building often involves some level of simplification,
adding that ’this is as true for the experimentalists informal model – the
cartoon that is sketched on the whiteboard – as it is for the mathematicians
formal model’ (Gunawardena 2014) .
The utility of a mathematical model also rests on its approval and recogni-
tion by those it is intended to benefit. In the clinical sphere such quantitative
models, burdened with assumptions and confined by numerical parameters,
present complex and questionable reasoning that is perhaps (and rightly so)
a more difficult pill to swallow. This is obviously and understandably true
in the science of intensive care, where the models of this thesis apply, as
lives are constantly at risk.
However, quantitative models with assumptions and abstractions are al-
ready widely used in these fields, but are often hidden from view. They
escape notice when they are either packaged in such a way that conveys an
air of authority – for example within a clinical device, where the results are
conveniently displayed graphically – or if they have entered into the realm
of tradition – have always been used, and so have become part of the furni-
ture. Research trends and the emergence of umbrella terms such as systems
biology have spotlighted quantitative models in recent times, laying them
bare to more scrutiny and targeted scepticism. This is nonetheless good for
the field of quantitative modelling in biology, as it forces a more thorough
inspection of its fundamental behaviour and encourages more principled
and credible endeavours.
We must take a guarded approach in the endorsement of quantitative mod-
els. It is important to understand whether the model being used is appro-
priate and suitable for the problem being investigated. This is especially
true when applying existing models to new problems. In data-driven mod-
elling, it is necessary to examine whether the data can answer the question
being asked. The scope of the model is inevitably constrained by the limi-
tations of the original environment or experiment from which the data was
obtained. One must also refrain from generalising the results obtained from
the model, keeping in mind the original assumptions that were made in the
building process.
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4.1.1 The good models
There are three simple rules for creating a model.
Unfortunately, nobody knows what they are.
— James Haefner, in Modelling Biological Systems
Haefner (2005)
The characteristics of an ideal model can vary from one application and
field to another. However, there are a number of common attributes that are
desirable in a mathematical model. Some of these are listed below, inspired
by Smye and Clayton (2002).
Accuracy – Model validation is task more difficult in practice than may
seem, and more commonly and ideally done by comparing predicted val-
ues with measured ones. Cloutier et al. (2009) go so far as to claim that
mathematical models are only credible when calibrated with relevant exper-
imental data. However, this is not always possible - a forward model may
be purely theoretical, an investigation of scenario for which experimental
data is not available, such as is likely in astrophysics. The model may be the
only source of information at all. Where it is possible, care must be taken
to ensure that the methods used to improve the accuracy of the predictions
reflect the accuracy of the data itself (Smye and Clayton 2002). It is also
important to understand that a model is by definition not the real thing and
will never be.
The best model of a cat is another cat, or preferably the
same cat.
— Arturo Rosenblueth
Prediction – Good models will not simply describe what has already been
observed (Smye and Clayton 2002), but will further current knowledge by
either adding detail to the unseen processes that gave rise to what has been
observed, or predict that which has not (as discussed briefly above). Al-
though stochastic processes are common in biology, models can be predic-
tive of processes on a larger scale (Smye and Clayton 2002).
Economy – It is advisable to follow the Occam’s razor principle – entities
should not be multiplied unnecessarily or in more applicable terms when you
have two competing theories that make exactly the same predictions, the simpler one
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is the better. This is what Smye and Clayton (2002) refer to as ”the real skill
of the model builder – the ability to identify and describe the essential elements of a
biological process.”
Utility – Perhaps obvious, but a model should be, if anything, useful. This is
an attribute that can be easily overlooked by those creating models especially
if they normally reside outside the field of application. If a mathematical
model in a medical context cannot provide information of use to the clinician
it is intended to benefit, then the model would it have failed its purpose.
As to where the models presented in this thesis lie in the spectrum of useful-
ness, goodness and applicability – I leave this to the discussion at the end of
this thesis (Chapter 9). For now, we move to consider a number of existing
physiological models of the brain.
4.2 Physiological models of the brain metabolism and
circulation
Creating a mathematical model to predict the complex behaviour of the
brain is both a daunting and interesting challenge. A number of different
approaches have been used to investigate various areas and functions of the
brain. An exhaustive list of all the different varieties of models is beyond
the realm of this thesis. However, a selection of physiological models is
listed in Table 4.1. Some of these models either focus only on metabolism or
circulation whilst others combine both.
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Table 4.1: Models of cerebral metabolism and blood flow.
Model Focus Simulation Clinical Application
Korzeniewski
and Froncisz
(1991)
Oxidative phos-
phorylation
Respiration in isolated cells – CCO,
ATP synthesis and use
Comparison with experimental re-
sults
Czosnyka et al.
(1993)
Circulation Arterial CO2 – PaCO2 – cerebral
perfusion pressure, cerebral blood
flow, blood pressure, cerebrovascu-
lar resistance and autoregulation
Interhemispheric asymmetry of
CBF reactivity to changes in
PaCO2 in patients with carotid
artery stenosis
Ursino and Lodi
(1998)
Circulation Intracranial pressure, cerebral
blood flow, autoregulation and
CO2
Hyder et al.
(1998)
Oxygen delivery CMRO2, CBF, haemoglobin con-
centrations and oxygenation
Proportionality between CBF and
CMRO2, in graded anesthesia in
rats and humans and for functional
activations in humans
Korzeniewski
and Zoladz
(2001)
Oxidative phos-
phorylation
Extension of previous models to in-
clude creatine kinase system
To demonstate that in skeletal mus-
cle, the creatine kinase system has
no significant influence on kinetic
properties of oxidative phosphory-
lation.74
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Table 4.1: Models of cerebral metabolism and blood flow.
Model Focus Simulation Clinical Application
Aubert et al.
(2001)
Oxygen delivery
and metabolism
CBF, oxygenation, metabolites –
NAD, NADH, lactate, ATP ADP,
AMP, creatine, phosphocreatine,
glucose, glycogen, pyruvate and
sodium membrane transport
Interpretation of MRS and fMRI
data obtained during prolonged
simulations
Gjedde (2002) Oxygen delivery CBF, oxygenation and oxygen con-
sumption (CMRO2)
Investigate the mismatch between
increased blood flow and oxygen
consumption during neuronal exci-
tation
Aubert and
Costalat (2005)
Oxygen delivery
and metabolism
in astrocytes and
neurons
covers quantities in previous
model above, now compartmen-
talised in astrocytes and neurons
Test the astrocyte-neuron lactate
shuttle hypothesis
75
4.2.
Physiologicalm
odels
of
the
brain
m
etabolism
and
circulation
Table 4.1: Models of cerebral metabolism and blood flow.
Model Focus Simulation Clinical Application
Jung et al. (2005) Circulation Cerebral blood flow, blood pres-
sure, cerebrospinal fluid, autoreg-
ulation, and oxygenation,
Connection between arterial blood
pressure and the production of
cerebrospinal fluid. Correlation of
partial oxygen pressure of brain tis-
sue to the mean arterial blood pres-
sure in the case of an impaired au-
toregulation mechanism
Beard (2006) Oxygen transport
and metabolism
ATP, ADP, creatine phosphate, in-
organic phosphate, NAD, NADH,
oxygenation and blood flow
Reproduce experimental observa-
tions of ATP, ADP, CrP, and in-
organic phosphate levels in canine
hearts. Quantitative predictions of
changes in phosphate metabolites
during cardiac ischemia.
Vatov et al. (2006) Metabolism CBF, partial oxygen pressure, mito-
chondrial NADH redox state and
extracellular potassium
Complete and partial ischemia,
cortical spreading depression un-
der normoxic and partial ischemic
conditions. Real-time computation
of variables during clinical or ex-
perimental procedures76
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Table 4.1: Models of cerebral metabolism and blood flow.
Model Focus Simulation Clinical Application
Simpson et al.
(2007)
Metabolism in
astrocytes and
neurons
glucose, glucose transporter pro-
teins, lactate and monocarboxylate
transporters
Investigate the astrocyte-neuron
lactate shuttle hypothesis
Alastruey et al.
(2008)
Circulation Cerbral blood flow, autoregulation,
arterial haemodynamics
Effect of anatomical variations in
the circle of Willis, following
carotid artery occlusion
Cloutier et al.
(2009)
Metabolism in
astrocytes and
neurons
Based on Aubert and Costalat
(2005), includes gltamate cycling
and glycogen
Simulations compared with data
from a sensory stimulation (re-
straint) in rats
Linninger et al.
(2009)
Circulation Blood, cerebrospinal fluid, brain
parenchyma, spinal canal and in-
tracranial pressure
Cerebrospinal fluid flow differ-
ences in patients with hydro-
cephalus (fluid build-up inside the
skull)
Orlowski et al.
(2011)
Metabolism in
astrocytes and
neurons
Based on Cloutier et al. (2009), ex-
tended to simulate pH response
during ischaemia
Understand pH dynamics in dam-
aged and vulnerable brain tissue
after stroke
Orlowski et al.
(2013)
Metabolism in
astrocytes and
neurons
Extension of previous model to in-
clude extracellular concentrations
Oedema and propagation of stroke
across the brain
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A few good models of brain metabolism and blood flow relevant to this the-
sis have been summarised below. These models have been implemented and
run in different modelling environments, the results of which are presented
here.
4.2.1 The Korzeniewski model
A model of oxidative phosphorylation in mammalian skeletal muscle, the
Korzeniewski and Zoladz (2001) model was also built upon earlier work
(Korzeniewski 1998). It includes substrate dehydrogenation, complex I, III
and IV, cytochrome c oxidase, proton concentration in both cytosol and mio-
chondria and the proton leak. The model also incorporates ATP synthase,
ATP/ADP carrier, phosphate carrier, the use of ATP, adenylate kinase, and
creatine kinase (see Chapter 2, Section 2.4.3 for an overview of oxidative
phosphorylation). Figure 4.1 displays a simulation of muscle activation (and
increased energy demand).
Copyright material removed.
Figure 4.1: Simulation presented in Korzeniewski and Zoladz (2001) of muscle
activation, using an increase in energy demand.
A hypoxia simulation was run using the model with the Braincirc interface
(see Section 4.3.1), instigated by a 50% drop in O2 concentration (Figure
4.2). The model predicts a drop in oxidised cytochrome and a rise in re-
duced cytochrome, as might be expected with low metabolism. A drop is
also observed in both mitochondrial and cytosolic ATP concentration and a
consequent drop in PCr and rise in Cr concentration.
4.2.2 The Beard model
Beard (2005) introduced a model of mitochondrial respiration, including
the electron transport chain and ATP synthesis, based on data from cardiac
mitochondria. In order to simulate cardiac energetics, the model is focused
on the chemical and electrical components of the proton motive force. It also
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Figure 4.2: A 50% drop in O2 input to the Korzeniewski and Zoladz (2001) model
to simulate hypoxia.
incorporates cytochrome c concentration and consists of two mitochondrial
compartments - the matrix and intermembrane space.
This model was made available on the CellML repository (Yu et al. 2011).
Figure 4.5 illustrates hypoxia simulations from this model, stimulated by a
80% decrease in O2 and compiled using the OpenCell environment (Ope
2009). This environment allows the user to state parameter values before
the model is run, but is not set up in such a way that allows time-dependent
changes, unless a new time-dependent function is declared for that param-
eter. Predicted value of reduced cytochrome c is similar to that presented in
the Beard (2005). There is a decrease in mitochondrial NAD and pH while
a slightly higher than normal value of free mitochondrial ATP.
The model of cellular energetics was extended to simulate oxygen transport
in cardiac tissue in Beard (2006). It simulates capillary, interstitial and cel-
lular space (in this case myocyte). The concentration of oxygen and other
metabolites primarily vary along the length of the capillary, incorporating
an axially distributed blood-tissue oxygen exchange model. The interstitial
and cellular spaces are assumed to be stagnant. Cytoplasmic and mito-
chondrial compartments compose the cellular region. This model was not
available online but the published model analysis with data on blood flow
and oxygen consumption showed a linear relationship between whole-heart
perfusion and the rate of ATP consumption(Beard 2006) . However, the au-
thors note that ATP hydrolysis is likely to vary across the regions of the
heart. The model also predicted inorganic phosphate to be a key regulator
of oxidative phosphorylation.
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Figure 4.3: Simulation of hypoxia in the Korzeniewski and Zoladz (2001) model
with a 50% drop in O2
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Copyright material removed.
Figure 4.4: Schematic of the Beard (2005) model
Figure 4.5: Simulations of the Beard (2005) model following an 80% decrease in O2.
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4.2.3 The Ursino-Lodi model
Copyright material removed.
Figure 4.6: Intracranial dynamics of the Ursino and Lodi (1998) model. G1, G2 and
C1, C2 are the hydraulic conductances and compliances of the proximal and distal
cerebral arteries respectively. Pa, P1 and P2 represent systemic arterial pressure and
pressure in large pial and smaller arteries. Pic and Cic are intracranial pressure
and compliance. Gpv, Gve and Cvi, Cve are the conductances and compliances of
large cerebral veins and extracranial pathways. Gvs, G f , Go are conductances of
terminal intracranial veins, cerrbrospinal fluid formation and CSF outflow. q, q f ,
qo, Ii represent cerebral blood flow and CSF formation, outflow and injection rate
respectively.
Copyright material removed.
Figure 4.7: The action of regulatory mechanisms in the Ursino and Lodi (1998)
model, on smooth muscle activation factor Mj of large and small pial arteries
(j = 1, 2). The top branch represents the autoregulation mechanism and the bottom
branch the CO2 response. The inputs for the autoregulation branch are different in
the two segments – large pial arteries respond actively to variations in cerebral per-
fusion pressure, whereas small pial arteries are sensitive to CBF changes. Dynamics
are simulated by a gain factor G and a first-order low-pass filter with time constant
τ . ACO2 is a corrective factor which lowers CO2 reactivity at low levels of CBF as
a consequence of ischemia. The two regulatory mechanisms interact nonlinearly
through a sigmoidal static relationship.
A model of cerebral haemodynamics and pressure was published by Ursino
and Lodi (1998), following earlier similar work (Ursino and Lodi 1997). The
model investigates the relationship between cerebral blood flow, blood vol-
ume, intracranial pressure and the regulatory mechanisms – autoregulation
and CO2 reactivity. Figure 4.6 illustrates the intracranial dynamics in the
form of an electric analog diagram. Cerebrovascular regulation is controlled
by the radius and tension of smooth muscle. The autoregulation and CO2
reactivity mechanisms are displayed in Figure 4.7.
The model was run on the in-house interface Braincirc (see Section 4.3.1).
Ischemia was simulated by a 50% drop in blood pressure (Figure 4.8). The
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results are displayed in Figure 4.9. The model predicts a drop in CBF, and a
drop in the radius of the middle cerebral artery, as it attempts to compensate.
Intracranial and venous pressure is observed to rise whilst blood velocity is
maintained relatively constant.
Figure 4.8: A 50% drop in blood pressure input to the Ursino-Lodi model to simu-
late ischemia
4.2.4 The Cloutier model
Focused on energy metabolism, this model was based on an earlier model
by Aubert et al. (Aubert and Costalat 2005, 2007; Cloutier et al. 2009). An im-
portant aspect of these models is that they simulate neurons and astrocytes
as separate compartments.
The model includes the exchange of glucose, lactate, oxygen carbon diox-
ide between the capillaries and the cells. Reactions involved in energy
metabolism, including glycolysis and the production and consumption of
ATP are modelled. Also incorporated is an astrocyte-neuron lactate shut-
tle. The main distinction in the metabolic activity of neurons and astrocytes
comes into play in the simulation of neural stimulation. Maintaining ionic
gradients in these cells is considered to be a major energy consumer. The
coordination of neuronal and astrocytic responses to stimuli is controlled by
the cycling of glutamate between the two cells. This activates the sodium
pump in astrocytes to maintain the sodium gradient.
Figure 4.11 displays simulations of the model run using an in-house com-
piler BCMD (see Section 4.3.1). The model incorporates stimulus functions
that affect sodium and glutamate concentrations, so no additional input pa-
rameters are required to model the stimulus on execution.
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Figure 4.9: Simulation of ischemia in the Ursino-Lodi model with a 50% drop in
blood pressure.
Copyright material removed.
Figure 4.10: Schematic diagram of the Cloutier model.(Cloutier et al. 2009)
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Figure 4.11: Simulations of the Cloutier et al. (2009) model of the response to a
stimulus
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4.2.5 The Orlowski model
Copyright material removed.
Figure 4.12: Schematic diagram of the Orlowski model. The additional notation
indicates changes made to the Cloutier model. (Orlowski et al. 2011)
Orlowski et. al extended the Cloutier model to simulate pH dynamics under
ischaemia (Orlowski et al. 2011). The authors here assume a linear relation-
ship between the concentration of H+ ions and the concentration of ATP, the
production of lactate and the concentration of phosphocreatine (PCr).
Changes in glycogen concentration are made sensitive to changes in AMP
concentration in the astrocyte. pH is regulated in the model by an intra-
cellular buffer solution of carbonic acid and the products of its dissociation
and the movement of H+ ions to the extracellular space. Carbon dioxide
dynamics are also investigated by simulating its concentration in the capil-
laries and the extracellular space. ATP consumption is linked to the rate of
the sodium-potassium pump. Figure 4.13 illustrates results from the model
during ischaemia, simulated by an 80% drop in cerebral blood flow. Espe-
cially notable here is the drop in pH in both neurons and astrocytes.
Copyright material removed.
Figure 4.13: Simulations of the Orlowski model following a 80% reduction in CBF
(Orlowski et al. 2011)
.
The model was made available on the CellML platform (Yu et al. 2011). It
was downloaded and run using the OpenCell environment (Ope 2009), as
was used in the original publication. A simulation of ischemia using an
80% drop in cerebral blood flow confirmed the results in Orlowski et al.
(2011). Figure 4.14 displays a simulation of hypoxia-ischaemia, caused by
an 80% drop in cerebral blood flow and arterial oxygen. These simulations
actually show a smaller drop in pH in both neurons and astrocytes, and a
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quicker recovery, than that observed in the ischaemia simulation presented
in the authors’ paper. Lactate increases thoughout, possibly due to anaerobic
metabolism. Both intracellular Na and ATP showed a more linear increase
and decrease respectively. The changes in ATP is not as marked either.
The simulations do not seem to be successful beyond the 6000 seconds time
period in this environment.
Figure 4.14: Simulations of the Orlowski model following a 80% reduction in CBF
and O2
The model was further extended in Orlowski et al. (2013) to investigate tis-
sue damage caused by oedema following ischemic stroke, by incorporating
simulations of cell volume change and diffusion of ions in the extracellular
space. Figure 4.15B displays their results from simulations of the size of
the extracellular and cellular space and Na+ ion concentration after a 90%
decrease in blood flow, with and without diffusion of Na+ ions to the ex-
tracellular space. Figure 4.15C shows a simulation of a cubic mesh of 1000
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cubic cells representing tissue, where blood flow is decreased to 90% in cells
2cm away from the left surface. Also displayed is the CO2 levels across the
front surface of the tissue model, showing a higher concentration closer to
the stroke area.
Copyright material removed.
Figure 4.15: Simulations of the Orlowski et al. (2013) model
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4.3 The UCL brain models
The Biomedical Optics Research Laboratory (BORL) at UCL’s department
of Medical Physics lays claim to a number of mathematical and compu-
tational models of brain metabolism and circulation. This work spans al-
most a decade to date, and runs alongside an extensive research effort into
non-invasive clinical measurement techniques, including near infrared spec-
troscopy. These measurement techniques are detailed more thoroughly in
the next chapter.
4.3.1 History of model development at UCL
The models presented in this thesis are derived from a number of previously
published brain models – a timeline of which is illustrated in Table 4.3. A
brief history and description of these models is summarised below.
BrainCirc
The first model, an elaborate adult brain model, was published in 2005 by
Banaji et al (Banaji et al. 2005). Three preexisting models of circulation,
brain biochemistry and vascular smooth muscle function were united in one.
Thus, a physiological approach was used and the model was constructed in
a modular way so as to enable easy modification.
The model encompasses three ’sites’: blood vessels, brain tissue and vascular
smooth muscle. Each of these are further divided into different components:
arteries, arterioles, capillaries and veins in the vascular system, extracellular,
intracellular, cytoplasmic and mitochondrial compartments in brain tissue,
and vascular smooth muscle in the proximal and distal arterial segments.
Biochemical reactions are represented as mass action or Michaelis Menten
equations. Other equations included are those representing the biomechan-
ics of vessel walls and circulation, and volume balance equations between
different compartments derived from conservation laws.
BrainCirc is the largest of all the models in this series, including a vast
number of variables and parameters. In order to manage and run such
a large and complex model, the BRAINCIRC modelling environment was
built. This software focuses on the biological processes (eg. chemical reac-
tions) that are central to the model. These can be input into the interface
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Figure 4.16: Main processes and compartments of the Braincirc model(Banaji et al.
2005).
and the environment then converts them into differential equations (Banaji
2005).
BrainSignals
Technical developments allowed the measurement of oxidised CCO concen-
tration using NIRS. In order to better understand and interpret these mea-
surements, the model was extended to simulate them. The BrainCirc model
was first greatly simplified in order to maintain the possibility of optimis-
ing parameters for each individual patient. The BrainSignals model was
then used to successfully simulate ∆oxCCO and tissue oxygen saturation
(TOS) measurements from patients undergoing hypoxia and hypercapnia
challenges (Banaji et al. 2008). The model was later also shown to predict
data from a hypoxemia challenge (low blood oxygen levels) (Jelfs et al. 2012).
Copyright material removed.
Figure 4.17: Schematic of the BrainSignals model (Banaji et al. 2008).
BrainPiglet
Following the commencement of hypoxia-ischaemia experiments in piglets
by a collaborating research group, in 2012 Moroz et al. published the first
version of the BrainPiglet model. This is an adaptation and extension of
the BrainSignals model (Moroz et al. 2012). 11 of the 107 parameters were
altered to suit the piglet brain. The model was also extended to simulate
magnetic resonance spectroscopy (MRS) measurements - ATP, PCr, Pi and
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lactate - which were recorded simultaneously during the experiments. The
next section details this model.
Comparison
The general differences between the BrainCirc, BrainSignals and BrainPiglet
v1.0 models are detailed in Table 4.2. Compartments included are volume
compartments in reactions and do not include blood compartments. The
number of parameters include those that are explicitly set as well as those
that are derived from other parameters.
Table 4.2: A comparison of the three models.
BrainCirc BrainSignals BrainPiglet v1.0
Compartments 4 1 2
Reactions 81 5 16
Differential equations 5 5 5
Algebraic relations 72 3 3
Variables 168 12 30
Parameters 697 196 270
Computational environments
With the development of the first model BrainCirc, the team also created
a similarly named interface BRAINCIRC to compile the model. The mod-
els are encoded as a combination of reactions, differential equations and
algebraic relations. However, this interface was ridden with many issues -
exasperated further by a lack of proper documentation. A new simpler in-
terface has been recently developed by Matthew Caldwell, called BCMD –
Table 4.3 Timeline of models of cerebral metabolism produced at UCL
2005 • Braincirc
2008 • BrainSignals
2012 • BrainPiglet v1.0
2013 • BrainPiglet v2.0
2014 • BrainPiglet v2.1
• Brainsignals neonatal
• Baby Brain
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Brain/Circulation Model Developer (Figure 4.18). BCMD retains the same
logical basis of model construction – the model is described in reactions
and differential equations – and uses the same RADAU5 solver, but offers a
much better understanding of model behaviour. The interface software and
all model definitions are freely available from http://tinyurl.com/ucl-bcmd.
Unlike BRAINCIRC which only runs in a Linux environment, BCMD is also
compatible with Windows and Mac environments.
BCMD is mainly written in Python 2.7, however models are translated into
C and linked against a Fortran library. It uses the RADAU 5 DAE solver by
Hairer and Wanner (1996) – an implicit Runge-Kutta method of order 5 for
integrating stiff systems of differential-algebraic equations. BCMD offers a
number of functions. In model compilation and running, the graphical user
interface (GUI) is able to outline any errors. Initial values of model param-
eters can be altered, artificial inputs can be generated (including noise), and
outputs can be plotted. The software enables sensitivity analysis (including
the morris method used in this thesis) and can generate relevant heatmaps.
It also allows for optimisation of parameter values to better simulate known
outputs, using the particle swarming method used in this thesis. BCMD
can further be used to create dependency graphs of model variables and
parameters such as those presented in the discussion in Chapter 5.
As discussed earlier in this chapter, several other modelling environments
are used in systems biology. The systems biology markup language (SBML)
(Hucka et al. 2003) and CellML (Cuellar et al. 2003) are the most popular
languages for model specification. Both are based on XML and enable the
computational representation of biological processes, which must be com-
piled using suitable software. Commonly, these software environments do
not support the use of time series data, and we have not identified one
that does. The models encoded are often perturbed from steady state by
altering parameter values, the effect of which may be observed over time.
These environments are hence not compatible with the objective of the UCL
metabolism models.
The early BRAINCIRC interface does facilitate the import and export of
SBML models. The metabolism models are thus available in SBML format,
although their functionality is significantly reduced by the environment.
The BCMD interface may also include a similar feature in the future. MAT-
LAB is another popular environment for systems biology models. While
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it useful (and has been used) for signal processing of measurements and
plotting results, confining the model to MATLAB restricts access to those
who have license to use the software. BRAINCIRC and BCMD on the other
hand are open-source, and freely available. They also compile the model
first before it is run, unlike MATLAB, and so have a lower computational
cost.
Figure 4.18: The BRAINCIRC and BCMD modelling environenments.
4.4 Modelling principles
Although the UCL group have produced a number of different models, they
all follow the same general principles. This section is an overview of the
modelling approach taken to simulate chemical reactions and transport pro-
cesses. These methods are widely used in quantitative biology – a good
review can be found in Haefner (2005).
4.4.1 Chemical reactions
Mathematical models represent chemical reactions in different ways, de-
pending on the type of reaction and the information the model aims to con-
vey. The BrainPiglet model uses the same technique that was conceptualised
in the BrainCirc model. The types of reactions encoded in these models, and
how they are constructed is described below.
93
4.4. Modelling principles
Mass Action
These reactions can be reversible or irreversible, with two rate constants or
just one in the latter case. For example, take the reversible reaction involving
substrates A and B to produce C and D. This reaction is represented by
na A + nbB
k1−⇀↽−
k−1
ncC + ndD (4.1)
where na, nb, nc and nd represent the quantities of each substrate and k1 and
k−1 represent the rates of the forward and backward reactions respectively.
The rate of formation of any product can be calculated. For example, for
product C;
˙[C] = k1[A]na [B]nb − k−1[C]nc [D]nd (4.2)
At equilibrium, the forward and backward rates are equal and so the equi-
librium constant Keq is thus
Keq =
k1
k−1
=
[A]na [B]nb
[C]nc [D]nd
(4.3)
The Gibbs free energy change for the reaction is zero at equilibrium, but at
other times is is given by
∆G = RT
[
− lnKeq + ln
( [A]na [B]nb
[C]nc [D]nd
)]
(4.4)
Michaelis Menten
Reactions catalysed by enzymes are represented mathematically as Michaelis
Menten equations, which capture the following kinetics between a substrate
S, enzyme E and product P:
S + E
k1−⇀↽−
k−1
ES k2−→ E + P (4.5)
The first reaction forming the substrate complex (ES) is reversible but the
second creating the product is not. The total concentration of enzyme is
assumed constant. For example, take the simple enzyme-catalysed reaction
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A
Vmax ,KmA−−−−−→ B (4.6)
where Vmax is the maximum rate of reaction and KmA is the Michaelis con-
stant for A - the concentration of A at which the reaction rate is half the
maximum. We assume that the concentration of the ES complex also re-
mains constant i.e. ˙[ES] = 0. This leads to
Vmax = k2[ET] (4.7)
KmA =
k−1 + k2
k−1
(4.8)
where [ET] is the total concentration of enzyme (= [E] + [ES]). The rate of
formation of product is represented by
˙[A] = − Vmax[A]
KmA + [A]
(4.9)
4.4.2 Transport
Passive diffusion across a barrier is simulated in the model as a mass action
process.
δc1
δt
= −D(c1 − c2) (4.10)
where c1 and c2 are the concentrations in the two compartments, and D is
the diffusion coefficient. Active or carrier-mediated transport of substances,
such as those instigated by membrane proteins, are represented in a more
complex format such as Michaelis-Menten equations.
4.5 Model optimisation
There are two main approaches to model optimisation - first the optimisa-
tion of the model itself to develop, for example, a faster, simpler and more
accurate model, and second the optimisation of model parameters to pro-
duce a better simulation. The first approach is discussed in Chapter 9. This
section focuses on the latter.
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It is often advantageous and sometimes necessary to optimise a model to the
particular event or environment being simulated. This is especially true for
data driven models, where the results are so dependent on the individual
data set being used.
The models presented in this thesis aim to be patient- and state-specific.
That is, they simulate a clinical scenario in a particular patient and at a
particular moment in time when their cerebral health maybe changing. Thus
for accurate simulations it is vital that the model parameters are optimised
to the greatest possible extent.
4.5.1 Sensitivity analysis
Some models, such as those presented in this thesis, incorporate a large
number of parameters which can be computationally exhaustive to opti-
mise. Thus, methods of sensitivity analysis can be used to determine the
most influential parameters for the variables that we are investigating. This
initial selection greatly reduces the computational cost and complexity of
optimisation, allowing a smaller set of parameters to be optimised to achieve
significantly more accurate simulations.
A very simple form of this analysis would be to increment each parameter
x by ∆x in turn and measure the effect on the model output. While this
maybe sufficient for small, simple models, when working with a large num-
ber of parameters it is essential to take into account the interaction between
parameters as well.
The Morris method
The Morris method is one of the most popular sensitivity analysis methods
for models with a large number of parameters. It aims to determine the
factors with effects that are (i) negligible, (ii) linear and additive and (iii)
non-linear or involved in interactions with other factors. These effects are
calculated by changing one factor at a time (Saltelli et al. 2004).
For a k-dimensional vector of parameters X, with components Xi, each can
assume integer values in the set 0, 1/(p− 1), 2/(p− 1), ..., 1. The parameter
space is then a k-dimensional p-level grid. Let ∆ be a predetermined multi-
ple of 1/(p− 1). For a given value x of X, the elementary effect for the ith
input factor is
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di(x) =
[y(x1, ..., xi−1, xi + ∆, xi+1, ..., xk)− y(x)]
∆
(4.11)
where x = (x1, x2, ..., xk) is any selected value in the parameter space such
that for all i = 1, ..., k, (x + ei∆) is still in the parameter space, where ei is a
vector of zeros with a unit as its ith component (Saltelli et al. 2004; Morris
1991).
A distribution of elementary effects Fi for each ith input factor is calculated
by randomly sampling different x from the parameter space. The number
of effects of each Fi is pk−1[p− ∆(p− 1)]. The mean µ of the distribution Fi,
or more commonly to allow for non-linear effects, the mean of the absolutes
µ∗, and the standard deviation σ, is calculated for each parameter. Thus
parameters with a greater influence have a larger value of µ∗. A greater
standard deviation σ indicates that the parameter’s influence on the output
depends on its interaction with other parameters.
4.5.2 Parameter optimisation
There are a number of different methods of optimising parameter values to
suit different models and modelling approaches.
The Powell method
The Powell’s conjugate direction method locates a minimum of a function
of several variables, without calculating derivatives. The best known ap-
proximation of the minimum is used as a starting point. On each iteration,
the algorithm selects a new direction to search for a minimum. However,
it is possible that the minimum calculated in this manner may be a local
minimum and not a global one (Powell 1964).
This method was used as an initial optimisation technique (via SciPy (Jones
et al.)). However, locating local minimums is not sufficient for a parameter
space as complex as this one. Therefore, a global minimum method was
used instead.
The PSwarm method
The particle swarm or PSwarm method, also derivative-free, is a global opti-
misation algorithm for variables that have specific lower and upper bounds
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(Vaz and Vicente 2007, 2009). Each iteration is divided into two steps. The
first, the poll step, applies a pattern search method (more specifically a co-
ordinate search). The second, the search step, uses particle swarming to
generate points in the feasible region, in order to find a global minimum.
Generating a population in the search step allows the algorithm to then poll
around the best particle, and so improves the overall robustness of the algo-
rithm (Vaz and Vicente 2009). This method was used to optimise the models
in this thesis.
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4.6 The BrainSignals model
This section introduces the first of two previously published models that
have been used and extended in this thesis. The BrianSignals model pre-
sented here was published by Banaji et al. (2008) and simulates circulation
and metabolism in the adult human brain. Following another much larger
model of brain metabolism (Banaji et al. 2005), it was distinct in its ability to
predict changes in CCO and simulate brain activation.
4.6.1 Model structure
This was the first model to simulate and predict the state of the CuA centre
in cytochrome-c-oxidase in an in vivo setting. The model also incorporates
functional activation, and so respond to four stimuli: changes in blood pres-
sure, arterial oxygenation, arterial carbon dioxide and functional activation.
Figure 4.19 illustrates the processes included in the model.
Functional activation is simulated by a parameter u which represents en-
ergy demand in the brain. The normal value for this parameter is set as 1.
Increasing this value represents activation.
Circulation
A simplified version of the circulatory model published by Ursino and Lodi
(1998) has been incorporated in to the model. It includes a proximal and
distal arterial compartment which regulates flow by responding to stimuli
differently. It is divided into three compartments: the arteries (and arte-
rioles), capillaries and veins with volumes Va, Vc and Vv respectively. Vc
is assumed to be negligible. Va is proportional to the square of the arte-
rial radius. On the other hand, Vv is constant. CBF – the volume of blood
which flows through a unit volume of tissue in unit time – is defined by the
following:
CBF = (Pa − Pv)G (4.12)
where Pa and Pv are the arterial and venous blood pressures. G is the con-
ductance, determined by:
G = KGr4 (4.13)
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Figure 4.19: Schematic of the BrainSignals model
where KG is a constant and r is the typical radius of the blood vessel accord-
ing to the Poiseuille law. The radius is governed by its relationship with the
elastic and muscular forces of the vessel wall, Te and Tm respectively:
Te + Tm =
(
Pa + Pv
2
− Pic
)
r (4.14)
where Pic is the intracrainial pressure (assumed constant).
Te =
(
σe0
(
eKσ(r−r0)/r0 − 1
)
− σcoll
)
h (4.15)
where σe0, Kσ, r0 and σcoll are constants. h is thickness of the thickness of
the vessel wall, determined by the following which conserves wall volume:
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(r + h)2 − r2 = (r0 + h0)2 − r20 (4.16)
h0 and r0 are the normal thickness and radius of the vessel wall.
Tm = Tmaxexp
(
−
∣∣∣∣ r + rmr1 − rm
∣∣∣∣nm) (4.17)
where Tmax is the maximum tension, rm is the radius at Tmax and rt and nm
are parameters which control the shape of the curve. Tmax determines the
influence of stimuli on tension, and hence is controlled by SaO2, PaCO2, Pa
and the energy demand (u). η represents this influence,
η =∑
x
Rx
(
νx
νxn
− 1
)
(4.18)
where x represents one of the four quantities above. Rx represents the sen-
sitivity to the stimulus and νx is time filtered x
dνx
dt
=
1
τx
(x− νx) (4.19)
where τx is constant that determines how long it takes for the stimulus to
have a vasoactive effect. Tmax relates to η
Tmax = Tmax(1+ kautµ) (4.20)
where kaut is a constant that simulates the autoregulation capacity of the
brain, normally set to 1. µ represents the level of regulatory input, which
depends on η via a sigmoidal function and is defined by
µ =
µmin + µmaxeη
1+ eη
(4.21)
where µmin and µmax are the bounds of µ. Figure 4.20 illustrates the effect of
kaut on autoregulation in the model.
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Figure 4.20: The autoregulation curve at steady state, with the two extreme values
of the autoregulation constant kaut.
Oxygen Transport
The model simulates oxyhaemoglobin (HbO2) and deoxyhaemoglobin (HHb)
concentrations in blood. The total concentration of haemoglobin ([Hbtot]) is
assumed to remain constant;
[HbO2,a] + [HHba] = [HbO2,v] + [HHbv] = [Hbtot] (4.22)
where subscripts a and v denote arterial and venous compartments respec-
tively. Arterial oxygenation can be determined using arterial oxygen satura-
tion (SaO2), which is often measured;
[HbO2,a] = SaO2[Hbtot] (4.23)
SvO2 is venous oxygen saturation and is similarly calculated:
[HbO2,v] = SvO2[Hbtot] (4.24)
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Oxygen concentration in the capillaries ([O2,c]) depends on capillary satura-
tion ScO2.
[O2,c] = φ
(
ScO2
1− ScO2
) 1
nh
(4.25)
where φ is the concentration of oxygen at half the maximum saturation and
nh is the Hill coefficient for the dissociation of oxygen from haemoglobin.
This model does not incorporate the Bohr effect and so this value remains a
constant.
ScO2 =
SaO2 + SvO2
2
(4.26)
Oxygen is transported from the capillaries to the mitochondria at rate JO2,min,
where
JO2,min = DO2([O2,c]− [O2]) (4.27)
where DO2 is the diffusion coefficient and [O2] and [O2,c] are oxygen concen-
trations in the mitochondria and the capillary respectively. Under normal
conditions, DO2 is such that the rate of use of oxygen (CMRO2) is equal to
the rate of delivery. Further, we assume
JO2,min = CBF([HbO2,a]− [HbO2,v]). (4.28)
Thus combining the above equations provide the means of calculating oxy-
gen saturations in the veins and capillaries and JO2,min.
The tissue oxygenation saturation (TOS) is calculated b y the following:
TOS =
Volart[HbO2,a] +Volven[HbO2,v]
(Volart +Volven)[Hbtot]
(4.29)
Volart is assumed proportional to r2, so
Volart = Volart,nr2/r2n (4.30)
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where Volart,n and rn are the corresponding normal values. With normal
arterio-venous volume ratio AVRn,
AVRn = Volart,n/Volven (4.31)
TOS can be defined as :
TOS =
(r/rn)2[HbO2,a] + [HbO2,v]/AVRn(
(r/rn)2 + 1AVRn
)
[Hbtot]
(4.32)
Volblood,n is defined as an estimate of blood volume in tissue. Hence the
concentration of total, oxy- and deoxy-haemoglobin can be calculated by:
HbT =
1000
4
(Volart +Volven)[Hbtot]Volblood,n (4.33)
HbO2 =
1000
4
(Volart[HbO2,a +Volven[HbO2,v])Volblood,n (4.34)
HHb = HbT − HbO2 (4.35)
The values are multiplied by Volblood,n to convert hem to tissue concentra-
tions and the factor of 1000/4 arises from the conversion of units (mM to
µM) and the 4 binding sites on haemoglobin. The NIRS quantities of ∆HbT,
∆HbO2 and ∆HHb are thus
∆HbO2 = HbO2− HbO2n (4.36)
∆HHb = HHb− HHbn (4.37)
∆HbT = HbT − HbTn (4.38)
Metabolism
A mitochondrial submodel is used here as an approximation of the more de-
tailed processes, inspired by earlier models Korzeniewski and Zoladz (2001),
Beard (2005) and Banaji (2006), and focuses on oxidative phosphorylation.
Protons are pumped into the mitochondria creating a proton motive force,
∆p. Protons then return back to the cytoplasm via ATP synthase, and thus
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drive the production of ATP. The proton motive force ∆p has a chemical and
an electrical component:
∆p = ∆Ψ+ Z∆pHn (4.39)
where ∆Ψ is the membrane potential and ∆pHn is the difference between
cytoplasmic pH, pHo, and mitochondrial pH, pHm. Z is a constant defined
by
Z =
RT
log10(e)F
(4.40)
where R is the ideal gas constant, T is temperature and F is the Faraday
constant. Cytoplasmic pH is constant in the model but mitochondrial pH
is related to the concentration of protons. The mitochondrial volume of
protons is RHiVmit, where Vmit is the mitochondrial volume and RHi is a
scaling factor given by
RHi =
Cbu f f i
(10−pHm − 10(−pHm−dpH))/dpH (4.41)
where Cbu f f i and dpH are constants.
The model simulates oxidative phosphorylation by way of two redox cen-
tres in cytochrome c oxidase – CuA and the terminal electron acceptor cy-
tochrome a3. These centres can be in either oxidised or reduced state. The
electron transport chain is modelled as three reactions. The first combines
Complexes I-III and involves the transfer of four electrons from NADH to
the CuA centre and p1 protons across the mitochondrial membrane. This
reversible reaction has rate f1;
f1 = k1CuA,o − k−1CuA,r (4.42)
where k1 and k−1 are the forward and backward rates respectively.
k1 = k1,0 exp(−ck1(∆p− ∆pn)) (4.43)
where k1,0 is related to NAD/NADH, ck,1 is a constant and ∆pn is the nor-
mal value of ∆p. The ratio of the forward and backward rates is given by
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k1
k1,0
= Keq1 =
CuA,oeq
CuA,req
(4.44)
The free energy produced by this reaction is represented as ∆G1:
∆G1 = −4
(
E1 + Zlog
(
CuA,o
CuA,r
))
+ p1∆p (4.45)
where E1 is defined by:
E1 = ε0(CuA)− ε0(NADH) + Z2 log
(
1
[NAD]/[NADH]
)
(4.46)
where ε0 is a standard redox potential. ∆G1 = 0 at equilibrium, so the
equilibrium constant can be calculated as
Keq1 = 10−(p1∆p/4−E1)/Z (4.47)
The second reaction involved the transfer of four electrons to the haemoglobin
a3/CuB centre and the movement of p2 protons across the membrane. The
reversible reaction has rate
f2 = k2CuA,rcyta3,o − k−2CuA,ocyta3,r (4.48)
where k2 and k−2 are the forward and backward rates respectively.
k2 = k2,n exp(−ck2(∆p− ∆pn)) (4.49)
where k2,n and ck,2 are constants. As with the first reaction, the free energy
is given by
∆G2 = −4
(
E2 + Z
(
log
(
CuA,r
CuA,o
)
+ log
(
cyta3,o
cyta3,r
)))
+ p2∆p (4.50)
which gives equilibrium constant
k2
k−2
= Keq2 = 10(p2∆p/4−E2)/Z (4.51)
106
4.6. The BrainSignals model
In the last reaction, oxygen is reduced and p3 protons are moved across the
membrane. The rate is given by
f3 = k3[O2]cyta3,0
(
ec3(∆p−∆p30)
1+ ec3(∆p−∆p30)
)
(4.52)
where ∆p30, c3 and k3 are constants. The rate of oxygen consumption (CMRO2)
is determined by the rate of this reaction:
CMRO2 = Vmit f3 (4.53)
Under normal conditions, f1 ≡ f2 ≡ f3. The membrane potential ∆Ψ is
proportional to the rates of these reactions:
d∆Ψ
dt
=
p1 f1 + p2 f2 + p3 f3
Cim
(4.54)
where Cim is the capacitance of the inner mitochondrial membrane. The
flow rate of protons through Complex V, through the membrane, LCV is
simulated as
LCV = LCV,max
(
1− e−θ
1+ rCVe−θ
)
(4.55)
where LCV,max is the maximum flow rate and rCV is a constant that accounts
for the difference between forward and backward rates.
θ = kCV(∆p + Zlog(u)− ∆pCV0) (4.56)
where ∆pCV0 is the proton motive force at which no movement of protons
would be induced. Normal conditions see 25 % of protons return through
leak channels. This percentage varies with the proton motive force ∆p .
Llk = kuncLlk0(exp(klk2∆p)− 1) (4.57)
where Llk0 and klk2 are constants. kunc represents uncouplers - under normal
conditions this value is set as 1.
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Table 4.4: BrainSignals model equations. These reactions are are modelled as simple
diffusion, and take place in the mitochondrial compartment.
Reaction Equation
Oxidative phosphorylation 14H+mit + 4CuA,o →
4H+mit → 4CuA,o + 4cyta3,r
O2 + 4H+mit + 4cyta3,r →
Protons re-enter mitochondrial matrix (via
leak and complex V)
→ H+mit
Oxygen in → O2
4.6.2 Steady state simulations
Figures 4.21 and 4.22 illustrate the BrainSignals adult model at steady state
within a range of input values in SaO2, Pa, PaCO2 and demand u. Increasing
SaO2 sees decreasing CBF and blood volume as less blood is required to
oxygenate the tissue (Figure 4.21). Correspondingly, increased oxygenation
and metabolic activity are observed (TOI, ∆oxCCO and ∆CMRO2). These
relationships are largely almost linear. Increasing blood pressure is followed
by increasing oxygenation and metabolic activity. CBF displays the typical
autoregulation curve, with a steady phase around the normal blood pressure
value of 100 mmHg. Normalised blood volume reaches a maximum higher
than 1 around 50mmHg before returning to normal around 100mmHg, as
blood volume rises to compensate for low pressure.
Model behaviour at very low values of SaO2 and Pa (for example below
50% and 40 mmHg respectively) are unreliable as these values are quite
unlikely in an adult patient. While these functions in this range may be
of mathematical interest, care must be taken in interpreting model results
beyond the range commonly observed in clinical data.
Increases in demand cause an almost linear increase in CBF, blood volume,
∆oxCCO and ∆CMRO2 (Figure 4.22). Note that at demand lower than nor-
mal (0 < u < 1), these values are below normal as well. TOI also dis-
plays low values at demand less than normal, but increases as demand rises.
PaCO2 also shows almost linear relationships with each of the variables, in-
creasing with higher metabolic activity.
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Figure 4.21: Steady state simulations of the BrainSignals model with varying arterial
oxygen saturation SaO2 (a–e) and blood pressure Pa (f–j).
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Figure 4.22: Steady state simulations of the BrainSignals model with varying de-
mand u (a–e) and partial pressure of carbon dioxide PaCO2 (f–j).
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Figure 4.23: Inputs to the BrainSignals model to simulate hypoxia-ischaemia. (a)
Blood pressure, Pa, and (c) arterial oxygen saturation, SaO2 are reduced temporarily
while (b) partial pressure of carbon dioxide, PaCO2 and (d) the energy demand, u
are kept constant.
4.6.3 Simulating hypoxia-ischaemia
The BrianSignals model is used here to simulate the response to a temporary
decrease in oxygenation and blood flow, to illustrate the model’s capability.
Blood pressure and SaO2 are reduced by approximately half, to 50mmHg
and 50% respectively (Figure 4.23). The model predicts a decrease in ∆HbO2
and rise in ∆HHb, together with a rise in ∆HbT. The model also simulates
a drop in metabolic activity; ∆oxCCO and CMRO2 drops due to the low
availability of oxygen, as seen in the TOI (Figure 4.24).
4.6.4 Simulating functional activation
A simple simulation is carried out here, by increasing the energy demand
u by in the model 20% to 1.2. Figure 4.25 displays the model inputs. The
model then predicts a corresponding rise in ∆HbO2 and fall in ∆HHb (Fig-
ure 4.26). ∆oxCCO also rises, as does CMRO2 indicating an increase in
metabolism. The increase in ∆HbT and CBF suggest an increase in flow to
the tissue which also shows an increase in oxygenation via TOI. Thus, this
is the overcompensation of flow that is typically observed in adults, with an
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Figure 4.24: Outputs of the BrainSignals model simulation of hypoxia-ischaemia.
Changes in (a,b,c) oxy-haemoglobin deoxy-haemoglobin and total haemoglobin,
∆HbO2, ∆HHb, ∆HbT and (d) oxidised cytochrome-c-oxidase ∆oxCCO. Percent-
age change in (e) cerebral blood flow, CBF, (f) cerebral metabolic rate of oxygen
consumption CMRO2 and (g) tissue oxygenation index, TOI
increase in blood flow overcompensating the increased demand for oxygen,
and hence leading to a decrease in ∆HHb.
When the energy demand returns to baseline, so do the variables above.
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Figure 4.25: Inputs to the BrainSignals model to simulate brain activation. (a) Blood
pressure, Pa, (b) partial pressure of carbon dioxide, PaCO2 and (c) arterial oxygen
saturation, SaO2 are kept constant while (d) the energy demand, u is increased
temporarily.
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Figure 4.26: Outputs of the BrainSignals model simulation of brain activation.
Changes in (a,b,c) oxy-haemoglobin deoxy-haemoglobin and total haemoglobin,
∆HbO2, ∆HHb, ∆HbT and (d) oxidised cytochrome-c-oxidase ∆oxCCO. Percent-
age change in (e) cerebral blood flow, CBF, (f) cerebral metabolic rate of oxygen
consumption CMRO2 and (g) tissue oxygenation index, TOI
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4.7 The BrainPiglet model
Following the commencement of hypoxia-ischaemia experiments in piglets
by a collaborating research group, in 2012 Moroz et al. published the first
version of the BrainPiglet model. This is an adaptation and extension of
the BrainSignals model (Moroz et al. 2012). 11 of the 107 parameters were
altered to suit the piglet brain. The model was also extended to simulate
magnetic resonance spectroscopy (MRS) measurements - ATP, PCr, Pi and
lactate - which were recorded simultaneously during the experiments. This
section details this model.
4.7.1 Model structure
The model is focused on simulating cerebral NIRS and MRS measurements
in piglets during anoxic, hypoxic and ischaemic insults. Figure 3.6 illustrates
a simple schematic of the model.
Copyright material removed.
Figure 4.27: Schematic of the BrainPiglet model v1.0 (Moroz et al. 2012).
Circulation
The circulatory part of BrainPiglet1.0 is an extended form of the circulation
model in BrainSignals. Venous volume is no longer constant, and is deter-
mined by the change of venous pressure Pv from its normal value Pv,n:
Vv = Vv,n + Cv(Pv − Pv,n) (4.58)
where Vv,n is the normal value and Cv is the compliance of the venous com-
partment, which remains constant. Pv is determined by
Pv =
GvPvs + GnPan
Gn + Gv
(4.59)
Arterial volume Va is defined by the arterial radius r:
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Va = Va,n
(
r
rn
)2
(4.60)
where Va,n is the arterial volume and rn is the arterial radius under normal
conditions. The radius is also controlled by the following relation with the
elastic tensions:
Te + Tm − (P1 − Pic)r = 0 (4.61)
P1 is the average pressure in arteries and veins:
P1 =
Pa + Pv
2
(4.62)
Metabolism
A number of of additions have been made to the metabolic component of the
BrainSignals model. ATP synthesis is simulated in the mitochondrial com-
partment. However, the movement of ADP and ATP out of the mitochondria
is not explicitly modelled. The rate of return of protons through Complex
V is altered from BrainSignals to include protons required to phosphorylate
ATP .
θ = kCV(∆p +
Z
na
log
(
gp
gp,n
)
− ∆pCV0) (4.63)
where na is the number of protons required to phosporylate one ATP molecule
and ∆pCV0 is the proton motive force at which no movement of protons
would be induced. gp is the phosphorylation potential.
gp =
([ADP]/cθ)([Pi]/cθ)
[ATP]/cθ
(4.64)
which is the equilibrium constant for the hydrolysis of ATP. As the concen-
tration of solute is low, the activity is represented by the solute concentra-
tion divided by the standard concentration cθ (1M). Therefore, gp, like other
equilibrium constants is a dimensionless quantity, defined by
gp =
[ADP][Pi]
(1000mM)[ATP]
(4.65)
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The Gibb free energy of ATP hydrolysis is given by
∆G = ∆Go + ZF log(gp) (4.66)
where ∆Go is the standard Gibbs free energy of hydrolysis and F is the
Faraday’s constant. Given the above, the proton motive force at which there
is no net flow of protons, ∆pCV0, is calculated as
∆pCV0 =
−∆Gn
naF
(4.67)
where ∆Gn is the normal value of ∆G . ATP synthesis occurs in the mito-
chondria by Complex V at a rate
LCVVmit
na
(4.68)
The entirety of the TCA cycle is simulated as a single simple diffusion reac-
tion in the model. The rate of this reaction is given by
vTCA[Py][NAD]
(km,tcaN + [NAD])(km,tcaP + [Py])
(4.69)
The km value for pyruvate is small, suggesting that pyruvate concentration
does not greatly influence the TCA cycle unless it is very low. The rate is
also influenced by [ATP] and [ADP], but mainly by the NAD/NADH ratio.
Glycolysis is simplified as a single Michaelis Menten reaction, with maxi-
mum rate vglyc
vglyc =
vglyc,n(I + 1)
1+ I [ATP]
[ATP]n
[AMP]n
[AMP]
(4.70)
where vglyc,n is the normal maximum rate, I relates to the dependency on
AMP and ATP concentrations. Under normal conditions, the rate of glycol-
ysis is set equivalent to the rate of glucose consumption (CMRgluc,n). The
net rate of glucose transport between capillaries and the cell is
vglut
(
[glucc]
[glucc] + kglut
− [gluc]
[gluc] + kglut
)
(4.71)
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where [glucc] and [gluc] are the capillary and cytoplasm glucose concentra-
tions respectively. [glucc] is assumed to be constant. kglut is an average of
different GLUT transporters found in the brain. The maximum rate vglut is
set so that this net rate is equivalent to the normal rate of glucose consump-
tion, CMRgluc,n.
The transport of lactate in and out of the cell is simulated similarly. The net
rate of transport is thus
vMCT
(
[lacc]
[lacc] + kMCT
− [lac]
[lac] + kMCT
)
(4.72)
where [lacc] and [lac] are the capillary and cytoplasm lactate concentrations
respectively, and [lacc] is assumed constant. The maximum rate vMCT is
calculated from the normal rate of lactate consumption, CMRlac,n.
Under normal conditions,
1
6
CMRO2,n − CMRgluc,n = 12CMRlac,n (4.73)
Pyruvate-lactate conversion is simulated as a mass action reaction. This
occurs very fast and so effectively the interchange is at equilibrium. The
rate of this reaction is given by
kpl [Py][H+cyt]− k−pl [lac][NADcyt] (4.74)
where k−pl is a constant and kpl is related to [NADHcyt]. Under normal con-
ditions, the ratio kpl/k−pl is such that the net rate of the reaction is equivalent
to CMRlac,n.
ATP hydrolysis is simulated as a Michaelis Menten reaction, the maximum
rate of which is dependent on a demand parameter, u. Creatine kinase uses
phosphocreatine, PCr, to produce ATP. Adenylate kinase convert ADP to
AMP and ATP. These mass action reactions have rates
kPCr[PCr][ADP][H+cyt]− k−PCr[ATP][Cr] (4.75)
kAK[ADP]2 − k−AK[ATP][AMP] (4.76)
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respectively. These reactions occur at a rate much faster than the others and
so are effectively at equilibrium.
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Table 4.5: BrainPiglet v1.0 model equations
Reaction Equation Type of reaction Compartments
involved
ADP to ATP ADP + Pi→ ATP Simple diffusion Cytoplasm
ATP to ADP ATP→ ADP + Pi Michaelis Menten Cytoplasm
ADP to AMP and ATP 2ADP→ AMP + ATP Reversible mass action Cytoplasm
Oxidative phosphorylation 14H+mit + 4CytCox → 2NAD+ Simple diffusion Mitochondria
4H+mit → 4CytCox + 4a3r Simple diffusion Mitochondria
O2 + 4H+mit + 4a3r → Simple diffusion Mitochondria
Glycolysis 2ADP + 2Pi + gluc→ 2ATP + 2Py Michaelis Menten Cytoplasm
Pyruvate to Lactate Py↔ lac Reversible mass action Cytoplasm
TCA cycle Py + 6NAD → Simple diffusion Mitochondria,
Cytoplasm
Phosphocreatine to ATP PCr + ADP↔ ATP + Cr Reversible mass action Mitochondria
Protons re-enter mitochondrial
matrix (via leak and complex V)
→ H+mit Simple diffusion Mitochondria
Lactate in → lac Rate term Cytoplasm
Lactate out lac→ Michaelis Menten Cytoplasm
Glucose in → gluc Rate term Cytoplasm
Glucose out gluc→ Michaelis Menten Cytoplasm
Oxygen in → O2 Simple diffusion Mitochondria
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4.7.2 Steady state simulations
Steady state simulations in the BrainPiglet model with varying SaO2 show
similar results to BrainSignals (Figure 4.28). Mitochondrial pH also increases
with SaO2, which indicates acidosis caused by hypoxia. Pa also displays
similar results to BrainSignals, including the typical autoregulation curve
with CBF, here with the steady phase around the normal pressure value of
50mmHg.
The effect of demand on the model seems to plateau by u = 2, unlike
BrainSignals (Figure 4.29). Mitochondrial pH is observed to decrease with
increased metabolic activity. Variables increase almost linearly with PaCO2.
4.7.3 Simulating hypoxia-ischaemia
As in the previous section, the BrainPiglet v1.0 model is used here to sim-
ulate the effect of a decrease in oxygen and blood flow (Figures 4.30 and
4.31). Blood pressure was reduced by 40% and SaO2 by approximately
30%. Although baseline parameter values such as blood pressure are dif-
ferent between the adult human BrainSignals model and the BrainPiglet
model, there is a significant difference in the response of the model to the
hypoxic-ischaemic stimulus. The predicted changes suggest more complex
behaviour. Mitochondrial pH is also simulated here, showing a slight drop
during HI as might be expected. NTP/EPP also decreased during HI, fol-
lowing a decrease in metabolism.
4.7.4 Simulating functional activation
The model was also used to produce a functional response, by increasing
the demand parameter u by 20%. Figures 4.32 and 4.33 illustrate the inputs
and predicted changes. The haemoglobin variables, CBF, CMRO2, and TOI
display a slower return to baseline than the others. NTP/EPP decreases due
to the increased use of ATP, and mitochondrial pH decreases as more pro-
tons re-enter the mitochondria through leak channels following increased
oxidative phosphorylation.
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Figure 4.28: Steady state simulations of the BrainPiglet v1.0 model with varying
arterial oxygen saturation SaO2 (a–f) and blood pressure Pa (g–l).
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Figure 4.29: Steady state simulations of the BrainPiglet v1.0 model with varying
demand u (a–f) and partial pressure of carbon dioxide PaCO2 (g–l).
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Figure 4.30: Inputs to BrainPiglet v1.0 to simulate hypoxia-ischaemia. (a) Blood
pressure, Pa, and (c) arterial oxygen saturation, SaO2 are reduced temporarily while
(b) partial pressure of carbon dioxide, PaCO2 and (d) the energy demand, u are kept
constant.
4.8 Discussion
Mathematical models are a valuable medium to further our understanding
of complex behaviour. As discussed at the start of this chapter, there are a
number of considerations to be taken into account in the construction and
application of models in biology. There exist discrepancies between the na-
ture of functioning in and advancement of the two fields. Biological models
incorporate significantly more guesswork than a strict mathematician would
like to admit and be comfortable with. However, this very balance of detail
and often plausible but subjective assumptions is one of the most important
skills of a good modeller.
It is sometimes necessary to clarify the value of systems biology models
such as those presented in this thesis. Models provide a method for bring-
ing pieces of information together, to understand the relationships between
them, and to derive and translate the cumulative reasoning. These models
are not meant to be stand-alone directors of intelligence, but are meant to
be used in conjunction with other sources of information – such as measure-
ment data – to aid overall understanding. They aim to add value, not to be
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Figure 4.31: Outputs of BrainPiglet v1.0 simulation of hypoxia-ischaemia. Changes
in (a,b,c) oxy-haemoglobin deoxy-haemoglobin and total haemoglobin, ∆HbO2,
∆HHb, ∆HbT and (d) oxidised cytochrome-c-oxidase ∆oxCCO. Percentage change
in (e) cerebral blood flow, CBF, (f) cerebral metabolic rate of oxygen consumption
CMRO2 and (g) tissue oxygenation index, TOI. (h) Mitochondrial pH and (i) per-
centage change in NTP/EPP.
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Figure 4.32: Inputs to the BrainPiglet v1.0 model to simulate brain activation. (a)
Blood pressure, Pa, (b) partial pressure of carbon dioxide, PaCO2 and (c) arterial
oxygen saturation, SaO2 are kept constant while (d) the energy demand, u is in-
creased temporarily.
the sole perpetrators of it.
A mathematical model’s core characteristic can also be its greatest downfall.
Parameter values govern model behaviour, but in a biological world, these
values are often vague or non-existent. This is a powerful argument for
model simplicity.
There are a number of good models of cellular metabolism. Both the Cloutier
and Orlowski models, being related, have very similar mechanisms but
their implementation is focused on different applications and hence different
model behaviours. The Cloutier model was created primarily to investigate
the effect of neuronal stimulation, and so can provide interesting results of
short-term changes in ATP and other metabolites in astrocytes and neurons.
The Orlowski model is primarily used to investigate stroke, and so focuses
more on the long-term changes. Its simulation of hypoxia-ischaemia in par-
ticular showed interestingly different results compared to the ischaemia only
simulation.
The Beard and Korzeniewski models are focused on mitochondrial activity
and hence necessarily limited in the simulations they offer. However, both
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Figure 4.33: Outputs of the BrainPiglet v1.0 model simulation of brain activation.
Changes in (a,b,c) oxy-haemoglobin deoxy-haemoglobin and total haemoglobin,
∆HbO2, ∆HHb, ∆HbT and (d) oxidised cytochrome-c-oxidase ∆oxCCO. Percent-
age change in (e) cerebral blood flow, CBF, (f) cerebral metabolic rate of oxygen
consumption CMRO2 and (g) tissue oxygenation index, TOI. (h) Mitochondrial pH
and (i) percentage change in NTP/EPP.
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models exhibit similar behaviour during hypoxia. The circulatory Ursino-
Lodi model also displays interesting vascular behaviour during ischaemia.
In running and implementing these models the role of the model environ-
ment was quite evident. The Orlowski model was run in the OpenCell
environment and set up in such a way that allowed the user to observe the
effect of disrupting parameter values from their norm. On the other hand
the Cloutier model, run on our in-house interface BCMD, could be run on a
series of input data. This enables a greater ability to probe the model, using
complex, time-dependent inputs. Similar observations were made with the
hypoxia simulations run on the Beard (OpenCell) and Korzeniewski (Brain-
circ) models. Therefore, the value of a model can sometimes be constrained
simply by the computational environment in which it exists.
The UCL models have been developed with a definitive scope in mind – to
investigate data produced by clinical systems that have also been developed
by the group. They are hence at an advantage, by having real clinical data to
ground the model throughout the building process. Braincirc, BrainSingals
and BrainPiglet have all been driven by data collected during various clinical
experiments conducted by the group. BrainSignals is the simplest of the
three, and a very effective predictor of haemodynamics in the adult brain,
simulating ∆HbT, ∆HbO2, ∆HHb, ∆CCO, CBF and CMRO2. BrainPiglet
on the other hand incorporates more of the metabolic activity in the cell
and therefore can display, in addition to more predictions, more complex
results. BrainPiglet v1.0 adds predictions of mitochondrial pH and ATP (or
NTP). Both models are able to simulate changes that occur during functional
activation and hypoxia-ischaemia as illustrated in this chapter, however it
must be noted that this is not exhaustive of the model’s capabilities.
It is difficult to categorise the UCL models within the phenomenological
and mechanistic characteristic framework. They are phenomenological by
their nature of being data-driven, but also mechanistic by incorporation of
the biochemistry that gives rise to the changes observed. Indeed this charac-
terisation depends on the modelling process rather than solely on the stand-
alone model itself. If model results are compared to experimental or clinical
data and this feeds back into the model building process, than the model
could be said to have phenomenological or top-down characteristics. The
amount of detail incorporated in these models also depends heavily on the
application. For example the Cloutier and Orlowski models differ between
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astrocytes and neurons, whereas in the UCL models this is not an important
differentiation to make, because the measurement techniques don’t either
(among other reasons).
Nearly all of the models mentioned in this chapter have been based on others
and since publication have inspired even more models. Thus many systems
biology models are often connected by a hidden underlying framework, and
the design choices made in one are easily transferred to another regardless of
the intended applications. It is hard to determine whether this has any real
detrimental effect on the new application of the model, but it is important
to be mindful of this in the implementation.
The optimisation of large systems biology models is a difficult task. The
models presented in this thesis have been optimised using the PSwarm al-
gorithm to select the best value for each of the parameters considered to
be influential in the model (as suggested by the sensitivity analysis Morris
method). It is necessary in this context to define the range of values for each
parameter. However, this is more easily said than done. Where parameter
values can be determined from literature, they vary greatly from one source
to another. In cases where the values are not available, the range is at best an
educated guess. This process determines the boundaries of the multidimen-
sional space in which a model exists. There is no guarantee however, that
the combination of parameter values selected by the algorithm, and hence
the trajectory of model behaviour within the space, is biologically feasible.
These important considerations must be taken into account in the translation
of model results.
The next chapter describes the extension and further development of the
BrainPiglet model to simulate intracellular pH.
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Developing the BrainPiglet
model to simulate intracellular
pH
The role of pH in brain injury is of considerable clinical interest. Changes
in pH can alter protein structure, vital to many cellular processes. Brain
acidosis is thought to augment cell death under certain conditions. pH
is also known to become more acidic in hypoxic-ischaemic environments,
while alkalosis following hypoxia-ischaemia has been correlated with ad-
verse outcome (often leading to secondary energy failure) (Robertson et al.
2002). Recent hypoxia-ischaemia experiments conducted in piglets collected
both NIRS and MRS measurements of metabolites during and in the after-
math of the insult. The MRS measurements also provided an estimate of
cerebral pH. In order to investigate these further, the simulation of pH in
the BrainPiglet model was improved.
This chapter details the extension of the BrainPiglet model for its appli-
cation to measurement data from the piglet experiments. The model was
developed incrementally in three phases, by incorporating biochemical pro-
cesses known to influence pH in the cell. The effects of these additions are
analysed at each stage.
130
5.1. Hypoxia-ischaemia piglet experiments
5.1 Hypoxia-ischaemia piglet experiments
A novel multi-modal measurement technique, combining both near-infrared
spectroscopy and magnetic resonance spectroscopy, was used to monitor
cerebral metabolism and haemodynamics in newborn piglets undergoing
a hypoxia-ischaemia insult. This data provides a valuable insight into the
changes that occur during and in the aftermath of a hypoxia-ischaemia event
in the neonatal brain. The protocol is detailed in the next chapter, which cov-
ers simulations of the experiments. To summarise briefly here, both blood
flow to brain and inspired oxygen were reduced during the insult phase and
subsequently returned to normal. Both NIRS and MRS measurements were
continuously recorded during the experiment.
5.2 BrainPiglet v2.0
The development of the model was carried out in three phases, all focused
on the capacity of the model to simulate intracellular pH. This section details
the first phase.
5.2.1 Modelling intracellular pH
The BrainPiglet model was extended to improve the simulation of mito-
chondrial pH and to simulate a varying cytoplasmic pH. A number of pre-
existing reactions in the model were altered to include the main H+ dy-
namics in the cell - these are listed below. The water produced by these
reactions was ignored as water is not currently simulated in the model and
its addition would complicate it further, requiring more complex revision.
Oxidative phosphorylation
2NADH + 14H+mit + 4CytCox → 2NAD+ + 4CytCred + 16H+cyt (5.1)
4CytCred + 4H+mit + 4a3o → 4CytCox + 4H+cyt + 4a3r (5.2)
O2 + 4H+mit + 4a3r → 4a3o (5.3)
Glycolysis
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Figure 5.1: Schematic of the BrainPiglet v2.0 model.
2ADP + 2Pi + gluc + 2NAD+ → 2ATP + 2Py + 2NADH (5.4)
Tricarboxylic acid cycle
Py + 5NAD+ + H+cyt → 4H+mit (5.5)
Pyruvate to lactate
Py + H+cyt −⇀↽− lac + NADcyt (5.6)
Lactate transport in and out of the cell
→ lac + H+cyt (5.7)
lac + H+cyt → (5.8)
The corresponding rates of reactions have also been modified to include
protons.
132
5.2. BrainPiglet v2.0
Malate-aspartate shuttle
The malate-aspartate shuttle facilitates the movement of electrons across
the mitochondrial membrane and involves the interconversion of NAD and
NADH on either side (see Section 2.4.4 and Figure 2.7). A simplified repre-
sentation of this process was also incorporated into the model:
H+cyt + NAD
+ + NADHcyt → H+mit + NADcyt + NADH (5.9)
The malate-aspartate shuttle is simulated as a mass action process. The rate
of this reaction is given by
kMAshut[H+cyt][NAD]− k−MAshut[NADcyt][H+mit] (5.10)
The buffering of H+ ions in the cytoplasm is simulated in a similar way to
those in the mitochondria, with an identical value for dpH and a slightly
higher value of Cbu f f ,c as in Korzeniewski and Zoladz (2001).
Figure 5.2: Movement of H+ ions in the BrainPiglet v2.0 model.
The normal value of pH in the cytoplasm was set at 7.00. The normal mi-
tochondrial pH was increased to 8.00 (from the previous value of 7.40) to
reflect values found in Casey et al. (2010).
5.2.2 Modelling arterial occlusion
In order to accurately simulate hypoxia-ischemia, the model was also ex-
tended to simulate occlusion of the carotid arteries. This work detailed
below, and included in this version of the model, was carried out by Tracy
Moroz (Moroz et al. 2012, 2013).
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An additional arterial compartment, simulating the carotid and vertebral ar-
teries was introduced. This compartment directly supplies the main arterial
compartment and has a conductance G0. Consequently, simply reducing
G0 simulates occlusion of the arteries, and decreases the pressure of blood
supplied to the brain. The pressure of the carotid and vertebral arteries is
denoted by Pa while this pressure of the cerebral arteries is now denoted as
Pa2, and can be calculated by equating the blood flow in the two compart-
ments;
G0(Pa − Pa2) = 2G(Pa2 − P1) (5.11)
where P1 is the average pressure. Vv is now dependent on pressure;
Vv = Vv,n + Cv(Pv − Pv,n) (5.12)
where Pv and Pv,n represent venous blood pressure at the start of the com-
partment, with the latter under normal conditions. Cv is the compliance of
the venous compartment, which remains constant. Pv can be calculated from
the conductance of the veins Gv as a fraction of the total conductance Gt;
Pv =
Gt
Gv
(Pa − Pvs) + Pvs (5.13)
where Pvs is the constant pressure at the venous sinuses and
Gt =
GG0Gv
GG0 + GGv + GvG0
(5.14)
The radius in the elastic tension relationship r0 (see equation 4.15) is now
determined by
r0 = (1− r f racrocc) (5.15)
where rocc and r f rac are the fractions by which the radius of the carotid ar-
teries and the supplying artery compartment respectively has been reduced.
r f rac is given by
1− c f rac = (1− r f rac)4 (5.16)
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where c f rac is the fraction of arterial blood which flows through the carotid
arteries under normal conditions. To simulate occlusion, G0 is determined
by
G0 = G0,n(1− c f rac) (5.17)
where G0,n is the conductance when there is no occlusion, which can be
calculated by
G0,n = G0,ratGn (5.18)
Gn is the normal conductance of the cerebral arterial compartment. The
ratio G0,rat was set by observing the results of model simulations. With a
high G0,rat, CBF remains high until the conductance is only a small fraction
of its normal value. When G0,rat is low, the relationship is more linear. A
value of 10.0 was thus chosen for G0,rat.
Copyright material removed.
Figure 5.3: Circuit diagram of circulation in the BrainPiglet v2.0 model (Moroz et al.
2012)
5.2.3 Steady state simulations
The model behaviour at steady state is quite similar to that in BrainPiglet
v1.0 for CBF, blood volume and TOI (Figures 5.4 and 5.5). Acidosis in the
mitochondria at low values of SaO2 is much more pronounced in Brain-
Piglet v2.0 than in v1.0. Cytoplasmic pH is also similarly affected. Very
little change in pH is observed with changes in blood pressure. pH is seen
to decrease with increasing demand u. However mitochondrial pH is ob-
served to reach a maximum around u = 1, the normal value of demand,
and decrease as u drops below 1. This may be due to the low metabolic rate,
and the movement of protons from cytoplasm to the mitochondria. Indeed
cytoplasmic pH rises slightly above the normal value of 7.00 for u < 1. pH
increases with PaCO2 in both mitochondria and cytoplasm.
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Table 5.1: New parameters in BrainPiglet v2.0
Parameter Description Value Source
KmglucNN Km for NAD in the carica-
ture of glycolysis
1.0 Banaji et al.
(2005)
KeqMAshut Equilibrium constant for the
malate-aspartate shuttle
10.0 Banaji et al.
(2005)
NADcytn Normal concentration of
NAD in the cytoplasm
359 mM Williamson et al.
(1967)
NADHcytn Normal concentration of
NADH in the cytoplasm
50 mM Williamson et al.
(1967)
G0,rat Ratio between the conduc-
tance of the cerebral arter-
ies and the supplying artery
compartment
10.0 Determined from
model simula-
tions
It must be noted here that the simulation of demand in the model has been
implemented with the intension of investigating increases in demand be-
yond the normal - at a resting state. Hence, the effect of a lower than normal
demand (u < 1) has not been investigated or tested, and it not a focus of
the group’s current research. It is nevertheless interesting to observe these
changes.
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Figure 5.4: Steady state simulations of the BrainPiglet v2.0 model with varying
arterial oxygen saturation SaO2 (a–e) and blood pressure Pa (f–j).
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Figure 5.5: Steady state simulations of the BrainPiglet v2.0 model with varying
demand u (a–e) and partial pressure of carbon dioxide PaCO2 (f–j).
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5.2.4 Simulating hypoxia-ischaemia in piglets
In order to test the performance of the new model, it was run using a data
set from the piglet experiments (Piglet LWP173).
Sensitivity analysis and optimisation
First the model parameters need to be optimised to the data set, so a sensi-
tivity analysis using the Morris method was conducted. Table 5.2 displays
the results - parameters ranked by importance for each of the variables that
we are interested in optimising (∆HbO2, ∆HHb, ∆oxCCO and cytoplasmic
pH, pHo). For brevity, the table only includes the 10 top parameters for each
variable. Based on this ranking, 6 parameters were selected to be optimised.
These are indicated by an asterisk in Table 5.2. Parameters related to the reg-
ulation of blood flow feature heavily for ∆HbO2 and ∆HHb. Although the
parameter controlling the sensitivity of autoregulatory stimuli to demand
Rautu ranks first for cytoplasmic pH pHo, it was not selected to be optimised
as demand is not thought to change in this experiment. The concentration
of cytochrome in tissue [CCO]tis is not very well defined in literature. Thus
this parameter was also selected, to gain a better understanding of how it
may vary in piglets before and after hypoxia-ischaemia.
Measurements were divided into two sections, with the start of titration as
the dividing point (see protocol in Figure 6.1). This is done in an attempt
to represent the state of the brain before and after the insult, so that the
parameter optimisation process may expose the specific cerebral physiology
that has been altered during the hypoxic-ischaemic insult. The division
here is obviously not definitive – it is hard to pinpoint the exact moment
when injury or irreversible change occurs. As this period of uncertainty is
relatively small compared to the rest of the signal, it is conceivable that the
optimisation will not be greatly affected. There are a number of continuous
processes that occur in the brain, regardless of health. The aim here is to
gauge average overall changes during the experiment.
Simulations of ∆HbO2, ∆HHb and ∆oxCCO were compared with their coun-
terpart NIRS measurements. Simulated cytoplasmic pH pHo was compared
with the phosphate-derived pH measurement. The ATP-derived pH mea-
surement was not used for optimisation as the measurement was signifi-
cantly more noisy. The optimised parameter values are presented in Table
139
5.2. BrainPiglet v2.0
5.3. Before the insult, the autoregulation constant has been reduced signif-
icantly from the normal value. This could be due to an abnormality in the
piglet, or an underdeveloped autoregulative capacity. The concentration of
CCO has been significantly increased compared to normal (0.00566 mM vs.
0.0022 mM). The normal mitochondrial pH in also slightly higher (7.81 vs.
7.4). The largest change in value over the course of the insult was in the
NADpool parameter (+50%). The autoregulation constant also reduced by
approximately 30%.
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Table 5.2: Sensitivity analysis of BrainPiglet v2.0 using data from Piglet LWP173. Parameters ranked in order of influence in optimising
selected output variables. Asterisks indicate parameters selected for optimisation.
Variable Parameter Description
HbO2 HHb ∆ oxCCO pHo
1 1 kaut* Autoregulation constant
2 2 Pa,n* Normal arterial blood pressure
3 3 7 rm* Value of vessel radius giving maximum muscular tension
4 4 Pa Arterial blood pressure
5 5 PaCO2,n Normal arterial partial pressure of CO2
6 6 8 5 σcoll Value of pressure at which vessels collapse
7 7 h0 Vascular wall thickness when radius is r0
8 8 Volmit Fraction of brain water which is mitochondria
9 9 11 SaO2n Normal saturation of the arterial haemoglobin
10 10 7 19 rn Normal radius of blood vessels
11 11 6 4 rt Parameter in the muscular tension relationship
13 9 2 NADcyt,n* Normal concentration of NAD in the cytoplasm
13 10 NADHcyt,n Normal concentration of NADH in the cytoplasm
1 9 pHmn* Normal mitochondrial pH
2 KmglucNgl Km for glucose in the caricature of glycolysis
3 ck2 Controls sensitivity of forward rate of the second oxidative phosphorylation
reaction to the proton motive force
4 CVinh Control parameter representing the action of complex V inhibitors
5 klk2 Controls rate at which protons reenter the mitochondrial matrix through leak
channels
10 a f rac,n Normal oxidised fraction of CuA
1 Rautu Controls sensitivity of autoregulatory stimuli to demand
3 NADpool* Total mitochondrial NAD and NADH concentration
6 nm Exponent in the muscular tension relationship
8 pHon Normal cytoplasmic pH
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Table 5.3: Optimised BrainPiglet v2.0 parameter values for Piglet LWP173
Parameter Description Normal
Value
Before
Insult
After
Insult
%
Change
kaut Autoregulation constant 1.0 0.582 0.404 -30.6
Pa,n Normal arterial blood
pressure
50
mmHg
45.0 46.4 3.11
pHm,n Normal mitochondrial
pH
7.4 7.81 8.15 4.35
NADcytn Normal concentration of
NAD in the cytoplasm
359.0
mM
318.0 400.0 25.8
NADpool Total mitochondrial NAD
and NADH concentra-
tion
3.0 mM 2.4 3.60 50.0
rm Value of vessel radius
giving maximum muscu-
lar tension
0.027
cm
0.0304 0.0324 6.58
[CCO]tis Concentration of cy-
tochrome in tissue
0.0022
mM
0.00566 0.00620 9.54
Model simulation
SaO2 and blood pressure Pa measurements from the piglet were used as
model inputs (Figure 5.6). During occlusion, a sharp drop is observed in
SaO2 and Pa, leading to a hypoxic-ischaemic environment. Following re-
moval of the occlusion, blood flow and oxygenation recover back to near-
baseline levels. The fraction rocc was also increased to 1.0 during the occlu-
sion phase to simulate complete occlusion of the carotid arteries.
The optimised parameter values for the section before the insult were used
at the start of the run, and were gradually changed to the optimised values
for the section after the insult. This change occurs over a period of 1 minute,
from the start of titration.
Figure 5.6 illustrates the model simulations of ∆HbO2, ∆HHb, ∆HbT, ∆oxCCO
plotted against corresponding measurements from the piglet experiment for
comparison. Both optimised and non-optimised simulations are presented
here. The model is able to simulate the drop in ∆HbO2, ∆HbT and ∆oxCCO,
and the rise in ∆HHb. In particular, model optimisation has greatly im-
proved the simulation ∆oxCCO.
Simulations of ∆CBF and ∆CMRO2 indicate a drop, as may be expected,
during the insult phase. The model simulation of cytoplasmic pH is com-
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pared with the the two pH measurements - that calculated from phosphate
and ATP. Both measurements indicate a more acidic pH during the insult
phase, although the ATP measurement is very noisy. Simulated mitochon-
drial pH indicates an alkaline rise in pH towards the end the insult. How-
ever the optimised simulation differs significantly, with a much more pro-
nounced acidic drop immediately afterwards followed by a slow recovery.
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Figure 5.6: Simulating hypoxia-ischaemia in Piglet LWP173 using the BrainPiglet
v2.0 model. Vertical lines indicate the start and end of occlusion of the carotid ar-
teries. (a) SaO2 and (b) blood pressure Pa measurements are model inputs. (c,d,e,
f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT and ∆oxCCO. (g,h)
Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic pH compared with
measured (i) phosphate-derived pH and (j) ATP-derived pH. (k) Simulated mito-
chondrial pH. 144
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5.3 BrainPiglet v2.0.1
5.3.1 Modelling carbonic acid
The association and dissociation of intracellular carbonic acid is expected to
significantly affect intracellular proton concentration. The following equa-
tion models the dissolution of CO2 and the dissociation of carbonic acid
H2CO3 in the cytoplasm as a mass action reaction:
CO2cyt
kCHi−−⇀↽ −
knCHi
HCO−3cyt + H
+
cyt (5.19)
where knCHi and kCHi are calculated from the half time value. Similarly in
the mitochondria:
CO2mit
kCHm−−−⇀↽ −
knCHm
HCO−3mit + H
+
mit (5.20)
CO2 diffuses into and out of the mitochondria:
CO2cyt
kCO2shut−−−−⇀↽ −
kCO2shut
CO2mit (5.21)
where kCO2shut is set so that when there exists a concentration gradient, the
net rate is equivalent to CMRO2. Carbonic acid H2CO3 also moves into and
out of the mitochondria:
HCO−3cyt
knBiCshut−−−−⇀↽ −
kBiCshut
HCO−3mit (5.22)
The rate of this mass action reaction is determined by half-time and equilib-
rium data. Diffusion of CO2 out of the cell is simulated by:
CO2cyt
kCO2out−−−→ (5.23)
The rate kCO2out is set so that at equilibrium the rate is equivalent to CMRO2.
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Tricarboxylic acid cycle
The TCA cycle was also updated to include the production of CO2:
Pyruvate + 5NAD+ + H+cyt
kTCA−−→ 4H+mit + 3CO2mit (5.24)
Table 5.4: New parameters in BrainPiglet v2.1
Parameter Description Value Source
kCHmht halftime for the produc-
tion of carbonic acid in
mitochondria
25 mM Banaji et al. (2005)
kCHiht halftime for the produc-
tion of carbonic acid in
cell cytoplasm
3.2 mM Banaji et al. (2005)
kCHeq equilibrium constant for
the production and disso-
ciation of carbonic acid
7.9e-4 mM Banaji et al. (2005)
kBiCshutht the rate of transfer of bi-
carbonate ions from cyto-
plasm to mitochondria
2.2e3 mM Banaji et al. (2005)
PtCO2 partial pressure of CO2 in
tissue
54 mmHg Banaji et al. (2005)
henryCO2t solubility of CO2 in tissue 0.038
mM/mmHg
Banaji et al. (2005)
5.3.2 Steady state simulations
The behaviour of the BrainPiglet v2.0.1 model at steady state for SaO2 and
blood pressure Pa are very similar to that of v2.0 (Figure 5.7). However,
the addition of carbonic acid has affected the behaviour of the model at
lower than normal demand (u < 1), with pH rising to become more alkaline
at lower demand (Figure 5.8). Cytoplasmic pH also drops much faster as
demand increases in the new model, even beyond feasibility into negative
numbers around (u = 3).
With PaCO2, model behaviour remain similar to v2.0 (Figure 5.8). There is a
slight difference in sensitivity of Cytoplasmic pH, with a slower decrease as
PaCO2 decreases. Mitchondrial pH at PaCO2 values below normal (less than
40) shows irregular behaviour, which is an indication of increased complex-
ity of the model.
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Figure 5.7: Steady state simulations of the BrainPiglet v2.0.1 model with varying
arterial oxygen saturation SaO2 (a–e) and blood pressure Pa (f–j).
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Figure 5.8: Steady state simulations of the BrainPiglet v2.0.1 model with varying
demand u (a–e) and partial pressure of carbon dioxide PaCO2 (f–j).
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5.3.3 Simulating hypoxia-ischaemia in piglets
The model was applied to measurement data from Piglet LWP173, as before,
to test the performance of the new additions.
Sensitivity analysis and optimisation
Table 5.5 displays the sensitivity analysis results for the altered model, us-
ing data from Piglet LWP173. The 10 most influential parameters are shown
here for each of the four variables. Consequently, 6 parameters (indicated by
an asterisk in Table 5.5) were selected to be optimised, along with the con-
centration of cytochrome in tissue [CCO]tis as before and the autoregulation
constant kaut, to gauge the autoregulative capacity of the piglet. It is notice-
able here that parameter influence is more convoluted than in BrainPiglet
v2.0.1.
As with BrainPigletv2.0, the optimised autoregulation constant was lower
than normal, and decreased after the insult. The optimised concentration of
CCO was again higher than the normal value in the model and increased
during the insult. The largest changes were in NADpool and Volmit which
both increased by 50%.
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Table 5.5: Sensitivity analysis of BrainPiglet v2.0.1 using data from Piglet LWP173. Parameters ranked in order of influence in optimising
selected output variables. Asterisks indicate parameters selected for optimisation.
Variable Parameter Description
HbO2 HHb ∆ oxCCO pHo
1 1 Pvs* Pressure in the venous sinuses
2 2 18 13 SaO2n Normal saturation of the arterial haemoglobin
3 7 9 3 nm* Exponent in the muscular tension relationship
4 9 13 18 knADPATP Backward rate for conversion of two molecules of ADP to one of ATP and
one of AMP
5 3 16 10 σcoll* Value of pressure at which vessels collapse
6 4 InhglucN Controls how strongly the AMP/ATP ratio inhibits the conversion of glucose
to pyruvate
7 5 rCV Controls ratio of maximal to minimal rates of oxidative phosphorylation
8 6 Cbu f f i Buffering capacity for protons in mitochondria
9 8 6 5 Pa Arterial blood pressure
10 17 Kσ Controls sensitivity of elastic stress in vessel walls to radius
12 15 5 9 r0 A special radius in the elastic tension relationship
13 20 10 4 Pic Intracranial blood pressure
14 14 3 7 c3* Controls the sensitivity of the third oxidative phosphorylation reaction to the
proton motive force
15 10 blood f rac Normal blood volume as a fraction of brain tissue volume
16 18 17 8 kaut* Autoregulation constant
17 12 7 6 phi Value of O2 at half maximal saturation
13 2 1 NADpool* Total mitochondrial NAD and NADH concentration
16 8 2 u Demand
1 Volmit* Fraction of brain water which is mitochondria
4 11 na Number of protons passing through Complex V for each ATP synthesised
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Table 5.6: Optimised BrainPiglet v2.0.1 parameter values for Piglet LWP173
Parameter Description Normal
Value
Before
Insult
After
Insult
%
Change
Pv,s Pressure in the venous si-
nuses
1.5
mmHg
1.22 1.20 -1.64
nm Exponent in the muscular
tension relationship
1.83 1.46 2.20 50.7
Volmit Fraction of brain water
which is mitochondria
0.067 0.0536 0.0804 50.0
NADpool Total mitochondrial NAD
and NADH concentra-
tion
3.0 mM 2.4 3.60 50.0
c3 Controls the sensitivity of
the third oxidative phos-
phorylation reaction to
the proton motive force
0.11
m/V
0.0880 0.0880 0
σcoll Value of pressure at
which vessels collapse
62.79
mmHg
75.3 75.3 0
kaut Autoregulation constant 1.0 0.687 0.567 -17.5
[CCO]tis Concentration of cy-
tochrome in tissue
0.0022
mM
0.00593 0.007 18.0
Model simulation
As before, SaO2 and blood pressure Pa measurements from the piglet were
used as model inputs, and the fraction rocc was used to simulate occlusion.
Optimised parameters were used before and after the insult.
Model simulations of the unoptimised model are very similar to that of
BrainPigletv2.0, including the simulation of cytoplasmic and mitochondrial
pH. However, optimisation of the model has not been as successful here. In
both ∆HbO2 and ∆HHb, the baseline of the optimised simulation after the
insult has a significant error compared to the measurements. ∆oxCCO sim-
ulation does not reach the magnitude of the drop measured. The ∆CMRO2
optimised simulation shows a large rise following the insult. Cytoplasmic
pH differs very little after optimisation, and thus does not show an im-
provement. Mitochondrial pH simulation has again changed significantly
after optimisation, with a stronger alkaline rise during the insult, followed
by an acidic drop afterwards.
It appears that the addition of carbonic acid has not improved the simulation
of cytoplasmic pH. For mitochondrial pH, as there is no measurement data
for comparison, the simulation is difficult to validate. Indeed, it seems that
151
5.3. BrainPiglet v2.0.1
with these additions, the efficiency of the optimisation process has been
weakened, most notably for ∆oxCCO.
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Figure 5.9: Simulating hypoxia-ischaemia in Piglet LWP173 using the BrainPiglet
v2.0.1 model. (a) SaO2 and (b) blood pressure Pa measurements are model inputs.
(c,d,e, f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT and ∆oxCCO.
(g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic pH compared
with measured (i) phosphate-derived pH and (j) ATP-derived pH. (k) Simulated
mitochondrial pH.
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5.4 BrainPiglet v2.1
5.4.1 Modelling sodium transporters
Sodium-driven transporters are thought to play an important role in regu-
lating intracellular pH by co-transporting H+ ions across the cell membrane
(see Chapter 2, Section 2.5.1). In order to simulate these, the concentration
of sodium was introduced as a new variable in the model. Transport of
sodium ions into in the cell is governed by:
kNA−−→ Na+ (5.25)
where kNA depends on deviations from the normal intracellular sodium
concentration Nan. The sodium-potassium pump on the plasma membrane
helps maintain a Na+ gradient to drive solute transport:
ATP + 3Na+
Vpp−→ ADP + Pi (5.26)
This Michaelis-Menten reaction has the rate Vpp :
Vpp =
VmaxKATPm(ATP− ATPn)(Na− Nan)3
(KmkATPA + (ATP− ATPn))(Km3kATPNa + (Na− Nan)3)
(5.27)
The Sodium-hydrogen exchanger (NHE) on the membrane is simulated by
the following reaction;
H+cyt
iN HE−−−→ Na+ (5.28)
where the rate iNHE is adapted from Orlowski et al. (2011). The rate is pH-
dependent – NHE is inactive for a pH above 7.2 and reaches a maximum at
6.2 (Orlowski et al. 2011; Helbig et al. 1988; Fuster et al. 2008). It also follows
MichaelisMenten kinetics with respect to the Na+ gradient. Thus,
iNHE =
VmaxNHE(Na+n − Na+)
KmNHE + (Na+n − Na+)
× 1
1+ eNapH(pHo−6.7)
(5.29)
where NapH is a constant. The Sodium bicarbonate cotransporter is mod-
elled by another Michaelis-Menten equation:
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VNaBiC−−−→ Na+ + HCO−3cyt (5.30)
where the rate is defined by
VNaBiC =
VmaxKATPm(Na+n − Na+)(HCO−3cytn − HCO−3cyt)
(KmNaBiC + (Na+n − Na+))(KmNaBiC + (HCO−3cytn − HCO−3cyt))
(5.31)
Figure 5.10 illustrates the proton dynamics in the new model.
Figure 5.10: Movement of H+ ions in the BrainPiglet v2.1 model.
5.4.2 Steady state simulations
As in BrainPiglet v2.0, the steady state behaviour of modelled CBF, blood
volume and TOI are quite similar in v2.1 (Figures 5.11 and 5.12). However,
pH drops less appreciably at low SaO2 and mitochondrial pH exhibits more
linear behaviour at demand u < 1.
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Figure 5.11: Steady state simulations of the BrainPiglet v2.1 model with varying
arterial oxygen saturation SaO2 (a–e) and blood pressure Pa (f–j).
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Figure 5.12: Steady state simulations of the BrainPiglet v2.1 model with varying
demand u (a–e) and partial pressure of carbon dioxide PaCO2 (f–j).
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Table 5.7: New parameters in BrainPiglet v2.1
Parameter Description Value Source
KmKATPA Km for intracellular
ATP for the sodium-
potassium pump
1.4 mM de Lima Santos and
Ciancaglini (2003)
KmKATPNa Km for intracellular
sodium for the sodium
potassium pump
20 mM 12–44 mM Zahler et al.
(1997), 8.3–24.7 mM
Crambert et al. (2000), 11
mM de Lima Santos and
Ciancaglini (2003)
KmNaBiC Km for the sodium-
bicarbonate transporter
10.4 mM Akiba et al. (1986)
KmNHE Km for the sodium-
hydrogen exchanger
33 mM Helbig et al. (1988)
Nan normal concentration of
intracellular sodium
15 mM 15 mM Aubert and Costa-
lat (2002) 5–14 mM Lo
et al. (2006)
NapH constant in the rate of
the sodium-hydrogen ex-
changer
1.0 Orlowski et al. (2011)
VmaxkATPm Vmax for the sodium-
potassium pump
94.2 mM 38.4–150 mM Zahler et al.
(1997)
VmaxNaBiC Vmax for the sodium-
bicarbonate transporter
0.001 mM An estimate. 1.84–2.07
nmol/mg protein/2s Ak-
iba et al. (1987)
VmaxNHE Vmax for the sodium-
hydrogen exchanger
0.01 mM An estimate. 9.2
nmol/mg protein/min
Narins et al. (2004), 1.62
nmol/cm2 sample/min
Helbig et al. (1988)
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5.4.3 Simulating hypoxia-ischaemia in piglets
The model was run with measurement data from Piglet LWP173.
Sensitivity analysis and optimisation
Sensitivity analysis results are displayed in Table 5.8. 5 parameters (indi-
cated by an asterisk) were selected to be optimised, along with the concen-
tration of cytochrome in tissue [CCO]tis and the autoregulation constant kaut,
as with the previous model. It is apparent here that the new parameter rep-
resenting normal sodium concentration Nan has a significant influence on
the four variables.
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Table 5.8: Sensitivity analysis of BrainPiglet v2.1 using data from Piglet LWP173. Parameters ranked in order of influence in optimising
selected output variables. Asterisks indicate parameters selected for optimisation.
Variable Parameter Description
HbO2 HHb ∆ oxCCO pHo
1 1 blood f rac* Normal blood volume as a fraction of brain tissue volume
2 2 1 1 Nan* Normal concentration of sodium
3 3 3 9 Volmit* Fraction of brain water which is mitochondria
4 5 16 7 rt Parameter in the muscular tension relationship
5 4 12 σe0 Parameter in relationship determining elastic stress in vessel walls
6 14 nm Exponent in the muscular tension relationship
7 11 [lac]n Normal concentration of lactate in the cytoplasm
8 10 17 6 NADHcyt,n Normal concentration of NADH in the cytoplasm
9 6 2 3 NADpool* Total mitochondrial NAD and NADH concentration
10 18 rn Normal radius of blood vessels
11 7 Pic Intracranial blood pressure
12 16 20 10 r0 A special radius in the elastic tension relationship
13 9 4 5 rocc Controls occlusion of the carotid arteries
14 8 Cv Compliance of the veins (normalised)
18 13 9 4 u Demand
5 2 NADcyt,n* Normal concentration of NAD in the cytoplasm
6 ck2 Controls sensitivity of forward rate of the second oxidative phosphorylation
reaction to the proton motive force
7 12 Cbu f f i Buffering capacity for protons in mitochondria
8 EN0 NADH standard redox potential
10 18 na Number of protons passing through Complex V for each ATP synthesised
15 8 CMRO2,n Resting cerebral metabolic rate of oxygen consumption
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Table 5.9: Optimised BrainPiglet v2.1 parameter values for Piglet LWP173
Parameter Description Normal
Value
Before
Insult
After
Insult
%
Change
NADcyt Normal concentration of
NAD in the cytoplasm
359.0
mM
318.0 318.0 0
blood f rac Normal blood volume as
a fraction of brain tissue
volume
0.0325 0.0304 0.0336 10.5
NADpool Total mitochondrial NAD
and NADH concentra-
tion
3.0 mM 2.4 3.60 50.0
Volmit Fraction of brain water
which is mitochondria
0.067 0.0536 0.0804 50.0
[CCO]tis Concentration of cy-
tochrome in tissue
0.0022
mM
0.00584 0.007 19.9
kaut Autoregulation constant 1.0 0.689 0.596 -13.5
Nan Normal concentration of
sodium
15.0
mM
15.7 15.1 -3.82
Model simulation
As before, SaO2 and blood pressure measurements from the piglet were
used as model inputs, and the fraction rocc was used to simulate occlusion.
Optimised parameters were used before and after the insult.
The results are very similar to BrainPigletv2.0.1, except in the optimised
simulation of ∆HbT, where the error margin after the insult is much larger
in this model. In short, there has been no visible improvement in the simu-
lation of pH which the addition of the sodium transporters. Instead it has
only further weakened the capacity of the optimisation process.
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Figure 5.13: Simulating hypoxia-ischaemia in Piglet LWP173 using the BrainPiglet
v2.1 model. (a) SaO2 and (b) blood pressure Pa measurements are model inputs.
(c,d,e, f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT and ∆oxCCO.
(g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic pH compared
with measured (i) phosphate-derived pH and (j) ATP-derived pH. (k) Simulated
mitochondrial pH.
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5.5 Discussion
The BrainPiglet v2.0 model incorporates a significant representation of the
movement, use and production of protons within the cell to simulate cyto-
plasmic and mitochondrial pH. The model was able to replicate the steady
state simulations seen in BrainPiglet v1.0, with the addition here of pH. Both
simulations had responses which might have been expected – more acidic
pH at lower oxygenation, blood pressure and PaCO2 and at higher demand.
In the simulation of hypoxia-ischaemia in the piglet, the optimisation of
parameters was necessary to obtain a good prediction of ∆oxCCO, and a
better simulation of the acidic drop in cytoplasmic pH. The optimisation
also significantly altered the simulation of mitochondrial pH, displaying a
more acidic pH following the insult phase.
BrainPiglet v2.0.1 added the dynamics of carbonic acid, however it was
found that these developments did not result in an improvement in model
predictions. Steady state simulation were overall similar to v2.0, but it is in
the simulations of data from the piglet experiments that the true complexity
of the model starts to emerge. First in the sensitivity analysis suggested a
much more complex model than that in v2.0. The optimised model behaved
less accurately in relation to ∆oxCCO and cytoplasmic pH in particular. It
also resulted in larger errors in post-insult values of ∆HbO2 and ∆HHb,
and an unusually large increase in ∆CMRO2 compared to the normal un-
optimised model. These results and the sensitivity analysis suggest that the
increase in model parameters, variables and complexity have made it more
difficult to optimise, and therefore less effective in simulating individual
patients and precise events.
The further development of the model to include sodium transporters –
BrainPiglet v2.1 – did not prove more successful in simulating cytoplasmic
pH during the piglet experiment. The optimised model did not perform bet-
ter than BrainPiglet v2.0.1 or BrainPiglet v2.0. Therefore, in moving forward
to accurately simulate the complete piglet experiments, BrainPiglet v2.0 was
selected. These simulations are presented in the next chapter.
It is reassuring, in some ways, to see that the unoptimised model is capable
of producing good simulations of the measurements . Firstly, this implies
that the underlying physiology of the cell produces the changes observed in
the measurements – a validation of the techniques used to measure clinically
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important metabolites. Secondly, the model with its normal parameters is a
better defined and known system. Optimisation of these variables also takes
a considerable amount of processing power at the moment. For each piglet
data set, the morris sensitivity analysis takes approximately a day and a half
to run on a better than average PC and the parameter value optimisations
take approximately half an hour. These time scales are not conducive to the
possibility of an online system.
The validity of such optimisations of biological parameters are undermined
by the lack of knowledge about how they vary in relation to one another.
Although the optimisations can take into account the individual ranges for
each parameter, it is unknown whether the optimised combination is biolog-
ically plausible. This is likely to augment the differences observed between
optimised simulations and measurements. The ranges prescribed to the pa-
rameters are also constrained by available literature (if any). Furthermore,
the progression of parameters from the optimised values before the insult to
those after the insult may not be compatible with the physiological network
of the cell.
The extensions of BrainPiglet embody the significantly increasing complex-
ity of the models. Figure 5.14 illustrates schematics of v2.1, v2.0.1 and
v2.0 showing all variables and parameters in the model, along with that for
BrainSignals for comparison. These were created using the in-house bcmd
software and GraphViz. What looks like an increasingly artless mess is rep-
resentative of the divergence from the more modular and simpler format of
the BrainSignals model to the more interconnected, intricate and detailed
BrainPiglet model. These differences are naturally a consequence of the bi-
ology the models aim to simulate. In order to increase the capacity of the
model to predict changes in clinically important variables, the models must
become more elaborate. However, as discussed earlier in Chapter 4, a bal-
ance should be achieved between the volume of information that is included
and the complexity and therefore accuracy of the model itself. This is a very
fine theoretical line. Indeed, although BrainPiglet v2.0.1 and v2.1 includes
more of the dynamics thought to be influential in cellular metabolism, espe-
cially in pH dynamics, in practice, the optimised model simulations of the
v2.0 model were overall far more effective and accurate than that observed
in v2.0.1 and v2.1. This is indicative of the greater instability of of the larger
models.
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Figure 5.14: Schematic of variables and parameters in the four models. Rectangles
and circles indicate parameters and variables respectively. Lines represent depen-
dencies.
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Chapter 6
Simulating hypoxia-ischaemia
in the piglet brain
A study in newborn piglets used NIRS and MRS measurements to investi-
gate the metabolic changes that occur in the brain in response to a hypoxia-
ischaemia insult. Although the protocol remained the same, some of these
piglets recovered well immediately following the insult whilst others did
not. The recovery of ∆oxCCO was notably lacking in piglets with poor
outcomes. The underlying differences between these piglets is not entirely
clear. The BrainPiglet model v2.0 was used to investigate the discrepancies
in the recovery of signals in piglets with different outcomes, by simulating
the measurements to better understand the biological network of the cell
that gives rise to the changes observed. Measurement data from 22 piglets
were obtained for this investigation.
In this chapter, the model is first used to simulate measurements from
piglets on an individual basis, initially from 15 piglets with good outcomes
and subsequently from 7 with poor outcomes. The measurements for each
group are then averaged and simulated by the model to examine overall
changes and variations. Model parameters were optimised for each simu-
lation to obtain the best possible fit of the model to the observed measure-
ments, and to gain an insight into possible physiological changes caused by
the insult.
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6.1. Piglet experiments
6.1 Piglet experiments
Experiments were under UK Home Office Guidelines (Animals [Scientific
Procedures] Act, 1986) and approved by the Institute of Neurology, Uni-
versity College London. In this study, 1-day-old piglets were mechanically
ventilated and anaesthetised. Inflatable occluders were surgically inserted
around the carotid arteries. Normal levels of arterial oxygen and carbon
dioxide, blood glucose and heart rate were maintained. Changes (∆) in
concentrations of oxyhaemoglobin and deoxyhaemoglobin (∆HbO2, ∆HHb)
and brain oxidised CCO (∆oxCCO) were monitored using broadband NIRS.
31P-MRS was used to measure changes in concentrations of metabolites such
as inorganic phosphate (Pi), phosphocreatine (PCr) and nucleotide triphos-
phate (NTP – mainly adenosine triphosphate (ATP)). Comparable with nor-
mal clinical practice, systemic variables - arterial blood pressure (Pa), arterial
oxygen saturation (SaO2), breathing rate and heart rate - were continuously
recorded. Firstly baseline 31P-MRS and NIRS were recorded. Transient
hypoxia-ischaemia was then induced (over approximately 1 hour) by in-
flating the carotid artery occluders and reducing fractional inspired oxygen
(FiO2) to 12% from a normal value of 21%. Once β-NTP (mainly adenosine
triphosphate; ATP) had reduced to approximately 40% of baseline, FiO2 was
gradually brought back to normal. This titration was completed over 10-20
minutes and the carotid occluders were then released. 31P-MRS and broad-
band NIRS were acquired every 1 minute throughout hypoxia-ischaemia
and for approximately a further 2 hours to monitor recovery.
The above protocol is illustrated in Figure 6.1. Intracellular pH was calcu-
lated from MRS measurements via two methods, the first using inorganic
phosphate (Pi) and phosphoethanolamine (PEt), and the second using NTP
concentrations. These methods are detailed in Section 3.1.2.
6.2 Sensitivity analysis of the model
As the Morris method of sensitivity analysis is dependent on the input data
used to run the model, each of the 22 data sets was analysed using the
BrainPiglet v2.0 model to investigate the most influential parameters for
each data set. Figures 6.2, and 6.3 detail these results.
For the haemodynamic variables ∆HbO2 and ∆HHb, the results are quite
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Figure 6.1: Experimental protocol for the hypoxia-ischaemia piglet experiments
similar. The exponent in the muscular tension relationship nm, normal con-
centration of oxygen in the mitochondria [O2]n, sensitivity of elastic stress
in vessel walls to radius Kσ, and sensitivity of autoregulatory stimuli to de-
mand Rautu ranked most important among the data sets.
∆oxCCO is more influenced by the normal mitochondrial inner membrane
potential, ∆ψn, normal concentration of oxygen in the mitochondria, [O2]n,
demand u and normal oxidised fraction of CuA, CuA, f rac,n. In comparison
to the other three variables, Cytoplasmic pH, pHo, is strongly influenced by
a larger subset of parameters. At the top of these are the normal value of
pH in the cytoplasm pHo,n, normal concentration of NAD in the cytoplasm
NADcytn, normal arterial oxygen saturation SaO2,n and total mitochondrial
NAD and NADH concentration NADpool.
Following this analysis, 8 parameters were chosen to be optimised, includ-
ing the autoregulation constant kaut and the concentration of cytochrome in
tissue [CCO]tis . These parameters are listed in Table 6.1.
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∆ HbO2
∆HHb
Figure 6.2: Morris method sensitivity analysis of the 22 piglet monitoring data sets
for the ∆HbO2 and ∆HHb variables. Darker shading against an input file indicates
greater sensitivity. Circles and triangles indicate mean and maximum µ* values
respectively for each parameter. The top 25% of most influential parameters are
labelled.
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∆oxCCO
pHo
Figure 6.3: Morris method sensitivity analysis of the 22 piglet monitoring data
sets for the ∆oxCCO and cytoplasmic pH pHo variables. Darker shading against an
input file indicates greater sensitivity. Circles and triangles indicate mean and max-
imum µ* values respectively for each parameter. The top 25% of most influential
parameters are labelled.
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Table 6.1: BrainPiglet v2.0 parameters selected for optimisation to simulate hypoxia-
ischaemia piglet experiments
Parameter Description
∆ψn Normal mitochondrial inner membrane potential
[O2]n Normal concentration of oxygen in the mitochondria
nm Exponent in the muscular tension relationship
Kσ Controls sensitivity of elastic stress in vessel walls to radius
NADcyt,n Normal concentration of NAD in the cytoplasm
[CCO]tis Concentration of cytochrome in tissue
kaut Autoregulation constant
pHo,n Normal value of pH in the cytoplasm
6.3 Individual results
This section details the analysis of data from each of the 22 piglets. NIRS
and MRS data were synchronised and each data set was smoothed using the
MATLAB smooth function (Mat 2013) and some very large spikes most likely
caused by mechanical movements were manually removed. The MRS data
was especially noisy during the insult phase. Signals were then re-sampled
to a resolution of 1 Hz.
Measurements of arterial oxygen saturation (SaO2) and blood pressure (Pa)
from the 22 piglets were input into the model. PaCO2 was not recorded dur-
ing these experiments, however the fraction of inspired carbon dioxide was
maintained constant throughout. Therefore, we have assumed that PaCO2
remains constant at 40mmHg. The times of occlusion of the carotid arteries
(rocc) was also input. At the moment when occlusion of the carotid arter-
ies takes place, the value of the occlusion parameter rocc increases from 0
to 1 over the time period of one minute, returning back to zero when the
occlusion is removed.
In order to investigate potential differences in the metabolic activity, the 22
piglets were divided into two groups according to their recovery immedi-
ately following the hypoxia-ischaemia insult, predominantly in ∆oxCCO.
This approach aims to provide some insight into how the haemodynamic
and metabolic events during hypoxia-ischaemia relate to injury severity.
Outcomes were classified as ’good’ or ’poor’ according to the recovery of
the piglet immediately following the insult. Note that it does not take into
account the overall health of the piglet at the end of the 48-hour monitoring
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period. Table 6.2 details these outcomes.
Table 6.2: Piglet Outcomes
Good Poor
LWP173 LWP183
LWP175 LWP185
LWP179 LWP188
LWP180 LWP207
LWP186 LWP208
LWP198 LWP215
LWP200 LWP218
LWP201
LWP202
LWP204
LWP206
LWP210
LWP211
LWP213
LWP216
6.3.1 Good outcomes
15 piglets exhibited a good recovery immediately following the insult. The
parameters listed in Table 6.1 were optimised for each data set for the base-
line and recovery periods separately as indicated in Figure 6.1 (before and
after the insult). Table 6.3 lists the optimised values for each data set.
The BrainPiglet v2.0 model was run using SaO2 and Pa measurements as
inputs, with optimised parameters gradually changing from baseline to re-
covery values over a period of 3 minutes from the start of titration (see
Figure 6.1). This period of time was selected to minimise fluctuations in
variables caused by sudden changes in parameter values. Figures 6.5 to 6.19
show the 15 data sets compared with model simulations.
Although the same protocol was followed, and these 15 piglets had good
outcomes, there is considerable variation observed in these measurements.
This is perhaps to be expected as with most clinical recordings. These vari-
ations will be revisited in the next section on group analysis where they
are quantified. Considering individual piglets, the parameter optimisations
show changes in pre-insult and post-insult values (Figure 6.4). Normal
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cytoplasmic pH pHon was slightly increased following the insult in most
piglets. The concentration of cytochrome in tissue [CCO]tis showed consid-
erable variation, increasing in some piglets but decreasing in others. The
autoregulation constant kaut decreased following the insult, which may be
expected and is perhaps characteristic of possible injury. The normal con-
centration of oxygen in the mitochondria [O2]n and the normal concentration
of NAD in the cytoplasm NADcyt,n were both decreased in the majority of
the piglets, most likely due to the decrease in oxygen delivery and thus in
oxidative phosphorylation. Similarly, the normal mitochondrial inner mem-
brane potential, ∆ψn reduced in the majority of piglets, but increased in
some. This affects the proton motive force which the rate of the oxidative
phosphorylation reactions are sensitive to (greater ∆ψn leads to faster rates).
The parameter controlling the sensitivity of elastic stress in vessel walls to
the radius Kσ increased in most piglets but decreased in others (hence re-
spectively increasing and decreasing elastic stress). The effect of decreases
in the exponent in the muscular tension relationship nm is however less
straightfoward. nm has a positive or negative effect on the muscular tension
depending on whether the radius is less than or greater than the value of
the constant rt (see Chapter 4, Section 4.6, Equation 4.17). The value of the
radius does change during the simulation, but largely remains higher than
rt. Thus, on average, decreases in nm result in a higher muscular tension.
Increases in elastic and muscular tension in vessel walls result in a larger
radius (see Chapter 4, Section 4.7, Equation 4.61)
In the measurements, the general drop and recovery can be detected in most
piglets, except in LWP200 and LWP210 where although oxygenation recov-
ers, Pa does not. The changes in haemoglobin variables are fairly consistent
across the piglets, with a drop in ∆HbO2 during the insult accompanied by
a rise in ∆HHb. These changes are well simulated by the model, except in
LWP216, where the magnitude of the change is not replicated in the simula-
tion. The decrease in ∆HbT was not well predicted in some piglets (LWP175,
LWP179, LWP180, LWP198). On the other hand two piglets showed a rise
in ∆HbT (LWP209 and LWP216) which as not well replicated in the simula-
tions. In LWP200, the model predicts a poorer recovery than that observed
in ∆HHb and ∆HbT.
The magnitude of the drop in ∆oxCCO is relatively well simulated across
the piglets. In LWP206 and LWP209 the model predicts a smaller drop and
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better recovery than that observed. Simulated ∆CBF and ∆CMRO2 also
showed a drop during the insult in most piglets. In four piglets, CBF did
not recover quite so well (LWP180, LWP198, LWP200 and LWP206).
There were considerable differences in the two pH measurements, although
both generally displayed more acidic values in response to the insult. There
was a wider variation in the measured pH values than that simulated. The
nadir of the drop in modelled pH was often reached at the end of the in-
sult, whereas the measurement nadir was not always thus defined. The
magnitude of the drop in pH was well simulated in some piglets (such as
LWP173, LWP200, LWP201, LWP206) while in some the drop of simulated
pH was insufficient (LWP 198, LWP204). In some cases the simulation better
suited one measurement and not the other (such as in LWP175) or the mea-
surements were very noisy making it difficult to compare with simulations
and optimise simulations against them (LWP204, LWP216). Note here that
only the phosphate-derived pH measurement was used for optimisation, the
ATP-derived measurement was not.
Simulated mitochondrial pH also displayed a lot of variation between the
piglets, generally registering a small rise during the insult phase and a sub-
sequent drop immediately afterwards. It remained more acidic in the pe-
riod following the insult phase in most piglets, except in LWP173, which
displayed a slow recovery back to baseline values.
Table 6.3: Optimised parameter values
Normal mitochondrial inner membrane potential, ∆ψn
Normal value: 145
Piglet Before Insult After Insult % Change
173 150 150 0
175 150 128.2890 -14.4740
179 150 129.5580 -13.6280
180 150 145.5670 -2.9553
186 127.8410 150 17.3332
198 127.3560 137.0320 7.5976
200 150 141.4520 -5.6987
201 150 150 0
204 150 150 0
206 150 148.4290 -1.0473
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209 150 150 0
210 149.9990 125 -16.6661
211 150 150 0
213 150 150 0
216 125 136.7530 9.4024
Average 145.3464 142.8053 -1.7483
Concentration of cytochrome in tissue, [CCO]tis
Normal value: 0.0022
Piglet Before Insult After Insult % Change
173 0.0050 0.0064 26.6460
175 0.0066 0.0070 5.9660
179 0.0070 0.0070 -0.0334
180 0.0053 0.0065 23.3449
186 0.0052 0.0010 -80.6733
198 0.0070 0.0013 -81.0393
200 0.0061 0.0070 13.8807
201 0.0030 0.0022 -25.6047
204 0.0062 0.0070 13.7381
206 0.0070 0.0070 -0.0021
209 0.0070 0.0070 -0.0021
210 0.0047 0.0070 49.8721
211 0.0062 0.0070 12.5242
213 0.0070 0.0070 -0.0021
216 0.0050 0.0046 -8.1048
Average 0.0059 0.0057 -3.6854
Autoregulation constant, kaut
Normal value: 1.0
Piglet Before Insult After Insult % Change
173 1 0.9298 -7.0151
175 1 0.4466 -55.3438
179 1 1 0
180 0.9475 0 -99.9999
186 1 1 -0.0012
198 0.6857 0.6857 0
200 0.6191 0.4798 -22.4911
201 1 0.6245 -37.5534
204 1 0.4272 -57.2782
206 1 0.4809 -51.9149
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209 1 0.9262 -7.3822
210 0.7235 0.7235 0
211 1 0.8402 -15.9788
213 1 0.7705 -22.9520
216 1 1 0
Average 0.9317 0.7284 -25.1940
Sensitivity of elastic stress in vessel walls to radius, Kσ
Normal value: 10
Piglet Before Insult After Insult % Change
173 11.0391 12 8.7045
175 10.3736 9.4173 -9.2184
179 8 10.2671 28.3388
180 8.3231 11.9222 43.2421
186 11.3765 11.3699 -0.0580
198 12 8 -33.3333
200 12 12 0
201 8 8 0
204 10.1555 8 -21.2250
206 8 12 50
209 8 8 0
210 12 8 -33.3333
211 9.9259 11.0382 11.2060
213 10.3814 12 15.5913
216 8 10.6646 33.3075
Average 9.8383 10.1786 3.4587
Normal concentration of oxygen in the mitochondria, [O2]n
Normal value: 0.024
Piglet Before Insult After Insult % Change
173 0.0202 0.0192 -4.8011
175 0.0284 0.0192 -32.3813
179 0.0288 0.0278 -3.4319
180 0.0288 0.0203 -29.3962
186 0.0263 0.0192 -26.9981
198 0.0281 0.0192 -31.6595
200 0.0228 0.0192 -15.7107
201 0.0192 0.0192 0
204 0.0271 0.0194 -28.3554
206 0.0248 0.0192 -22.4396
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209 0.0247 0.0192 -22.1500
210 0.0192 0.0288 49.9995
211 0.0268 0.0200 -25.5549
213 0.0248 0.0192 -22.7333
216 0.0288 0.0286 -0.5885
Average 0.0253 0.0212 -16.0973
Exponent in the muscular tension relationship, nm
Normal value: 1.0
Piglet Before Insult After Insult % Change
173 1.4640 2.1960 50
175 2.1960 1.4796 -32.6248
179 2.1960 1.4640 -33.3333
180 2.1960 2.1783 -0.8078
186 1.4641 1.4640 -0.0082
198 2.1953 1.4640 -33.3118
200 2.1942 2.1960 0.0811
201 2.0886 2.1960 5.1427
204 2.1960 1.4640 -33.3333
206 2.1960 2.1960 0
209 2.1960 2.1960 0
210 2.1960 1.4640 -33.3330
211 2.1960 1.6053 -26.8975
213 2.1960 1.4640 -33.3333
216 2.1960 2.1450 -2.3210
Average 2.0911 1.8115 -13.3712
Normal concentration of NAD in the cytoplasm, NADcyt,n
Normal value: 359
Piglet Before Insult After Insult % Change
173 400 399.9990 -0.0002
175 400 318 -20.5000
179 318 318 0
180 400 318.0070 -20.4983
186 399.9930 318 -20.4986
198 399.8830 318.0010 -20.4765
200 400 318.0010 -20.4998
201 399.9990 318.0010 -20.4996
204 400 318.0220 -20.4945
206 399.9990 318 -20.4998
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209 318.0010 400 25.7858
210 400 396.3180 -0.9205
211 318 400 25.7862
213 400 318 -20.5000
216 400 328.7620 -17.8095
Average 383.5917 340.3407 -11.2753
Normal value of pH in the cytoplasm, pHo,n
Normal value: 7
Piglet Before Insult After Insult % Change
173 6.8920 6.9385 0.6746
175 6.8957 7.1765 4.0719
179 7.2564 7.1988 -0.7927
180 6.8920 7.2789 5.6135
186 7.1698 7.1363 -0.4678
198 7.1126 7.1061 -0.0914
200 6.8933 7.1537 3.7770
201 6.9840 7.0580 1.0593
204 7.1604 6.8999 -3.6379
206 6.9114 7.1489 3.4362
209 6.9938 7.1565 2.3259
210 7.1699 6.9663 -2.8395
211 6.9049 7.2031 4.3179
213 6.9509 7.1708 3.1642
216 6.9631 7.2836 4.6036
Average 7.010 7.1250 1.6411
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Figure 6.4: Changes in optimised parameter values for piglets with good outcomes.
Recovery values after the insult compared to values before the insult
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LWP173
Figure 6.5: Piglet LWP173. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP175
Figure 6.6: Piglet LWP175. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP179
Figure 6.7: Piglet LWP179. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP180
Figure 6.8: Piglet LWP180. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP186
Figure 6.9: Piglet LWP186. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP198
Figure 6.10: Piglet LWP198. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP200
Figure 6.11: Piglet LWP200. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
186
6.3. Individual results
LWP201
Figure 6.12: Piglet LWP201. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP204
Figure 6.13: Piglet LWP204. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP206
Figure 6.14: Piglet LWP206. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP209
Figure 6.15: Piglet LWP209. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP210
Figure 6.16: Piglet LWP210. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP211
Figure 6.17: Piglet LWP211. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP213
Figure 6.18: Piglet LWP213. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP216
Figure 6.19: Piglet LWP216. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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6.3.2 Poor outcomes
This section presents results from 7 piglets that did not recover well after the
hypoxic-ischaemic insult. This is evidenced by a lower than baseline value
of the oxygenation measurements, especially∆HbO2, in the aftermath of the
insult. Table 6.4 lists the optimised values. Figures 6.21 to 6.27 illustrate the
data compared with optimised model simulations.
The changes in optimised parameters before and after the insults are quite
similar to that of the good outcome group (Table 6.3). Normal cytoplasmic
pH was slightly increased post-insult in most piglets. Concentration of cy-
tochrome [CCO]tis increased in three piglets, decreased in one and remained
near constant in the others. Autoregulation constant kaut remained constant
in some piglets, and decreased in others. The normal concentration of oxy-
gen in the mitochondria [O2]n and the normal concentration of NAD in the
cytoplasm NADcyt,n both reduced in the majority of the piglets. The param-
eter controlling the sensitivity of elastic stress in vessel walls to the radius
Kσ increased in most piglets but decreased in two. The normal mitochon-
drial inner membrane potential ∆ψn decreased in some piglets but stayed
near constant in others. However, the main difference in the poor outcome
group is the lack of change in exponent of the muscular tension relationship
nm, which suggests that the muscular tension of vessel walls did not alter
significantly after the insult.
The piglets in the poor outcome group displayed a drop in SaO2 and Pa dur-
ing the insult, except in LWP215, where an increase in Pa was recorded, and
in LWP218 where Pa did not recover following the insult. Consequently,
model simulation of ∆HbT in LWP215 suggested an increase, although a
decrease in ∆HbT was measured. The model simulates ∆HbO2 and ∆HHb
relatively well, except in LWP185 and LWP218 where the magnitude of the
change observed during the insult is not reached. In many piglets, the
∆oxCCO measurement did not recover to baseline values following the in-
sult, however this was not reflected in the simulations. It is feasible there-
fore that some level of injury may have occurred leading to an impairment
of metabolic function, that is not reflected in the model.
Simulated CBF and CMRO2 showed a drop during the insult. pH mea-
surements again displayed a lot of variation. Although less discernible, val-
ues become more acidic during the insult. The cytoplasmic pH simulations
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achieve a good estimate of the measurements overall. Simulated mitochon-
drial pH displays a similar rise and drop trend to that observed in the good
outcome group, except in LWP188 and LWP218 where it drops fairly con-
tinuously from the start.
Table 6.4: Optimised parameter values
Normal mitochondrial inner membrane potential, ∆ψn
Normal value: 145
Piglet Before Insult After Insult % Change
183 133.215 127.311 -4.4319
185 150 150 0
188 150 150 0
207 150 150 0
208 150 125.001 -16.6660
215 150 150 0
218 125 125.687 0.5496
Average 144.0307 139.7141 -2.9970
Concentration of cytochrome in tissue, [CCO]tis
Normal value: 0.0022
Piglet Before Insult After Insult % Change
183 0.0047 0.0070 48.6935
185 0.0040 0.0070 76.2522
188 0.0057 0.0038 -33.6448
207 0.007 0.0070 -0.0006
208 0.007 0.007 0
215 0.0070 0.007 0.0021
218 0.007 0.007 0
Average 0.0061 0.0065 8.0466
Autoregulation constant, kaut
Normal value: 1.0
Piglet Before Insult After Insult % Change
183 1 1 0
185 0 0 0
188 1 0.6042 -39.5840
207 1 1 0
208 1 0.1659 -83.4066
215 1 1 0
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218 1 0 -100
Average 0.8571 0.6814 -20.4983
Sensitivity of elastic stress in vessel walls to radius, Kσ
Normal value: 10
Piglet Before Insult After Insult % Change
183 11.5692 9.2094 -20.3971
185 12 8.9600 -25.3343
188 8 12 50
207 9.3711 11.3263 20.8645
208 8 12 50
215 9.8345 8.7615 -10.9105
218 9.3059 11.9999 28.9490
Average 9.725814286 10.60814429 9.0720
Normal concentration of oxygen in the mitochondria, [O2]n
Normal value: 0.024
Piglet Before Insult After Insult % Change
183 0.02135 0.0288 34.9142
185 0.0192 0.0192 0
188 0.02808 0.0192 -31.6236
207 0.0243 0.0192 -20.9766
208 0.0259 0.0212 -17.9390
215 0.0192 0.0192 0.0005
218 0.0288 0.0219 -23.8531
Average 0.0238 0.0213 -10.8122
Exponent in the muscular tension relationship, nm
Normal value: 1.0
Piglet Before Insult After Insult % Change
183 1.464 1.464 0
185 1.464 1.464 0
188 2.196 2.196 0
207 2.196 2.196 0
208 2.196 2.196 0
215 2.196 2.196 0
218 1.4947 1.464 -2.0533
Average 1.8867 1.8823 -0.2324
Normal concentration of NAD in the cytoplasm, NADcyt,n
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Normal value: 359
Piglet Before Insult After Insult % Change
183 400 318.001 -20.4998
185 400 318 -20.5
188 396.11 318.001 -19.7190
207 400 318.001 -20.4998
208 400 318 -20.5
215 318 318 0
218 336.45 318.003 -5.4828
Average 378.6514 318.0009 -16.0175
Normal value of pH in the cytoplasm, pHo,n
Normal value: 7
Piglet Before Insult After Insult % Change
183 6.9199 7.1594 3.4609
185 6.892 7.2656 5.4201
188 7.1984 7.1368 -0.8559
207 6.892 7.1538 3.7992
208 7.0526 7.1168 0.9112
215 6.892 7.1306 3.4614
218 7.1126 7.1272 0.2047
Average 6.9942 7.1557 2.3094
Figure 6.20: Changes in optimised parameter values for piglets with poor outcomes.
Recovery values after the insult compared to values before the insult
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LWP183
Figure 6.21: Piglet LWP183. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
199
6.3. Individual results
LWP185
Figure 6.22: Piglet LWP185. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP188
Figure 6.23: Piglet LWP188. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP207
Figure 6.24: Piglet LWP207. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP208
Figure 6.25: Piglet LWP208. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP215
Figure 6.26: Piglet LWP215. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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LWP218
Figure 6.27: Piglet LWP218. (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated cytoplasmic
pH compared with measured (i) phosphate-derived pH and (j) ATP-derived pH.
(k) Simulated mitochondrial pH.
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6.4 Group results
By combining data from a number of piglets, we can get a much better
overview of the metabolic and haemodynamic events that occur during the
experiments. This averaging also reduces the effect of arbitrary noise in the
signals. As the duration of each piglet experiment varied slightly, in order
to average the signals effectively the data was manually divided into five
time periods:
Phase 1: The baseline from the start of recording to the start of the insult,
when the vascular occluders are applied and fraction of inspired oxygen is
reduced.
Phase 2: Start of the hypoxic-ischaemic insult to the nadir, when ATP drops
to approximately 40%.
Phase 3: The nadir of the insult to the moment when the occluders are re-
leased. During this period the fraction of inspired oxygen, FiO2 is gradually
increased.
Phase 4: The restoration of blood flow to the end of recovery.
Phase 5: Post recovery from hypoxia-ischaemia.
Figure 6.28: Group analysis. Measurements are divided into 5 phases, and averaged
across the piglets.
Each phase was divided into 10 sections which were then averaged individ-
ually using a Python script. The mean of each section across all piglets was
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then calculated. The mean time for each phase across all piglets was also
calculated and an average signal produced. This allows an investigation
both in the variations of concentration and the relative time at which these
events occur. Figure 6.28 illustrates this process. This procedure was done
for each measurement and for each of the two groups - those with good and
poor outcomes.
6.4.1 Good outcomes
Table 6.5 lists the optimised BrainPiglet v2.0 parameter values for averaged
data from the 15 piglets with good outcomes. Baseline cytochrome con-
centration [CCO]tis was much higher than the normal value in the model,
and increased slightly following the insult. The autoregulation constant kaut
was 1 at baseline and decreased to 0 following the insult. Other signifi-
cant changes during the insult were decreases in the normal concentration
of oxygen in the mitochondria [O2]n and the exponent of the muscular ten-
sion relationship nm. The first is a likely result of hypoxia, and the second
possibly due to ischemia as the muscular tension in the vessel increases to
compensate for low blood flow.
Averaged measurements and optimised simulations are presented in Figure
6.29. A lot of variation was observed in Pa and pH throughout the mea-
surements. ∆HbT and ∆oxCCO displayed more variation during the insult
and in the recovery phase, while SaO2, ∆HbO2 and ∆HHb displayed most
variation during the insult. The time of recovery in the ∆oxCCO and pH
measurements is also notably different among the piglets.
∆HHb was well simulated here, while the simulated drop in ∆HbO2 fell just
outside the error margins of the measurements. Simulated ∆HbT showed a
higher rise at the start of the insult than that observed. ∆oxCCO was well
predicted, and simulated ∆CBF and ∆CMRO2 decreased considerably dur-
ing the insult. ∆CMRO2 was predicted to recover well following the insult,
while ∆CBF showed a slower recovery. These last four simulated signals
displayed a spike at the end of the insult phase – at the point where param-
eter values changed to those optimised for the region after the insult.This is
further discussed in the discussion section at the end of this chapter.
Cytoplasmic pH simulations did not replicate the magnitude of the drop
during the insult, but did simulate an acidic change. Simulated mitochon-
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drial pH dropped from the start of the experiment to lower than baseline
values, with a slow recovery after the insult.
Table 6.5: Optimised parameter values for the good outcome group
Parameter Description, Unit Normal
Value
Before
insult
After
insult
%
Change
∆ψn Normal mitochon-
drial inner membrane
potential, mV
145 149.965 150 0.0233
[O2]n Normal concentration
of oxygen in the mito-
chondria, mM
0.024 0.0288 0.0198 -31.25
nm Exponent in the mus-
cular tension relation-
ship, None
1.83 2.1858 1.464 -33.0222
Kσ Controls sensitivity of
elastic stress in vessel
walls to radius, None
10 8 9.5600 19.5
NADcyt,n Normal concentration
of NAD in the cyto-
plasm, mM
359 400 318 -20.5
[CCO]tis Concentration of cy-
tochrome in tissue,
mM
0.0022 0.0066 0.0070 0.0061
kaut Autoregulation con-
stant, None
1 1 0 -100
pHo,n Normal value of pH in
the cytoplasm, None
7.0 7.1879 7.1944 0.0904
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Figure 6.29: Group analysis of 15 piglets with good outcome. Vertical and hori-
zontal standard deviation of measurements shown. (a) SaO2 and (b) blood pres-
sure Pa measurements are model inputs. (c,d,e,f) Simulations and measurements
of ∆HbO2, ∆HHb, ∆HbT and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2.
Simulated cytoplasmic pH compared with measured (i) phosphate-derived pH and
(j) ATP-derived pH. (k) Simulated mitochondrial pH.
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6.4.2 Poor outcomes
The process was repeated for the 7 piglets with poor outcomes. Table 6.6
lists the optimised parameter values, which again suggest a higher baseline
value of cytochrome [CCO]tis than the normal value in the model. Over
the insult phase there is a larger increase in [CCO]tis and the parameter
controlling the sensitivity of elastic stress to the vessel radius Kσ than that
calculated fro the good outcome group. The autoregulation constant also
changes similarly, dropping to a near 0 value. The normal concentration
of oxygen in the mitochondria [O2]n also decreased as before. However,
in this case there was no change in the exponent of the muscular tension
relationship nm, which may suggest a more significant impairment of the
piglets’ autoregulative capacities and the ability of the vessels to compensate
for the lack of blood flow. Normal cytoplasmic pH value was calculated to
be slightly lower in this case before the insult, and rising after.
Figure 6.30 illustrates the measurements and optimised model simulations.
The variations in measurements are similar here, with Pa and pH displaying
a lot of deviations from the mean throughout. Both ∆HbO2 and ∆HHb were
fairly well simulated here. Simulated ∆HbT displays a rise at the start of the
insult, not observed in the measurements.
Compared to the good outcomes group, the most notable difference in the
measurements here is the lack of recovery in the measured ∆oxCCO val-
ues which achieve lower than baseline levels following the insult. However,
this is not reflected in the simulation which shows a good recovery follow-
ing the insult, suggesting either irreversible impairment that has not been
simulated, or other un-modelled processes may play a role.
pH measurements achieve similar values to that observed in the good out-
come group during the insult, and are simulated relatively well by the
model’s cytoplasmic pH. Mitochondrial pH simulation increases slightly to-
wards the end of the insult phase, and drops immediately afterwards to
more acidic values. The acidic pH reached after the insult in this simulation
is similar to that in the good outcome group.
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Table 6.6: Optimised parameter values for the poor outcome group
Parameter Description, Unit Normal
Value
Before
insult
After
insult
%
Change
∆ψn Normal mitochon-
drial inner membrane
potential, mV
145 150 150 0
[O2]n Normal concentration
of oxygen in the mito-
chondria, mM
0.024 0.0253 0.0192 -24.1107
nm Exponent in the mus-
cular tension relation-
ship, None
1.83 2.196 2.1960 0
Kσ Controls sensitivity of
elastic stress in vessel
walls to radius, None
10 8 12 50
NADcyt,n Normal concentration
of NAD in the cyto-
plasm, mM
359 400 318.001 -20.4998
[CCO]tis Concentration of cy-
tochrome in tissue,
mM
0.0022 0.0065 0.0070 7.6923
kaut Autoregulation con-
stant, None
1 1 0.1195 -88.05
pHo,n Normal value of pH in
the cytoplasm, None
7.0 6.895 7.1404 3.5591
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Figure 6.30: Group analysis of piglets with poor outcome. Vertical and horizontal
standard deviation of measurements shown. (a) SaO2 and (b) blood pressure Pa
measurements are model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2,
∆HHb, ∆HbT and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. Simulated
cytoplasmic pH compared with measured (i) phosphate-derived pH and (j) ATP-
derived pH. (k) Simulated mitochondrial pH.
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6.5 Discussion
The BrainPiglet v2.0 model performed quite well in predicting the changes
observed during hypoxia-ischaemia in piglets. The model is able to simu-
late most of the changes observed in the individual NIRS and MRS mea-
surements. It replicated the typical haemodynamic response observed in
the piglets during the insult (drop in ∆HbO2 and rise in ∆HHb), the decline
in oxidative phosphorylation (drop in ∆oxCCO) and the acidic changes ob-
served in intracellular pH measurements. The change in ∆HbT was less con-
sistent, with some experiments showing a rise while other dropped during
the insult. Simulations were similarly different, and not always successful in
predicting the change. The lack of recovery in ∆oxCCO following the insult
was indicative of poor outcome. However, the model simulated a complete
recovery of ∆oxCCO in these piglets as well. This suggests that the cellular
physiology included in the model may not be the driving force behind the
differences in ∆oxCCO recovery values in the poor outcome group. It is
feasible that this may result from cell death caused by the insult. Although
the model has in the past been used to simulate cell death by introducing a
simple linear function (Moroz et al. 2013), simulating cell death in relation
to pH dynamics is a more complicated affair, as acidosis is known to have
differing effects on apoptosis during and in the aftermath of oxygen and
glucose deprivation (Almaas et al. 2003).
Optimisation of model parameters showed that the model was able to detect
a change in autoregulatory capacity, by suggesting a lower value of the au-
toregulation constant kaut following the insult. This was true of piglets with
both good and poor outcome (Figures 6.4 and 6.20). Optimisation of the nor-
mal concentration of cytochrome in tissue [CCO]tis suggests higher values
at baseline than that found in current literature (∼0.006mM vs. ∼0.002mM).
The main difference in between the good and poor outcome piglets was in
the optimised values of the exponent of the muscular tension relationship
nm, which decreased following the insult – leading to higher tension – in the
good outcome group, but did not change noticeably in the poor outcome
group. This may be suggestive of a decreased ability in the poor outcome
piglets to regulate blood flow.
It must be understood that the model’s scope is limited by the chosen in-
puts – SaO2 and blood pressure. The model is only able to translate changes
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observed in these two measurements. Optimisation of model parameters
attempts to incorporate other variations, however it cannot infer the multi-
tude of other possible influences. It is also important to reiterate which vari-
ables the model has been optimised to predict – ∆HbO2, ∆HHb, ∆oxCCO
and cytoplasmic pH pHo. In particular, cytoplasmic pH is optimised to the
phosphate-derived pH measurement, and not the ATP-derived one, mainly
due to noise issues. However, the phosphate-derived pH measurement was
considerably noisier than the NIRS measurements. Optimising to noisy sig-
nals inevitably lessens the efficacy of the optimisation process. ∆HbT was
not optimised, and so it is not surprising to obtain simulations that better
predict the other variables in comparison.
The pH measurements were compared against simulated cytoplasmic pH
as the measurements were more likely to be representative of this variable
rather than mitochondrial pH. Little is known of the pH changes in mito-
chondria, mainly due to the difficulty in obtaining measurements of pH in
them, isolated from changes in other cellular compartments. Overall, the
model suggests a drop in mitochondrial pH, although the timing of this
decrease varies in the simulations. In some, the drop occurs only after the
occlusion is released, while in others it occurs from the start of the exper-
iment. There is no discernible difference in this change between the good
and poor outcome piglets. It must be noted here that blood pH is not sim-
ulated in this model. This may have a significant effect on intracellular pH,
and in particular ties in with haemoglobin affinity for oxygen.
The group analysis figures display the significant differences in measure-
ments observed in the individual piglets, although the general trends re-
main similar (Figures 6.29 and 6.30). There is a notable lack of recovery in
∆oxCCO in the poor outcome group. Although this particular change was
again not simulated, overall the simulations did well to replicate the mea-
surements. As before, in the optimised parameter values, the exponent of
the muscular tension relationship nm decreased following the insult in the
good outcome group, but did not change in the poor outcome group.
The gradual transition of optimised parameter values, from those optimised
for the measurements before the insult and after, does have a noticeable ef-
fect on the simulations, sometimes resulting in a spike, as the model adjusts
itself to the new set of parameters. Care has been taken to employ a selec-
tive period of time over which this transition occurs (3 mins), in order to
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minimise such noise.
The BrainPiglet model has been shown to be capable of simulating changes
in metabolic activity of the piglet brain during hypoxia-ischaemia. These
experiments and simulations and occur over a relatively short period of time
(approximately 1 hour). It remains to be seen whether long term changes,
such as secondary energy failure, can be similarly simulated.
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Chapter 7
Simulating hypoxia-ischaemia
in the term neonatal brain
The well-being of the developing neonatal brain can be particularly difficult
to ascertain. This is partly due to the lack of clinical information surround-
ing brain injury and the stages of development in such vulnerable patients.
There are a great many factors that contribute to differences in cerebral
metabolism and behaviour in neonates as they develop. For example, sig-
nificant changes in cortical folding are visible in magnetic resonance images
from the 23rd week of gestation. Substantial increases in surface area and
tissue volume occur between 24 and 42 weeks (Rutherford 2002). Blood flow
is affected by changes in development of the vascular system while white
matter development and myelination enable better transmission of neural
impulses. These changes also vary with gestational age, current age and sex
among numerous other factors. Therefore, the application of mathematical
and computational techniques in the field of neonatology to decipher the
amalgamation of these factors is especially potent.
Newborn infants who have sustained a hypoxic-ischaemic insult may be at
risk for evolving brain injury. While some cell death occurs during hypoxia-
ischaemia, considerable cell death may occur hours or days later (Edwards
et al. 1998). For those suffering from hypoxic-ischaemic encephalopathy, ef-
fective management and treatment is critical to mitigate severe consequences
(Perlman 2006). Understanding the underlying mechanisms responsible for
these cascading events is vital for the development of suitable interventions.
The BrainPiglet model was adapted to the term human neonate to inves-
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tigate hypoxic-ischaemic events in monitoring measurements from patients
with acute brain injury. The model is applied to data from three neonates
with mild, moderate and severe hypoxic-ischaemic encephalopathy. As the
neonates have abnormal cerebral health, model parameters were optimised
to better predict the changes observed and to gain some insight into the
differences between the neonates.
7.1 BabyBrain
Recent developments by our research group in the application of a new clini-
cal measurement system (CYRIL) in the neontal intensive care unit at UCLH
lead to the collection of monitoring data from term neonates suffering from
hypoxic-ischaemic encephalopathy (Bale et al. 2014). In order to investigate
this data, the BrainPiglet v2.0 model was adapted to the term neonatal brain.
Model parameters were altered as shown in Table 7.1. Normal brain blood
fraction Vblood,n remains the same as for preterm neonates as the source mea-
surement was conducted in both preterm and term neonates (Wyatt et al.
1990).
Figure 7.1 illustrates the autoregulation curve of the BabyBrain term neonate
model, compared with that of the BrainPiglet model and the BrainSignals
preterm model. Steady state simulations of ∆HbO2 and ∆oxCCO are dis-
played in Figure 7.2. Desaturations which drop to between 85% to 75%
produce much more significant changes in ∆oxCCO.
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Figure 7.1: Autoregulation curves of the BrainPiglet model, the BabyBrain term
neonate model and the BrainSignals preterm neonate model.
Figure 7.2: Steady state simulations of ∆HbO2 and ∆oxCCO in the BabyBrain model
with varying arterial oxygen saturation SaO2.
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Table 7.1: Altered BrainPiglet parameter values.
Parameter Description Units BrainPiglet Term neonate Source
CBFn Normal cerebral blood flow
(CBF)
ml 100 g−1
min−1
46 40 Altman et al. (1988)
CMRO2,n Normal cerebral metabolic
rate of oxygen consumption
(CMRO2)
µmol 100 g−1
min−1
114 64.13 Polin et al. (2010)
Pa and Pa,n Mean arterial blood pressure mmHg 50 45 Vutskits (2014); Polin
et al. (2010)
[Hbtot] and
[Hbtot]n
Total concentration of
haemoglobin in blood
mM 5.4 11.17 Polin et al. (2010)
Vblood,n Normal blood volume as a frac-
tion of brain tissue volume
0.0325 0.0233 Wyatt et al. (1990)
Pic and Pic,n Intracranial pressure mmHg 4.5 5.3 Easa (1983)
219
7.2. Simulating hypoxic-ischaemic events
7.2 Simulating hypoxic-ischaemic events
Term neonates undergoing treatment for acute brain injury at the Neona-
tal Intensive Care Unit at at UCLH were monitored over the first 6 days
of life. Each neonate was graded using the Sarnat system which considers
the severity of neonatal encephalopathy. They were scored as mild (Stage
I), moderate (Stage II) or severe (Stage III) based on clinical and EEG ob-
servations. Also measured was the Lac/NAA ratio, known to be a better
predictor of outcome than the Sarnat Grade (Barkovich 2006; Thayyil et al.
2010), and so was used to classify the neonates. Higher ratios are indicative
of poorer outcomes (Thayyil et al. 2010). A novel multi-distance broad-
band NIRS system, the CYtochrome Research Instrument and appLication
(CYRIL) was used to measure ∆HbO2, ∆HHb and ∆oxCCO at a sampling
frequency of 1 Hz. SaO2 was measured by pulse oximetry and mean arterial
blood pressure by an intra-arterial catheter. Neonates were continuously
monitored using NIRS, with some interruptions due to clinical procedures.
Hypoxic-ischaemic events in three of these term neonates were selected to
be investigated by the BabyBrain model. Details of these three neonates are
presented in Table 7.2.
Table 7.2: Physiological characteristics of the term neonate subjects.
Gestational
age
(weeks)
Actual
age
(hours)
Weight
(g)
Gender Sarnat
Grade
Lac/NAA
Neonate 1 38.9 48.6 2850 Male Moderate 0.16
Neonate 2 37.7 35.6 3750 Male Mild 0.25
Neonate 3 40.3 51.7 3110 Male Severe 0.39
7.2.1 Neonate 1
A significant hypoxic event was recorded in Neonate 1, with the smallest
Lac/NAA ratio.
Sensitivity analysis and optimisation
Sensitivity analysis results are displayed in Table 7.3. 6 parameters were
chosen to be optimised, indicated in the table with an asterisk, along with
the normal cytochrome concentration in tissue [CCO]tis. Table 7.4 lists the
optimised values. The exponent in the muscular tension relationship nm,
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was optimised to be higher than normal at baseline, but decreased follow-
ing the event. In general, this increases muscular tension in the vessel walls
(see Chapter 4, Section 4.7, Equation 4.61 for dependencies). Baseline cyto-
plasmic pH was remained close to the normal value throughout. The rate of
the third oxidative phosphorylation reaction (which uses O2) k3,0 increased
following the event. The largest change was in the cytochrome concentra-
tion [CCO]tis, which was optimised to be higher than normal and decreased
during the event.
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Table 7.3: Sensitivity analysis of BabyBrain using data from Neonate 1. Parameters ranked in order of influence in optimising selected
output variables. Asterisks indicate parameters selected for optimisation.
Variable Parameter Description
∆HbO2 ∆HHb ∆HbT ∆ oxCCO
1 1 20 r0* A special radius in the elastic tension relationship
2 2 20 rocc Arterial occlusion constant
3 3 5 nm* Exponent in the muscular tension relationship
4 4 17 9 CBFn Normal cerebral blood flow
5 5 12 h0 Vascular wall thickness when radius is r0
6 6 9 4 rn Normal radius of blood vessels
7 7 19 [Py]n Normal concentration of pyruvate ions in the cytoplasm
8 8 18 kpl Rate of forward reaction in the pyruvate lactate equilibrium
9 9 Pic,n Normal intracranial blood pressure
10 10 19 Cbu f f ic Buffering capacity for protons in cytoplasm
14 14 10 NADpool Total mitochondrial NAD and NADH concentration
1 [Hbtot]n* Normal total haemoglobin concentration in the arteries and veins.
2 kaut* Autoregulation constant
3 φ Value of [O2] at half maximal saturation
4 13 [CCO]tis * Concentration of cytochrome in tissue
6 Pvs Pressure in the venous sinuses
7 rt Parameter in the muscular tension relationship
8 σcoll Value of pressure at which vessels collapse
14 6 CVinh Control parameter representing the action of complex V inhibitors
1 pHon* Normal cytoplasmic pH
2 k3,0* Rate constant for third oxidative phosphorylation reaction at zero PMF
3 klk2 Controls rate at which protons reenter the mitochondrial matrix through leak
channels
5 LCV,0 Normal complex V flux as a fraction of maximum possible flux
7 [gluc]n Normal cellular concentration of glucose
8 kAK Forward rate constant for the conversion of ADP to ATP and AMP
10 G0,rat Ratio between conductance of cerebral arteries and supplying artery com-
partment
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Table 7.4: Optimised parameter values for Neonate 1
Parameter Description Normal
Value
Before
Event
After
Event
%
Change
r0 A special radius in the
elastic tension relation-
ship
0.0126
cm
0.0151 0.0151 0
nm Exponent in the muscular
tension relationship
1.83 2.1954 1.464 -33.3151
pHon Normal cytoplasmic pH 7 7.0219 7.0518 0.4258
[Hbtot]n Total concentration of
haemoglobin in blood
11.17
mM
4.0606 3.5004 -13.7960
k3,0 Rate constant for third
oxidative phosphory-
lation reaction at zero
PMF
250000
mM−1
s−1
200000 272523 36.2615
kaut Autoregulation constant 1 1 1 0
[CCO]tis Concentration of cy-
tochrome in tissue
0.0022
mM
0.007 0.001 -85.7143
Model simulation
SaO2 was observed to decrease by 27% although Pa varied throughout and
no significant change was visible during the event (Figure 7.3). Changes in
haemoglobin concentrations are well predicted, with an increase in ∆HHb
and ∆HbT. However, the significant decrease in ∆oxCCO was not predicted.
Looking more closely at the change in ∆oxCCO shows that the drop here
does not coincide with the decrease in oxygenation or the other variables.
Hence it is possible that some other mechanism or significant injury maybe
responsible for this decline, which is not encapsulated by the input variables
used here by the model – SaO2 and Pa.
Simulated CBF shows a significant increase during the event, which seems
to correspond to the changes observed in the haemoglobin concentrations.
Simulated CMRO2 decreases very little during the event. The simulation
here also shows a spike at the end of the event, caused by the change in
model parameter values. The simulated pH values change slightly dur-
ing the event, however cytoplasmic pH becomes increasingly alkaline and
mitochondrial pH acidic with time. To reiterate, these changes in simulated
variables are only in response to variations in the the input parameters SaO2
and Pa. While the haemodynamic changes appear to be consistent with the
measurements, the metabolic changes are not (evidenced by the lack of ac-
curacy in the prediction of ∆oxCCO). Thus the model prediction of CMRO2
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and pH are less likely to be accurate. In fact, a significant drop in ∆oxCCO
would normally be accompanied by a drop in CMRO2 as less oxygen is
being used.
7.2.2 Neonate 2
The youngest of the three subjects, Neonate 2 had a mild hypoxic-ischaemic
event. Figure 7.5 illustrates the measured SaO2 and Pa values which dropped
approximately 10% and 8% respectively during the event, although Pa varied
significantly throughout.
Sensitivity analysis and optimisation
The morris method was used to determine the most influential parameters
for ∆HbO2, ∆HHb, ∆HbT and ∆oxCCO. Results are displayed in Table 7.5.
6 parameters were chosen to be optimised, indicated in the table with an
asterisk, along with the normal cytochrome concentration in tissue [CCO]tis
and the autoregulation constant kaut.
Each parameter was optimised at baseline before the hypoxic-ischaemic
event and after, to investigate any potential physiological changes. Opti-
mised values are presented in Table 7.6. The ratio between the conduc-
tance of the cerebral arteries and the supplying artery compartment G0,rat
was decreased from its normal model value at baseline, perhaps suggest-
ing reduced blood delivery in the neonate. It was increased following the
event, and was the largest change in the optimised parameters. However, the
autoregulation constant remained at the maximum throughout, suggesting
good autoregulative capacity. Cytoplasmic pH was slightly decreased from
the normal model value, while baseline cytochrome concentration [CCO]tis
was approximately half the normal model value. Optimised [CCO]tis did
not change during the event.
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Figure 7.3: Neonate 1: (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. (i, k) Simulated cytoplas-
mic pH and mitochondrial pH.
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Table 7.5: Sensitivity analysis of BabyBrain using data from Neonate 2. Parameters ranked in order of influence in optimising selected
output variables. Asterisks indicate parameters selected for optimisation.
Variable Parameter Description
∆HbO2 ∆HHb ∆HbT ∆ oxCCO
1 1 G0,rat* Ratio between the conductance of the cerebral arteries and the supplying
artery compartment
2 2 CBFn* Normal cerebral blood flow
3 3 3 σe0* Parameter in relationship determining elastic stress in vessel walls
4 4 2 h0* Vascular wall thickness when radius is r0
5 5 10 [Hbtot]n Normal total haemoglobin concentration in the arteries and veins.
6 6 1 Pa Arterial blood pressure
7 7 11 Kσ Controls sensitivity of elastic stress in vessel walls to radius
8 8 6 NADcyt,n Normal concentration of NAD in the cytoplasm
9 9 8 10 SaO2,n Normal arterial oxygen saturation
10 10 7 2 SaO2 Arterial oxygen saturation
17 17 1 pHon* Normal cytoplasmic pH
4 15 rm Value of vessel radius giving maximum muscular tension
5 σcoll Value of pressure at which vessels collapse
9 rn Normal radius of blood vessels
3 ck2* Controls sensitivity of forward rate of the second oxidative phosphorylation
reaction to the proton motive force
4 k3,0 Rate constant for third oxidative phosphorylation reaction at zero PMF
5 km,tcaN, f km for NAD in the TCA cycle as a fraction of normal NAD concentration
6 Rautop Controls sensitivity of autoregulatory stimuli to arterial blood pressure
7 nh Hill coefficient for haemoglobin saturation
8 na Number of protons passing through Complex V for each ATP synthesised
9 φ Value of [O2] at half maximal saturation
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Table 7.6: Optimised parameter values for Neonate 2
Parameter Description Normal
Value
Before
Event
After
Event
%
Change
G0,rat Ratio between the con-
ductance of the cerebral
arteries and the supply-
ing artery compartment
10.0 4 5.9973 49.9325
CBFn Normal cerebral blood
flow
0.007
ml/m-
l/s
0.0064 0.0064 0
σe0 Parameter in relationship
determining elastic stress
in vessel walls
0.1425
mmHg
0.114 0.114 0
h0 Vascular wall thickness
when radius is r0
0.003
cm
0.0036 0.0036 0
pHon Normal cytoplasmic pH 7 6.8247 6.8255 0.1802
ck2 Controls sensitivity of
forward rate of the
second oxidative phos-
phorylation reaction to
the proton motive force
0.02
m/V
0.016 0.016 0
kaut Autoregulation constant 1 1 1 0
[CCO]tis Concentration of cy-
tochrome in tissue
0.0022
mM
0.001 0.001 0
Model simulation
Figure 7.5 displays ∆HbO2, ∆HHb, ∆HbT and ∆oxCCO simulations from
the model compared with measurements from Neonate 2. ∆HHb and ∆HbT
are observed to increase during the event while ∆HbO2 decreases. All three
return to baseline. These changes are well simulated by the model. How-
ever, the magnitude of the simulated change in ∆HbT is much larger than
observed.
There is a rise in ∆oxCCO observed during this phase. This is an unusual
response to the decrease in oxygenation and blood flow, which is often pre-
dicted to result in lower levels of aerobic metabolism. The model thus pre-
dicts a slight decrease in ∆oxCCO. A study in piglets conducted by Tsuji
et al. (1995) recorded a slight increase in ∆oxCCO during hypoxia brought
about by reducing the inspired oxygen concentration to 12% (from 25%), but
recorded a decrease at 8% and lower (Figure 7.4). Although they offered no
explanation for this change, it is currently hypothesised that at these slight
reductions of oxygen delivery, the anesthetic or analgesic may have an effect
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on the response in ∆oxCCO.
Copyright material removed.
Figure 7.4: Hypoxia experiments in piglets by Tsuji et al. (1995), brought about
by reducing inspired oxygen concentration to 12% , 8%, 6%, 4% and 0%. Mea-
surements in HbO2, HHb (Hb) and oxidised cytochrome (CytO2) from one piglet
displayed at the top. Average values from 8 piglets are shown in the table. A slight
increase in ∆oxCCO is observed at 12%.
Also presented in Figure 7.5 are the predicted changes in CBF and CMRO2.
∆CBF increases during the event while ∆CMRO2 decreases. However, as
the model does not predict the increase in ∆oxCCO, the change here in
∆CMRO2 is put in question since the rate of use of O2 is so directly depen-
dent on oxidative phosphorylation. pH simulations show a slight change
during the event, however cytoplasmic pH becomes increasingly acidic,
while mitochondrial pH becomes increasingly alkaline.
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Figure 7.5: Neonate 2: (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. (i, k) Simulated cytoplas-
mic pH and mitochondrial pH.
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7.2.3 Neonate 3
Neonate 3 suffered from severe encephalopathy and was the oldest of the
group.
Sensitivity analysis and optimisation
Sensitivity analysis results are displayed in Table 7.7. 6 parameters were
chosen to be optimised, indicated in the table with an asterisk, along with
the autoregulation constant kaut. The buffering capacity for protons in the
cytoplasm Cbu f f ic was reduced during the event, leading to a slower change
in cytoplasmic proton concentration. The sensitivity of autoregulatory stim-
uli to oxygen in the capillary Rauto was increased at baseline and dropped
again after the event by more than 90%. Although the autoregulatory con-
stant remained at maximum throughout, this perhaps signals a loss in the
capacity to regulate oxygen delivery. The sensitivity of elastic stress in ves-
sel walls to the radius Kσ was decreased at baseline, but remained constant
thereafter. The normal radius of the blood vessels r0 also decreased during
the event, perhaps in response to the lack of oxygen.
Baseline cytochrome values [CCO]tis were again higher than normal model
values and remained approximately the same throughout. The oxidised
fraction of cytochrome a f rac,n was very high at baseline (close to 1) and
dropped to a 0.4 after the event. This combination signals a high con-
centration of oxidised cytochrome before the event and a substantial loss
afterwards.
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Table 7.7: Sensitivity analysis of BabyBrain using data from Neonate 3. Parameters ranked in order of influence in optimising selected
output variables. Asterisks indicate parameters selected for optimisation.
Variable Parameter Description
∆HbO2 ∆HHb ∆HbT ∆ oxCCO
1 1 Rautu Controls sensitivity of autoregulatory stimuli to demand
2 2 Rauto* Controls sensitivity of autoregulatory stimuli to oxygen in the capillary
3 3 15 Cbu f f ic* Buffering capacity for protons in cytoplasm
4 4 7 Pa,n Normal arterial blood pressure
5 5 Pa Arterial blood pressure
6 6 14 [NAD]n/NADHn Normal NAD/NADH ratio
7 7 2 a f rac,n* Normal oxidised fraction of CuA
8 8 c3 Controls sensitivity of third oxidative phosphorylation reaction to PMF
9 9 r0 A special radius in the elastic tension relationship
10 10 8 SaO2 Arterial oxygen saturation
15 15 11 7 h0 Vascular wall thickness when radius is r0
18 18 2 9 Kσ* Controls sensitivity of elastic stress in vessel walls to radius
1 rn* Normal radius of blood vessels
3 Volt,n Normal total blood volume
4 blood f rac Normal blood volume as a fraction of brain tissue volume
5 [Hbtot]n Normal total haemoglobin concentration in the arteries and veins.
6 c f rac Fraction of arterial blood which flows through the carotid arteries
9 NADpool Total mitochondrial NAD and NADH concentration
10 20 σcoll Value of pressure at which vessels collapse
15 10 φ Value of [O2] at half maximal saturation
1 [CCO]tis* Concentration of cytochrome in tissue
3 GVArat,n Normal ratio of conductances between arteries and veins Gv/Gn (determines
venous pressure)
4 nh Hill coefficient for haemoglobin saturation
5 NADcyt,n Normal concentration of NAD in the cytoplasm
6 NADHcyt,n Normal concentration of NADH in the cytoplasm
8 pHon Normal cytoplasmic pH
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Table 7.8: Optimised parameter values for Neonate 3
Parameter Description Normal
Value
Before
Event
After
Event
%
Change
Cbu f f ic Buffering capacity for
protons in cytoplasm
0.025 0.0200 0.0300 50
Rauto Controls sensitivity of au-
toregulatory stimuli to
oxygen in the capillary
1.5 10 0.7875 -92.125
a f rac,n Normal oxidised fraction
of CuA
0.67 0.9730 0.4 -58.89
Kσ Controls sensitivity of
elastic stress in vessel
walls to radius
10 8 8 0
rn Normal radius of blood
vessels
0.0187
cm
0.0218 0.0150 -31.1927
kaut Autoregulation constant 1 1 1 0
[CCO]tis Concentration of cy-
tochrome in tissue
0.0022
mM
0.0069 0.0068 -1.4493
Model simulation
This neonate exhibited the most severe hypoxic-ischaemic event, with SaO2
dropping by 80% and Pa also significantly decreasing by 50% (Figure 7.6).
Simulated changes in haemoglobin – ∆HbO2, ∆HHb and ∆HbT – were
greater than that observed. All three returned to baseline following the
event.
∆oxCCO was well predicted in this case, showing a considerable drop dur-
ing the event. The simulation returned to baseline immediately after, al-
though the measurement did not. Significant reductions in CBF and CMRO2
were predicted during the event. In this case, simulated cytoplasmic and mi-
tochondrial pH decreased, becoming more acidic during the event and sub-
sequently returned to baseline values. Mitochondrial pH decreased again
immediately afterwards.
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Figure 7.6: Neonate 3: (a) SaO2 and (b) blood pressure Pa measurements are
model inputs. (c,d,e,f) Simulations and measurements of ∆HbO2, ∆HHb, ∆HbT
and ∆oxCCO. (g,h) Simulations of ∆CBF and ∆CMRO2. (i, k) Simulated cytoplas-
mic pH and mitochondrial pH.
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7.3 Discussion
The BabyBrain term neonate model was created by altering parameter val-
ues in BrainPiglet v2.0 to suit the human term neonate. The autoregulation
curves of the two models are fairly similar, but shifted in BabyBrain due to
the lower normal blood pressure and CBF values (Figure 7.1). Sensitivity
analysis suggests that the concentration of sodium in the model is influen-
tial.
The BabyBrain term model was used to investigate monitoring data of term
neonates suffering from hypoxic-ischaemic encephalopathy of different lev-
els of severity. Neonates 1 and 3, with the lowest and highest Lac/NAA ra-
tios respectively, went through more severe hypoxic-ischaemic events com-
pared to Neonate 2. The model was able to simulate changes in haemoglobin
relatively well. All three neonates exhibited a decrease in ∆HbO2 and an in-
crease in ∆HHb and ∆HbT. The magnitude of the change was in some cases
not well represented (such as in Neonate 3).
The neonates showed varied responses in ∆oxCCO. In Neonate 1 ∆oxCCO
decreased significantly, although this decrease did not coincide with the hy-
poxic event. While the model predicted a small drop in ∆oxCCO in response
to hypoxic conditions, it did not predict the changes observed. It is likely
that these changes were caused by some other mechanism(s) not incorpo-
rated into the model or in the input signals. Indeed at steady state, the drop
in ∆oxCCO caused by varying SaO2 is not large (Figure 7.2).
In Neonate 2 ∆oxCCO rose during the event. Although slight increases have
been recorded with small decreases in oxygenation in piglet experiments
(Tsuji et al. 1995), the mechanism responsible is unclear. The model predicts
a small drop in ∆oxCCO as would be expected during hypoxic conditions.
At the time of writing, similar increases in ∆oxCCO have been observed
during desaturations in 3 other term neonates in the same study. These
neonates vary in injury severity. Details of treatment have been requested
but yet to be acquired at the time of writing.
Changes in PaCO2 are known to affect ∆oxCCO. While PaCO2 was measured
in these neonates, the measurement was unreliable and incomplete, with
significant sections missing from the recordings, and so was not used as
an input to the model. However, the measurements during the events in
Neonate 1 and 2 showed no significant change in PaCO2.
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The sensitivity analysis results from Neonate 1 and 2 both suggest that the
concentration and movement of protons has a heavy influence on variations
in ∆oxCCO (Tables 7.5 and 7.3). Indeed, altering the normal cytoplasmic pH
in the model shows a strong response in the ∆oxCCO simulation (Figure
7.7). As there is no continuous measurement of pH in these subjects, it is
not possible to determine whether the brain pH was close to normal at the
start of the measurement.
Figure 7.7: BabyBrain model simulation of ∆oxCCO in response to changes in the
input normal cytoplasmic pH
Simulations of Neonate 1 and 2 were repeated with the BrainPiglet v2.1
model adapted to the term neonate, to test whether the more detailed model
of pH dynamics, including carbonic acid and sodium transporters, would
be capable of simulating the observed changes. The simulation of ∆oxCCO
was no better than in v2.0. Other factors such as blood pH are likely to
have an important role. However, this addition would further increase the
complexity of the model and the difficulty in optimising it.
In the more severe case, Neonate 3, the drop in ∆oxCCO was quite clearly
a product of the drastic loss of SaO2. Here, the model was able to simulate
the change very well.
Model simulations of CBF, CMRO2, and pH also give an insight into changes
not observed by the monitoring systems. CBF is predicted to increase in
Neonates 1 and 2, where blood pressure does not change significantly dur-
ing the event. In contrast, in the more severe case (Neonate 3) CBF drops
significantly, mirroring the decrease blood pressure during the event.
CMRO2 is predicted to drop slightly in mild and moderate cases and much
more significantly in the severe case as might be expected. However, in
mild and moderate cases (Neonates 1 and 2) where the observed change in
∆oxCCO is not well simulated, these predictions in CMRO2 are those ex-
pected to arise simply in conjunction with the simulated ∆oxCCO. As it
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appears that other mechanisms are at play effecting oxidative phosphoryla-
tion, it is likely that the actual change in CMRO2 will be different.
The simulation of pH in Neonates 1 and 2 did not yield significant event-
related responses. However, in Neonate 3 the model predicted an acidic
change in both cytoplasmic and mitochondrial pH. Both values subsequently
returned to baseline, although mitochondrial pH decreased again immedi-
ately afterwards. There are two key observations here - the first is that the
hypoxic-ischaemic stimulus need to be of significant magnitude for a size-
able change in pH to be simulated. Second, mitochondrial pH may vary
differently from cytoplasmic pH. In the current model, cytoplasmic pH ap-
pears to have a stronger capacity for recovery than the mitochondrial pH.
As discussed before, the model’s capacity for prediction is limited not only
by the scope of the select biological mechanisms that have been incorporated
into the model, but also by the model inputs. The model translates the varia-
tions it detects in SaO2 and blood pressure into the simulations of NIRS and
MRS variables via a network of reactions considered relevant. The optimisa-
tion of model parameters is able to incorporate other changes or differences
to some degree. However, it largely ignores (as it must) other possible in-
fluences, which the observed measurements are subject to. Therefore, the
differences between simulated and measured variables can be indicative of
processes not incorporated into the model.
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Chapter 8
Simulating functional
activation in the preterm
neonatal brain
This chapter describes the adaptation of the human adult BrainSignals model
to the human preterm neonatal brain, and its application to clinical data to
investigate different functional haemodynamic responses observed in healthy
subjects in two published studies. The first was conducted by Kozberg et al.
(2013) in rats using a somatosensory stimulus, and reported an increase in
HHb in some rats and a decrease in others. The second study by Roche-
Labarbe et al. (2014) also using a somatosensory stimulus observed a de-
crease in HHb in preterm human neonates. The model is also applied to
data from a recent functional study in preterm neonates using a visual stim-
ulus. This study also observed both increases and decreases in HHb. The
model was used to replicate these responses, to explore possible explana-
tions for these differences.
8.1 BrainSignals preterm neonatal model
The BrainSignals model of human adult cerebral metabolism was published
by Banaji et al. (2008). The model is described in detail in Chapter 4, Section
4.6. In order to adapt the model to the human preterm neonate, a number of
parameters, known to be significantly different in the young, were altered
(Table 8.1). This is a similar process to that taken in the creation of the
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BrainPiglet model (Moroz et al. 2012). The cytochrome parameters [CCO]tis
and CuA, f rac,n have been measured in piglets as this technique is invasive.
All other parameters in the table have been obtained from human subjects.
Figure 8.1 displays the autoregulation curves for the adult and neonatal
BrainSignals models, comparable to approximations in literature (Volpe 2008).
Figure 8.1: Autoregulation curves cerebral blood flow (CBF) against blood pressure
(Pa) - of the Brainsignals preterm neonate and adult models.
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Table 8.1: Altered BrainSignals parameter values
Parameter Description Units BrainSignals Preterm
neonate
Source
CBFn Normal cerebral blood flow
(CBF)
ml 100 g−1
min−1
49 19.8 Greisen (1986)
[CCO]tis Total concentration of
cytochrome-c-oxidase (CCO) in
tissue
µM 5.5 2.2 Cooper et al. (1997),
Springett et al. (2000)
CuA, f rac,n Normal fraction of oxidised
CCO
0.8 0.67 Springett et al. (2000)
CMRO2,n Normal cerebral metabolic
rate of oxygen consumption
(CMRO2)
µmol 100 g−1
min−1
155 40.865 Elwell et al. (2005)
Pa and Pa,n Mean arterial blood pressure mmHg 100 30 Polin et al. (2010)
[Hbtot] and
[Hbtot]n
Total concentration of
haemoglobin in blood
mM 9.1 9.75 Polin et al. (2010), Jopling
et al. (2009)
Vblood,n Normal blood volume as a frac-
tion of brain tissue volume
0.04 0.0233 Wyatt et al. (1990)
Pic and Pic,n Intracranial pressure mmHg 9.5 5.1 Easa (1983)
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8.1.1 Sensitivity analysis
Table 8.2 illustrates results of the morris method analysis. Results show that
the most influential parameters are related to the characteristics of blood
flow and vessel walls (σe0, Kσ, r0, rt, rm, h0), related to the rate of which
protons re-enter the mitochondrial matrix (klk2) and normal model inputs
SaO2, Pa, and PaCO2n.
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Table 8.2: Sensitivity analysis of BrainSignals preterm neonate model at steady state. Parameters ranked in order of influence in
optimising selected output variables.
Variable Parameter Description
∆HHb ∆HbO2 ∆HbT ∆ oxCCO
1 1 15 6 r0 A special radius in the elastic tension relationship
2 2 7 σe0 Parameter in relationship determining elastic stress in vessel walls
3 3 10 SaO2 Arterial oxygen saturation
4 4 9 2 Pa Arterial blood pressure
5 5 12 5 rt Parameter in the muscular tension relationship
6 6 Volmit Normal mitochondrial volume
7 7 2 PaCO2,n Normal arterial partial pressure of CO2
8 8 17 8 Pic,n Normal intracranial blood pressure
9 9 8 1 rm Value of vessel radius giving maximum muscular tension
10 10 4 4 h0 Vascular wall thickness when radius is r0
11 11 6 blood f rac Normal blood volume as a fraction of brain tissue volume
12 12 10 9 [Hbtot]n Normal total haemoglobin concentration in the arteries and veins.
15 15 5 11 Pvs Pressure in the venous sinuses
17 16 3 3 Kσ Controls sensitivity of elastic stress in vessel walls to radius
1 18 klk2 Controls rate at which protons reenter the mitochondrial matrix through leak
channels
7 16 [CCO]tis Concentration of cytochrome in tissue
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8.1.2 Simulating functional activation
The BrainSignals preterm neonatal model was used to investigate the varied
observations in the neonatal brain responses to functional activation, namely
the changes in HHb and HbO2 recorded (see Chapter 3, Section 3.3.2). Ob-
servations as reported in Kozberg et al. (2013) and Roche-Labarbe et al.
(2014) were simulated. The model was further applied to data collected
from a recent stimulus-evoked haemodynamic response study in preterm
neonates.
The Kozberg study
Kozberg et al. (2013) is a functional study conducted in postnatal rats, age-
equivalent to human newborns, subjected to a somatosensory stimulus. Al-
though our model is focused on the human neonate, we were interested in
replicating the qualitative response observed in these animals. The results
were divided into two groups – rats which exhibited a rise in blood pressure
in response to the stimulus and those which did not.
Rats that exhibited a rise in blood pressure also showed an increase in HbO2
and HbT and a decrease in HHb, where the increase in HbO2 was greater
than the decrease in HHb (functional hyperemia). In the rats that showed
a slight decrease or no change in blood pressure, the opposite results were
observed – a decrease in HbO2 and HbT and a rise in HHb. These conflicting
results were attributed to a lack of functional hyperemia and an overarching
effect of arterial vasoconstriction in the latter group.
In order to simulate these results, we increased the models demand pa-
rameter u to simulate functional activation with the shape of a steep rising
haemodynamic response function (HRF):
u = 1.0+ αHRF (8.1)
where α is a real number (Figure 8.2). We simulated blood pressure also
using the function
Pa = Pa,n + βHRF. (8.2)
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where β is a real number. The values for α and β were optimised to obtain
the best fit of model simulations to the observed results. SaO2 and PaCO2
were assumed to remain constant. The model was used to predict changes
HbO2, HHb and HbT which were compared against the observations.
Figure 8.2: Demand as a model input, using a haemodynamic response function,
to simulate functional activation
For the first group of animals who showed an increase in blood pressure,
the values α = 2 and β = 1.5 were used. Figures 8.3 and 8.4 show the
results of the model simulations superimposed with that observed in the
study. 1. Although vasoconstriction was observed in the study, preventing
the dilation of the vessels in the model actually reversed these results.
Figure 8.3: Model simulated and observed haemodynamic response of the Kozberg
et al. study (Kozberg et al. 2013), investigating functional response in rats, with
an increase in demand and blood pressure (BP). Changes in deoxy- and oxy-
haemoglobin (HHb, HbO2) concentrations.
For the second group of rats, which exhibited no rise in blood pressure, we
reduced the arterial radius by 1% and and used β = −0.18.
1Plot Digitizer software was used to extract data from the published figures (Huwaldt
and Steinhorst)
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Figure 8.4: Model simulated and observed haemodynamic response of the Kozberg
et al. study (Kozberg et al. 2013), investigating functional response in rats, with an
increase in demand and blood pressure (BP). Changes in blood pressure (BP) and
total haemoglobin (HbT).
r = rn(1− 0.01HRF) (8.3)
We did not need to increase the demand u, suggesting that an increase in
oxygen consumption was not required to produce this response. Figures
8.5 and 8.6 illustrate these results, which are very closely comparable to the
original data obtained by Kozberg et al. (2013).
Figure 8.5: Model simulated and observed haemodynamic response of the Kozberg
et al. study (Kozberg et al. 2013), investigating functional response in rats, with a
slight decrease in arterial radius and blood pressure (BP). Changes in deoxy- and
oxy- haemoglobin (HHb, HbO2) concentrations.
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Figure 8.6: Model simulated and observed haemodynamic response of the Kozberg
et al. study (Kozberg et al. 2013), investigating functional response in rats, with a
slight decrease in arterial radius and blood pressure (BP). Changes in BP and total
haemoglobin (HbT).
The Roche-Labarbe study
The second study investigated was conducted in preterm human neonates
by Roche-Labarbe et al. (2014). They observed a decrease in HHb and an in-
crease in HbO2, CBF, CMRO2 and cerebral blood volume (CBV) in response
to a somatosensory stimulus. These results were replicated relatively well
by simply increasing the models demand (α = 0.5) (Figure 8.7, 8.8 and 8.9).
However our predicted CBF and CMRO2 was higher and HHb slightly lower
than that observed.
Figure 8.7: Model simulated and observed haemodynamic response of the Roche-
Labarbe et al. study (Roche-Labarbe et al. 2014), investigating functional response
in human preterm neonates, with an increase in demand. Relative changes in oxy-
and deoxy- haemoglobin (rHbO2, rHHb)
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Figure 8.8: Model simulated and observed haemodynamic response of the Roche-
Labarbe et al. study (Roche-Labarbe et al. 2014), investigating functional response
in human preterm neonates, with an increase in demand. Relative changes cerebral
blood volume (rCBV) and cerebral blood flow (rCBF)
Figure 8.9: Model simulated and observed haemodynamic response of the Roche-
Labarbe et al. study (Roche-Labarbe et al. 2014), investigating functional response
in human preterm neonates, with an increase in demand. Relative changes in cere-
bral metabolic rate of oxygen consumption (rCMRO2).
The USZ study
A functional near infrared spectroscopy (fNIRS) study was recently con-
ducted at University Hospital Zurich (USZ), investigating the functional re-
sponse in the preterm brain evoked by a visual stimulus. A blinking pocket
LCD display was used as the stimulus and changes in tissue oxygenation
and haemodynamics were measured over the prefrontal cortex using a novel
spatially-resolved NIRS device (OxyPrem). Measurements of changes in
HbO2, HHb and HbT were averaged over repeated stimuli. Characteristics
of two preterm subjects are detailed in Table 8.3.
SaO2 and PaCO2 were unlikely to vary greatly in these infants and so were
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Table 8.3: Physiological characteristics of the two preterm infant subjects.
Gestational
age (weeks)
Actual age
(weeks)
Weight (g) Hematocrit
(%)
Neonate 1 33.3 33.4 2380 52.5
Neonate 2 25.9 39.0 3460 30.0
Haemoglobin
(g/dL)
FiO2 (%) Baseline
SpO2 (%)
Baseline heart
rate (BPM)
Neonate 1 17.08 21.0 95 148
Neonate 2 9.70 28.0 92-95 165
kept constant. Pa was also assumed to remain constant in the first instance.
In Neonate 1, the measurements showed an increase in ∆HbO2 and ∆HbT
during the stimulus, and a decrease in ∆HHb (Figure 8.10). This response
was simulated in the model by a simple increase in demand (α = 0.7). Mod-
elled CBF and CMRO2 showed a corresponding rise during the stimulus.
In Neonate 2, a similar increase in CMRO2, ∆HbO2 and ∆HbT was observed
during the stimulus. However, an increase in ∆HHb was also observed (Fig-
ure 8.11). This response was simulated in ∆HHb by an increase in demand
(α = 0.7) while maintaining CBF constant at its normal value throughout the
stimulus. Better predictions of ∆HbO2 and ∆HbT were obtained by adding
a decrease in blood pressure during the stimulus (Equation 8.2 with β = −7)
to match the magnitude of ∆HbO2 and ∆HbT. However this decrease was
too large to be physiologically likely within this timeframe (-7 mmHg).
8.2 Discussion
The BrainSignals model was successfully adapted to the preterm neonatal
brain by changing a number of parameters. The autoregulatory capacity of
the preterm brain remains unclear. However, as our model simulation sug-
gests, preterm neonates may be able to maintain constant blood flow only
within a very narrow range of blood pressure values (Figure 8.1). Sensitiv-
ity analysis suggests that the parameters related to the functioning of blood
vessel walls are influential in this model. These were not altered from the
BrainPiglet values, but it is unlikley that such values in the human neonate
can be accurately sourced owing to the difficulty in obtaining them, and to
the changes in these vessels brought about by vascular development.
A number of studies have observed that the response of HHb to a functional
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Figure 8.10: Model simulation of Neonate 1 of the USZ study. Simulated haemody-
namic response with an increase in demand u (a). Vertical lines indicate stimulus
period. Measured and simulated changes in (b) oxy- and deoxy- haemoglobin
(HbO2, HHb) and (c) total haemoglobin (HbT). (d) Simulated cerebral metabolic
rate of oxygen consumption (CMRO2) cerebral blood flow (CBF).
Figure 8.11: Model simulation of Neonate 2 of the USZ study. Simulated haemo-
dynamic response with an increase in demand u and CBF maintained constant (a).
Vertical lines indicate stimulus period. Measured and simulated changes in (b)
oxy- and deoxy- haemoglobin (HbO2, HHb) and (c) total haemoglobin (HbT). (d)
Simulated cerebral metabolic rate of oxygen consumption (CMRO2).
stimulus is sometimes inverted in healthy preterm neonates as compared to
adults. The preterm model is capable of simulating the varied haemody-
namic responses observed in studies performed by Kozberg et al. (2013) and
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Roche-Labarbe et al. (2014). The model predicted an HHb decrease in re-
sponse to the stimulus unless vasoconstriction was imposed as observed by
Kozberg et al. (2013). Decreasing the radius of the blood vessel resulted in
the inverted response.
The BrainSignals preterm model was also able to simulate fNIRS data from
the USZ study relatively well. In Neonate 1 a similar response of hyper-
emia was observed as in the Roche-Labarbe et al. (2014) study. In Neonate
2, the observed rise in ∆HHb was simulated here by a constant CBF. How-
ever, the magnitude of ∆HbO2 and ∆HbT response was not sufficiently sim-
ulated. Neonates 1 and 2 are markedly different in both gestational and
actual age. The former, being older, is more likely to have a developed au-
toregulatory capacity although both subjects showed an increased HbT re-
sponse. Their differences in haematocrit and haemoglobin are also notable.
Indeed it has been suggested previously that HbT may have an effect on the
haemodynamic response in newborns (Zimmermann et al. 2012). However,
by changing baseline HbT, no effect was seen on the magnitude or shape
of the model’s simulations. These initial results suggest that the interaction
of many variables affect the functional haemodynamic response including
CBF, blood pressure and the varied stages of development. This makes it
very difficult to define a normal functional response for all neonates.
It is important here to discuss the scope of the model presented in this
chapter. It is perhaps obvious that the BrainSignals model is much more
limited in its capacity to simulate metabolites than the BrainPiglet models
(presented in previous chapters). The BrainSignals model was created with
a focus on functional activation and predicting ∆oxCCO, whilst the Brain-
Piglet model was produced to investigate hypoxia-ischaemia and developed
to examine intracellular pH. Although adapted to neonatal parameters, the
preterm model does not take into account the effects of fetal haemoglobin
which is present in significant concentrations at birth (see Chapter 2, Sec-
tion 2.7). It is also likely that many model parameters will be affected by the
stage of development of the neonate. As mentioned in this chapter, preterm
neonates have significant differences in physiology. The stage of develop-
ment of healthy preterm neonates at term-equivalent age is also unclear at
present. Possible genetic differences introduce further variability. In the ap-
plication of these models, this complexity becomes more convoluted when
the subjects being investigated are suffering from brain injury or exhibiting
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non-normal symptoms. Indeed the majority of literature on the physiologi-
cal characteristics of human neonates are studies of infants who are or have
been ill. This is not very surprising, as most neonates are unlikely to be kept
for monitoring in their first days of life unless their health necessitates their
stay.
Simulating functional activation, and the measurements obtained during
such experiments, is a more challenging task than simulating hypoxia is-
chaemia. The latter is gross global insult and produces a more significant
change in cerebral metabolism and health, which is in turn more easily and
clearly detected. During functional activation, the variations in the input
signals – blood pressure and SaO2 – are less marked, leading to smaller per-
turbations from the norm in the model. Thus, functional activation models
may require much more data for development and validation.
The work presented in these last two chapters is the realisation of an im-
portant goal in the continuous progress of a series of computational models.
This adaptation of the models to simulate metabolism in the human neonate
marks the beginning of what is likely to be a series of neonatal models to
investigate clinical data from young patients in intensive care.
250
Chapter 9
Conclusions and Future Work
In this thesis, five new models of cerebral metabolism are presented. They
are all adaptations and extensions of previously published models, and are
focused on simulating and interpreting cerebral NIRS and MRS measure-
ments during hypoxia-ischaemia and functional activation events. The mod-
els also provide a predictive capability for parameters that are indicative of
mechanisms of metabolic activity, such as the redox state of cytochrome,
autoregulation and cerebral oxygen consumption.
Mathematical and computational models are powerful mechanisms for in-
vestigating biological complexity. However, their authority is hindered by
the dichotomy between the nature of the method and that of the subject it is
being applied to. Quantitative concepts employ specific and concrete struc-
tures and values, which are seldom identifiable in biological environments.
The creation of exact or completely accurate models of cerebral metabolism
is an extremely difficult task in the current scientific sphere, with the ex-
ception of those producing very broad, general predictions. The accuracy
and complexity of a model are strongly related to the question that is being
asked. It is often easier to understand if there is a cerebral response than to
understand what the response is. In order to answer the more complex ques-
tions, as discussed in Chapter 4, the impulse in model building to include
as much detail as possible can be a risky fault. The aim is the creation of a
model that is on the one hand accurate enough to suit the needs of the ap-
plication, and on the other simple enough to be translated and understood.
The cerebral metabolism models built at UCL add to a growing collection
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of such models that are based on brain physiology. Many of these are built
upon others, extending, adapting and refining to suit the needs of the ap-
plication at hand. The UCL BrainSignals and BrainPiglet models are great
examples of this approach – both are derived from earlier models and were
created specific to a particular clinical application. BrainSignals was reduced
and extended from the earlier much more convoluted Braincirc model, fo-
cused on human adult cerebral metabolism and simulating NIRS measure-
ments (∆oxCCO in particular). BrainPiglet is an adapted and extended form
of BrainSignals to suit cerebral metabolism in the piglet, and to simulate
both NIRS and MRS measurements. These models aim to aid in the investi-
gation of cerebral activity by relating changes observed in clinical measure-
ments to the physiology that gives rise to them.
The BrainPiglet model was extended in this thesis in an effort to better
simulate intracellular pH dynamics, by incorporating cellular mechanisms
known to govern intracellular proton concentrations. The first version of the
model improved the representation of proton use and production in pre-
existing reactions, in addition to the introduction of the malate-aspartate
shuttle. These changes allowed a more authoritative simulation of cytoplas-
mic pH and the new modelling of mitochondrial pH, and were coupled with
parallel work on improving the simulation of artery occlusion. The second
version, BrainPiglet v2.0.1, integrates the simulation of carbonic acid in both
mitochondrial and cytoplasmic compartments. The third, BrainPiglet v2.1,
adds the workings of the sodium transporters on the cellular membrane –
the sodium-potassium pump and the sodium-hydrogen exchanger. These
new models therefore required the introduction of a significant number of
new variables and parameters.
The improved BrainPiglet models have been shown to capable of simulating
changes observed during cerebral hypoxia-ischaemia in piglets. In an ini-
tial investigation using data from one piglet, the models accurately predict
the observed increases in ∆HbO2 and ∆HbT and decrease in ∆HHb during
the insult. The models also simulate the decreases observed in ∆oxCCO,
albeit with less precision in v2.0.1 and v2.1, mainly due to a weaker perfor-
mance by the optimisation process. This relates to increased complexity in
v2.0.1 and v2.1, and back to the arguments around, and need for, a balance
between model efficacy and detail.
Indeed the developments in BrainPiglet v2.0.1 and v2.1 did not noticeably
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improve the simulation of cytoplasmic pH compared to BrainPiglet v2.0,
which predicts quite well the acidic pH observed in the MRS measurements
during the insult. More interesting perhaps is the model’s prediction of mi-
tochondrial pH, which had a varied response during the hypoxic-ischaemic
insult, but became more acidic following the release of blood occlusion.
These results suggest that intracellular pH dynamics maybe considerably
more intricate than may seem. However, the known regulators of intracel-
lular pH thought to be biologically important did not have a considerable
effect on the model’s capacity to simulate it. It could be argued that the
effect of these additions fall short simply because of the increased difficulty
in optimisation.
Following this initial trial of the three models, BrainPiglet v2.0 was chosen
to investigate the full set of experiments of piglets with both poor and good
outcomes. The model simulated the observed acidic drop in cytoplasmic pH
relatively well. Mitochondrial pH again displayed varying changes during
the insult phase, but became more acidic in all piglets following the release
of blood occlusion. There was no particular pattern in good or poor outcome
groups. It remains to be seen whether changes in mitochondrial pH can have
significant effects on intracellular pH as a whole, and whether these changes
lead to complex dynamics post-insult, resulting in secondary energy failure.
Chapter 7 presented the adaptation of the BrainPiglet v2.0 model to the term
neonate (and hence named the BabyBrain model). This involved changes in
the normal range of values for parameters known to be significantly dif-
ferent in the young. These changes worked surprisingly well, even though
the parameters were chosen for their biological importance (as was done
with earlier adaptations) and not necessarily for their calculated influence.
The model was employed in simulating events in NIRS measurements from
term neonates with hypoxic-ischaemic encephalopathy. Three neonates with
different severities of encephalopathy were investigated. The neonates dis-
played different variations in ∆oxCCO. Neonate 1 displayed a decrease in
∆oxCCO not corresponding to the event, which was not well predicted by
the model, as it simulated event-related responses. Neonate 2 showed a
slight increase in ∆oxCCO, an unusual response to a drop in oxygenation.
Neonate 3, the most severe case, displayed a significant drop in response to
the event, which was well simulated by the model. Event-related changes
in intracellular pH in Neonate 2 are also predicted, suggesting an acidic
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drop in both cytoplasmic and mitochondrial pH, followed by an acidic drop
in the mitochondrial pH while cytoplasmic pH returns to baseline. Taking
into account the earlier results from the piglet experiments, this indicates
that mitochondrial pH may indeed fluctuate very differently to that in the
cytoplasm, and that its role in influential cellular mechanisms must be scru-
tinised in more detail.
The next chapter covered the adaptation of the adult BrainSignals model to
the human preterm neonate brain. Preterm neonate physiology is slightly
different to the term, with values further away from adult values in most
cases. The adapted BrainSignals model was subsequently used to simulate
NIRS data from two published functional activation studies that reported
different responses in the preterm brain. Roche-Labarbe et al. (2014) ob-
served a decrease in ∆HHb in preterm neonates in response to a somatosen-
sory stimulus, contrary to the established normal response in the adult
which involves an increase in ∆HHb. Kozberg et al. (2013) conducted the
study in age-equivalent rats and observed an increase in ∆HHb in some and
a decrease in others. The model was able to simulate a decrease in ∆HHb,
except in the presence of vasoconstriction as was observed in Kozberg et al.
(2013). The BrainSignals preterm model was also used to simulate changes
observed in a neonatal NIRS study conducted by a collaborating group at
University Hospital Zurich, using a visual stimulus. Here the two subjects
displayed opposite responses, and the model was able to simulate the in-
crease in ∆HHb by keeping CBF constant. These results collectively point
to the differing role of autoregulation in developing infants, the extent of
which has not yet been determined. The physiology of preterm infants
varies greatly. The development of preterm neonates is also not synony-
mous with that of term neonates, even though their actual ages may be
equivalent. This makes it more difficult to characterise preterm neonatal
health.
The models presented in this thesis are quite large, complex models, nec-
essarily so because of the physiological approach taken in building them.
Each development and extension was born from the emergence of new re-
search interests in different aspects of cerebral physiology, and not from the
mathematical or computational bearings of such additions. That is, model
development has so far given priority and importance to the biological phe-
nomena, while the mathematical and computational implications of such
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developments, such as increases in complexity and possible error, were sec-
ondary and/or considered unavoidable.
As is typical for systems biology models, many of the model parameters are
poorly defined in literature, often due to technical limitations, while some
do not represent a measurable physical property. In the case of neonatal pa-
tients, many of these values are also based on studies of infants who are not
in their best health. Sensitivity analysis results have consistently shown that
for most model variables, the majority of parameters exert very little influ-
ence on model output. The upside here is that these inaccuracies have little
impact on model behaviour. If so, however, what then is the parameter’s
function? Such parameters therefore form part of physiological window dress-
ing - parameters which do not offer much function other than to ornament
for apparent biological validation. Thus the supposed biological complexity
here is simply a smokescreen, masking the real drivers of a dynamical sys-
tem. Model simplification is therefore paramount to the continued effective-
ness and applicability of such models. However, in physiological models it
is difficult to contrive a simplified, estimated system, without first consider-
ing the more detailed, complex one. Hence, the path to model simplification
must inevitably be a two step process, that starts with the formulation of an
unsimplified model, more concerned with biological relevance and less with
efficiency.
The current models do not incorporate the ability to simulate irreversible
injury such as cell death. Thus, in patients with severe injuries, or where the
time course being simulated includes a severe insult (such as the hypoxia-
ischaemia insults), this must be taken into account. The model also has no
spatial characteristics at present. However, it is feasible that several units
of the model could be connected in a three-dimensional mesh to create a
spatial representation of the brain, such as in Orlowski et al. (2013).
The models presented in this thesis have provided an insight into the phys-
iological basis of cerebral activity observed in a number of different studies,
conducted in both humans and animals. They have facilitated a look into
the workings of a complex cellular network that generates changes observed
in clinical measurements and ultimately governs patient health. The mod-
els are thus instruments that assist by aggregating and augmenting clinical
data, for improved understanding and therefore a clearer resolution on pa-
tient treatment and outcome.
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9.1 Future work
9.1.1 Blood pH
The model extensions focused on improving intracellular pH. However,
changes in blood pH are more commonly measured in clinical settings
and also affect cerebral metabolism. Changes in pH alter the affinity of
haemoglobin to bind oxygen, with a higher affinity at more acidic levels
(Bohr effect). This is likely to have an impact on intracellular metabolism,
but does require a significant model extension, leading to more variables
and parameters and the issues of increased complexity.
9.1.2 Model simplification
The group’s recent work in the modelling domain has turned to model sim-
plification, starting with the BrainSignals model (Caldwell et al. 2015). To
start the process with the simplest model in the series may not perhaps seem
to be an intuitive choice, however it is therefore also the easiest to tackle.
This effort has focused on reducing the model, by removing superfluous
elements and substituting model relationships with approximate functions.
Figures 9.1 and 9.2 illustrate the simplification of the metabolic submodel,
and the results of simulating data from adult hypercapnia experiments us-
ing the simplified model variations and the original submodel. It is clear
that the simplification has preserved the capacity of the model to simulate
such variations very well (Caldwell et al. 2015).
Copyright material removed.
Figure 9.1: BrainSignals model simplification. The complete metabolic submodel
with parameters omitted (A), and progressively reduced variants (B,C,D,E) (Cald-
well et al. 2015)
This work has so far been tested with clinical data from healthy patients.
However, it is the physiology of critically ill patients that will be a much
greater challenge for the reduced model.
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Copyright material removed.
Figure 9.2: BrainSignals model simplification. (A) Steady state simulations for three
variants compared with the original metabolic submodel. (B) Simulations of data
from human adult hypercapnia experiments. (Caldwell et al. 2015)
9.1.3 Model optimisation
Biological parameters must be optimised for each patient, especially in a
simplified model system. While a couple of sensitivity analysis and opti-
misation methods have been explored in this thesis and in the group’s past
work, it is apparent that better, more efficient methods would be benefi-
cial. For example, a variance-based global sensitivity analysis method –
Extended Fourier Amplitude Sensitivity Test (eFAST) – has been suggested
as a possible alternative to the Morris method that is currently used by the
group (Saltelli et al. 1999). It is suggested that eFAST maybe more capable
of handling the large number of model parameters.
9.1.4 Simulation of electrical activity
Electroencephalography (EEG) measurements are often recorded alongside
NIRS at the bedside. This combination of measurement techniques has re-
cently been used to investigate neonatal seizures, which are currently poorly
classified and associated with poor neurodevelopmental outcomes. Changes
in blood volume and oxygenation have been found to correlate with electro-
graphic events (Singh et al. 2014; Cooper et al. 2011).
The current UCL cerebral metabolism models do not incorporate the elec-
trical activity of the cell. Such additions would allow the simulation of
neonatal seizures, further enhancing the capacity of the model. However, as
discussed above, some simplifications maybe required to make these devel-
opments feasible.
9.1.5 Simulations of clinical treatments
Many of the clinical procedures used to alleviate the effects of brain injury
aim to inhibit select metabolic activity. For example, therapeutic hypother-
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mia has been proven to be an effective treatment to better the outcomes
of hypoxia-ischaemia in certain cases, when administered in the first 24 h
to reduce cerebral metabolic activity (Austin et al. 2013; Lobo et al. 2013;
Robertson et al. 2008). However, the physiological underpinnings of this
process are not well understood. It is quite feasible that the model could be
applied to investigate such treatments, by using long-term continuous data
from the patient.
9.2 Impact
The newborn is a delicate and vulnerable patient. Injury to the brain can
be life-threatening or have severe life-long consequences. The impact on
the individual is immense, and on their families immeasurable. The wider
impact on society, both socially and economically, is extensive.
Therefore, therapies that can improve the quality of life, to any degree, are of
vital importance. Mathematical and computational modelling are avenues
to explore and assess the mechanisms of such injuries, and the response to
clinical interventions. They help shape our understanding of experimen-
tal results and by simulating possible treatments, improve our likelihood of
success. In a world where the amount of clinical data collected becomes
unmanageable, such models can bring together a wide range of linked in-
formation and translate them into actionable insights. Today, they are an
almost necessary precursor to the development of effective evidence-based
clinical strategies that can be introduced at the bedside.
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Appendix A
Model definitions
A.1 BrainSignals
A.1.1 Overview
• 9 differential state variables
• 3 algebraic state variables
• 52 intermediate variables
• 213 parameters
A.1.2 Differential equations
dCuA,o
dt
= 4 f2 − 4 f1 (A.1)
da3r
dt
= 4 f2 − 4 f3 (A.2)
d∆Ψ
dt
=
p2 f2 + p1 f1 + p3 f3 − L
Cim
(A.3)
dH+m
dt
=
1
RHi
L− p3
RHi
f3 − p1RHi f1 −
p2
RHi
f2 (A.4)
d[O2]
dt
=
1
CBFn
JO2 − f3 (A.5)
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dvc
dt
=
1
vu,n
(PaCO2− vc) (A.6)
dvo
dt
=
1
vu,n
([O2,c]− vo) (A.7)
dvp
dt
=
1
vu,n
(
Pa − vp
)
(A.8)
dvu
dt
=
1
vu,n
(CBF− vu) (A.9)
A.1.3 Algebraic equations
[O2,c,init]
(
ScO2
1− ScO2
) 1
nh − [O2,c] = 0 (A.10)
Te + Tm − (P1 − Pic) r = 0 (A.11)
CBF ([HbO2,a]− [HbO2,v])− JO2 = 0 (A.12)
A.1.4 Chemical reactions
p2
RHi
H+m
f2−−→ 4 CuA,o + 4 a3r (A.13)
4 CuA,o +
p1
RHi
H+m
f1−−→ (A.14)
[O2] + 4 a3r +
p3
RHi
H+m
f3−−→ (A.15)
JO2−−→ 1
CBFn
[O2] (A.16)
L−−→ 1
RHi
H+m (A.17)
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A.1.5 State variables
Symbol Units Initialiser Notes
CuA,o m M l−1 CuAo,init The concentration of oxidised
cytochrome-c-oxidase
a3r m M l−1 a3r,init Concentration of reduced cyt a3
in mitochondria
∆Ψ m V ∆Ψinit Mitochondrial inner membrane
potential
H+m m M l−1 H+m,init Concentration of hydrogen ions
in mitochondria
[O2] m M l−1 O2,init The concentration of oxygen in
the mitochondria
[O2,c] m M l−1 [O2,c,init] The concentration of oxygen in
the capillary.
r cm rinit Typical radius of cerebral ves-
sels
vc m M l−1 vCO2,n CO2 passed through a first or-
der filter.
vo m M l−1 vO2,n capillary O2 passed through a
first order filter.
vp mmHg vPa ,n Arterial blood pressure passed
through a first order filter.
vu dimensionless vu,n The demand parameter u
passed through a first order
filter.
[HbO2,v] m M l−1 [HbO2,v,init] The concentration of bound
oxygen in the veins.
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A.1.6 Intermediate variables
Symbol Units Expression Notes
CuA,o m M l−1 E0(cyt a3)−CuA,o The concentration of reduced cytochrome-c-
oxidase in the mitochondria.
AVR dimensionless
Volart
Volven
Arterio-venous volume ratio
a3o m M l−1 E0(cyt a3)− a3r Concentration of oxidised cyt a3 in mito-
chondria
C0i dimensionless
10−pHm − 10−pHm−dpH
dpH
Natural buffering capacity for protons in mi-
tochondria
CBF m lblood−1
m ltissue−1 s−1
G (Pa − Pv) Cerebral blood flow
CBFnorm dimensionless
CBF
CBFn
∆oxCCO µM l−1(brain
tissue)
∆oxCCOo f f set + 1000CBFn (CuA,o −VAratn) The expected CCO signal (as measured by
NIRS)
CMRO2 m MO2
l−1(brain tis-
sue) s−1
f3 CBFn Cerebral metabolic rate for oxygen
∆G1 mV p1 ∆p− 4
(
E1 + E0(cyt a3) log10
(
CuA,o
CuA,o
))
Free energy associated with reaction 1
∆G2 mV
p2 ∆p
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o
CuA,o
)
− log10
(
a3r
a3o
))) Free energy associated with reaction 2
DHbdi f f dimensionless DHbdi f fo f f set + ∆HbO2− ∆HHb262
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∆HbO2 µM l−1(brain
tissue)
DHbO2o f f set +HbO2 −HbO2n Change in total oxygenated haemoglobin
(NIRS)
∆Hbt µM l−1(brain
tissue)
DHbTo f f set +Hbt−Hbtn Change in total haemoglobin (NIRS)
∆HHb µM l−1(brain
tissue)
DHHbo f f set +HHb−HHbn Change in total deoxygenated haemoglobin
(NIRS)
∆p m V ∆Ψ+ E0(cyt a3) (pHm − pHo) The proton motive force across the mitochon-
drial inner membrane.
η dimensionless RP
(
vp
vPa ,n
− 1
)
+ RO
(
vo
vO2,n
− 1
)
+ Ru
(
1− vu
vu,n
)
+
RC
(
1− vc
vCO2,n
) Total autoregulatory stimuli
f1 m M l−1 s−1 k1 CuA,o − k−1 CuA,o The rate at which CuA is reduced
f2 m M l−1 s−1 k2 CuA,o a3o − k−2 CuA,o a3r The rate at which CuA is oxidised and cyt a3
reduced.
f3 m M l−1 s−1
k3,0 [O2] a3r exp (−c3 (∆p− ∆p30))
1+ exp (−c3 (∆p− ∆p30)) The rate at which cyt a3 is oxidised
G mmHg Ru r4 Resistance of cerebral circulation
h cm (r r + 2r0 h0 + h0 h0)
1
2 − r Wall thickness of cerebral vessels
HbO2 µM l−1(brain
tissue)
Volart [HbO2,a] +Volven [HbO2,v]
4
Volblood,n × 1000 Total oxygenated haemoglobin (NIRS)
Hbt µM l−1(brain
tissue)
(Volart +Volven) [HbO2,a,n]
4
Volblood,n × 1000 Total haemoglobin (NIRS)
HHb µM l−1(brain
tissue)
Volart [Hba] +Volven [Hbv]
4
Volblood,n × 1000 Total deoxygenated haemoglobin (NIRS)263
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JO2 m MO2
l−1(brain tis-
sue) s−1
(1− JO2,swtch) JO2+ JO2,swtch JO2smth The rate at which oxygen is supplied to the
mitochondria.
JO2 dimensionless fmin (DO2 ([O2,c]− [O2]) , CBF [HbO2,a])
JO2smth dimensionless −
1
2
(
(DO2 ([O2,c]− [O2])−CBF [HbO2,a])2 + eps2
) 1
2
− 12 DO2 ([O2,c]− [O2]) + 32 CBF [HbO2,a]
k1 s−1 k1,0 exp (−ck1 (∆p− SaO2n)) Forward rate constant for reaction 1
k2 m−1 M s−1 k2,n exp (−ck2 (∆p− SaO2n)) Forward rate constant for reaction 2
Keq1 dimensionless 10
−1
E0(cyt a3)
(
p1 ∆p
4 −E1
)
Equilibrium constant for reaction 1
Keq2 dimensionless 10
−1
E0(cyt a3)
(
p2 ∆p
4 −E2
)
Equilibrium constant for reaction 2
k−1 s−1
k1
Keq1
Backward rate constant for reaction 1
k−2 m−1 M s−1
k2
Keq2
Backward rate constant for reaction 2
L m M l−1 s−1 LCV + Llk The rate at which protons reenter the mito-
chondrial matrix
LCV m M l−1 s−1
LCV, f rac LCV,max (1− exp (−θ))
1+ rCV exp (−θ) The rate at which protons reenter the mito-chondrial matrix associated with ADP phos-
phorylation
Llk m M l−1 s−1 ∆p3,corr fn (exp (∆p fn)− 1) The rate at which protons reenter the mito-
chondrial matrix through leak channels
µ dimensionless
µmin + µmax exp (η)
1+ exp (η)
Total autoregulatory stimuli filtered through
sigmoidal function264
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pHm pHunits −log10
(
H+m
1000
)
Mitochondrial pH
rbu f f i dimensionless
Cbu f f i
C0i
Buffering capacity for protons in mitochon-
dria
RHi dimensionless rbu f f i Relative mitochondrial volume for protons
ScO2 dimensionless
SaO2+ SvO2
2
Capillary oxygen saturation
σe mmHg σe0
(
exp
(
Kσ (r− r0)
r0
)
− 1
)
− σcoll Elastic stress in vessel walls
SvO2 dimensionless
[HbO2,v]
[HbO2,a,n]
Venous oxygen saturation
Te mmHg cm σe h Elastic tension in vessel walls
Tm mmHg cm Tmax exp
(
−
∣∣∣∣ r− rmrt − rm
∣∣∣∣nm) Muscular tension in vessel walls
Tmax mmHg cm Tmax0 (1+ Te,n µ) Maximum muscular tension developed by
circulation
θ dimensionless kCV (∆p+ E0(cyt a3) log10 (CBF)− LCV,max) Driving force for complex V
TOS dimensionless
100
( (
r
[Hbtotc ]
)2
[HbO2,a ](
r
[Hbtotc ]
)2
+ VolvenVolart,n
+
Volven
Volart,n
[HbO2,v ](
r
[Hbtotc ]
)2
+ VolvenVolart,n
)
[HbO2,a,n]
Tissue Oxygenation index.
Vmca m lblood−1
m ltissue−1 s−1
CBF CBFscale Blood velocity in the middle cerebral artery
Volart dimensionless Volart,n
(
r
[Hbtotc]
)2
Arterial blood volume as a fraction of normal
total blood volume
Voltot dimensionless Volart +Volven Normalised total blood volume265
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[Hbv] m M l−1 [HbO2,a,n]− [HbO2,v] The concentration of deoxyhaemoglobin in
the veins.
A.1.7 Parameters
Symbol Units Initialiser Notes
VAratn dimensionless 0.8 Normal oxidised fraction of CuA
CuAo,init m M l−1 VAratn Initial oxidized CuA
VAratn m M l−1 E0(cyt a3)VAratn Normal oxidized CuA
CuA,o,n m M l−1 E0(cyt a3)−VAratn The resting amount of reduced cytochrome-
c-oxidase
a3frac,n dimensionless 1− a3r,nE0(cyt a3) Normal oxidised fraction of cyt a3
a3o,init m M l−1 a3o,n Initial oxidised cytochrome a3
a3o,n m M l−1 E0(cyt a3)− a3r,n Normal oxidised cytochrome a3
Volblood,n dimensionless 0.04 Normal blood volume as a fraction of brain
tissue volume
a3r,init m M l−1 a3r,n Initial reduced cytochrome a3
a3r,n m M l−1
fn
k3,0
PaCO2n
exp(−c3 (SaO2n−∆p30))
1+exp(−c3 (SaO2n−∆p30))
Normal reduced cytochrome a3
c3 dimensionless 0.11 Parameter controlling the sensitivity of reac-
tion 3 to PMF
Cbu f f i dimensionless 0.022 Buffering capacity for protons in mitochon-
dria
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Cim mmol/L/mV 0.00675 Capacitance of mitochondrial inner mem-
brane
CNADH m V CNADH,n Redox potential minus standard redox po-
tential for NADH at normal demand
CNADH,n m V
E0(cyt a3)
2
log10
(
1
Nrat,n
)
Normal value of CNADH
CBFn m lblood−1
m ltissue−1 s−1
0.0125 Normal cerebral blood flow
CBFscale dimensionless 5000
∆oxCCOo f f set m M l−1 0 An arbitray baseline offset to the CCO signal
ck1 dimensionless 0.01 Parameter controlling sensitivity of k1 to
PMF
ck2 dimensionless 0.02 Parameter controlling sensitivity of k2 to
PMF
CMRO2n m lblood−1
m ltissue−1 s−1
0.034 The resting CMRO2.
LCV, f rac dimensionless 1 A control parameter representing the action
of complex V inhibitors
[CCO]mit m M l−1 0 Concentration of cytochrome c oxidase in mi-
tochondria
cytoxtis m M l−1 0.0055 Concentration of cytochrome c oxidase in tis-
sue
DNADH dimensionless 0.01 DNADH ∗Z is the change in NADH redox po-
tential for a ten-fold increase in u
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DO2 s−1
Ru
[O2,c,n]− PaCO2n Diffusion rate between capillaries and mito-chondria.
∆G1,n m V p1 SaO2n − 4
(
E1,n + E0(cyt a3) log10
(
VAratn
CuA,o,n
))
Normal free energy associated with reaction
1
∆G2,n m V
p2 SaO2n
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o,n
VAratn
)
+ log10
(
a3o,n
a3r,n
))) Normal free energy associated with reaction
2
DHbdi f fo f f set dimensionless 0 An arbitrary baseline offset to the signal
DHbO2o f f set dimensionless 0 An arbitrary baseline offset to the signal
DHbTo f f set dimensionless 0 An arbitrary baseline offset to the signal
DHHbo f f set dimensionless 0 An arbitrary baseline offset to the signal
∆p3,corr m V −25 Dp30 minus normal PMF
∆p30 m V ∆pn + ∆p3, corr Value of PMF at which reaction 3 is maxi-
mally sensitive to PMF
LCV,max m V 90 A constant in the rate of complex V
∆pn m V ∆Ψn + E0(cyt a3)∆pHn The resting value of the proton motive force.
dpH dimensionless 0.001 A constant in the buffering relationship
∆pHn dimensionless pHm,n − pHo,n The resting value of pH difference across mi-
tochondrial inner membrane
∆Ψinit m V ∆Ψn Initial value of mitochondrial inner mem-
brane potential
∆Ψn m V 145 Normal mitochondrial inner membrane po-
tential
E1,NADH m V E0(CuA)− E0(NADH) + CNADH E1 when the reducing substrate is NADH
E1,NADH,n m V E0(CuA)− E0(NADH) + CNADH,n Normal value of E1NADH
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E1 m V E1,NADH The energy provided by electron transfer to
CuA
E1,n m V E1,NADH,n The normal energy provided by electron
transfer to CuA
E2 m V E0(cyt a3)− E0(CuA) The energy provided by transfer of four elec-
trons from CuA to to cyt a3
E0(cyt a3) m V 350 Cyt a3 standard redox potential
E0(CuA) m V 247 CuA standard redox potential
E0(NADH) m V −320 NADH standard redox potential
fn m M l−1 s−1
CBFn
CBFn
Normal resting rate of f1 and f2.
Gn /mmHg/s
CBFn
Pa − Pv,n Normal resistance of cerebral circulation
h0 cm 0.003 Vascular wall thickness when radius is r0
H+m,init m M l
−1 H+m,n Initial hydrogen ion concentration in mito-
chondria
hn cm ([Hbtotc] [Hbtotc] + 2r0 h0 + h0 h0)
1
2 − [Hbtotc] Normal wall thickness of cerebral vessels
H+m,n m M l−1 103−pHm,n Normal hydrogen ion concentration in mito-
chondria
HbO2n µM l−1(brain
tissue)
Volart,n [HbO2,a] +Volven [HbO2,v,n]
4
Volblood,n × 1000 Normal total oxygenated haemoglobin
(NIRS)
Hbtn µM l−1(brain
tissue)
(Volart,n +Volven) [Hbtotn]
4
Volblood,n × 1000 Normal total haemoglobin (NIRS)
HHbn µM l−1(brain
tissue)
Volart,n [Hba] +Volven [Hbv,n]
4
Volblood,n × 1000 Normal total deoxygenated haemoglobin
(NIRS)
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k1,0 s−1
k1,nNADH
NADHn
Forward rate constant for reaction 1 at nor-
mal PMF
k1,n s−1
fn
VAratn − 1Keq1,n CuA,o,n
The value of k1 at normal ∆p and NADH
k2,n m−1 M s−1
fn
CuA,o,n a3o,n − 1Keq2,n VAratn a3r,n
Normal forward rate constant for reaction 2
k3,0 m−1 M s−1 2.5E + 5 An apparent second-order rate constant for
reaction 3 at zero PMF
Te,n dimensionless 1 Control parameter allowing destruction of
autoregulation
KG dimensionless
Gn
[Hbtotc]4
Constant of proportionality relating pressure
drop to flow
fn m V 0.038 Second constant controlling rate of Llk of Dp.
Kσ mmHg 10 Parameter controlling sensitivity of σe to ra-
dius
∆p3,corr dimensionless 1 Parameter representing the action of uncou-
plers
kCV m V
−1
Dpn − DpCV0 log(
1− LCV0
1+ rCVLCV0
) Parameter controlling the sensitivity of com-
plex V flux to driving force
Keq1,n dimensionless 10
−1
E0(cyt a3)
(
p1 SaO2n
4 −E1,n
)
Normal equilibrium constant for reaction 1
Keq2,n dimensionless 10
−1
E0(cyt a3)
(
p2 SaO2n
4 −E2
)
Normal equilibrium constant for reaction 2
k−1,0 s−1
fn
Keq1,n VAratn −CuA,o,n Backward rate constant for reaction 1 at nor-mal PMF270
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k−2,n m−1 M s−1
fn
Keq2,n CuA,o,n a3o,n −VAratn a3r,n Normal backward rate constant for reaction2
LCV,0 dimensionless 0.4 Normal complex V flux as a fraction of max-
imum possible flux
LCV, f rac dimensionless 1− Llk, f rac Normal fraction of proton entry into mito-
chondria associated with ADP phosphoryla-
tion
LCV,max m M l−1 s−1
LCVn
LCV0
The maximum rate of proton flow through
complex V.
LCV, n mV/s Ln LCV, f rac The resting flow of protons into the matrix
through complex V
fn mV/s
CBFn
exp (SaO2n fn)− 1 First constant controlling rate of Llk of Dp.
Llk, f rac dimensionless 0.25 Normal fraction of proton entry into mito-
chondria which is via leak channels
Llk,n mV/s Ln Llk, f rac The resting flow of protons into the matrix
via leak channels.
Ln mV/s ptot fn The total flow of protons back into mitochon-
dria
µmax dimensionless 1 Maximum value of mu
µmin dimensionless −1 Minimum value of mu
µn dimensionless 0 Normal value of mu
nh dimensionless 2.5 Hill coefficient for haemoglobin saturation
nm dimensionless 1.83 Exponent in the muscular tension relation-
ship
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NADHn m M l−1
Nt
1+Nrat,n
Normal mitochondrial NADH concentration
Nrat,n dimensionless 9 Normal NAD/NADH ratio
Nt m M l−1 3 Total mitochondrial NAD + NADH concen-
tration
O2,init m M l−1 0.024 Normal oxygen concentration in mitochon-
dria.
[O2,a] m M l−1 φ
(
SaO2sup
1− SaO2sup
) 1
nh
Arterial dissolved oxygen concentration
[O2,c,init] m M l−1 [O2,c,n] Initial concentration of dissolved oxygen in
the capillary.
[O2,c,n] m M l−1 [O2,c,init]
(
ScO2n
1− ScO2n
) 1
nh
Normal concentration of dissolved oxygen in
the capillary.
p1 dimensionless ptot− p23 The number of protons pumped by ared (re-
duction reaction)
p2 dimensionless 4 Total protons pumped by reaction 2
p23 dimensionless 8 Total protons pumped by reactions 2 and 3
p3 dimensionless p23 − p2 Total protons pumped by reaction 3
P1 mmHg
Pa + Pv
2
Average blood pressure in vessels
P1,n mmHg
Pa,n + Pv,n
2
Normal average blood pressure in vessels
Pa mmHg 100 Arterial blood pressure
pC1 dimensionless 8 Total protons pumped by complex 1
pC3 dimensionless 4 Total protons pumped by complex 3
Pic mmHg 9.5 Intracranial blood pressure
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Pic,n mmHg 9.5 Normal intracranial blood pressure
ptot dimensionless 20 Total protons pumped by reactions 1, 2 and
3
Pv mmHg 4 Venous blood pressure
Pv,n mmHg 4 Normal venous blood pressure
PaCO2 mmHg 40 Arterial partial pressure of CO2
PaCO2n mmHg 40 Normal arterial partial pressure of CO2
pHm,n pHunits 7.4 Normal mitochondrial pH
pHo pHunits 7 Extra-mitochondrial pH
pHo,n pHunits 7 Normal extra-mitochondrial pH
φ m M l−1 0.036 Value of O2 at half maximal saturation
r0 cm 0.0126 A special radius in the elastic tension rela-
tionship
RC dimensionless 2.2 Parameter controlling sensitivity of eta to ar-
terial CO2
RO dimensionless 1.5 Parameter controlling sensitivity of eta to ar-
terial O2
RP dimensionless 4 Parameter controlling sensitivity of eta to ar-
terial pressure
Ru dimensionless 0.5 Parameter controlling sensitivity of eta to u
rCV dimensionless 5 Parameter controlling the ratio of maximal to
minimal rates of oxidative phosphorylation
rm cm 0.027 Value of vessel radius giving maximum mus-
cular tension
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rn cm 0.0187 Normal radius of blood vessels normal ra-
dius of blood vessels
rt cm 0.018 Parameter in the muscular tension relation-
ship
SaO2n dimensionless 0.96 Normal saturation of the arterial
haemoglobin
SaO2 dimensionless 0.96 Saturation of the arterial haemoglobin
ScO2n dimensionless
SaO2n + SvO2n
2
Normal capillary oxygen saturation
σcoll mmHg 62.79 Value of pressure at which vessels collapse
σe0 mmHg 0.1425 Parameter in relationship determining σe
σe,n mmHg σe0
(
exp
(
Kσ ([Hbtotc]− r0)
r0
)
− 1
)
− σcoll Normal elastic stress in vessel walls
SvO2n dimensionless
[HbO2,v,n]
[Hbtotn]
Normal venous oxygen saturation
vu,n dimensionless 5 The time constant associated with vc
Te,n mmHg cm σe,n hn Normal elastic tension in vessel walls
Tmax0 mmHg cm
Tmax,n
1+ Te,n µn
Tmax at normal µ
Tmax,n mmHg cm
Tm,n
exp
(
−
∣∣∣∣ [Hbtotc ]−rmrt−rm
∣∣∣∣nm) Normal maximum muscular tension devel-oped by circulation
Tm,n mmHg cm (P1,n − Pic,n) [Hbtotc]− Te,n Normal muscular tension in vessel walls
vo,n dimensionless 20 The time constant associated with vo
vp,n dimensionless 5 The time constant associated with vp
vu,n dimensionless 0.5 the time constant associated with vu274
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u dimensionless LCV, f rac + (PaCO2− PaCO2n) u f The representation of ”demand” in the
model.
un dimensionless 1 Resting ”demand”
u∆p dimensionless
∆Ψn
SaO2n
Membrane potential as a fraction of total
PMF
u f dimensionless 0 Parameter controlling the effect of PaCO2n
on demand
vCO2,n m M l
−1 PaCO2n Normal value of vc (CO2 passed through a
first order filter)
vO2,n m M l
−1 [O2,c,n] Normal value of vo (capillary O2 passed
through a first order filter)
vPa ,n mmHg Pa Normal value of vp (ABP passed through a
first order filter)
vu,n dimensionless un Normal value of vu (u passed through a first
order filter)
VAratn dimensionless 3 The normal ratio of the volume of the veins
to the volume of the arteries
Volart,n dimensionless
mathrmVoltot,n
1+VAratn
Normal arterial blood volume as a fraction of
total blood volume
Volmit dimensionless 0.067 Fraction of brain water which is mitochon-
dria
Voltot,n dimensionless 1 Normal total blood volume
Volven dimensionless Voltot,n
VAratn
1+VAratn
Venous blood volume as a fraction of total
blood volume275
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[HbO2,a,n] m M l−1 [Hbtotn] SaO2n Normal concentration of arterial oxy-
haemoglobin.
[HbO2,v,init] m M l−1 [HbO2,v,n] Tnitial concentration of venous oxy-
haemoglobin.
[HbO2,v,n] m M l−1
CBFn [HbO2,a,n]− Ru
CBFn
Normal concentration of venous oxy-
haemoglobin.
[Hbtotn] m M l−1 9.1 Normal total haemoglobin concentration in
the arteries and veins.
[Hbv,n] m M l−1 [Hbtotn]− [HbO2,v,n] Normal unsaturated venous haemoglobin
Z m V 59.028 2.303*RT/F
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A.2 BrainPiglet v2.0
A.2.1 Overview
• 21 differential state variables
• 3 algebraic state variables
• 95 intermediate variables
• 295 parameters
A.2.2 Differential equations
d[ADP]
dt
=
(
k−PCr + [ATP] [Cr]
)− 2(kAK + [ADP]2)− (kPCr + [PCr] [ADP] [H+])
+
Vmax,ATP [ATP]
km + [ATP]
+ 2
(
k−AK + [ATP] [AMP]
)− kATP,CV
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.18)
d[AMP]
dt
=
(
kAK + [ADP]
2
)
− (k−AK + [ATP] [AMP]) (A.19)
d[ATP]
dt
=
(
kAK + [ADP]
2
)
− (k−PCr + [ATP] [Cr])+ (kPCr + [PCr] [ADP] [H+])
− Vmax,ATP [ATP]
km + [ATP]
− (k−AK + [ATP] [AMP])+ kATP,CV
+ 2
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.20)
d[Cr]
dt
=
(
kPCr + [PCr] [ADP] [H+]
)− (k−PCr + [ATP] [Cr]) (A.21)
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d[gluc]
dt
= Vglucosein vglut
− vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
− vglut [gluc]
kglut + [gluc]
(A.22)
d[H+]
dt
=
1
RHic
(
k−PCr + [ATP] [Cr]
)− 1
RHic
(
kPCr + [PCr] [ADP] [H+]
)
+
p1 + 4
RHic
CBFn
f1
− 1
RHic
vMCT [lac] [H+]
(kMCT + [lac]) (kMCT + [H+])
+
1
RHic
(
k−pl + [lac]NADcyt
)
+
1
RHic
Vlacin vMCT
+
1
RHic
(
k−MAshut +NADcyt H
+
m
)
+
p2
RHic
CBFn
f2− 1RHic
(
kMAshut + [H+] [NAD]
)− 1RHic
CBFn
L
− 1
RHic
(
kpl + [Py] [H+]
)
− 1RHic
CBFn
kTCA
+
4
RHic
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.23)
d[lac]
dt
= Vlacin vMCT − vMCT [lac] [H
+]
(kMCT + [lac]) (kMCT + [H+])
−
(
k−pl + [lac]NADcyt
)
+
(
kpl + [Py] [H+]
)
(A.24)
d[Pi]
dt
=
Vmax,ATP [ATP]
km + [ATP]
− kATP,CV
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.25)
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d[PCr]
dt
=
(
k−PCr + [ATP] [Cr]
)− (kPCr + [PCr] [ADP] [H+]) (A.26)
d[Py]
dt
=
(
k−pl + [lac]NADcyt
)
−
(
kpl + [Py] [H+]
)
− 11
CBFn
kTCA
+ 2
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.27)
dCuA,o
dt
= 4 f2 − 4 f1 (A.28)
dcyta3r
dt
= 4 f2 − 4 f3 (A.29)
d∆Ψ
dt
=
p2 f2 + p1 f1 + p3 f3 − L
Cim
(A.30)
dH+m
dt
=
1
RHi CBFn
(
kMAshut + [H+] [NAD]
)− p1 + 53
RHi
f1
− 1
RHi CBFn
(
k−MAshut +NADcyt H
+
m
)− p2
RHi
f2 − p3RHi f3 +
1
RHi
L +
4
RHi
kTCA
(A.31)
d[NAD]
dt
= 2 f1 +
1
CBFn
(
k−MAshut +NADcyt H
+
m
)
− 1
CBFn
(
kMAshut + [H+] [NAD]
)− 5kTCA (A.32)
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dNADcyt
dt
=
(
kMAshut + [H+] [NAD]
)− (k−pl + [lac]NADcyt)
− (k−MAshut +NADcyt H+m)+ (kpl + [Py] [H+])
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.33)
d[O2]
dt
=
1
CBFn
JO2 − f3 (A.34)
dνCO2
dt
=
1
νu,n
(
PaCO2 − νCO2
)
(A.35)
dνO2
dt
=
1
νu,n
(
[O2,c]− νO2
)
(A.36)
dνPa
dt
=
1
νu,n
(Pa2 − νPa) (A.37)
dνu
dt
=
1
νu,n
(CBF− νu) (A.38)
A.2.3 Algebraic equations
[O2,c]init
(
ScO2
1− ScO2
) 1
nh − [O2,c] = 0 (A.39)
Te + Tm − (P1 − Pic) r = 0 (A.40)
CBF ([HbO2,a]− [HbO2,v])− JO2 = 0 (A.41)
A.2.4 Chemical reactions
p2
RHi
H+m
f2−−→ 4 CuA,o + 4 cyta3r + p2RHic
CBFn
[H+] (A.42)
4 CuA,o +
p1 + 53
RHi
H+m
f1−−→ 2 [NAD] + p1 + 4RHic
CBFn
[H+] (A.43)
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2 [ADP] MA←−→
MA
[ATP] + [AMP] (A.44)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kAK + [ADP]
2. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term k−AK + [ATP] [AMP].
[ADP] + [Pi]
kATP,CV−−−−→ [ATP] (A.45)
[ATP] MM−−→ [ADP] + [Pi] (A.46)
Michaelis-Menten kinetics are assumed, with calculated rate term
Vmax,ATP [ATP]
km + [ATP]
.
[O2] + 4 cyta3r +
p3
RHi
H+m
f3−−→ (A.47)
Vglucosein vglut−−−−−−−→ [gluc] (A.48)
[gluc] MM−−→ (A.49)
Michaelis-Menten kinetics are assumed, with calculated rate term
vglut [gluc]
kglut + [gluc]
.
2 [ADP] + 2 [Pi] + [gluc] + 2 NADcyt
MM−−→ 2 [ATP] + 2 [Py] + 4
RHic
[H+] (A.50)
Michaelis-Menten kinetics are assumed, with calculated rate term
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
) .
Vlacin vMCT−−−−−−→ [lac] + 1
RHic
[H+] (A.51)
[lac] +
1
RHic
[H+]
vMCT [lac] [H
+]
(kMCT+[lac]) (kMCT+[H+])−−−−−−−−−−−−−−→ (A.52)
1
RHic
[H+] +
1
CBFn
[NAD] MA←−→
MA
NADcyt +
1
RHi CBFn
H+m (A.53)
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Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kMAshut + [H+] [NAD]. Mass Action kinetics are assumed for the reverse reac-
tion, with calculated rate term k−MAshut +NADcyt H
+
m.
JO2−−→ 1
CBFn
[O2] (A.54)
[PCr] + [ADP] +
1
RHic
[H+] MA←−→
MA
[ATP] + [Cr] (A.55)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kPCr + [PCr] [ADP] [H+]. Mass Action kinetics are assumed for the reverse
reaction, with calculated rate term k−PCr + [ATP] [Cr].
1
RHic
CBFn
[H+] L−−→ 1
RHi
H+m (A.56)
[Py] +
1
RHic
[H+] MA←−→
MA
[lac] +NADcyt (A.57)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kpl + [Py] [H+]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term k−pl + [lac]NADcyt.
1
1
CBFn
[Py] + 5 [NAD] +
1
RHic
CBFn
[H+]
kTCA−−→ 4
RHi
H+m (A.58)
A.2.5 State variables
Symbol Units Initialiser Notes
[ADP] m M [ADP]n ADP concentration in cyto-
plasm and mitochondria
[AMP] m M [AMP]n AMP concentration in cyto-
plasm
[ATP] m M [ATP]n ATP concentration in cytoplasm
and mitochondira
[Cr] m M [Cr]n Creatine concentration in cyto-
plasm
[gluc] m M [gluc]n Concentration of glucose in the
cytoplasm
[H+] m M [H+]n Concentration of hydrogen ions
in the cytoplasm
[lac] m M [lac]n Concentration of lactate in the
cytoplasm
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[Pi] m M [P]n Inorganic phosphate concentra-
tion in cytoplasm and mito-
chondria
[PCr] m M [PCr]n Phosphocreatine concentration
in cytoplasm
[Py] m M [Py]n Concentration of pyruvate in
the cytoplasm
CuA,o m M CuA,o,init The concentration of oxidised
cytochrome-c-oxidase
cyta3r m M [a3r]init Concentration of reduced cyt a3
in mitochondria
∆Ψ m V ∆Ψinit Mitochondrial inner membrane
potential
H+m m M H
+
m,init Concentration of hydrogen ions
in mitochondria
[NAD] m M [NAD]n Concentration of NAD in the
mitochondria
NADcyt m M NADcytn Concentration of NAD in the
cytoplasm
[O2] m M [O2]init The concentration of oxygen in
the mitochondria
[O2,c] m M [O2,c]init The concentration of oxygen in
the capillary.
r cm rinit Typical radius of cerebral ves-
sels
νCO2 mmHg νCO2,n CO2 passed through a first or-
der filter.
νO2 m M νO2,n capillary O2 passed through a
first order filter.
νPa mmHg νPa ,n Arterial blood pressure passed
through a first order filter.
νu dimensionless νu,n The demand parameter u
passed through a first order
filter.
[HbO2,v] m M [HbO2,v]init The concentration of bound
oxygen in the veins.
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A.2.6 Intermediate variables
Symbol Units Expression Notes
CuA,o m M E0(cyt a3)−CuA,o The concentration of reduced
cytochrome-c-oxidase in the mito-
chondria.
AVR dimensionless
Va
Vv
Arterio-venous volume ratio
cyta3o m M E0(cyt a3)− cyta3r Concentration of oxidised cyt a3 in mi-
tochondria
C0i dimensionless
10−pHm − 10−pHm−dpH
dpH
Natural buffering capacity for protons
in mitochondria
C0ic dimensionless
10−pHo − 10−pHo−dpH
dpH
Natural buffering capacity for protons
in cytoplasm
CNADH m V
E0(cyt a3)
2
log10
(
1
[NAD]/[NADH]
)
Redox potential minus standard re-
dox potential for NADH at normal de-
mand
CBF m l m−1 l s−1 G (Pa2 − Pv) Cerebral blood flow
∆oxCCO µM ∆oxCCOoffset + 1000CBFn (CuA,o −VAratn) The expected CCO signal (as mea-
sured by NIRS)
CMRO2 m M s−1 f3 CBFn Cerebral metabolic rate for oxygen
∆G1 m V p1 ∆p− 4
(
E1 + E0(cyt a3) log10
(
CuA,o
CuA,o
))
Free energy associated with reaction 1
∆G2 m V
p2 ∆p
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o
CuA,o
)
− log10
(
cyta3r
cyta3o
))) Free energy associated with reaction 2284
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∆G J mol−1 ∆G◦ + E0(cyt a3) F log10
(
gp
)
Gibbs free energy of ATP hydrolysis
∆Hbdiff µM ∆Hbdiffoffset + ∆HbO2− ∆HHb Change in Hbdiff (NIRS)
∆HbO2 µM ∆HbO2,offset +HbO2 −HbO2n Change in total oxygenated
haemoglobin (NIRS)
∆Hbt µM ∆HbToffset +Hbt−Hbtn Change in total haemoglobin (NIRS)
∆HHb µM ∆HHboffset +HHb−Hbtn Change in total deoxygenated
haemoglobin (NIRS)
∆p m V ∆Ψ+ E0(cyt a3)∆pH The proton motive force across the mi-
tochondrial inner membrane.
∆pH dimensionless pHm − pHo The pH difference across mitochon-
drial inner membrane
E1,NADH m V E0(CuA)− E0(NADH) + CNADH E1 when the reducing substrate is
NADH
E1 m V E1,NADH The energy provided by electron trans-
fer to CuA
η dimensionless RP
(
νPa
νPa ,n
− 1
)
+ RO
(
νO2
νO2,n
− 1
)
+ Ru
(
1− νu
νu,n
)
+
RC
(
1− νCO2
νCO2,n
) Total autoregulatory stimuli
f1 m M s−1 k1 CuA,o − k−1 CuA,o The rate at which CuA is reduced
f2 m M s−1 k2 CuA,o cyta3o − k−2 CuA,o cyta3r The rate at which CuA is oxidised and
cyt a3 reduced.
f3 m M s−1
ck2 [O2] cyta3r exp (−c3 (∆p− ∆p30))
1+ exp (−c3 (∆p− ∆p30)) The rate at which cyt a3 is oxidised
G mmHg−1 s−1 Ru r4 Resistance of cerebral circulation285
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gp dimensionless
[ADP] [Pi]
[ATP]× 1000 (Normalised) phophorylation poten-
tial (or ADP/ATP ratio)
Gt mmHg−1 s−1
G G0 Gv
G G0 + G Gv + Gv G0
The total conductance of the cerebral
blood vessels
h cm
(
r2 + 2r0 h0 + h0 h0
) 1
2 − r Wall thickness of cerebral vessels
HbO2 µM
Va [HbO2,a] +Vv [HbO2,v]
4
Vblood,n × 1000 Total oxygenated haemoglobin (NIRS)
Hbt µM
(Va +Vv) [HbO2,a]n
4
Vblood,n × 1000 total haemoglobin (NIRS)
HHb µM
Va [HHba] +Vv [HHbv]
4
Vblood,n × 1000 Total deoxygenated haemoglobin
(NIRS)
JO2 m M s−1 JO2,min The rate at which oxygen is supplied
to the mitochondria.
JO2,min m M s−1 fmin (DO2 ([O2,c]− [O2]) , CBF [HbO2,a]) Rate at which oxygen is supplied to
the mitochondria, minimum of diffu-
sion rate and delivery rate
k1 s−1 k1,0 exp (−ck1 (∆p− SaO2,n)) Forward rate constant for reaction 1
k1,0 s−1
k1,n
Nt
1+[NAD]/[NADH]
[NADH]n
Forward rate constant for reaction 1 at
normal PMF
k2 m−1 M s−1 k2,n exp (−ck2 (∆p− SaO2,n)) Forward rate constant for reaction 2
kMAshut s−1
CBFn NADHcyt
3
[NAD]n [H+]n NADHcyt − 1KeqMAshut NADcytn H
+
m,n NADH
Rate of forward reaction in the malate-
aspartate shuttle
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k−MAshut s
−1
kMAshut NADH
NADHcyt
KeqMAshut
Rate of backward reaction in the
malate-aspartate shuttle
k−PCr m
−1 M s−1 log (2)(
Keq,PCr
(
[PCr]n + [ADP]n +
[H+ ]n
RHic
)
+ [Cr]n + [ATP]n
)
t1/2,PCr
The backward rate of reaction for
the reaction in which phosphocreatine
combines with ADP to give creatine
and ATP
kPCr m−1 M s−1
log (2)(
[PCr]n + [ADP]n +
[H+ ]n
RHic
+ [Cr]n+[ATP]nKeq,PCr
)
t1/2,PCr
The forward rate of reaction for the re-
action in which phosphocreatine com-
bines with ADP to give creatine and
ATP
kpl s−1
2CMRgluc,n − CBFn3 + k−pl [lac]n NADcytn
[Py]n [H+]n
mathrmNADHcyt
NADHcytn
Rate of forward reaction in the pyru-
vate lactate equilibrium
kTCA m M s−1
vTCA [Py] [NAD]
(km,tcaN + [NAD]) (km,tcaP + [Py])
Rate of the TCA cycle
kATP,CV m M s
−1 LCV CBFn
na
Rate of ATP synthesis by Complex V
Keq1 dimensionless 10
−1
E0(cyt a3)
(
p1 ∆p
4 −E1
)
Equilibrium constant for reaction 1
Keq2 dimensionless 10
−1
E0(cyt a3)
(
p2 ∆p
4 −E2
)
Equilibrium constant for reaction 2
k−1 s−1
k1
Keq1
Backward rate constant for reaction 1
k−2 m−1 M s−1
k2
Keq2
Backward rate constant for reaction 2
L m M s−1 LCV + Llk The rate at which protons reenter the
mitochondrial matrix
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LCV m M s−1
LCV,frac LCV,max (1− exp (−θ))
1+ rCV exp (−θ) The rate at which protons reenter themitochondrial matrix associated with
ADP phosphorylation
Llk m M s−1 ∆p3,corr fn (exp (∆p fn)− 1) The rate at which protons reenter
the mitochondrial matrix through leak
channels
µ dimensionless
µmin + µmax exp (η)
1+ exp (η)
Total autoregulatory stimuli filtered
through sigmoidal function
NADH m M Nt − [NAD] Concentration of NADH in the mito-
chondria mitochondrial NADH con-
centration
NADHcyt m M NADcytn + NADHcytn−NADcyt Concentration of NADH in the cyto-
plasm
[NAD]/[NADH] dimensionless Nrat NAD/NADH ratio in the mitochon-
dria
NTP/EPP dimensionless
[ATP]
EPP
NTP/EPP calculation
P1 mmHg
Pa2 + Pv
2
Average blood pressure in vessels
Pa2 mmHg
G0 Pa + G Pv
G + G0
The pressure at the start of the cerebral
artery compartment
Pv mmHg
Gt
Gv
(Pa − Pvs) + Pvs Venous blood pressure
pHm dimensionless −log10
(
H+m
1000
)
Mitochondrial pH
pHo dimensionless −log10
(
[H+]
1000
)
Extra-mitochondrial pH
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rbuffi dimensionless
Cbuffi
C0i
Buffering capacity for protons in mito-
chondria
rbuffic dimensionless
Cbuffic
C0ic
Buffering capacity for protons in cyto-
plasm
RHi dimensionless rbuffi Relative mitochondrial volume for
protons
RHic dimensionless rbuffic Relative cytoplasmic volume for pro-
tons
ScO2 dimensionless
SaO2 + SvO2
2
Capillary oxygen saturation
σe mmHg σe0
(
exp
(
Kσ (r− r0)
r0
)
− 1
)
− σcoll Elastic stress in vessel walls
SvO2 dimensionless
[HbO2,v]
[HbO2,a]n
Venous oxygen saturation
Te mmHg cm σe h Elastic tension in vessel walls
Tm mmHg cm Tmax exp
(
−
∣∣∣∣ r− rmrt − rm
∣∣∣∣nm) Muscular tension in vessel walls
Tmax mmHg cm Tmax0 (1+ Te,n µ) Maximum muscular tension devel-
oped by circulation
θ dimensionless kCV
(
∆p+
E0(cyt a3)
na
log10
(
gp
gp,n
)
− LCV,max
)
Driving force for complex V
TOS dimensionless
100
( (
r
[Hbtotc ]
)2
(
r
[Hbtotc ]
)2
+ VvVa,n
[HbO2,a] +
Vv
Va,n(
r
[Hbtotc ]
)2
+ VvVa,n
[HbO2,v]
)
[HbO2,a]n
Tissue Oxygenation index.
vglyc m M s−1
vglyc,n (I + 1)
1+ I [ATP]
[ATP]n
[AMP]n
[AMP]
Vmax for glycolysis289
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Vmca cm s−1 CBF CBFscale The velocity of blood in the middle
cerebral artery
Va dimensionless Va,n
(
r
[Hbtotc]
)2
Arterial blood volume as a fraction of
normal total blood volume
Vt dimensionless Va +Vv Normalised total blood volume
Vv dimensionless Vv,n + Cv (Pv − Pv,n) Venous blood volume as a fraction of
total blood volume
[HHbv] m M [HbO2,a]n − [HbO2,v] The concentration of deoxy-
haemoglobin in the veins.
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Symbol Units Initialiser Notes
[ADP]n m M 0.012 The normal concentration of ADP in
the cytoplasm
[AMP]n m M
KeqADPATP [ADP]n
2
[ATP]n
Normal AMP concentration in cyto-
plasm
[ATP]n m M 1.2 The normal concentration of ATP in
the cytoplasm
[Cr]n m M
K∗eq,PCr [ADP]n [PCr]n
[ATP]n
Normal concentration of creatine in
cytoplasm
[gluc]n m M 1.2 Normal cellular concentration of glu-
cose
[H+]n m M 1000
(
10−pHo,n
)
Normal hydrogen ion concentration in
the cytoplasm
[lac]n m M 3 Normal concentration of lactate in the
cytoplasm
[PCr]n m M 2.6 Normal concentration of phosphocre-
atine in cell cytoplasm
[P]n m M
[PCr]n
[PCr]n/[Pi]n
The normal concentration of inorganic
phosphate in the cytoplasm
[Py]n m M 0.1 Normal concentration of pyruvate ions
in the cytoplasm
CuA,frac dimensionless 0.67 Normal oxidised fraction of CuA
291
A
.2.
BrainPiglet
v2.0
CuA,o,init m M CuA,o,n Initial oxidized CuA
CuA,o,n m M [CCO]mit CuA,frac Normal oxidized CuA
CuA,red,n m M 0.01084 The resting amount of reduced
cytochrome-c-oxidase
a3frac,n dimensionless 1− cyta3r,n[CCO]mit Normal oxidised fraction of cyt a3
a3o,init m M a3o,n Initial oxidised cytochrome a3
a3o,n m M [CCO]mit − cyta3r,n Normal oxidised cytochrome a3
Vblood,n dimensionless 0.0325 Normal blood volume as a fraction of
brain tissue volume
[a3r]init m M cyta3r,n Initial reduced cytochrome a3
cyta3r,n m M
fn
ck2
PaCO2,n
exp(−c3 (SaO2,n−∆p30))
1+exp(−c3 (SaO2,n−∆p30))
Normal reduced cytochrome a3
c3 m−1 V 0.11 Parameter controlling the sensitivity
of reaction 3 to PMF
Cbuffi dimensionless 0.022 Buffering capacity for protons in mito-
chondria
Cbuffic dimensionless 0.025 Buffering capacity for protons in cyto-
plasm
Ccytc m V −30 Redox potential minus standard redox
potential for cyt c Z log C2+C3+
Ccytc,n m V −30 Normal value of Ccytc
occfrac dimensionless 0.8 Fraction of arterial blood which flows
through the carotid arteries under nor-
mal conditions
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Cim m M m−1 V 0.00675 Capacitance of mitochondrial inner
membrane
CNADH,n m V
Z
2
log10
(
1
[NAD]n/[NADH]n
)
Normal value of CNADH
Cv mmHg−1 0.047 Compliance of the veins (normalised)
CBFn m l m−1 l s−1 0.008 Normal cerebral blood flow
CBFscale cm 5000 Ratio between Vmca and CBF
∆oxCCOoffset µM 0 An arbitrary baseline offset to the
CCO signal (NIRS)
ck1 m−1 V 0.01 Parameter controlling sensitivity of k1
to PMF
ck2 m−1 V 0.02 Parameter controlling sensitivity of k2
to PMF
CMRgluc,n dimensionless 0.0044 Normal rate of glucose metabolism for
the brain
CMRO2n m M s−1 0.02 The resting CMRO2.
LCV,frac dimensionless 1 A control parameter representing the
action of complex V inhibitors
[CCO]mit m M
[CCO]tis
Volmit
Concentration of cytochrome c oxi-
dase in mitochondria
[CCO]tis m M 0.0022 Concentration of cytochrome c oxi-
dase in tissue
DO2 s−1
Ru
[O2,c]n − PaCO2,n Diffusion rate between capillaries andmitochondria.293
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∆G1,n m V p1 SaO2,n − 4
(
E1,n + E0(cyt a3) log10
(
VAratn
CuA,o,n
))
Normal free energy associated with re-
action 1
∆G2,n m V
p2 SaO2,n
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o,n
VAratn
)
− log10
(
cyta3r,n
a3o,n
)))Normal free energy associated with re-
action 2
∆Gn J mol−1 ∆G◦ + E0(cyt a3) F log10
(
gp,n
)
Normal Gibbs free energy of ATP hy-
drolysis
∆Hbdiffoffset µM 0 An arbitrary baseline offset to the
HHb signal (NIRS)
∆HbO2,offset µM 0 An arbitrary baseline offset to the
HbO2 signal (NIRS)
∆HbToffset µM 0 An arbitrary baseline offset to the HbT
signal (NIRS)
∆HHboffset µM 0 An arbitrary baseline offset to the
HHb signal (NIRS)
∆p3,corr m V −25 ∆p30 minus normal PMF
∆p30 m V SaO2,n + ∆p3,corr Value of PMF at which reaction 3 is
maximally sensitive to PMF
LCV,max m V
−∆Gn
na F
A constant in the rate of complex V
Dpn m V ∆Ψn + E0(cyt a3)∆pHn The resting value of the proton motive
force.
dpH dimensionless 0.001 A constant in the buffering relation-
ship
∆pHn dimensionless pHm,n − pHo,n The resting value of pH difference
across mitochondrial inner membrane
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∆Ψinit m V ∆Ψn Initial value of mitochondrial inner
membrane potential
∆Ψn m V 145 Normal mitochondrial inner mem-
brane potential
E1,NADH,n m V E0(CuA)− E0(NADH) + CNADH,n Normal value of E1NADH
E1,n m V E1,NADH,n The normal value of E1
E2 m V E0(cyt a3)− E0(CuA) The energy provided by transfer of
four electrons from CuA to to cyt a3
E0(cyt a3) m V 350 Cyt a3 standard redox potential
E0(CuA) m V 250 CuA standard redox potential
E0(NADH) m V −320 NADH standard redox potential
EPP dimensionless Pin + PCrn + 2ATPn + ADPn Exchangeable phosphate pool
fn m M s−1
CBFn
CBFn
Normal resting rate of f1 and f2.
F C m−1 mol 96.4853 Faraday constant
G0 mmHg−1 s−1 KG,0r04 Conductance of the supplying artery
compartment
G0,n mmHg−1 s−1 G0,ratGn Normal conductance of the supplying
artery compartment
G0,rat dimensionless 10 Ratio between the conductance of the
cerebral arteries and the supplying
artery compartment
Gv mmHg−1 s−1 GVArat,n Gn Conductance of the veins
GVArat,n dimensionless 4 Normal ratio of conductances between
arteries and veins Gv/Gn (determines
venous pressure).
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[glucc] m M 5.3 Concentration of glucose in the blood
glyca,n dimensionless
([ADP]n)
2(
km,glycA
)2
+ ([ADP]n, 2)
2
Term in the expression for normal gly-
colysis rate
glycg,n dimensionless
[gluc]n
km,glycG + [gluc]n
Term in the expression for normal gly-
colysis rate
glycn,n dimensionless
(
NADcytn
)2(
km,glycN
)2
+
(
NADcytn
)2 Term in the expression for normal gly-
colysis rate
glycp,n dimensionless
([P]n)
2(
km,glycP
)2
+ ([P]n)
”
Term in the expression for normal gly-
colysis rate
Gn mmHg−1 s−1
CBFn
Pa − Pvs
(
1+
1
G0,rat
+
1
GVArat,n
)
Normal resistance of cerebral circula-
tion
∆G◦ J mol−1 −30500 Standard Gibbs free energy of ATP hy-
drolysis
gp,n dimensionless
[ADP]n [P]n
[ATP]n × 1000 Normal phosphorylation potential
Gt,n mmHg−1 s−1
Gn G0,n Gv
Gn G0,n + Gn Gv + Gv G0,n
Normal value of the total Conductance
of all blood vessel compartments
h0 cm 0.003 Vascular wall thickness when radius is
r0
H+m,init m M H
+
m,n Initial hydrogen ion concentration in
mitochondria
H+m,n m M 10
3−pHm,n Normal hydrogen ion concentration in
mitochondria
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hn cm
(
[Hbtotc]2 + 2r0 h0 + h0 h0
) 1
2 − [Hbtotc] Normal wall thickness of cerebral ves-
sels
Hon m M 103−pHo,n Normal hydrogen ion concentration in
the cytoplasm
HbO2n µM
Va,n [HbO2,a]n +Vv,n [HbO2,v]n
4
Vblood,n × 1000 Normal total oxygenated haemoglobin
(NIRS)
kH,O2 m M mmHg
−1 0.0014000 Constant setting relationship between
oxygen saturation and oxygen concen-
tration in artery
Hbtn µM
(Va,n +Vv,n) [Hbtot]n
4
Vblood,n × 1000 Normal total deoxygenated
haemoglobin (NIRS)
I dimensionless 3 The parameter which describes how
strongly the AMP/ATP ratio inhibits
the conversion of glucose to pyruvate
Ru m M s−1 CBFn The resting rate of supply of oxygen to
the mitochondria.
k1,n s−1
fn
VAratn − 1Keq1,n CuA,o,n
The value of k1 at normal ∆p and
NADH
k2,n m−1 M s−1
fn
CuA,o,n a3o,n − 1Keq2,n VAratn cyta3r,n
Normal forward rate constant for re-
action 2
ck2 m−1 M s−1
k3,0
exp(−c3 (SaO2,n−∆p30))
1+exp(−c3 (SaO2,n−∆p30))
Rate constant for reaction 3
k3,0 m−1 M s−1 2.5E + 5 An apparent second-order rate con-
stant for reaction 3 at zero PMF
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kAK m−1 M s−1 1055 The forward rate constant for the con-
version of two molecules of ADP to
one of ATP and one of AMP
KeqADPATP dimensionless
kAK
k−AK
Equilibrium constant for the conver-
sion of ADP to ATP and AMP
t12,ADPATP s 0.000002 Halftime for the conversion of ADP to
ATP and AMP
Te,n dimensionless 1 Control parameter allowing destruc-
tion of autoregulation
KG mmHg−1 s−1 cm−4
Gn
pow ([Hbtotc], 4)
Constant of proportionality relating
pressure drop to flow
KG0 mmHg−1 s−1 cm−4G0,n Constant in relationship between nor-
mal conductance of supplying artery
and its radius
kglut m M 6.2 Km for the transport of glucose in and
out of the cell
kMCT m M 2 Km for the transport of lactate in and
out of the cell.
fn m−1 V 0.038 Second constant controlling rate of Llk
of ∆p.
k−AK m
−1 M s−1 379 The backward rate constant for the
conversion of two molecules of ADP
to one of ATP and one of AMP
k−pl s
−1 t1/2,pl Rate of backwards reaction in the
pyruvate lactate equilibrium
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Keq,PCr m−1 M
K∗eq,PCr
[H+]n
Equilibrium of the reaction in which
phosphocreatine combines with ADP
to give creatine and ATP
K∗eq,PCr dimensionless 166 Effective equilibrium constant for the
reaction in which phosphocreatine
combines with ADP to give creatine
and ATP
t1/2,PCr s 0.00002 Halftime for the reaction in which
phosphocreatine combines with ADP
to give creatine and ATP
t1/2,pl s−1 10 Time constant for pyruvate to lactate
interconvertion
Kσ dimensionless 10 Parameter controlling sensitivity of σe
to radius
kTCAn m M s
−1 1
3
CBFn
CBFn
Normal rate of the TCA cycle
∆p3,corr dimensionless 1 A parameter representing the action of
uncouplers
kCV m−1 V
−1
SaO2,n − LCV,max log
(
1− LCV,0
1+ rCV LCV,0
)
A parameter controlling the sensitivity
of complex V flux to driving force
Keq1,n dimensionless 10
−1
E0(cyt a3)
(
p1 SaO2,n
4 −E1,n
)
Normal equilibrium constant for reac-
tion 1
Keq2,n dimensionless 10
−1
E0(cyt a3)
(
p2 SaO2,n
4 −E2
)
Normal equilibrium constant for reac-
tion 2
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KeqMAshut dimensionless 10 Equilibrium constant for the malate-
aspartate shuttle
km,ATP dimensionless 0.025 Km for ATP use as a fraction of normal
ATP concentration .
km,glycA m M km,glycA,f [ADP]n Km for ADP in the caricature of gly-
colysis
km,glycA,f dimensionless 0.2 Km for ADP in glycolysis as a fraction
of normal ADP concentration
km,glycG m M 0.05000 Km for glucose in the caricature of gly-
colysis
km,glycN m M km,glycN,f [NAD]n Km for NAD in the caricature of gly-
colysis
km,glycN,f m M 0.2 Km for NAD in glycolysis as a fraction
of normal NAD concentration
km,glycP m M km,glycP,f [P]n Km for inorganic phosphate in the car-
icature of glycolysis.
km,glycP,f dimensionless 0.2 Km for inorganic phosphate in glycol-
ysis as a fraction of normal phosphate
concentration
kmNAD m M 100000 Km for NAD in the TCA cycle as a
fraction of the normal NAD concentra-
tion
KmNAD,TCA m M kmNAD [NAD]n Km for NAD in the TCA cycle
300
A
.2.
BrainPiglet
v2.0
kmPy m M 0.005 Km for pyruvate for the TCA cycle as
a fraction of the normal pyruvate con-
centration
KmPy,TCA m M kmPy [Py]n Km for pyruvate in the TCA cycle
km,ATP m M 0.025
km m M [ATP]n km,ATP Km for ATP use
k−1,0 s−1
fn
Keq1,n VAratn −CuA,o,n Backward rate constant for reaction 1at normal PMF
kn1n dimensionless
fn
Keq1,n VAratn −CuA,o,n The value of k1 at normal ∆p andNADH
k−2,n m−1 M s−1
fn
Keq2,n CuA,o,n a3o,n −VAratn cyta3r,n Normal backward rate constant for re-action 2
LCV,0 dimensionless 0.4 Normal complex V flux as a fraction of
maximum possible flux
LCV,n m M s−1 LnLCV, f rac Normal rate of protons rentering mi-
tochondrial matrix
LCV,frac dimensionless 1− Llk,frac Normal fraction of proton entry into
mitochondria associated with ADP
phosphorylation
LCV,max m M s−1
CBFn
LCV,0
The maximum rate of proton flow
through complex V.
Llk0 m M s−1
CBFn
exp (SaO2,n fn)− 1 First constant controlling rate of Llk of∆p.301
A
.2.
BrainPiglet
v2.0
Llk,frac dimensionless 0.25 Normal fraction of proton entry into
mitochondria which is via leak chan-
nels
Llkn m M s−1 LlnLlk,frac The resting flow of protons into the
matrix via leak channels.
Ln m M s−1 ptot fn The total flow of protons back into mi-
tochondria
[lacc] m M 1 Capillary lactate concentration .
µmax dimensionless 1 Maximum value of mu
µmin dimensionless −1 Minimum value of mu
µn dimensionless 0 Normal value of mu
nh dimensionless 2.5 Hill coefficient for haemoglobin satu-
ration
nm dimensionless 1.83 Exponent in the muscular tension re-
lationship
na dimensionless 4.33 Number of protons passing through
Complex V for each ATP synthesised
NADcytn m M 359 Normal concentration of NAD in the
cytoplasm
NADHcytn dimensionless 50 Normal concentration of NADH in the
cytoplasm
[NADH]n m M Nt − [NAD]n Normal mitochondrial NADH concen-
tration
[NAD]n m M
Nt
1+ 1
[NAD]n/[NADH]n
Normal concentration of NAD in the
mitochondria
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[NAD]n/[NADH]n dimensionless 9 Normal NAD/NADH ratio
Nt m M 3 Total mitochondrial NAD + NADH
concentration
[O2]init m M [O2]n Initial oxygen concentration in mito-
chondria.
[O2]n m M 0.024 Normal oxygen concentration in mito-
chondria.
[O2,a] m M φ
(
SaO2sup
1.0− SaO2sup
) 1
nh
Arterial dissolved oxygen concentra-
tion
[O2,c]init m M [O2,c]n Initial concentration of dissolved oxy-
gen in the capillary.
[O2,c]n m M [O2,c]init pow
(
ScO2,n
1− ScO2,n ,
1
nh
)
Normal concentration of dissolved
oxygen in the capillary.
p1 dimensionless ptot − p23 The number of protons pumped by
ared (reduction reaction)
p2 dimensionless 4 Total protons pumped by reaction 2
p23 dimensionless 8 Total protons pumped by reactions 2
and 3
p3 dimensionless p23 − p2 Total protons pumped by reaction 3
P1,n mmHg
Pa2,n + Pv,n
2
Normal average blood pressure in ves-
sels
Pa mmHg 50 Arterial blood pressure
Pa2,n mmHg
G0,n Pa + Gn Pv,n
Gn + G0,n
Normal arterial blood pressure at the
start of the cerebral arteries
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Pa mmHg 50 Normal value of arterial blood pres-
sure
pC1 dimensionless 8 Total protons pumped by complex 1
pC3 dimensionless 4 Total protons pumped by complex 3
Pic mmHg 4.5 Intracranial blood pressure
Pic,n mmHg 4.5 Normal intracranial blood pressure
ptot dimensionless 18.40 Total protons pumped by reactions 1,
2 and 3
ptot,NADH dimensionless pC1 + pC3 + p23 Total protons pumped when the re-
ducing agent is NADH
Pv,n mmHg
Gt,n
Gv
(Pa − Pvs) + Pvs Normal venous blood pressure
Pvs mmHg 1.5 Pressure in the venous sinuses
PaCO2 mmHg 40 Arterial partial pressure of CO2
PaCO2,n mmHg 40 Normal arterial partial pressure of
CO2
PaO2 mmHg
[O2,a]
kH,O2
Partial pressure of oxygen in the arter-
ies
[PCr]n/[Pi]n dimensionless 2.73 Normal Pcr/Pi concentration in the
cytoplasm. Set this way because this is
often measured by MRS (although mi-
tochondria/cytoplasm differences are
ignored).
pHm,n dimensionless 8 Normal mitochondrial pH
pHo,n dimensionless 7 Normal extra-mitochondrial pH
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φ m M 0.036 Value of O2 at half maximal saturation
r0 cm 1− r f racrocc Radius of the supplying artery com-
partment
r0 cm 0.0126 A special radius in the elastic tension
relationship
RC dimensionless 2.2 Parameter controlling sensitivity of η
to PaCO2
RO dimensionless 1.5 Parameter controlling sensitivity of η
to [O2,c]
RP dimensionless 4 Parameter controlling sensitivity of η
to Pa
Ru dimensionless 0 parameter controlling sensitivity of η
to u
rCV dimensionless 5 A parameter controlling the ratio of
maximal to minimal rates of oxidative
phosphorylation
rinit cm [Hbtotc] Initial radius of blood vessels
rm cm 0.027 Value of vessel radius giving maxi-
mum muscular tension
[Hbtotc] cm 0.0187 Normal radius of blood vessels nor-
mal radius of blood vessels
rt cm 0.018 Parameter in the muscular tension re-
lationship
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rfrac dimensionless 1− (sqrt (1− occfrac))
1
2 Fraction by which the radius of the
supplying artery compartment has
been reduced
rocc dimensionless 0 Fraction by which the radius of the
carotid arteries has been reduced
SaO2,n dimensionless 0.96 Normal saturation of the arterial
haemoglobin
SaO2 dimensionless 0.96 Saturation of the arterial haemoglobin
ScO2,n dimensionless
SaO2,n + SvO2n
2
Normal capillary oxygen saturation
σcoll mmHg 62.79 Value of pressure at which vessels col-
lapse
σe0 mmHg 0.1425 Parameter in relationship determining
σe
σe,n mmHg σe0
(
exp
(
Kσ ([Hbtotc]− r0)
r0
)
− 1
)
− σcoll Normal elastic stress in vessel walls
SvO2n dimensionless
[HbO2,v]n
[Hbtot]n
Normal venous oxygen saturation
νu,n s 5 The time constant associated with
vCO2
Te,n mmHg cm σe,nhn Normal elastic tension in vessel walls
Tmax0 mmHg cm
Tmax,n
1+ Te,n µn
Tmax at normal mu
Tmax,n mmHg cm
Tm,n
exp
(
−pow
(
fabs
(
[Hbtotc ]−rm
rt−rm
)
, nm
)) Normal maximum muscular tension
developed by circulation
Tm,n mmHg cm (P1,n − Pic,n) [Hbtotc]− Te,n Normal muscular tension in vessel
walls
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νu,n s 20 The time constant associated with vO2
νu,n s 5 The time constant associated with vPa
νu,n s 0.5 The time constant associated with vu
u dimensionless 1 The representation of ”demand” in the
model.
un dimensionless 1 Resting ”demand”
Vmax,ATP m M s−1
(
LCVnVolmit
na
+ 2.0CMRglucn
)
(1.0+ km) u Vmax of ATP use
νCO2,n mmHg PaCO2,n Normal value of vCO2 (CO2 passed
through a first order filter)
Vglucosein dimensionless
[glucc]
kglut + [glucc]
Rate term for glucose transported into
the cell. This ia a michaelis menten
term, but fixed because blood glucose
concentration is fixed.
vglut m M
CMRgluc,n
Vglucosein − [gluc]n[gluc]n+kglut
Vmax for glucose transport both in
and out of the cell from the capillary.
Vlacin dimensionless
[lacc]
kMCT + [lacc]
Rate of lactate transport into the cell
vMCT m M s−1
2CMRgluc,n − CBFn3
[lac]n [H+ ]n
([lac]n+kMCT) ([H+ ]n+kMCT)
−Vlacin
νO2,n m M [O2,c]n Normal value of vO2 (capillary O2
passed through a first order filter)
νPa ,n mmHg Pa2,n Normal value of vPa (ABP passed
through a first order filter)307
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vTCA m M s−1
kTCAn
[Py]n [NAD]n
(km,tcaN + [NAD]n) (km,tcaP + [Py]n) Vmax for the TCA cycle
νu,n dimensionless LCV,frac Normal value of vu (u passed through
a first order filter)
VAratn dimensionless 3 The normal ratio of the volume of the
veins to the volume of the arteries
vglyc,n m M s−1
CMRgluc,n
glycg,n glycp,n glyca,n glycnn
Normal Vmax for glycolysis which is
assumed to be modified by the ratio of
AMP to ATP normal
Va,n dimensionless
t,n
1+VAratn
Normal arterial blood volume as a
fraction of total blood volume
Volmit dimensionless 0.067 Fraction of brain water which is mito-
chondria
Vt,n dimensionless 1 Normal total blood volume
Vv,n dimensionless t,n
VAratn
1+VAratn
Normal venous volume
[HHba] m M [Hbtot] (1− SaO2) Unsaturated arterial haemoglobin
[HHba]n m M [Hbtot]n (1− SaO2,n) Normal unsaturated arterial
haemoglobin
[HbO2,a] m M [Hbtot] SaO2 Concentration of arterial oxy-
haemoglobin.
[HbO2,a]n m M [Hbtot]n SaO2,n Normal concentration of arterial oxy-
haemoglobin.
[HbO2,v]init m M [HbO2,v]n Initial concentration of venous oxy-
haemoglobin.308
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[HbO2,v]n m M
CBFn [HbO2,a]n − Ru
CBFn
Normal concentration of venous oxy-
haemoglobin.
[HbO2,a]n m M [Hbtot]n Total haemoglobin concentration in
the arteries and veins.
[Hbtot]n m M 5.4 Normal total haemoglobin concentra-
tion in the arteries and veins.
[HHbv]n m M [Hbtot]n − [HbO2,v]n Normal unsaturated venous
haemoglobin
Z m V 59.028 2.303*RT/F
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A.3 BrainPiglet v.2.0.1
A.3.1 Overview
• 25 differential state variables
• 3 algebraic state variables
• 128 intermediate variables
• 338 parameters
A.3.2 Differential equations
d[ADP]
dt
=
(
k−PCr + [ATP] [Cr]
)−kATP,CV + 2 (k−AK + [ATP] [AMP])− 2 (kAK + [ADP]2)
+
Vmax,ATP [ATP]
km + [ATP]
− (kPCr + [PCr] [ADP] [H+])
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.59)
d[AMP]
dt
=
(
kAK + [ADP]
2
)
− (k−AK + [ATP] [AMP]) (A.60)
d[ATP]
dt
= kATP,CV −
(
k−PCr + [ATP] [Cr]
)− (k−AK + [ATP] [AMP])+(kAK + [ADP]2)
− Vmax,ATP [ATP]
km + [ATP]
+
(
kPCr + [PCr] [ADP] [H+]
)
+ 2
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.61)
d[BiCcyt]
dt
=
(
kCHi + [CO2,cyt]
)− (knCHi + [H+] [BiCcyt])− (kBiCshut + [BiCcyt])
+ (knBiCshut + [BiCmit]) (A.62)
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d[CO2,cyt]
dt
=
(
knCHi + [H+] [BiCcyt]
)− (kCHi + [CO2,cyt])+(kCO2shut + [CO2,mit])
− kCO2,out −
(
kCO2shut + [CO2,cyt]
)
(A.63)
d[Cr]
dt
=
(
kPCr + [PCr] [ADP] [H+]
)− (k−PCr + [ATP] [Cr]) (A.64)
d[gluc]
dt
= Vglucosein vglut −
vglut [gluc]
kglut + [gluc]
− vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.65)
d[H+]
dt
=
p1 + 4
RHic
CBFn
f1− 1RHic
(
kMAshut + [H+] [NAD]
)− 1
RHic
(
knCHi + [H+] [BiCcyt]
)
+
1
RHic
(
kCHi + [CO2,cyt]
)
+
1
RHic
(
k−PCr + [ATP] [Cr]
)
+
1
RHic
(
k−pl + [lac]NADcyt
)
+
1
RHic
Vlacin vMCT +
p2
RHic
CBFn
f2 − 1RHic
(
kpl + [Py] [H+]
)
− 1RHic
CBFn
kTCA − 1RHic
CBFn
L
− 1
RHic
vMCT [lac] [H+]
(kMCT + [lac]) (kMCT + [H+])
+
1
RHic
(
k−MAshut +NADcyt H
+
m
)
+
4
RHic
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
− 1
RHic
(
kPCr + [PCr] [ADP] [H+]
)
(A.66)
d[lac]
dt
=
(
kpl + [Py] [H+]
)
−
(
k−pl + [lac]NADcyt
)
− vMCT [lac] [H
+]
(kMCT + [lac]) (kMCT + [H+])
+Vlacin vMCT (A.67)
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d[BiCmit]
dt
=
1
CBFn
(
kBiCshut + [BiCcyt]
)− 1
CBFn
(knBiCshut + [BiCmit])
− (knCHm +H+m [BiCmit])+ (kCHm + [CO2,mit]) (A.68)
d[CO2,mit]
dt
= 3kTCA− 1CBFn (kCO2shut + [CO2,mit])+
1
CBFn
(
kCO2shut + [CO2,cyt]
)
+
(
knCHm +H+m [BiCmit]
)− (kCHm + [CO2,mit]) (A.69)
d[Pi]
dt
=
Vmax,ATP [ATP]
km + [ATP]
− kATP,CV
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.70)
d[PCr]
dt
=
(
k−PCr + [ATP] [Cr]
)− (kPCr + [PCr] [ADP] [H+]) (A.71)
d[Py]
dt
=
(
k−pl + [lac]NADcyt
)
−
(
kpl + [Py] [H+]
)
− 11
CBFn
kTCA
+ 2
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.72)
dCuA,o
dt
= 4 f2 − 4 f1 (A.73)
dcyta3r
dt
= 4 f2 − 4 f3 (A.74)
d∆Ψ
dt
=
p2 f2 + p1 f1 + p3 f3 − L
Cim
(A.75)
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dH+m
dt
=
1
RHi CBFn
(
kMAshut + [H+] [NAD]
)− p1 + 53
RHi
f1 − p2RHi f2 −
p3
RHi
f3
+
4
RHi
kTCA +
1
RHi
L− 1
RHi
(
knCHm +H+m [BiCmit]
)
− 1
RHi CBFn
(
k−MAshut +NADcyt H
+
m
)
+
1
RHi
(kCHm + [CO2,mit]) (A.76)
d[NAD]
dt
= 2 f1 − 1CBFn
(
kMAshut + [H+] [NAD]
)− 5kTCA
+
1
CBFn
(
k−MAshut +NADcyt H
+
m
)
(A.77)
dNADcyt
dt
=
(
kMAshut + [H+] [NAD]
)− (k−pl + [lac]NADcyt)+ (kpl + [Py] [H+])
− (k−MAshut +NADcyt H+m)
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.78)
d[O2]
dt
=
1
CBFn
JO2 − f3 (A.79)
dνCO2
dt
=
1
νu,n
(
PaCO2 − νCO2
)
(A.80)
dνO2
dt
=
1
νu,n
(
[O2,c]− νO2
)
(A.81)
dνPa
dt
=
1
νu,n
(Pa2 − νPa) (A.82)
dνu
dt
=
1
νu,n
(CBF− νu) (A.83)
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A.3.3 Algebraic equations
[O2,c]init pow
(
ScO2
1− ScO2 ,
1
nh
)
− [O2,c] = 0 (A.84)
Te + Tm − (P1 − Pic) r = 0 (A.85)
CBF ([HbO2,a]− [HbO2,v])− JO2 = 0 (A.86)
A.3.4 Chemical reactions
p2
RHi
H+m
f2−−→ 4 CuA,o + 4 cyta3r + p2RHic
CBFn
[H+] (A.87)
4 CuA,o +
p1 + 53
RHi
H+m
f1−−→ 2 [NAD] + p1 + 4RHic
CBFn
[H+] (A.88)
2 [ADP] MA←−→
MA
[ATP] + [AMP] (A.89)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kAK + [ADP]
2. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term k−AK + [ATP] [AMP].
[ADP] + [Pi]
kATP,CV−−−−→ [ATP] (A.90)
[ATP] MM−−→ [ADP] + [Pi] (A.91)
Michaelis-Menten kinetics are assumed, with calculated rate term
Vmax,ATP [ATP]
km + [ATP]
.
[O2] + 4 cyta3r +
p3
RHi
H+m
f3−−→ (A.92)
[BiCcyt]
MA←−→
MA
1
CBFn
[BiCmit] (A.93)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kBiCshut + [BiCcyt]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term knBiCshut + [BiCmit].
[CO2,cyt]
kCO2,out−−−−→ (A.94)
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[CO2,cyt]
MA←−→
MA
1
CBFn
[CO2,mit] (A.95)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kCO2shut + [CO2,cyt]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term kCO2shut + [CO2,mit].
[CO2,mit]
MA←−→
MA
1
RHi
H+m + [BiCmit] (A.96)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kCHm + [CO2,mit]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term knCHm +H+m [BiCmit].
[CO2,cyt]
MA←−→
MA
1
RHic
[H+] + [BiCcyt] (A.97)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kCHi + [CO2,cyt]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term knCHi + [H+] [BiCcyt].
Vglucosein vglut−−−−−−−→ [gluc] (A.98)
[gluc] MM−−→ (A.99)
Michaelis-Menten kinetics are assumed, with calculated rate term
vglut [gluc]
kglut + [gluc]
.
2 [ADP] + 2 [Pi] + [gluc] + 2 NADcyt
MM−−→ 2 [ATP] + 2 [Py] + 4
RHic
[H+] (A.100)
Michaelis-Menten kinetics are assumed, with calculated rate term
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
) .
Vlacin vMCT−−−−−−→ [lac] + 1
RHic
[H+] (A.101)
[lac] +
1
RHic
[H+]
vMCT [lac] [H
+]
(kMCT+[lac]) (kMCT+[H+])−−−−−−−−−−−−−−→ (A.102)
1
RHic
[H+] +
1
CBFn
[NAD] MA←−→
MA
NADcyt +
1
RHi CBFn
H+m (A.103)
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Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kMAshut + [H+] [NAD]. Mass Action kinetics are assumed for the reverse reac-
tion, with calculated rate term k−MAshut +NADcyt H
+
m.
JO2−−→ 1
CBFn
[O2] (A.104)
[PCr] + [ADP] +
1
RHic
[H+] MA←−→
MA
[ATP] + [Cr] (A.105)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kPCr + [PCr] [ADP] [H+]. Mass Action kinetics are assumed for the reverse
reaction, with calculated rate term k−PCr + [ATP] [Cr].
1
RHic
CBFn
[H+] L−−→ 1
RHi
H+m (A.106)
[Py] +
1
RHic
[H+] MA←−→
MA
[lac] +NADcyt (A.107)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kpl + [Py] [H+]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term k−pl + [lac]NADcyt.
1
1
CBFn
[Py] + 5 [NAD] +
1
RHic
CBFn
[H+]
kTCA−−→ 4
RHi
H+m + 3 [CO2,mit] (A.108)
A.3.5 State variables
Symbol Units Initialiser Notes
[ADP] m M [ADP]n ADP concentration in cyto-
plasm and mitochondria
[AMP] m M [AMP]n AMP concentration in cyto-
plasm
[ATP] m M [ATP]n ATP concentration in cytoplasm
and mitochondira
[BiCcyt] m M [BiCcyt,n] The concentration of bicarbon-
ate ions in the cytoplasm
[CO2,cyt] m M [CO2,cyt,n] The concentration of dissolved
carbon dioxide in the cytoplasm
[Cr] m M [Cr]n Creatine concentration in cyto-
plasm
[gluc] m M [gluc]n Concentration of glucose in the
cytoplasm
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[H+] m M [H+]n Concentration of hydrogen ions
in the cytoplasm
[lac] m M [lac]n Concentration of lactate in the
cytoplasm
[BiCmit] m M [BiCmit,n] The concentration of bicarbon-
ate ions in the mitochondria
[CO2,mit] m M [CO2,mit,n] The concentration of dissolved
carbon dioxide in the mitochon-
dria
[Pi] m M [P]n Inorganic phosphate concentra-
tion in cytoplasm and mito-
chondria
[PCr] m M [PCr]n Phosphocreatine concentration
in cytoplasm
[Py] m M [Py]n Concentration of pyruvate in
the cytoplasm
CuA,o m M CuA,o,init The concentration of oxidised
cytochrome-c-oxidase
cyta3r m M [a3r]init Concentration of reduced cyt a3
in mitochondria
∆Ψ m V ∆Ψinit Mitochondrial inner membrane
potential
H+m m M H
+
m,init Concentration of hydrogen ions
in mitochondria
[NAD] m M [NAD]n Concentration of NAD in the
mitochondria
NADcyt m M NADcytn Concentration of NAD in the
cytoplasm
[O2] m M [O2]init The concentration of oxygen in
the mitochondria
[O2,c] m M [O2,c]init The concentration of oxygen in
the capillary.
r cm rinit Typical radius of cerebral ves-
sels
νCO2 mmHg νCO2,n CO2 passed through a first or-
der filter.
νO2 m M νO2,n Capillary O2 passed through a
first order filter.
νPa mmHg νPa ,n Arterial blood pressure passed
through a first order filter.
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νu dimensionless νu,n The demand parameter u
passed through a first order
filter.
[HbO2,v] m M [HbO2,v]init The concentration of bound
oxygen in the veins.
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A.3.6 Intermediate variables
Symbol Units Expression Notes
CuA,o m M E0(cyt a3)−CuA,o The concentration of reduced
cytochrome-c-oxidase in the mito-
chondria.
AVR dimensionless
Va
Vv
Arterio-venous volume ratio
cyta3o m M E0(cyt a3)− cyta3r Concentration of oxidised cyt a3 in
mitochondria
C0i dimensionless
10−pHm − 10−pHm−dpH
dpH
Natural buffering capacity for pro-
tons in mitochondria
C0ic dimensionless
10−pHo − 10−pHo−dpH
dpH
Natural buffering capacity for pro-
tons in the cytoplasm
CNADH m V
E0(cyt a3)
2
log10
(
1
[NAD]/[NADH]
)
Redox potential minus standard re-
dox potential for NADH at normal
demand
CBF m l m−1 l s−1 G (Pa2 − Pv) Cerebral blood flow
TOS µM ∆oxCCOoffset + 1000CBFn (CuA,o −VAratn) The expected CCO signal (as mea-
sured by NIRS)
CMRO2 m M s−1 f3 CBFn Cerebral metabolic rate for oxygen
∆G1 m V p1 ∆p− 4
(
E1 + E0(cyt a3) log10
(
CuA,o
CuA,o
))
Free energy associated with reac-
tion 1
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∆G2 m V
p2 ∆p
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o
CuA,o
)
− log10
(
cyta3r
cyta3o
))) Free energy associated with reac-
tion 2
∆G J mol−1 ∆G◦ + E0(cyt a3) F log10
(
gp
)
Gibbs free energy of ATP hydroly-
sis
∆Hbdiff µM ∆Hbdiffoffset + ∆HbO2− ∆HHb Change in Hbdiff (NIRS)
∆HbO2 µM ∆HbO2,offset +HbO2 −HbO2n Change in total oxygenated
haemoglobin (NIRS)
∆Hbt µM ∆HbToffset +Hbt−Hbtn Change in total haemoglobin
(NIRS)
∆HHb µM ∆HHboffset +HHb−Hbtn Change in total deoxygenated
haemoglobin (NIRS)
∆p m V ∆Ψ+ E0(cyt a3)∆pH The proton motive force across the
mitochondrial inner membrane.
∆pH dimensionless pHm − pHo The pH difference across mito-
chondrial inner membrane
E1,NADH m V E0(CuA)− E0(NADH) + CNADH E1 when the reducing substrate is
NADH
E1 m V E1,NADH The energy provided by electron
transfer to CuA
η dimensionless RP
(
νPa
νPa ,n
− 1
)
+ RO
(
νO2
νO2,n
− 1
)
+ Ru
(
1− νu
νu,n
)
+
RC
(
1− νCO2
νCO2,n
) Total autoregulatory stimuli
f1 m M s−1 k1 CuA,o − k−1 CuA,o The rate at which CuA is reduced320
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f2 m M s−1 k2 CuA,o cyta3o − k−2 CuA,o cyta3r The rate at which CuA is oxidised
and cyt a3 reduced.
f3 m M s−1
ck2 [O2] cyta3r exp (−c3 (∆p− ∆p30))
1+ exp (−c3 (∆p− ∆p30)) The rate at which cyt a3 is oxidised
G mmHg−1 s−1 Ru pow (r, 4) Resistance of cerebral circulation
gp dimensionless
[ADP] [Pi]
[ATP]× 1000 (Normalised) phophorylation po-
tential (or ADP/ATP ratio)
Gt mmHg−1 s−1
G G0 Gv
G G0 + G Gv + Gv G0
The total conductance of the cere-
bral blood vessels
h cm (pow (r, 2) + 2r0 h0 + h0 h0)
1
2 − r Wall thickness of cerebral vessels
HbO2 µM
Va [HbO2,a] +Vv [HbO2,v]
4
Vblood,n × 1000 Total oxygenated haemoglobin
(NIRS)
Hbt µM
(Va +Vv) [HbO2,a]n
4
Vblood,n × 1000 Total haemoglobin (NIRS)
HHb µM
Va [HHba] +Vv [HHbv]
4
Vblood,n × 1000 Total deoxygenated haemoglobin
(NIRS)
JO2 m M s−1 JO2,min The rate at which oxygen is sup-
plied to the mitochondria.
JO2,min m M s−1 fmin (DO2 ([O2,c]− [O2]) , CBF [HbO2,a]) Rate at which oxygen is supplied
to the mitochondria, minimum of
diffusion rate and delivery rate
k1 s−1 k1,0 exp (−ck1 (∆p− SaO2,n)) Forward rate constant for reaction
1
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k1,0 s−1
k1,n
Nt
1+[NAD]/[NADH]
[NADH]n
Forward rate constant for reaction
1 at normal PMF
k2 m−1 M s−1 k2,n exp (−ck2 (∆p− SaO2,n)) Forward rate constant for reaction
2
kCO2,out dimensionless
CBFn [CO2,cyt]
[CO2,cyt,n]
Rate at which CO2 moves out of the
cell
kMAshut s−1
CBFn NADHcyt
3
[NAD]n [H+]n NADHcyt − 1KeqMAshut NADcytn H
+
m,n NADH
Rate of forward reaction in the
malate-aspartate shuttle
k−MAshut s
−1
kMAshut NADH
mathrmNADHcyt
KeqMAshut
Rate of backward reaction in the
malate-aspartate shuttle
k−PCr m
−1 M s−1 log (2)(
Keq,PCr
(
[PCr]n + [ADP]n +
[H+ ]n
RHic
)
+ [Cr]n + [ATP]n
)
t1/2,PCr
The backward rate of reaction for
the reaction in which phosphocre-
atine combines with ADP to give
creatine and ATP
kPCr m−1 M s−1
log (2)(
[PCr]n + [ADP]n +
[H+ ]n
RHic
+ [Cr]n+[ATP]nKeq,PCr
)
t1/2,PCr
The forward rate of reaction for the
reaction in which phosphocreatine
combines with ADP to give crea-
tine and ATP
kpl s−1
2CMRgluc,n − CBFn3 + k−pl [lac]n NADcytn
[Py]n [H+]n
mathrmNADHcyt
NADHcytn
Rate of forward reaction in the
pyruvate lactate equilibrium
kTCA m M s−1
vTCA [Py] [NAD]
(km,tcaN + [NAD]) (km,tcaP + [Py])
Rate of the TCA cycle322
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kATP,CV m M s
−1 LCV CBFn
na
Rate of ATP synthesis by Complex
V
Keq1 dimensionless pow
(
10,
−1
E0(cyt a3)
(
p1 ∆p
4
− E1
))
Equilibrium constant for reaction 1
Keq2 dimensionless pow
(
10,
−1
E0(cyt a3)
(
p2 ∆p
4
− E2
))
Equilibrium constant for reaction 2
k−1 s−1
k1
Keq1
Backward rate constant for reaction
1
k−2 m−1 M s−1
k2
Keq2
Backward rate constant for reaction
2
L m M s−1 LCV + Llk The rate at which protons reenter
the mitochondrial matrix
LCV m M s−1
LCV,frac LCV,max (1− exp (−θ))
1+ rCV exp (−θ) The rate at which protons reen-ter the mitochondrial matrix asso-
ciated with ADP phosphorylation
Llk m M s−1 ∆p3,corr fn (exp (∆p fn)− 1) The rate at which protons reenter
the mitochondrial matrix through
leak channels
µ dimensionless
µmin + µmax exp (η)
1+ exp (η)
Total autoregulatory stimuli fil-
tered through sigmoidal function
NADH m M Nt − [NAD] Concentration of NADH in the mi-
tochondria mitochondrial NADH
concentration
NADHcyt m M NADcytn + NADHcytn−NADcyt Concentration of NADH in the cy-
toplasm
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[NAD]/[NADH] dimensionless
[NAD]
NADH
NAD/NADH ratio
NTP/EPP dimensionless
[ATP]
EPP
NTP/EPP calculation
P1 mmHg
Pa2 + Pv
2
Average blood pressure in vessels
Pa2 mmHg
G0 Pa + G Pv
G + G0
The pressure at the start of the cere-
bral artery compartment
Pv mmHg
Gt
Gv
(Pa − Pvs) + Pvs Venous blood pressure
pHm dimensionless −log10
(
H+m
1000
)
Mitochondrial pH
pHo dimensionless −log10
(
[H+]
1000
)
Cytoplasmic pH
rbuffi dimensionless
Cbuffi
C0i
Buffering capacity for protons in
mitochondria
rbuffic dimensionless
Cbu f f ic
C0ic
Buffering capacity for protons in
the cytoplasm
RHi dimensionless rbuffi Relative mitochondrial volume for
protons
RHic dimensionless rbu f f ic Relative cytoplasmic volume for
protons
ScO2 dimensionless
SaO2 + SvO2
2
Capillary oxygen saturation
σe mmHg σe0
(
exp
(
Kσ (r− r0)
r0
)
− 1
)
− σcoll Elastic stress in vessel walls
SvO2 dimensionless
[HbO2,v]
[HbO2,a]n
Venous oxygen saturation324
A
.3.
BrainPiglet
v.2.0.1
Te mmHg cm σe h Elastic tension in vessel walls
Tm mmHg cm Tmax exp
(
−pow
(
fabs
(
r− rm
rt − rm
)
, nm
))
Muscular tension in vessel walls
θ dimensionless kCV
(
∆p+
E0(cyt a3)
na
log10
(
gp
gp,n
)
− LCV,max
)
Driving force for complex V
TOS dimensionless
100
(
pow
(
r
[Hbtotc ]
,2
)
pow
(
r
[Hbtotc ]
,2
)
+ VvVa,n
[HbO2,a] +
Vv
Va,n
pow
(
r
[Hbtotc ]
,2
)
+ VvVa,n
[HbO2,v]
)
[HbO2,a]n
Tissue Oxygenation index.
vglyc m M s−1
vglyc,n (I + 1)
1+ I [ATP]
[ATP]n
[AMP]n
[AMP]
Vmax for glycolysis Vmax for gly-
colysis
Vmca cm s−1 CBF CBFscale The velocity of blood in the middle
cerebral artery
Va dimensionless Va,n pow
(
r
[Hbtotc]
, 2
)
arterial blood volume as a fraction
of normal total blood volume
Vt dimensionless Va +Vv Normalised total blood volume
Vv dimensionless Vv,n + Cv (Pv − Pv,n) Venous blood volume as a fraction
of total blood volume
[HHbv] m M [HbO2,a]n − [HbO2,v] The concentration of deoxy-
haemoglobin in the veins.
325
A
.3.
BrainPiglet
v.2.0.1
A.3.7 Parameters
Symbol Units Initialiser Notes
[ADP]n m M 0.012 The normal concentration of ADP in
the cytoplasm
[AMP]n m M
KeqADPATP pow ([ADP]n, 2)
[ATP]n
Normal AMP concentration in cyto-
plasm
[ATP]n m M 1.2 The normal concentration of ATP in
the cytoplasm
[BiCcyt,n] m M
0.95kCH,eq [CO2,cyt,n]
[H+]n
The normal concentration of bicarbon-
ate ions in the cytoplasm
[CO2,cyt,n] m M PtCO2n kH,CO2,t The normal concentration of dissolved
carbon dioxide in the cytoplasm
[Cr]n m M
K∗eq,PCr [ADP]n [PCr]n
[ATP]n
Normal concentration of creatine in
cytoplasm
[gluc]n m M 1.2 Normal cellular concentration of glu-
cose
[H+]n m M 1000pow (10,−pHo,n) Normal hydrogen ion concentration in
the cytoplasm
[lac]n m M 3 Normal concentration of lactate in the
cytoplasm
[BiCmit,n] m M
kCH,eq [CO2,mit,n]
H+m,n
The normal concentration of bicarbon-
ate ions in the mitochondria326
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[CO2,mit,n] m M 1.2[CO2,cyt,n] The normal concentration of dissolved
carbon dioxide in the mitochondria
[PCr]n m M 2.6 Normal concentration of phosphocre-
atine in cell cytoplasm
[P]n m M
[PCr]n
[PCr]n/[Pi]n
The normal concentration of inorganic
phosphate in the cytoplasm
[Py]n m M 0.1 Normal concentration of pyruvate ions
in the cytoplasm
CuA,frac,n dimensionless 0.67 Normal oxidised fraction of CuA
CuA,o,init m M CuA,o,n Initial oxidized CuA
CuA,o,n m M [CCO]mit CuA,frac,n Normal oxidized CuA
CuA,r,n m M [CCO]mit −CuA,o,n The resting amount of reduced
cytochrome-c-oxidase
a3frac,n dimensionless 1− cyta3r,n[CCO]mit
Normal oxidised fraction of cyt a3
a3o,init m M a3o,n Initial oxidised cytochrome a3
a3o,n m M [CCO]mit − cyta3r,n Normal oxidised cytochrome a3
Vblood,n dimensionless 0.0325 Normal blood volume as a fraction of
brain tissue volume
[a3r]init m M cyta3r,n Initial reduced cytochrome a3
cyta3r,n m M
fn
ck2
PaCO2,n
exp(−c3 (SaO2,n−∆p30))
1+exp(−c3 (SaO2,n−∆p30))
Normal reduced cytochrome a3
c3 m−1 V 0.11 Parameter controlling the sensitivity
of reaction 3 to PMF327
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Cbuffi dimensionless 0.022 Buffering capacity for protons in mito-
chondria
Cbu f f ic dimensionless 0.025 Buffering capacity for protons in the
cytoplasm
occfrac dimensionless 0.8 Fraction of arterial blood which flows
through the carotid arteries under nor-
mal conditions
Cim m M m−1 V 0.00675 Capacitance of mitochondrial inner
membrane
Cim0 dimensionless 0.00675
CNADH,n m V
E0(cyt a3)
2
log10
(
1
[NAD]n/[NADH]n
)
Normal value of CNADH
Cv mmHg−1 0.047 Compliance of the veins (normalised)
CBFn m l m−1 l s−1 0.008 Normal cerebral blood flow
CBFscale cm 5000 Ratio between Vmca and CBF
∆oxCCOoffset µM 0 An arbitrary baseline offset to the
CCO signal (NIRS)
ck1 m−1 V 0.01 Parameter controlling sensitivity of k1
to PMF
ck2 m−1 V 0.02 Parameter controlling sensitivity of k2
to PMF
CMRgluc,n dimensionless 0.0044 Normal rate of glucose metabolism for
the brain
CMRO2n m M s−1 0.02 The resting CMRO2.
LCV,frac dimensionless 1 A control parameter representing the
action of complex V inhibitors
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[CCO]mit m M
[CCO]tis
Volmit
Concentration of cytochrome c oxi-
dase in mitochondria
[CCO]tis m M 0.0022 Concentration of cytochrome c oxi-
dase in tissue
DO2 s−1
Ru
[O2,c]n − PaCO2,n Diffusion rate between capillaries andmitochondria.
∆G1,n m V p1 SaO2,n − 4
(
E1,n + E0(cyt a3) log10
(
VAratn
CuA,o,n
))
Normal free energy associated with re-
action 1
∆G2,n m V
p2 SaO2,n
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o,n
VAratn
)
− log10
(
cyta3r,n
a3o,n
)))Normal free energy associated with re-
action 2
∆Gn J mol−1 ∆G◦ + E0(cyt a3) F log10
(
gp,n
)
Normal Gibbs free energy of ATP hy-
drolysis
∆Hbdiffoffset µM 0 An arbitrary baseline offset to the
HHb signal (NIRS)
∆HbO2,offset µM 0 An arbitrary baseline offset to the
HbO2 signal (NIRS)
∆HbToffset µM 0 An arbitrary baseline offset to the HbT
signal (NIRS)
∆HHboffset µM 0 An arbitrary baseline offset to the
HHb signal (NIRS)
∆p3,corr m V −25
∆p30 m V SaO2,n + ∆p3,corr Value of PMF at which reaction 3 is
maximally sensitive to PMF329
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LCV,max m V
−∆Gn
na F
A constant in the rate of complex V
∆pn m V ∆Ψn + E0(cyt a3)∆pHn The resting value of the proton motive
force.
dpH dimensionless 0.001 A constant in the buffering relation-
ship
∆pHn dimensionless pHm,n − pHo,n The resting value of pH difference
across mitochondrial inner membrane
∆Ψinit m V ∆Ψn Initial value of mitochondrial inner
membrane potential
∆Ψn m V 145 Normal mitochondrial inner mem-
brane potential
E1,NADH,n m V E0(CuA)− E0(NADH) + CNADH,n Normal value of E1NADH
E1,n m V E1,NADH,n The normal value of E1
E2 m V E0(cyt a3)− E0(CuA) The energy provided by transfer of
four electrons from CuA to to cyt a3
E0(cyt a3) m V 350 Cyt a3 standard redox potential
E0(CuA) m V 250 CuA standard redox potential
E0(NADH) m V −320 NADH standard redox potential
EPP dimensionless Pin + PCrn + 2ATPn + ADPn Exchangeable phosphate pool
fn m M s−1
CBFn
CBFn
Normal resting rate of f1 and f2.
F C m−1 mol 96.4853 Faraday constant
G0 mmHg−1 s−1 KG,0r04 Conductance of the supplying artery
compartment
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G0,n mmHg−1 s−1 G0,rat Gn Normal conductance of the supplying
artery compartment
G0,rat dimensionless 10 Ratio between the conductance of the
cerebral arteries and the supplying
artery compartment
Gv mmHg−1 s−1 GVArat,n Gn Conductance of the veins
GVArat,n dimensionless 4 Normal ratio of conductances between
arteries and veins Gv/Gn (determines
venous pressure) .
[glucc] m M 5.3 Concentration of glucose in the blood
glyca,n dimensionless
([ADP]n)
2(
km,glycA
)2
+ ([ADP]n)
2
Term in the expression for normal gly-
colysis rate
glycg,n dimensionless
[gluc]n
km,glycG + [gluc]n
Term in the expression for normal gly-
colysis rate
glycnn dimensionless
(
NADcytn
)2(
km,glycN
)2
+
(
NADcytn
)2 Term in the expression for normal gly-
colysis rate
glycp,n dimensionless
([P]n)
2(
km,glycP
)2
+ ([P]n)
2
Term in the expression for normal gly-
colysis rate
Gn mmHg−1 s−1
CBFn
Pa − Pvs
(
1+
1
G0,rat
+
1
GVArat,n
)
Normal resistance of cerebral circula-
tion
∆G◦ J mol−1 −30500 Standard Gibbs free energy of ATP hy-
drolysis331
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gp,n dimensionless
[ADP]n [P]n
[ATP]n × 1000 Normal phosphorylation potential
Gt,n mmHg−1 s−1
Gn G0,n Gv
Gn G0,n + Gn Gv + Gv G0,n
Normal value of the total conductance
of all blood vessel compartments
h0 cm 0.003 Vascular wall thickness when radius is
r0
H+m,init m M H
+
m,n Initial hydrogen ion concentration in
mitochondria
H+m,n m M 10
3−pHm,n Normal hydrogen ion concentration in
mitochondria
hn cm
(
([Hbtotc])
2 + 2r0 h0 + h0 h0
) 1
2 − [Hbtotc] Normal wall thickness of cerebral ves-
sels
Hcyt,n m M 103−pHo,n Normal hydrogen ion concentration in
the cytoplasm
HbO2n µM
Va,n [HbO2,a]n +Vv,n [HbO2,v]n
4
Vblood,n × 1000 Normal total oxygenated haemoglobin
(NIRS)
Hbtn µM
(Va,n +Vv,n) [Hbtot]n
4
Vblood,n × 1000 Normal total haemoglobin (NIRS)
henryCO2 dimensionless 0.030000 Solubility of CO2 in tissue
kH,CO2,t m M mmHg
−1 0.038000 Constant setting relationship between
carbon dioxide saturation and carbon
dioxide concentration in tissue
kH,O2 m M mmHg
−1 0.0014000 Constant setting relationship between
oxygen saturation and oxygen concen-
tration in artery
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Hbtn µM
Va,n [HHba]n +Vv,n [HHbv]n
4
Vblood,n × 1000 Normal total deoxygenated
haemoglobin (NIRS) normal total
deoxygenated haemoglobin (NIRS)
I dimensionless 3 The parameter which describes how
strongly the AMP/ATP ratio inhibits
the conversion of glucose to pyruvate
Ru m M s−1 CBFn The resting rate of supply of oxygen to
the mitochondria.
k1,n s−1
fn
VAratn − 1Keq1,n CuA,o,n
The value of k1 at normal ∆p and
NADH
k2,n m−1 M s−1
fn
CuA,o,n a3o,n − 1Keq2,n VAratn cyta3r,n
Normal forward rate constant for re-
action 2
ck2 m−1 M s−1
k3,0
exp(−c3 (SaO2,n−∆p30))
1+exp(−c3 (SaO2,n−∆p30))
Rate constant for reaction 3 rate con-
stant for reaction 3
k3,0 m−1 M s−1 2.5E + 5 An apparent second-order rate con-
stant for reaction 3 at zero PMF
kAK m−1 M s−1 1055 The forward rate constant for the con-
version of two molecules of ADP to
one of ATP and one of AMP.
KeqADPATP dimensionless
kAK
k−AK
equilibrium constant for the conver-
sion of ADP to ATP and AMP equi-
librium constant for the conversion of
ADP to ATP and AMP333
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t12,ADPATP s 0.000002 Halftime for the conversion of ADP to
ATP and AMP
Te,n dimensionless 1 Control parameter allowing destruc-
tion of autoregulation
kBiCshut ml · s−1 log(2.0)t1/2,BiCshut(1+ 1.0VolmitKeqBiCshut )
The rate of transfer of bicarbonate ions
from cytoplasm to mitochondria
KeqBiCshut dimensionless
HCO−3,mit
HCO−3,cyt
Equilibrium constant for the transport
of bicarbonate ions between mitochon-
dria and cytoplasm
t1/2,BiCshut dimensionless 2200 The half time for the transport of bi-
carbonate ions between mitochondria
and cytoplasm
kCH,eq dimensionless 0.00079000
KeqCHi dimensionless
H+cyt,n HCO
−
3,cyt
CO2,cyt,n
Equilibrium constant for the produc-
tion and dissociation of carbonic acid
in the cytoplasm
KeqCHm dimensionless
H+m,n HCO
−
3,mit
CO2,mit,n
Equilibrium constant for the produc-
tion and dissociation of carbonic acid
in the mitochondria
kCHi s−1
log(2.0)
t1/2,CHi(1.0+ H+cyt,n/KeqCHi)
The rate of conversion of CO2 to bicar-
bonate and protons in cytoplasm
t1/2,CHi dimensionless 3.2 Halftime for the production of car-
bonic acid in cell cytoplasm
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kCHm s−1
log(2.0)
t1/2,CHm(1.0+ H+m,n/KeqCHm)
The rate of conversion of CO2 to bicar-
bonate and protons in mitochondria
t1/2,CHm dimensionless 25 Halftime for the production of car-
bonic acid in the mitochondria
kCO2out ml · s−1
CMRO2nCO2,cyt
CO2,cyt,n
The rate at which CO2 moves out of
the cell
kCO2shut ml · s−1 CMRO2nCO2,mit,n − CO2,cyt,n The rate of transfer of CO2 betweenmitochondria to cytoplasm
KG mmHg−1 s−1 cm−4
Gn
([Hbtotc])
4 Constant of proportionality relating
pressure drop to flow
KG0 mmHg−1 s−1 cm−4G0,n Constant in relationship between nor-
mal conductance of supplying artery
and its radius
kglut m M 6.2 km for the transport of glucose in and
out of the cell
kMCT m M 10
−klac,ph km for the transport of lactate in and
out of the cell.
klac,ph dimensionless 7 Constant in Km for the transport of
lactate
fn m−1 V 0.038 Second constant controlling rate of Llk
of ∆p.
k−AK m
−1 M s−1 379 The backward rate constant for the
conversion of two molecules of ADP
to one of ATP and one of AMP
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knBiCshut ml · s−1 log(2.0)t1/2,BiCshut(KeqBiCshut + 1.0/Volmit) The rate of transfer of bicarbonate ionsfrom mitochondria to cytoplasm
knCHi mM−1 · s−1 log(2.0)t1/2,CHi(Hcyt,n +KeqCHi) The backward rate in the conversionof CO2 to bicarbonate and protons in
cytoplasm
knCHm mM−1 · s−1 log(2.0)t1/2,CHm(Hm,n +KeqCHm) The backward rate in the conversionof CO2 to bicarbonate and protons in
mitochondria
k−pl s
−1 t1/2,pl Rate of backwards reaction in the
pyruvate lactate equilibrium
Keq,PCr m−1 M
K∗eq,PCr
[H+]n
Equilibrium of the reaction in which
phosphocreatine combines with ADP
to give creatine and ATP
K∗eq,PCr dimensionless 166 Effective equilibrium constant for the
reaction in which phosphocreatine
combines with ADP to give creatine
and ATP
t1/2,PCr s 0.00002 Halftime for the reaction in which
phosphocreatine combines with ADP
to give creatine and ATP
t1/2,pl s−1 10 Time constant for pyruvate to lactate
interconvertion
Kσ dimensionless 10 Parameter controlling sensitivity of σe
to radius
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kTCAn m M s
−1 1
3
CBFn
CBFn
Normal rate of the TCA cycle
∆p3,corr dimensionless 1 A parameter representing the action of
uncouplers
kCV m−1 V
−1
SaO2,n − LCV,max log
(
1− LCV,0
1+ rCV LCV,0
)
A parameter controlling the sensitivity
of complex V flux to driving force
Keq1,n dimensionless 10
−1
Z
(
p1 SaO2,n
4 −E1,n
)
Normal equilibrium constant for reac-
tion 1
Keq2,n dimensionless 10
−1
Z
(
p2 SaO2,n
4 −E2
)
Normal equilibrium constant for reac-
tion 2
KeqMAshut dimensionless 10 Equilibrium constant for the malate-
aspartate shuttle
km,ATP dimensionless 0.025 Km for ATP use as a fraction of normal
ATP concentration.
km,glycA m M km,glycA,f [ADP]n Km for ADP in the caricature of gly-
colysis
km,glycA,f dimensionless 0.2 Km for ADP in glycolysis as a fration
of normal ADP concentration
km,glycG m M 0.05000 Km for glucose in the caricature of gly-
colysis
km,glycN m M km,glycN,f [NAD]n Km for NAD in the caricature of gly-
colysis
km,glycN,f m M 0.2 Km for NAD in glycolysis as a fraction
of normal NAD concentration
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km,glycP m M km,glycP,f [P]n Km for inorganic phosphate in the car-
icature of glycolysis.
km,glycP,f dimensionless 0.2 Km for inorganic phosphate in glycol-
ysis as a fraction of normal phosphate
concentration
kmNAD m M 100000 Km for NAD in the tca cycle as a frac-
tion of the normal NAD concentration
KmNAD,TCA m M kmNAD [NAD]n Km for NAD in the TCA cycle
kmPy m M 0 Km for pyruvate for the tca cycle as
a fraction of the normal pyruvate con-
centration
KmPy,TCA m M kmPy [Py]n Km for pyruvate in the TCA cycle
km,ATP m M 0 Km for ATP for the tca cycle as a frac-
tion of the normal ATP concentration
km m M [ATP]n km,ATP Km for ATP use
k−1,0 s−1
fn
Keq1,n VAratn −CuA,o,n Backward rate constant for reaction 1at normal PMF
kn1n dimensionless
fn
Keq1,n VAratn −CuA,o,n The value of k1 at normal ∆p andNADH
k−2,n m−1 M s−1
fn
Keq2,n CuA,o,n a3o,n −VAratn cyta3r,n Normal backward rate constant for re-action 2
m M 0.005 Explicit Km for O2 for reaction 3
LCV,0 dimensionless 0.4 Normal complex V flux as a fraction of
maximum possible flux338
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LCV,frac dimensionless 1− Llk,frac Normal fraction of proton entry into
mitochondria associated with ADP
phosphorylation
LCV,max m M s−1
CBFn
LCV,0
The maximum rate of proton flow
through complex V.
LCVn m M s−1 Ln LCV,frac The resting flow of protons into the
matrix through complex V
fn m M s−1
CBFn
exp (SaO2,n fn)− 1 First constant controlling rate of Llk of∆p.
Llk,frac dimensionless 0.25 Normal fraction of proton entry into
mitochondria which is via leak chan-
nels
Llkn m M s−1 Ln Llk,frac The resting flow of protons into the
matrix via leak channels.
Ln m M s−1 ptot fn The total flow of protons back into mi-
tochondria
[lacc] m M 1 Capillary lactate concentration
µmax dimensionless 1 Maximum value of mu
µmin dimensionless −1 Minimum value of mu
µn dimensionless 0 Normal value of mu
nh dimensionless 2.5 Hill coefficient for haemoglobin satu-
ration
nm dimensionless 1.83 Exponent in the muscular tension re-
lationship339
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na dimensionless 4.33 Number of protons passing through
Complex V for each ATP synthesised
NADcytn m M 359 Normal concentration of NAD in the
cytoplasm
NADHcytn dimensionless 50 Normal concentration of NADH in the
cytoplasm
[NADH]n m M Nt − [NAD]n Normal mitochondrial NADH concen-
tration
[NAD]n m M
Nt
1+ 1
[NAD]n/[NADH]n
Normal concentration of NAD in the
mitochondria
[NAD]n/[NADH]n dimensionless 9 Normal NAD/NADH ratio
Nt m M 3 Total mitochondrial NAD + NADH
concentration
[O2]init m M [O2]n Initial oxygen concentration in mito-
chondria.
[O2]n m M 0.024 Normal oxygen concentration in mito-
chondria.
[O2,a] m M φ
(
SaO2sup
1.0− SaO2sup
) 1
nh
Arterial dissolved oxygen concentra-
tion
[O2,c]init m M [O2,c]n Initial concentration of dissolved oxy-
gen in the capillary.
[O2,c]n m M [O2,c]init
(
ScO2,n
1− ScO2,n
) 1
nh
Normal concentration of dissolved
oxygen in the capillary.340
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p1 dimensionless ptot − p23 The number of protons pumped by
ared (reduction reaction)
p2 dimensionless 4 Total protons pumped by reaction 2
p23 dimensionless 8 Total protons pumped by reactions 2
and 3
p3 dimensionless p23 − p2 Total protons pumped by reaction 3
P1,n mmHg
Pa2,n + Pv,n
2
Normal average blood pressure in ves-
sels
Pa mmHg 50 Arterial blood pressure
Pa2,n mmHg
G0,n Pa + Gn Pv,n
Gn + G0,n
Normal arterial blood pressure at the
start of the cerebral arteries
Pa mmHg 50 Normal value of arterial blood pres-
sure
pC1 dimensionless 8 Total protons pumped by complex 1
pC3 dimensionless 4 Total protons pumped by complex 3
Pic mmHg 4.5 Intracranial blood pressure
Pic,n mmHg 4.5 Normal intracranial blood pressure
ptot dimensionless 18.40 Total protons pumped by reactions 1,
2 and 3
ptot,NADH dimensionless pC1 + pC3 + p23 Total protons pumped when the re-
ducing agent is NADH
Pv,n mmHg
Gt,n
Gv
(Pa − Pvs) + Pvs Normal venous blood pressure
Pvs mmHg 1.5 Pressure in the venous sinuses
PaCO2 mmHg 40 Arterial partial pressure of CO2
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PaCO2,n mmHg 40 Normal arterial partial pressure of
CO2
PaO2 mmHg
[O2,a]
kH,O2
Partial pressure of oxygen in the arter-
ies
[PCr]n/[Pi]n dimensionless 2.73 Normal Pcr/Pi concentration in the
cytoplasm. Set this way because this is
often measured by MRS (although mi-
tochondria/cytoplasm differences are
ignored).
pHm,n dimensionless 8 Normal mitochondrial pH
pHo,n dimensionless 7 Normal cytoplasmic pH
φ m M 0.036 Value of O2 at half maximal saturation
PtCO2n dimensionless 54.000 Partial pressure of CO2 in tissue
r0 cm 1− r f racrocc Radius of the supplying artery com-
partment
r0 cm 0.0126 A special radius in the elastic tension
relationship
RC dimensionless 2.2 Parameter controlling sensitivity of η
to PaCO2
RO dimensionless 1.5 Parameter controlling sensitivity of η
to [O2,c]
RP dimensionless 4 Parameter controlling sensitivity of η
to Pa
Ru dimensionless 0 Parameter controlling sensitivity of η
to u
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rCV dimensionless 5 A parameter controlling the ratio of
maximal to minimal rates of oxidative
phosphorylation
rinit cm [Hbtotc] Initial radius of blood vessels
rm cm 0.027 Value of vessel radius giving maxi-
mum muscular tension
[Hbtotc] cm 0.0187 Normal radius of blood vessels nor-
mal radius of blood vessels
rt cm 0.018 Parameter in the muscular tension re-
lationship
rfrac dimensionless 1− (1− occfrac)
1
2 Fraction by which the radius of the
supplying artery compartment has
been reduced
rocc dimensionless 0 Fraction by which the radius of the
carotid arteries has been reduced
SaO2,n dimensionless 0.96 Normal saturation of the arterial
haemoglobin
SaO2 dimensionless 0.96 Saturation of the arterial haemoglobin
ScO2,n dimensionless
SaO2,n + SvO2n
2
Normal capillary oxygen saturation
σcoll mmHg 62.79 Value of pressure at which vessels col-
lapse
σe0 mmHg 0.1425 Parameter in relationship determining
σe
σe,n mmHg σe0
(
exp
(
Kσ ([Hbtotc]− r0)
r0
)
− 1
)
− σcoll Normal elastic stress in vessel walls343
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SvO2n dimensionless
[HbO2,v]n
[Hbtot]n
Normal venous oxygen saturation
νu,n s 5 The time constant associated with
vCO2 the time constant associated with
vCO2
Te,n mmHg cm σe,n hn Normal elastic tension in vessel walls
Tmax0 mmHg cm
Tmax,n
1+ Te,n µn
Tmax at normal mu
Tmax,n mmHg cm
Tm,n
exp
(
−pow
(
fabs
(
[Hbtotc ]−rm
rt−rm
)
, nm
)) Normal maximum muscular tension
developed by circulation
Tm,n mmHg cm (P1,n − Pic,n) [Hbtotc]− Te,n Normal muscular tension in vessel
walls
νu,n s 20 Tthe time constant associated with vO2
νu,n s 5 The time constant associated with vPa
νu,n s 0.5 The time constant associated with vu
u dimensionless 1 The representation of ”demand” in the
model.
un dimensionless 1 Resting ”demand”
Vmax,ATP m M s−1
(
LCVnVolmit
na
+ 2.0CMRglucn
)
(1.0+ km) u Vmax of ATP use
νCO2,n mmHg PaCO2,n normal value of vCO2 (CO2 passed
through a first order filter)
Vglucosein dimensionless
[glucc]
kglut + [glucc]
Rate term for glucose transported into
the cell. This ia a michaelis menten
term, but fixed because blood glucose
concentration is fixed.
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vglut m M
CMRgluc,n
Vglucosein − [gluc]n[gluc]n+kglut
Vmax for glucose transport both in
and out of the cell from the capillary. .
Vlacin dimensionless
[lacc]
kMCT + [lacc]
Rate of lactate transport into the cell
vMCT m M s−1
2CMRgluc,n − CBFn3
[lac]n [H+ ]n
([lac]n+kMCT) ([H+ ]n+kMCT)
−Vlacin
νO2,n m M [O2,c]n Normal value of vO2 (capillary O2
passed through a first order filter)
νPa ,n mmHg Pa2,n Normal value of vPa (Arterial blood
pressure passed through a first order
filter)
vTCA m M s−1
kTCAn
[Py]n [NAD]n
(km,tcaN + [NAD]n) (km,tcaP + [Py]n) Vmax for the TCA cycle
νu,n dimensionless LCV,frac normal value of vu (u passed through
a first order filter)
VAratn dimensionless 3 The normal ratio of the volume of the
veins to the volume of the arteries
vglyc,n m M s−1
CMRgluc,n
glycg,n glycp,n glyca,n glycnn
Normal Vmax for glycolysis which is
assumed to be modified by the ratio of
AMP to ATP normal
Va,n dimensionless
t,n
1+VAratn
Normal arterial blood volume as a
fraction of total blood volume
Volmit dimensionless 0.067 Fraction of brain water which is mito-
chondria
Vt,n dimensionless 1 Normal total blood volume
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Vv,n dimensionless t,n
VAratn
1+VAratn
Normal venous volume
[HHba] m M [Hbtot] (1− SaO2) Unsaturated arterial haemoglobin
[HHba]n m M [Hbtot]n (1− SaO2,n) Normal unsaturated arterial
haemoglobin
[HbO2,a] m M [Hbtot] SaO2 Concentration of arterial oxy-
haemoglobin.
[HbO2,a]n m M [Hbtot]n SaO2,n Normal concentration of arterial oxy-
haemoglobin.
[HbO2,v]init m M [HbO2,v]n Initial concentration of venous oxy-
haemoglobin.
[HbO2,v]n m M
CBFn [HbO2,a]n − Ru
CBFn
Normal concentration of venous oxy-
haemoglobin.
[HbO2,a]n m M [Hbtot]n Total haemoglobin concentration in
the arteries and veins.
[Hbtot]n m M 5.4 Normal total haemoglobin concentra-
tion in the arteries and veins.
[HHbv]n m M [Hbtot]n − [HbO2,v]n Normal unsaturated venous
haemoglobin
Z m V 59.028 2.303*RT/F
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A.4 BrainPiglet v2.1
A.4.1 Overview
• 26 differential state variables
• 3 algebraic state variables
• 131 intermediate variables
• 338 parameters
A.4.2 Differential equations
d[ADP]
dt
=
(
k−PCr + [ATP] [Cr]
)− kATP,CV +Vpp + 2 (k−AK + [ATP] [AMP])
− 2
(
kAK + [ADP]
2
)
+
Vmax,ATP [ATP]
km + [ATP]
− (kPCr + [PCr] [ADP] [H+])
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.109)
d[AMP]
dt
=
(
kAK + [ADP]
2
)
− (k−AK + [ATP] [AMP]) (A.110)
d[ATP]
dt
= kATP,CV −
(
k−PCr + [ATP] [Cr]
)−Vpp − (k−AK + [ATP] [AMP])
+ 2
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
+
(
kAK + [ADP]
2
)
− Vmax,ATP [ATP]
km + [ATP]
+
(
kPCr + [PCr] [ADP] [H+]
)
(A.111)
d[BiCcyt]
dt
=
(
kCHi + [CO2,cyt]
)− (knCHi + [H+] [BiCcyt])
− (kBiCshut + [BiCcyt])+ (knBiCshut + [BiCmit]) +VNaBiC (A.112)
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d[CO2,cyt]
dt
=
(
knCHi + [H+] [BiCcyt]
)− (kCHi + [CO2,cyt])+(kCO2shut + [CO2,mit])
− kCO2,out −
(
kCO2shut + [CO2,cyt]
)
(A.113)
d[Cr]
dt
=
(
kPCr + [PCr] [ADP] [H+]
)− (k−PCr + [ATP] [Cr]) (A.114)
d[gluc]
dt
= Vglucosein vglut −
vglut [gluc]
kglut + [gluc]
− vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.115)
d[H+]
dt
=
p1 + 4
RHic
CBFn
f1− 1RHic
(
kMAshut + [H+] [NAD]
)− 1
RHic
(
knCHi + [H+] [BiCcyt]
)
+
1
RHic
(
kCHi + [CO2,cyt]
)
+
1
RHic
(
k−PCr + [ATP] [Cr]
)
+
1
RHic
(
k−pl + [lac]NADcyt
)
+
p2
RHic
CBFn
f2− 1RHic
(
kpl + [Py] [H+]
)
− 1RHic
CBFn
L− 1
RHic
vMCT [lac] [H+]
(kMCT + [lac]) (kMCT + [H+])
+
1
RHic
Vlacin vMCT +
1
RHic
(
k−MAshut +NADcyt H
+
m
)− 1
RHic
iNHE − 1RHic
CBFn
kTCA
+
4
RHic
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
− 1
RHic
(
kPCr + [PCr] [ADP] [H+]
)
(A.116)
d[lac]
dt
=
(
kpl + [Py] [H+]
)
−
(
k−pl + [lac]NADcyt
)
− vMCT [lac] [H
+]
(kMCT + [lac]) (kMCT + [H+])
+Vlacin vMCT (A.117)
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d[BiCmit]
dt
=
1
CBFn
(
kBiCshut + [BiCcyt]
)− 1
CBFn
(knBiCshut + [BiCmit])
− (knCHm +H+m [BiCmit])+ (kCHm + [CO2,mit]) (A.118)
d[CO2,mit]
dt
= 3kTCA− 1CBFn (kCO2shut + [CO2,mit])+
1
CBFn
(
kCO2shut + [CO2,cyt]
)
+
(
knCHm +H+m [BiCmit]
)− (kCHm + [CO2,mit]) (A.119)
d[Na]
dt
= kNa + iNHE − 3Vpp +VNaBiC (A.120)
d[Pi]
dt
= Vpp − kATP,CV +
Vmax,ATP [ATP]
km + [ATP]
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.121)
d[PCr]
dt
=
(
k−PCr + [ATP] [Cr]
)− (kPCr + [PCr] [ADP] [H+]) (A.122)
d[Py]
dt
=
(
k−pl + [lac]NADcyt
)
−
(
kpl + [Py] [H+]
)
− 11
CBFn
kTCA
+ 2
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.123)
dCuA,o
dt
= 4 f2 − 4 f1 (A.124)
dcyta3r
dt
= 4 f2 − 4 f3 (A.125)
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d∆Ψ
dt
=
p2 f2 + p1 f1 + p3 f3 − L
Cim
(A.126)
dH+m
dt
=
1
RHi CBFn
(
kMAshut + [H+] [NAD]
)− p1 + 53
RHi
f1− p2RHi f2−
p3
RHi
f3 +
4
RHi
kTCA
+
1
RHi
L− 1
RHi
(
knCHm +H+m [BiCmit]
)− 1
RHi CBFn
(
k−MAshut +NADcyt H
+
m
)
+
1
RHi
(kCHm + [CO2,mit]) (A.127)
d[NAD]
dt
= 2 f1 − 1CBFn
(
kMAshut + [H+] [NAD]
)
− 5kTCA + 1CBFn
(
k−MAshut +NADcyt H
+
m
)
(A.128)
dNADcyt
dt
=
(
kMAshut + [H+] [NAD]
)− (k−pl + [lac]NADcyt)+ (kpl + [Py] [H+])
− (k−MAshut +NADcyt H+m)
− 2 vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
)
(A.129)
d[O2]
dt
=
1
CBFn
JO2 − f3 (A.130)
dνCO2
dt
=
1
νu,n
(
PaCO2 − νCO2
)
(A.131)
dνO2
dt
=
1
νu,n
(
[O2,c]− νO2
)
(A.132)
dνPa
dt
=
1
νu,n
(Pa2 − νPa) (A.133)
dνu
dt
=
1
νu,n
(CBF− νu) (A.134)
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A.4.3 Algebraic equations
[O2,c]init pow
(
ScO2
1− ScO2 ,
1
nh
)
− [O2,c] = 0 (A.135)
Te + Tm − (P1 − Pic) r = 0 (A.136)
CBF ([HbO2,a]− [HbO2,v])− JO2 = 0 (A.137)
A.4.4 Chemical reactions
p2
RHi
H+m
f2−−→ 4 CuA,o + 4 cyta3r + p2RHic
CBFn
[H+] (A.138)
4 CuA,o +
p1 + 53
RHi
H+m
f1−−→ 2 [NAD] + p1 + 4RHic
CBFn
[H+] (A.139)
2 [ADP] MA←−→
MA
[ATP] + [AMP] (A.140)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kAK + [ADP]
2. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term k−AK + [ATP] [AMP].
[ADP] + [Pi]
kATP,CV−−−−→ [ATP] (A.141)
[ATP] MM−−→ [ADP] + [Pi] (A.142)
Michaelis-Menten kinetics are assumed, with calculated rate term
Vmax,ATP [ATP]
km + [ATP]
.
[O2] + 4 cyta3r +
p3
RHi
H+m
f3−−→ (A.143)
[BiCcyt]
MA←−→
MA
1
CBFn
[BiCmit] (A.144)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kBiCshut + [BiCcyt]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term knBiCshut + [BiCmit].
[CO2,cyt]
kCO2,out−−−−→ (A.145)
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[CO2,cyt]
MA←−→
MA
1
CBFn
[CO2,mit] (A.146)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kCO2shut + [CO2,cyt]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term kCO2shut + [CO2,mit].
[CO2,mit]
MA←−→
MA
1
RHi
H+m + [BiCmit] (A.147)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kCHm + [CO2,mit]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term knCHm +H+m [BiCmit].
[CO2,cyt]
MA←−→
MA
1
RHic
[H+] + [BiCcyt] (A.148)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kCHi + [CO2,cyt]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term knCHi + [H+] [BiCcyt].
Vglucosein vglut−−−−−−−→ [gluc] (A.149)
[gluc] MM−−→ (A.150)
Michaelis-Menten kinetics are assumed, with calculated rate term
vglut [gluc]
kglut + [gluc]
.
2 [ADP] + 2 [Pi] + [gluc] + 2 NADcyt
MM−−→ 2 [ATP] + 2 [Py] + 4
RHic
[H+] (A.151)
Michaelis-Menten kinetics are assumed, with calculated rate term
vglyc [ADP]
2 [Pi]
2 [gluc]NADcyt2(
k2m,glycA + [ADP]
2
) (
k2m,glycP + [Pi]
2
) (
km,glycG + [gluc]
) (
k2m,glycN +NADcyt
2
) .
Vlacin vMCT−−−−−−→ [lac] + 1
RHic
[H+] (A.152)
[lac] +
1
RHic
[H+]
vMCT [lac] [H
+]
(kMCT+[lac]) (kMCT+[H+])−−−−−−−−−−−−−−→ (A.153)
1
RHic
[H+] +
1
CBFn
[NAD] MA←−→
MA
NADcyt +
1
RHi CBFn
H+m (A.154)
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Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kMAshut + [H+] [NAD]. Mass Action kinetics are assumed for the reverse reac-
tion, with calculated rate term k−MAshut +NADcyt H
+
m.
VNaBiC−−−→ [Na] + [BiCcyt] (A.155)
MA−−→ [Na] (A.156)
Mass Action kinetics are assumed, with calculated rate term kNa.
1
RHic
[H+]
iNHE−−→ [Na] (A.157)
JO2−−→ 1
CBFn
[O2] (A.158)
[PCr] + [ADP] +
1
RHic
[H+] MA←−→
MA
[ATP] + [Cr] (A.159)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kPCr + [PCr] [ADP] [H+]. Mass Action kinetics are assumed for the reverse
reaction, with calculated rate term k−PCr + [ATP] [Cr].
[ATP] + 3 [Na]
Vpp−−→ [ADP] + [Pi] (A.160)
1
RHic
CBFn
[H+] L−−→ 1
RHi
H+m (A.161)
[Py] +
1
RHic
[H+] MA←−→
MA
[lac] +NADcyt (A.162)
Mass Action kinetics are assumed for the forward reaction, with calculated rate
term kpl + [Py] [H+]. Mass Action kinetics are assumed for the reverse reaction,
with calculated rate term k−pl + [lac]NADcyt.
1
1
CBFn
[Py] + 5 [NAD] +
1
RHic
CBFn
[H+]
kTCA−−→ 4
RHi
H+m + 3 [CO2,mit] (A.163)
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A.4.5 State variables
Symbol Units Initialiser Notes
[ADP] m M [ADP]n ADP concentration in cyto-
plasm and mitochondria
[AMP] m M [AMP]n AMP concentration in cyto-
plasm
[ATP] m M [ATP]n ATP concentration in cytoplasm
and mitochondira
[BiCcyt] m M [BiCcyt,n] The concentration of bicarbon-
ate ions in the cytoplasm
[CO2,cyt] m M [CO2,cyt,n] The concentration of dissolved
carbon dioxide in the cytoplasm
[Cr] m M [Cr]n Creatine concentration in cyto-
plasm
[gluc] m M [gluc]n Concentration of glucose in the
cytoplasm
[H+] m M [H+]n Concentration of hydrogen ions
in the cytoplasm
[lac] m M [lac]n Concentration of lactate in the
cytoplasm
[BiCmit] m M [BiCmit,n] The concentration of bicarbon-
ate ions in the mitochondria
[CO2,mit] m M [CO2,mit,n] The concentration of dissolved
carbon dioxide in the mitochon-
dria
[Na] mM [Na]n The concentration of sodium in
the cytoplasm
[Pi] m M [P]n Inorganic phosphate concentra-
tion in cytoplasm and mito-
chondria
[PCr] m M [PCr]n phosphocreatine concentration
in cytoplasm
[Py] m M [Py]n Concentration of pyruvate in
the cytoplasm
CuA,o m M CuA,o,init The concentration of oxidised
cytochrome-c-oxidase
cyta3r m M [a3r]init Concentration of reduced cyt a3
in mitochondria
∆Ψ m V ∆Ψinit Mitochondrial inner membrane
potential
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H+m m M H
+
m,init Concentration of hydrogen ions
in mitochondria
[NAD] m M [NAD]n Concentration of NAD in the
mitochondria
NADcyt m M NADcytn Concentration of NAD in the
cytoplasm
[O2] m M [O2]init The concentration of oxygen in
the mitochondria
[O2,c] m M [O2,c]init The concentration of oxygen in
the capillary.
r cm rinit Typical radius of cerebral ves-
sels
νCO2 mmHg νCO2,n CO2 passed through a first or-
der filter.
νO2 m M νO2,n Capillary O2 passed through a
first order filter.
νPa mmHg νPa ,n Arterial blood pressure passed
through a first order filter.
νu dimensionless νu,n The demand parameter u
passed through a first order
filter.
[HbO2,v] m M [HbO2,v]init The concentration of bound
oxygen in the veins.
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A.4.6 Intermediate variables
Symbol Units Expression Notes
CuA,o m M E0(cyt a3)−CuA,o The concentration of reduced
cytochrome-c-oxidase in the mito-
chondria.
AVR dimensionless
Va
Vv
Arterio-venous volume ratio
cyta3o m M E0(cyt a3)− cyta3r Concentration of oxidised cyt a3 in
mitochondria
C0i dimensionless
10−pHm − 10−pHm−dpH
dpH
Natural buffering capacity for pro-
tons in mitochondria
C0ic dimensionless
10−pHo − 10−pHo−dpH
dpH
Natural buffering capacity for pro-
tons in the cytoplasm
CNADH m V
E0(cyt a3)
2
log10
(
1
[NAD]/[NADH]
)
Redox potential minus standard re-
dox potential for NADH at normal
demand
CBF m l m−1 l s−1 G (Pa2 − Pv) Cerebral blood flow
∆oxCCO µM ∆oxCCOoffset + 1000CBFn (CuA,o −VAratn) The expected CCO signal (as mea-
sured by NIRS)
CMRO2 m M s−1 f3 CBFn Cerebral metabolic rate for oxygen
∆G1 m V p1 ∆p− 4
(
E1 + E0(cyt a3) log10
(
CuA,o
CuA,o
))
Free energy associated with reac-
tion 1
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∆G2 m V
p2 ∆p
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o
CuA,o
)
− log10
(
cyta3r
cyta3o
))) Free energy associated with reac-
tion 2
∆G J mol−1 ∆G◦ + E0(cyt a3) F log10
(
gp
)
Gibbs free energy of ATP hydroly-
sis
∆Hbdiff µM ∆Hbdiffoffset + ∆HbO2− ∆HHb Change in Hbdiff (NIRS)
∆HbO2 µM ∆HbO2,offset +HbO2 −HbO2n Change in total oxygenated
haemoglobin (NIRS)
∆Hbt µM ∆HbToffset +Hbt−Hbtn Change in total haemoglobin
(NIRS)
∆HHb µM ∆HHboffset +HHb−Hbtn Change in total deoxygenated
haemoglobin (NIRS)
∆p m V ∆Ψ+ E0(cyt a3)∆pH The proton motive force across the
mitochondrial inner membrane.
∆pH dimensionless pHm − pHo The pH difference across mito-
chondrial inner membrane
∆Ψrate dimensionless
p2 f2 + p1 f1 + p3 f3 − L
Cim
Rate of change of mitochondrial in-
ner membrane potential
E1,NADH m V E0(CuA)− E0(NADH) + CNADH E1 when the reducing substrate is
NADH
E1 m V E1,NADH The energy provided by electron
transfer to CuA
η dimensionless RP
(
νPa
νPa ,n
− 1
)
+ RO
(
νO2
νO2,n
− 1
)
+ Ru
(
1− νu
νu,n
)
+
RC
(
1− νCO2
νCO2,n
) Total autoregulatory stimuli
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f1 m M s−1 k1 CuA,o − k−1 CuA,o The rate at which CuA is reduced
f2 m M s−1 k2 CuA,o cyta3o − k−2 CuA,o cyta3r The rate at which CuA is oxidised
and cyt a3 reduced.
f3 m M s−1
ck2 [O2] cyta3r exp (−c3 (∆p− ∆p30))
1+ exp (−c3 (∆p− ∆p30)) The rate at which cyt a3 is oxidised
G mmHg−1 s−1 Ru pow (r, 4) Resistance of cerebral circulation
gp dimensionless
[ADP] [Pi]
[ATP]× 1000 (Normalised) phophorylation po-
tential (or ADP/ATP ratio)
Gt mmHg−1 s−1
G G0 Gv
G G0 + G Gv + Gv G0
The total conductance of the cere-
bral blood vessels
h cm (pow (r, 2) + 2r0 h0 + h0 h0)
1
2 − r Wall thickness of cerebral vessels
HbO2 µM
Va [HbO2,a] +Vv [HbO2,v]
4
Vblood,n × 1000 Total oxygenated haemoglobin
(NIRS)
Hbt µM
(Va +Vv) [HbO2,a]n
4
Vblood,n × 1000 Total haemoglobin (NIRS)
HHb µM
Va [HHba] +Vv [HHbv]
4
Vblood,n × 1000 Total deoxygenated haemoglobin
(NIRS)
iNHE dimensionless
VmaxNHE ([Na]n − [Na])
KmNHE + [Na]n − [Na]
1
1+ exp (NapH (pHo − 6.7)) Rate of the sodium-hydrogen ex-
changer
JO2 m M s−1 JO2,min The rate at which oxygen is sup-
plied to the mitochondria.
JO2,min m M s−1 fmin (DO2 ([O2,c]− [O2]) , CBF [HbO2,a]) Rate at which oxygen is supplied
to the mitochondria, minimum of
diffusion rate and delivery rate358
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k1 s−1 k1,0 exp (−ck1 (∆p− SaO2,n)) Forward rate constant for reaction
1
k1,0 s−1
k1,n
Nt
1+[NAD]/[NADH]
[NADH]n
Forward rate constant for reaction
1 at normal PMF
k2 m−1 M s−1 k2,n exp (−ck2 (∆p− SaO2,n)) Forward rate constant for reaction
2
kCO2,out dimensionless
CBFn [CO2,cyt]
[CO2,cyt,n]
Rate at which CO2 moves out of the
cell
kMAshut s−1
CBFn NADHcyt
3
[NAD]n [H+]n NADHcyt − 1KeqMAshut NADcytn H
+
m,n NADH
Rate of forward reaction in the
malate-aspartate shuttle
kNa ml · s−1 ([Na]n − [Na]) Rate constant for the diffusion of
sodium ions between the extracel-
lular space and the cytoplasm
k−MAshut s
−1
kMAshut NADH
mathrmNADHcyt
KeqMAshut
Rate of backward reaction in the
malate-aspartate shuttle
k−PCr m
−1 M s−1 log (2)(
Keq,PCr
(
[PCr]n + [ADP]n +
[H+ ]n
RHic
)
+ [Cr]n + [ATP]n
)
t1/2,PCr
The backward rate of reaction for
the reaction in which phosphocre-
atine combines with ADP to give
creatine and ATP
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kPCr m−1 M s−1
log (2)(
[PCr]n + [ADP]n +
[H+ ]n
RHic
+ [Cr]n+[ATP]nKeq,PCr
)
t1/2,PCr
The forward rate of reaction for the
reaction in which phosphocreatine
combines with ADP to give crea-
tine and ATP
kpl s−1
2CMRgluc,n − CBFn3 + k−pl [lac]n NADcytn
[Py]n [H+]n
NADHcyt
NADHcytn
Rate of forward reaction in the
pyruvate lactate equilibrium
kTCA m M s−1
vTCA [Py] [NAD]
(km,tcaN + [NAD]) (km,tcaP + [Py])
Rate of the TCA cycle
kATP,CV m M s
−1 LCV CBFn
na
Rate of ATP synthesis by Complex
V
Keq1 dimensionless pow
(
10,
−1
E0(cyt a3)
(
p1 ∆p
4
− E1
))
Equilibrium constant for reaction 1
Keq2 dimensionless pow
(
10,
−1
E0(cyt a3)
(
p2 ∆p
4
− E2
))
Equilibrium constant for reaction 2
k−1 s−1
k1
Keq1
Backward rate constant for reaction
1
k−2 m−1 M s−1
k2
Keq2
Backward rate constant for reaction
2
L m M s−1 LCV + Llk The rate at which protons reenter
the mitochondrial matrix
LCV m M s−1
LCV,frac LCV,max (1− exp (−θ))
1+ rCV exp (−θ) The rate at which protons reen-ter the mitochondrial matrix asso-
ciated with ADP phosphorylation
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Llk m M s−1 ∆p3,corr fn (exp (∆p fn)− 1) The rate at which protons reenter
the mitochondrial matrix through
leak channels
µ dimensionless
µmin + µmax exp (η)
1+ exp (η)
Total autoregulatory stimuli fil-
tered through sigmoidal function
NADH m M Nt − [NAD] Concentration of NADH in the mi-
tochondria
NADHcyt m M NADcytn + NADHcytn−NADcyt Concentration of NADH in the cy-
toplasm
[NAD]/[NADH] dimensionless
[NAD]
NADH
NAD/NADH ratio
NTP/EPP dimensionless
[ATP]
EPP
NTP/EPP calculation
P1 mmHg
Pa2 + Pv
2
Average blood pressure in vessels
Pa2 mmHg
G0 Pa + G Pv
G + G0
The pressure at the start of the cere-
bral artery compartment
Pv mmHg
Gt
Gv
(Pa − Pvs) + Pvs Venous blood pressure
pHm dimensionless −log10
(
H+m
1000
)
Mitochondrial pH
pHo dimensionless −log10
(
[H+]
1000
)
Cytoplasmic pH
rbuffi dimensionless
Cbuffi
C0i
Buffering capacity for protons in
mitochondria
rbu f f ic dimensionless
Cbu f f ic
C0ic
Buffering capacity for protons in
the cytoplasm
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RHi dimensionless rbuffi Relative mitochondrial volume for
protons
RHic dimensionless rbu f f ic Relative cytoplasmic volume for
protons
ScO2 dimensionless
SaO2 + SvO2
2
Capillary oxygen saturation
σe mmHg σe0
(
exp
(
Kσ (r− r0)
r0
)
− 1
)
− σcoll Elastic stress in vessel walls
SvO2 dimensionless
[HbO2,v]
[HbO2,a]n
Venous oxygen saturation
Te mmHg cm σe h Elastic tension in vessel walls
Tm mmHg cm Tmax exp
(
−pow
(
fabs
(
r− rm
rt − rm
)
, nm
))
Muscular tension in vessel walls
Tmax mmHg cm Tmax0 (1+ Te,n µ) Maximum muscular tension devel-
oped by circulation
θ dimensionless kCV
(
∆p+
E0(cyt a3)
na
log10
(
gp
gp,n
)
− LCV,max
)
Driving force for complex V
TOS dimensionless
100
(
pow
(
r
[Hbtotc ]
,2
)
pow
(
r
[Hbtotc ]
,2
)
+ VvVa,n
[HbO2,a] +
Vv
Va,n
pow
(
r
[Hbtotc ]
,2
)
+ VvVa,n
[HbO2,v]
)
[HbO2,a]n
Tissue Oxygenation index.
vglyc m M s−1
vglyc,n (I + 1)
1+ I [ATP]
[ATP]n
[AMP]n
[AMP]
Vmax for glycolysis
Vmca cm s−1 CBF CBFscale The velocity of blood in the middle
cerebral artery
Va dimensionless Va,n
(
r
[Hbtotc]
)2
Arterial blood volume as a fraction
of normal total blood volume362
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Vt dimensionless Va +Vv Normalised total blood volume
Vv dimensionless Vv,n + Cv (Pv − Pv,n) Venous blood volume as a fraction
of total blood volume
[HHbv] m M [HbO2,a]n − [HbO2,v] The concentration of deoxy-
haemoglobin in the veins.
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A.4.7 Parameters
Symbol Units Initialiser Notes
[ADP]n m M 0.012 The normal concentration of ADP in
the cytoplasm
[AMP]n m M
KeqADPATP pow ([ADP]n, 2)
[ATP]n
Normal AMP concentration in cyto-
plasm normal AMP concentration in
cytoplasm
[ATP]n m M 1.2 The normal concentration of ATP in
the cytoplasm
[BiCcyt,n] m M
0.95kCH,eq [CO2,cyt,n]
[H+]n
The normal concentration of bicarbon-
ate ions in the cytoplasm
[CO2,cyt,n] m M PtCO2n kH,CO2,t The normal concentration of dissolved
carbon dioxide in the cytoplasm
[Cr]n m M
K∗eq,PCr [ADP]n [PCr]n
[ATP]n
Normal concentration of creatine in
cytoplasm
[gluc]n m M 1.2 Normal cellular concentration of glu-
cose
[H+]n m M 1000pow (10,−pHo,n) Normal hydrogen ion concentration in
the cytoplasm
[lac]n m M 3 Normal concentration of lactate in the
cytoplasm
[BiCmit,n] m M
kCH,eq [CO2,mit,n]
H+m,n
The normal concentration of bicarbon-
ate ions in the mitochondria
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[CO2,mit,n] m M 1.2[CO2,cyt,n] The normal concentration of dissolved
carbon dioxide in the mitochondria
[Na]n mM 15 The normal concentration of sodium
in the cytoplasm
[PCr]n m M 2.6 normal concentration of phosphocrea-
tine in cell cytoplasm
[P]n m M
[PCr]n
[PCr]n/[Pi]n
The normal concentration of inorganic
phosphate in the cytoplasm
[Py]n m M 0.1 Normal concentration of pyruvate ions
in the cytoplasm
CuA,o,frac dimensionless 0.67 Normal oxidised fraction of CuA
CuA,o,init m M CuA,o,n Initial oxidized CuA
CuA,o,n m M [CCO]mit CuA,o,frac Normal oxidized CuA
CuA,r,n m M [CCO]mit −CuA,o,n The resting amount of reduced
cytochrome-c-oxidase
a3frac,n dimensionless 1− cyta3r,n[CCO]mit Normal oxidised fraction of cyt a3
a3o,init m M a3o,n Initial oxidised cytochrome a3
a3o,n m M [CCO]mit − cyta3r,n Normal oxidised cytochrome a3
[a3r]init m M cyta3r,n Initial reduced cytochrome a3
cyta3r,n m M
fn
ck2
PaCO2,n
exp(−c3 (SaO2,n−∆p30))
1+exp(−c3 (SaO2,n−∆p30))
Normal reduced cytochrome a3
c3 m−1 V 0.11 Parameter controlling the sensitivity
of reaction 3 to PMF365
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Cbuffi dimensionless 0.022 Buffering capacity for protons in mito-
chondria
Cbu f f ic dimensionless 0.025 Buffering capacity for protons in the
cytoplasm
occfrac dimensionless 0.8 Fraction of arterial blood which flows
through the carotid arteries under nor-
mal conditions
Cim m M m−1 V 0.00675 Capacitance of mitochondrial inner
membrane
CNADH,n m V
E0(cyt a3)
2
log10
(
1
[NAD]n/[NADH]n
)
normal value of CNADH
Cv mmHg−1 0.047 Compliance of the veins (normalised)
CBFn m l m−1 l s−1 0.008 Normal cerebral blood flow
CBFscale cm 5000 Ratio between Vmca and CBF
∆oxCCOoffset µM 0 An arbitrary baseline offset to the
CCO signal (NIRS)
ck1 m−1 V 0.01 Parameter controlling sensitivity of k1
to PMF
ck2 m−1 V 0.02 Parameter controlling sensitivity of k2
to PMF
CMRgluc,n dimensionless 0.0044 Normal rate of glucose metabolism for
the brain
CMRO2n m M s−1 0.02 The resting CMRO2.
LCV,frac dimensionless 1 A control parameter representing the
action of complex V inhibitors366
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[CCO]mit m M
[CCO]tis
Volmit
Concentration of cytochrome c oxi-
dase in mitochondria
[CCO]tis m M 0.0022 Concentration of cytochrome c oxi-
dase in tissue
DO2 s−1
Ru
[O2,c]n − PaCO2,n Diffusion rate between capillaries andmitochondria.
∆G1,n m V p1 SaO2,n − 4
(
E1,n + E0(cyt a3) log10
(
VAratn
CuA,o,n
))
Normal free energy associated with re-
action 1
∆G2,n m V
p2 SaO2,n
−4
(
E2 + E0(cyt a3)
(
log10
(
CuA,o,n
VAratn
)
− log10
(
cyta3r,n
a3o,n
)))Normal free energy associated with re-
action 2
∆Gn J mol−1 ∆G◦ + E0(cyt a3) F log10
(
gp,n
)
Normal Gibbs free energy of ATP hy-
drolysis
∆Hbdiffoffset µM 0 An arbitrary baseline offset to the
HHb signal (NIRS)
∆HbO2,offset µM 0 An arbitrary baseline offset to the
HbO2 signal (NIRS)
∆HbToffset µM 0 An arbitrary baseline offset to the HbT
signal (NIRS)
∆HHboffset µM 0 An arbitrary baseline offset to the
HHb signal (NIRS)
∆p3,corr m V −25
∆p30 m V SaO2,n + ∆p3,corr Value of PMF at which reaction 3 is
maximally sensitive to PMF367
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LCV,max m V
−∆Gn
na F
A constant in the rate of complex V
∆pn m V ∆Ψn + E0(cyt a3)∆pHn The resting value of the proton motive
force.
dpH dimensionless 0.001 A constant in the buffering relation-
ship
∆pHn dimensionless pHm,n − pHo,n The resting value of pH difference
across mitochondrial inner membrane
∆Ψinit m V ∆Ψn Initial value of mitochondrial inner
membrane potential
∆Ψn m V 145 Normal mitochondrial inner mem-
brane potential
E1,NADH,n m V E0(CuA)− E0(NADH) + CNADH,n Normal value of E1NADH
E1,n m V E1,NADH,n The normal value of E1
E2 m V E0(cyt a3)− E0(CuA) The energy provided by transfer of
four electrons from CuA to to cyt a3
E0(cyt a3) m V 350 Cyt a3 standard redox potential
E0(CuA) m V 250
E0(NADH) m V −320 NADH standard redox potential
EPP dimensionless Pin + PCrn + 2ATPn + ADPn Exchangeable phosphate pool
fn m M s−1
CBFn
CBFn
Normal resting rate of f1 and f2.
F C m−1 mol 96.4853 Faraday constant
G0 mmHg−1 s−1 KG,0r04 Conductance of the supplying artery
compartment
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G0,n mmHg−1 s−1 G0,rat Gn Normal conductance of the supplying
artery compartment
G0,rat dimensionless 10 Ratio between the conductance of the
cerebral arteries and the supplying
artery compartment
Gv mmHg−1 s−1 GVArat,n Gn Conductance of the veins
GVArat,n dimensionless 4 Normal ratio of conductances between
arteries and veins Gv/Gn (determines
venous pressure)
[glucc] m M 5.3 Concentration of glucose in the blood
glyca,n dimensionless
([ADP]n)
2(
km,glycA
)2
+ ([ADP]n)
2
Term in the expression for normal gly-
colysis rate
glycg,n dimensionless
[gluc]n
km,glycG + [gluc]n
Term in the expression for normal gly-
colysis rate
glycnn dimensionless
(
NADcytn
)2(
km,glycN
)2
+
(
NADcytn
)2 Term in the expression for normal gly-
colysis rate
glycp,n dimensionless
([P]n)
2(
km,glycP
)2
+ ([P]n)
2
Term in the expression for normal gly-
colysis rate
Gn mmHg−1 s−1
CBFn
Pa − Pvs
(
1+
1
G0,rat
+
1
GVArat,n
)
Normal resistance of cerebral circula-
tion
∆G◦ J mol−1 −30500 Standard Gibbs free energy of ATP hy-
drolysis369
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gp,n dimensionless
[ADP]n [P]n
[ATP]n × 1000 Normal phosphorylation potential
Gt,n mmHg−1 s−1
Gn G0,n Gv
Gn G0,n + Gn Gv + Gv G0,n
Normal value of the total conductance
of all blood vessel compartments
h0 cm 0.003 Vascular wall thickness when radius is
r0
H+m,init m M H
+
m,n Initial hydrogen ion concentration in
mitochondria
H+m,n m M 10
3−pHm,n Normal hydrogen ion concentration in
mitochondria
hn cm
(
([Hbtotc])
2 + 2r0 h0 + h0 h0
) 1
2 − [Hbtotc] Normal wall thickness of cerebral ves-
sels
Hcyt,n dimensionless 103−pHo,n Normal hydrogen ion concentration in
cytoplasm
HbO2n µM
Va,n [HbO2,a]n +Vv,n [HbO2,v]n
4
Vblood,n × 1000 Normal total oxygenated haemoglobin
(NIRS)
Hbtn µM
(Va,n +Vv,n) [Hbtot]n
4
Vblood,n × 1000 Normal total haemoglobin (NIRS)
henryCO2 dimensionless 0.030000 Solubility of CO2 in tissue
kH,CO2,t m M mmHg
−1 0.038000 Constant setting relationship between
carbon dioxide saturation and carbon
dioxide concentration in tissue
kH,O2 m M mmHg
−1 0.0014000 Constant setting relationship between
oxygen saturation and oxygen concen-
tration in artery
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Hbtn µM
Va,n [HHba]n +Vv,n [HHbv]n
4
Vblood,n × 1000 Normal total deoxygenated
haemoglobin (NIRS)
I dimensionless 3 The parameter which describes how
strongly the AMP/ATP ratio inhibits
the conversion of glucose to pyruvate
Ru m M s−1 CBFn The resting rate of supply of oxygen to
the mitochondria.
k1,n s−1
fn
VAratn − 1Keq1,n CuA,o,n
The value of k1 at normal ∆p and
NADH
k2,n m−1 M s−1
fn
CuA,o,n a3o,n − 1Keq2,n VAratn cyta3r,n
Normal forward rate constant for re-
action 2
ck2 m−1 M s−1
k3,0
exp(−c3 (SaO2,n−∆p30))
1+exp(−c3 (SaO2,n−∆p30))
Rate constant for reaction 3
k3,0 m−1 M s−1 2.5E + 5 an apparent second-order rate con-
stant for reaction 3 at zero PMF
kAK m−1 M s−1 1055 The forward rate constant for the con-
version of two molecules of ADP to
one of ATP and one of AMP
KeqADPATP dimensionless
kAK
k−AK
Equilibrium constant for the conver-
sion of ADP to ATP and AMP
t12,ADPATP s 0.000002 Halftime for the conversion of ADP to
ATP and AMP
Te,n dimensionless 1 Control parameter allowing destruc-
tion of autoregulation
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kBiCshut ml · s−1 log(2.0)t1/2,BiCshut(1+ 1.0VolmitKeqBiCshut )
The rate of transfer of bicarbonate ions
from cytoplasm to mitochondria
KeqBiCshut dimensionless
HCO−3,mit
HCO−3,cyt
Equilibrium constant for the transport
of bicarbonate ions between mitochon-
dria and cytoplasm
t1/2,BiCshut dimensionless 2200 The half time for the transport of bi-
carbonate ions between mitochondria
and cytoplasm
kCH,eq dimensionless 0.00079000 Equilibrium constant for the produc-
tion and dissociation of carbonic acid
at normal concentrations
KeqCHi dimensionless
H+cyt,n HCO
−
3,cyt
CO2,cyt,n
Equilibrium constant for the produc-
tion and dissociation of carbonic acid
in the cytoplasm
KeqCHm dimensionless
H+m,n HCO
−
3,mit
CO2,mit,n
Equilibrium constant for the produc-
tion and dissociation of carbonic acid
in the mitochondria
kCHi s−1
log(2.0)
t1/2,CHi(1.0+ H+cyt,n/KeqCHi)
The rate of conversion of CO2 to bicar-
bonate and protons in cytoplasm
t1/2,CHi dimensionless 3.2 Halftime for the production of car-
bonic acid in cell cytoplasm
kCHm s−1
log(2.0)
t1/2,CHm(1.0+ H+m,n/KeqCHm)
The rate of conversion of CO2 to bicar-
bonate and protons in mitochondria
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t1/2,CHm dimensionless 25 Halftime for the production of car-
bonic acid in the mitochondria
kCO2out ml · s−1
CMRO2nCO2,cyt
CO2,cyt,n
The rate at which CO2 moves out of
the cell
kCO2shut ml · s−1 CMRO2nCO2,mit,n − CO2,cyt,n The rate of transfer of CO2 betweenmitochondria to cytoplasm
KG mmHg−1 s−1 cm−4
Gn
([Hbtotc])
4 Constant of proportionality relating
pressure drop to flow
KG0 mmHg−1 s−1 cm−4G0,n Constant in relationship between nor-
mal conductance of supplying artery
and its radius
kglut m M 6.2
kMCT m M 10
−klac,ph Km for the transport of lactate in and
out of the cell.
klac,ph dimensionless 7 Constant in Km for the transport of
lactate
fn m−1 V 0.038 Second constant controlling rate of Llk
of ∆p.
k−AK m
−1 M s−1 379 The backward rate constant for the
conversion of two molecules of ADP
to one of ATP and one of AMP
knBiCshut ml · s−1 log(2.0)t1/2,BiCshut(KeqBiCshut + 1.0/Volmit) The rate of transfer of bicarbonate ionsfrom mitochondria to cytoplasm373
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knCHi mM−1 · s−1 log(2.0)t1/2,CHi(Hcyt,n +KeqCHi) The backward rate in the conversionof CO2 to bicarbonate and protons in
cytoplasm
knCHm mM−1 · s−1 log(2.0)t1/2,CHm(Hm,n +KeqCHm) The backward rate in the conversionof CO2 to bicarbonate and protons in
mitochondria
k−pl s
−1 t1/2,pl Rate of backwards reaction in the
pyruvate lactate equilibrium
Keq,PCr m−1 M
K∗eq,PCr
[H+]n
Equilibrium of the reaction in which
phosphocreatine combines with ADP
to give creatine and ATP
K∗eq,PCr dimensionless 166 Effective equilibrium constant for the
reaction in which phosphocreatine
combines with ADP to give creatine
and ATP
t1/2,PCr s 0.00002 Halftime for the reaction in which
phosphocreatine combines with ADP
to give creatine and ATP
t1/2,pl s−1 10 Time constant for pyruvate to lactate
interconvertion
Kσ dimensionless 10 Parameter controlling sensitivity of σe
to radius
kTCAn m M s
−1 1
3
CBFn
CBFn
Normal rate of the TCA cycle374
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∆p3,corr dimensionless 1 A parameter representing the action of
uncouplers a parameter representing
the action of uncouplers
kCV m−1 V
−1
SaO2,n − LCV,max log
(
1− LCV,0
1+ rCV LCV,0
)
Parameter controlling the sensitivity
of complex V flux to driving force
Keq1,n dimensionless 10
−1
E0(cyt a3)
(
p1 SaO2,n
4 −E1,n
)
Normal equilibrium constant for reac-
tion 1
Keq2,n dimensionless 10
−1
E0(cyt a3)
(
p2 SaO2,n
4 −E2
)
Normal equilibrium constant for reac-
tion 2
KeqMAshut dimensionless 10 Equilibrium constant for the malate-
aspartate shuttle
km,ATP dimensionless 0.025 Km for ATP use as a fraction of normal
ATP concentration
km,glycA m M km,glycA,f [ADP]n Km for ADP in the caricature of gly-
colysis
km,glycA,f dimensionless 0.2 Km for ADP in glycolysis as a fration
of normal ADP concentration
km,glycG m M 0.05000 Km for glucose in the caricature of gly-
colysis
km,glycN m M km,glycN,f [NAD]n Km for NAD in the caricature of gly-
colysis
km,glycN,f m M 0.2 Km for NAD in glycolysis as a fraction
of normal NAD concentration375
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km,glycP m M km,glycP,f [P]n Km for inorganic phosphate in the car-
icature of glycolysis.
km,glycP,f dimensionless 0.2 Km for inorganic phosphate in glycol-
ysis as a fraction of normal phosphate
concentration
KmKATPA mM 1.4 Km for intracellular ATP for the
sodium potassium pump
KmKATPNa mM 20 Km for intracellular sodium for the
sodium potassium pump
KmNaBiC mM 10.4 Km for the sodium bicarbonate co-
transporter
KmNHE mM 33 Km for the sodium hydrogen ex-
changer
kmNAD m M 100000 Km for NAD in the tca cycle as a frac-
tion of the normal NAD concentration
KmNAD,TCA m M kmNAD [NAD]n Km for NAD in the TCA cycle
kmPy m M 0 Km for pyruvate for the tca cycle as
a fraction of the normal pyruvate con-
centration
KmPy,TCA m M kmPy [Py]n Km for pyruvate in the TCA cycle
km m M [ATP]n km,ATP Km for ATP use
k−1,0 s−1
fn
Keq1,n VAratn −CuA,o,n Backward rate constant for reaction 1at normal PMF
kn1n dimensionless
fn
Keq1,n VAratn −CuA,o,n
376
A
.4.
BrainPiglet
v2.1
k−2,n m−1 M s−1
fn
Keq2,n CuA,o,n a3o,n −VAratn cyta3r,n Normal backward rate constant for re-action 2
LCV,0 dimensionless 0.4 Normal complex V flux as a fraction of
maximum possible flux
LCV,frac dimensionless 1− Llk,frac Normal fraction of proton entry into
mitochondria associated with ADP
phosphorylation
LCV,max m M s−1
CBFn
LCV,0
The maximum rate of proton flow
through complex V.
LCVn m M s−1 Ln LCV,frac The resting flow of protons into the
matrix through complex V
fn m M s−1
CBFn
exp (SaO2,n fn)− 1 First constant controlling rate of Llk of∆p.
Llk,frac dimensionless 0.25 Normal fraction of proton entry into
mitochondria which is via leak chan-
nels
Llkn m M s−1 Ln Llk,frac The resting flow of protons into the
matrix via leak channels.
Ln m M s−1 ptot fn The total flow of protons back into mi-
tochondria
[lacc] m M 1 Capillary lactate concentration
µmax dimensionless 1 Maximum value of mu
µmin dimensionless −1 Minimum value of mu
µn dimensionless 0 Normal value of mu377
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nh dimensionless 2.5 Hill coefficient for haemoglobin satu-
ration
nm dimensionless 1.83 Exponent in the muscular tension re-
lationship
na dimensionless 4.33 Number of protons passing through
Complex V for each ATP synthesised
NADcytn m M 359 Normal concentration of NAD in the
cytoplasm
NADHcytn dimensionless 50 Normal concentration of NADH in the
cytoplasm
[NADH]n m M Nt − [NAD]n Normal mitochondrial NADH concen-
tration
[NAD]n m M
Nt
1+ 1
[NAD]n/[NADH]n
Normal concentration of NAD in the
mitochondria
[NAD]n/[NADH]n dimensionless 9 Normal NAD/NADH ratio
Nt m M 3 Total mitochondrial NAD + NADH
concentration
NapH dimensionless 1 Parameter controlling the sensitivity
of the sodium hydrogen exchanger to
cytoplasmic pH
[O2]init m M [O2]n Initial oxygen concentration in mito-
chondria.
[O2]n m M 0.024 Normal oxygen concentration in mito-
chondria.378
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[O2,a] m M φ
(
SaO2sup
1.0− SaO2sup
) 1
nh
Arterial dissolved oxygen concentra-
tion
[O2,c]init m M [O2,c]n Initial concentration of dissolved oxy-
gen in the capillary.
[O2,c]n m M [O2,c]init pow
(
ScO2,n
1− ScO2,n ,
1
nh
)
Normal concentration of dissolved
oxygen in the capillary.
p1 dimensionless ptot − p23 The number of protons pumped by
ared (reduction reaction)
p2 dimensionless 4 Total protons pumped by reaction 2
p23 dimensionless 8 Total protons pumped by reactions 2
and 3
p3 dimensionless p23 − p2 Total protons pumped by reaction 3
P1,n mmHg
Pa2,n + Pv,n
2
Normal average blood pressure in ves-
sels
Pa mmHg 50 Arterial blood pressure
Pa2,n mmHg
G0,n Pa + Gn Pv,n
Gn + G0,n
Normal arterial blood pressure at the
start of the cerebral arteries
Pa mmHg 50 Normal value of ABP Normal value of
ABP
pC1 dimensionless 8 Total protons pumped by complex 1
pC3 dimensionless 4 Total protons pumped by complex 3
Pic mmHg 4.5 Intracranial blood pressure
Pic,n mmHg 4.5 Normal intracranial blood pressure379
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ptot dimensionless 18.40 Total protons pumped by reactions 1,
2 and 3
ptot,NADH dimensionless pC1 + pC3 + p23 Total protons pumped when the re-
ducing agent is NADH
Pv,n mmHg
Gt,n
Gv
(Pa − Pvs) + Pvs Normal venous blood pressure
Pvs mmHg 1.5 Pressure in the venous sinuses
PaCO2 mmHg 40 Arterial partial pressure of CO2
PaCO2,n mmHg 40 Normal arterial partial pressure of
CO2
PaO2 mmHg
[O2,a]
kH,O2
Partial pressure of oxygen in the arter-
ies
[PCr]n/[Pi]n dimensionless 2.73 Normal Pcr/Pi concentration in the
cytoplasm. Set this way because this is
often measured by MRS (although mi-
tochondria/cytoplasm differences are
ignored).
pHm,n dimensionless 8 Normal mitochondrial pH
pHo,n dimensionless 7 Normal extra-mitochondrial pH
[O2,c]init m M 0.036 Value of O2 at half maximal saturation
PtCO2n dimensionless 54 Partial pressure of CO2 in tissue
r0 cm 1− r f racrocc Radius of the supplying artery com-
partment
r0 cm 0.0126 A special radius in the elastic tension
relationship380
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RC dimensionless 2.2 Parameter controlling sensitivity of η
to PaCO2
RO dimensionless 1.5 Parameter controlling sensitivity of η
to [O2,c]
RP dimensionless 4 Parameter controlling sensitivity of η
to Pa
Ru dimensionless 0 Parameter controlling sensitivity of η
to u
rCV dimensionless 5 A parameter controlling the ratio of
maximal to minimal rates of oxidative
phosphorylation
rinit cm [Hbtotc] Initial radius of blood vessels
rm cm 0.027 Value of vessel radius giving maxi-
mum muscular tension
[Hbtotc] cm 0.0187 Normal radius of blood vessels nor-
mal radius of blood vessels
rt cm 0.018 Parameter in the muscular tension re-
lationship
rfrac dimensionless 1− (1− occfrac)
1
2 Fraction by which the radius of the
supplying artery compartment has
been reduced
rocc dimensionless 0 Fraction by which the radius of the
carotid arteries has been reduced
SaO2,n dimensionless 0.96 Normal saturation of the arterial
haemoglobin
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SaO2 dimensionless 0.96 Saturation of the arterial haemoglobin
ScO2,n dimensionless
SaO2,n + SvO2n
2
Normal capillary oxygen saturation
σcoll mmHg 62.79 Value of pressure at which vessels col-
lapse
σe0 mmHg 0.1425 Parameter in relationship determining
σe
σe,n mmHg σe0
(
exp
(
Kσ ([Hbtotc]− r0)
r0
)
− 1
)
− σcoll Normal elastic stress in vessel walls
SvO2n dimensionless
[HbO2,v]n
[Hbtot]n
Normal venous oxygen saturation
νu,n s 5 The time constant associated with
vCO2
Te,n mmHg cm σe,n hn Normal elastic tension in vessel walls
Tmax0 mmHg cm
Tmax,n
1+ Te,n µn
Tmax at normal mu
Tmax,n mmHg cm
Tm,n
exp
(
−pow
(
fabs
(
[Hbtotc ]−rm
rt−rm
)
, nm
)) Normal maximum muscular tension
developed by circulation
Tm,n mmHg cm (P1,n − Pic,n) [Hbtotc]− Te,n Normal muscular tension in vessel
walls
νu,n s 20 The time constant associated with vO2
νu,n s 5 The time constant associated with vPa
νu,n s 0.5 The time constant associated with vu
u dimensionless 1 The representation of ”demand” in the
model.
un dimensionless 1 Resting ”demand”382
A
.4.
BrainPiglet
v2.1
Vmax,ATP m M s−1
(
LCVnVolmit
na
+ 2.0CMRglucn
)
(1.0+ km) u Vmax of ATP use
νCO2,n mmHg PaCO2,n Normal value of vCO2 (CO2 passed
through a first order filter)
Vglucosein dimensionless
[glucc]
kglut + [glucc]
Rate term for glucose transported into
the cell. This is a michaelis menten
term, but fixed because blood glucose
concentration is fixed.
vglut m M
CMRgluc,n
Vglucosein − [gluc]n[gluc]n+kglut
Vmax for glucose transport both in
and out of the cell from the capillary.
Vlacin dimensionless
[lacc]
kMCT + [lacc]
Rate of lactate transport into the cell
vMCT m M s−1
2CMRgluc,n − CBFn3
[lac]n [H+ ]n
([lac]n+kMCT) ([H+ ]n+kMCT)
−Vlacin
νO2,n m M [O2,c]n Normal value of vO2 (capillary O2
passed through a first order filter)
νPa ,n mmHg Pa2,n Normal value of vPa (Arterial blood
pressure passed through a first order
filter)
vTCA m M s−1
kTCAn
[Py]n [NAD]n
(km,tcaN + [NAD]n) (km,tcaP + [Py]n) Vmax for the TCA cycle
νu,n dimensionless LCV,frac normal value of vu (u passed through
a first order filter)
VAratn dimensionless 3 The normal ratio of the volume of the
veins to the volume of the arteries383
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vglyc,n m M s−1
CMRgluc,n
glycg,n glycp,n glyca,n glycnn
Normal Vmax for glycolysis which is
assumed to be modified by the ratio of
AMP to ATP
VmaxNaBiC mM ·ml · s−1 0.001 Vmax for the sodium bicarbonate co-
transporter
VmaxNHE mM ·ml · s−1 0.02 Vmax for the sodium hydrogen ex-
changer
Va,n dimensionless
t,n
1+VAratn
Normal arterial blood volume as a
fraction of total blood volume
Volmit dimensionless 0.067 Fraction of brain water which is mito-
chondria
Vt,n dimensionless 1 Normal total blood volume
Vv,n dimensionless t,n
VAratn
1+VAratn
Normal venous volume
[HHba] m M [Hbtot] (1− SaO2) Unsaturated arterial haemoglobin
[HHba]n m M [Hbtot]n (1− SaO2,n) Normal unsaturated arterial
haemoglobin
[HbO2,a] m M [Hbtot] SaO2 Concentration of arterial oxy-
haemoglobin.
[HbO2,a]n m M [Hbtot]n SaO2,n Normal concentration of arterial oxy-
haemoglobin.
[HbO2,v]init m M [HbO2,v]n Initial concentration of venous oxy-
haemoglobin.
[HbO2,v]n m M
CBFn [HbO2,a]n − Ru
CBFn
Normal concentration of venous oxy-
haemoglobin.
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[HbO2,a]n m M [Hbtot]n Total haemoglobin concentration in
the arteries and veins.
[Hbtot]n m M 5.4 Normal total haemoglobin concentra-
tion in the arteries and veins.
[HHbv]n m M [Hbtot]n − [HbO2,v]n Normal unsaturated venous
haemoglobin
Z m V 59.028 2.303*RT/F
385
Bibliography
The World Health Report 2005 make every mother and child count.
Technical report, World Health Organisation, Geneva, Switzerland,
2005. URL http://www.kfshrc.edu.sa/annals/articles/25_6/25-6_
516-517.pdf.
OpenCell, 2009. URL https://www.cellml.org/tools/opencell.
MATLAB R2013a, 2013.
Agulhon, C., Petravicz, J., McMullen, A. B., Sweger, E. J., Minton, S. K.,
Taves, S. R., Casper, K. B., Fiacco, T. a., and McCarthy, K. D. What is
the role of astrocyte calcium in neurophysiology? Neuron, 59(6):932–46,
September 2008. ISSN 1097-4199. doi: 10.1016/j.neuron.2008.09.004. URL
http://www.ncbi.nlm.nih.gov/pubmed/18817732.
Akiba, T., Alpern, R. J., Eveloff, J., Calamina, J., and Warnock, D. G.
Electrogenic sodium/bicarbonate cotransport in rabbit renal cortical
basolateral membrane vesicles. The Journal of clinical investigation, 78
(6):1472–8, December 1986. ISSN 0021-9738. doi: 10.1172/JCI112738.
URL http://www.ncbi.nlm.nih.gov/pubmed/423898http://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=423898&tool=
pmcentrez&rendertype=abstract.
Akiba, T., Rocco, V. K., and Warnock, D. G. Parallel adaptation of the
rabbit renal cortical sodium/proton antiporter and sodium/bicarbonate
cotransporter in metabolic acidosis and alkalosis. The Journal of clinical
investigation, 80(2):308–15, August 1987. ISSN 0021-9738. doi: 10.1172/
JCI113074. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=442239&tool=pmcentrez&rendertype=abstract.
386
Alastruey, J., Moore, S. M., Parker, K. H., David, T., Peiro´, J., and Sherwin,
S. J. Reduced modelling of blood flow in the cerebral circulation: Coupling
1-D, 0-D and cerebral auto-regulation models. International Journal for Nu-
merical Methods in Fluids, 56(8):1061–1067, March 2008. ISSN 02712091.
doi: 10.1002/fld.1606. URL http://doi.wiley.com/10.1002/fld.1606.
Almaas, R., Pytte, M., Lindstad, J. K., Wright, M., Saugstad, O. D., Pleasure,
D., and Rootwelt, T. Acidosis has opposite effects on neuronal survival
during hypoxia and reoxygenation. Journal of Neurochemistry, 84(5):1018–
1027, February 2003. ISSN 00223042. doi: 10.1046/j.1471-4159.2003.01593.
x. URL http://doi.wiley.com/10.1046/j.1471-4159.2003.01593.x.
Altman, D. I., Powers, W. J., Perlman, J. M., Herscovitch, P., Volpe, S. L.,
and Volpe, J. J. Cerebral blood flow requirement for brain viability in
newborn infants is lower than in adults. Annals of neurology, 24(2):218–26,
August 1988. ISSN 0364-5134. doi: 10.1002/ana.410240208. URL http:
//www.ncbi.nlm.nih.gov/pubmed/3263081.
Amess, P. N., Penrice, J., Cady, E. B., Lorek, A., Wylezinska, M., Cooper,
C. E., D’Souza, P., Tyszczuk, L., Thoresen, M., Edwards, A. D., Wy-
att, J. S., and Reynolds, E. O. Mild hypothermia after severe transient
hypoxia-ischemia reduces the delayed rise in cerebral lactate in the new-
born piglet. Pediatric research, 41(6):803–8, June 1997. ISSN 0031-3998.
doi: 10.1203/00006450-199706000-00002. URL http://www.ncbi.nlm.
nih.gov/pubmed/9167192.
Anderson, A. W., Marois, R., Colson, E. R., Peterson, B. S., Duncan, C. C.,
Ehrenkranz, R. A., Schneider, K. C., Gore, J. C., and Ment, L. R. Neonatal
auditory activation detected by functional magnetic resonance imaging.
Magnetic resonance imaging, 19(1):1–5, January 2001. ISSN 0730-725X. URL
http://www.ncbi.nlm.nih.gov/pubmed/11295339.
Aoyagi, T. Pulse oximetry: its invention, theory, and future. Journal
of anesthesia, 17(4):259–66, January 2003. ISSN 0913-8668. doi: 10.
1007/s00540-003-0192-6. URL http://www.ncbi.nlm.nih.gov/pubmed/
14625714.
Aubert, A. and Costalat, R. Compartmentalization of brain energy
metabolism between glia and neurons: insights from mathematical mod-
387
eling. Glia, 1279(April 2006):1272–1279, 2007. doi: 10.1002/glia. URL
http://onlinelibrary.wiley.com/doi/10.1002/glia.20360/full.
Aubert, A., Costalat, R., and Valabre`gue, R. Modelling of the coupling be-
tween brain electrical activity and metabolism. Acta biotheoretica, 49(4):
301–26, January 2001. ISSN 0001-5342. URL http://www.ncbi.nlm.nih.
gov/pubmed/11804241.
Aubert, A. and Costalat, R. A Model of the Coupling between Brain Elec-
trical Activity, Metabolism, and Hemodynamics: Application to the In-
terpretation of Functional Neuroimaging. NeuroImage, 17(3):1162–1181,
November 2002. ISSN 10538119. doi: 10.1006/nimg.2002.1224. URL
http://linkinghub.elsevier.com/retrieve/pii/S1053811902912243.
Aubert, A. and Costalat, R. Interaction between astrocytes and neu-
rons studied using a mathematical model of compartmentalized energy
metabolism. Journal of cerebral blood flow and metabolism : official journal of
the International Society of Cerebral Blood Flow and Metabolism, 25(11):1476–
90, November 2005. ISSN 0271-678X. doi: 10.1038/sj.jcbfm.9600144. URL
http://www.ncbi.nlm.nih.gov/pubmed/15931164.
Austin, T., Shanmugalingam, S., and Clarke, P. To cool or not to cool? Hy-
pothermia treatment outside trial criteria. Archives of disease in childhood.
Fetal and neonatal edition, 98(5):F451–3, September 2013. ISSN 1468-2052.
doi: 10.1136/archdischild-2012-302069. URL http://www.ncbi.nlm.nih.
gov/pubmed/22820487.
Azzopardi, D., Wyatt, J. S., Cady, E. B., Delpy, D. T., Baudin, J., Stewart,
a. L., Hope, P. L., Hamilton, P. a., and Reynolds, E. O. Prognosis of
newborn infants with hypoxic-ischemic brain injury assessed by phos-
phorus magnetic resonance spectroscopy. Pediatric research, 25(5):445–51,
May 1989. ISSN 0031-3998. doi: 10.1203/00006450-198905000-00004. URL
http://www.ncbi.nlm.nih.gov/pubmed/2717259.
Azzopardi, D. V., Strohm, B., Edwards, a. D., Dyet, L., Halliday, H. L.,
Juszczak, E., Kapellou, O., Levene, M., Marlow, N., Porter, E., Thore-
sen, M., Whitelaw, A., and Brocklehurst, P. Moderate hypothermia
to treat perinatal asphyxial encephalopathy. The New England jour-
nal of medicine, 361(14):1349–58, October 2009. ISSN 1533-4406. doi:
388
10.1056/NEJMoa0900854. URL http://www.ncbi.nlm.nih.gov/pubmed/
19797281.
Babbs, C. F. Oscillometric measurement of systolic and dias-
tolic blood pressures validated in a physiologic mathemat-
ical model. Biomedical engineering online, 11(1):56, January
2012. ISSN 1475-925X. doi: 10.1186/1475-925X-11-56. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3541069&tool=pmcentrez&rendertype=abstract.
Bainbridge, A., Tachtsidis, I., Faulkner, S., Price, D., Zhu, T., Baer, E., Broad,
K. D., Thomas, D. L., Cady, E. B., Robertson, N. J., and Golay, X. Brain
mitochondrial oxidative metabolism during and after cerebral hypoxia-
ischemia studied by simultaneous phosphorus magnetic-resonance and
broadband near-infrared spectroscopy. NeuroImage, pages 1–11, August
2013. ISSN 1095-9572. doi: 10.1016/j.neuroimage.2013.08.016. URL http:
//www.ncbi.nlm.nih.gov/pubmed/23959202.
Bale, G., Mitra, S., Meek, J., Robertson, N., and Tachtsidis, I. A
new broadband near-infrared spectroscopy system for in-vivo mea-
surements of cerebral cytochrome-c-oxidase changes in neona-
tal brain injury. Biomedical optics express, 5(10):3450–66, Octo-
ber 2014. ISSN 2156-7085. doi: 10.1364/BOE.5.003450. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
4206316&tool=pmcentrez&rendertype=abstract.
Banaji, M. The BRAINCIRC model: Modelling the Human Brain Circulation,
2005. URL http://www.medphys.ucl.ac.uk/braincirc/.
Banaji, M. A generic model of electron transport in mitochondria. Journal
of theoretical biology, 243(4):501–16, December 2006. ISSN 0022-5193. doi:
10.1016/j.jtbi.2006.07.006. URL http://www.ncbi.nlm.nih.gov/pubmed/
16938312.
Banaji, M., Tachtsidis, I., Delpy, D., and Baigent, S. A physiological model of
cerebral blood flow control. Mathematical biosciences, 194(2):125–73, April
2005. ISSN 0025-5564. doi: 10.1016/j.mbs.2004.10.005. URL http://www.
ncbi.nlm.nih.gov/pubmed/15854674.
389
Banaji, M., Mallet, A., Elwell, C. E., Nicholls, P., and Cooper, C. E.
A model of brain circulation and metabolism: NIRS signal changes
during physiological challenges. PLoS computational biology, 4(11):
e1000212, November 2008. ISSN 1553-7358. doi: 10.1371/journal.pcbi.
1000212. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=2573000&tool=pmcentrez&rendertype=abstract.
Barker, R. and Cicchetti, F. Neuroanatomy and Neuroscience at a Glance. Wiley,
4th edition, 2012. ISBN 978-0-470-65768-3.
Barkovich, A. J. MR imaging of the neonatal brain. Neuroimaging clinics of
North America, 16(1):117–35, viii–ix, February 2006. ISSN 1052-5149. doi:
10.1016/j.nic.2005.10.003. URL http://www.ncbi.nlm.nih.gov/pubmed/
16543088.
Bartocci, M., Winberg, J., Ruggiero, C., Bergqvist, L. L., Serra, G., and
Lagercrantz, H. Activation of olfactory cortex in newborn infants af-
ter odor stimulation: a functional near-infrared spectroscopy study.
Pediatric research, 48(1):18–23, July 2000. ISSN 0031-3998. doi: 10.
1203/00006450-200007000-00006. URL http://www.ncbi.nlm.nih.gov/
pubmed/10879795.
Bazin, J.-E., Constantin, J.-M., and Gindre, G. [Laboratory animal anaes-
thesia: influence of anaesthetic protocols on experimental models]. An-
nales franc¸aises d’anesthe`sie et de re`animation, 23(8):811–8, August 2004. ISSN
0750-7658. doi: 10.1016/j.annfar.2004.05.013. URL http://www.ncbi.nlm.
nih.gov/pubmed/15345253.
Beard, D. A biophysical model of the mitochondrial respiratory system
and oxidative phosphorylation. PLoS computational biology, 1(4), 2005.
doi: 10.1371/journal.pcbi.0010036. URL http://dx.plos.org/10.1371/
journal.pcbi.0010036.
Beard, D. a. Modeling of oxygen transport and cellular energet-
ics explains observations on in vivo cardiac energy metabolism.
PLoS computational biology, 2(9):e107, September 2006. ISSN 1553-
7358. doi: 10.1371/journal.pcbi.0020107. URL http://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=1570176&tool=
pmcentrez&rendertype=abstract.
390
Bertholdo, D., Watcharakorn, A., and Castillo, M. Brain Proton Magnetic
Resonance Spectroscopy. Am Soc Neuroradiology, 1980. URL http://www.
ajnr.org/site/fellows/files/MRS-chapter-Castillo.pdf.
Beutler, E. and Waalen, J. The definition of anemia: what is the lower limit
of normal of the blood hemoglobin concentration? Blood, 107(5):1747–50,
March 2006. ISSN 0006-4971. doi: 10.1182/blood-2005-07-3046. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1895695&tool=pmcentrez&rendertype=abstract.
Biallas, M., Trajkovic, I., Hagmann, C., Scholkmann, F., Jenny, C., Holper,
L., Beck, A., and Wolf, M. Multimodal recording of brain activity in term
newborns during photic stimulation by near-infrared spectroscopy and
electroencephalography. Journal of biomedical optics, 17(8):086011–1, August
2012. ISSN 1560-2281. doi: 10.1117/1.JBO.17.8.086011. URL http://www.
ncbi.nlm.nih.gov/pubmed/23224198.
Black, J. Drugs from emasculated hormones: the principle of syntopic
antagonism. Bioscience reports, 24(4-5):302–22, 2005. ISSN 0144-8463.
doi: 10.1007/s10540-005-2736-5. URL http://www.ncbi.nlm.nih.gov/
pubmed/16134017.
Brown, D. W., Hadway, J., and Lee, T.-Y. Near-infrared spectroscopy
measurement of oxygen extraction fraction and cerebral metabolic rate
of oxygen in newborn piglets. Pediatric research, 54(6):861–7, December
2003. ISSN 0031-3998. doi: 10.1203/01.PDR.0000090928.93045.BE. URL
http://www.ncbi.nlm.nih.gov/pubmed/12930911.
Cady, E., Dawson, M. J., and Hope, P. Non-invasive investigation of
cerebral metabolism in newborn infants by phosphorus nuclear mag-
netic resonance spectroscopy. The Lancet, (May):1–4, 1983. URL http:
//www.sciencedirect.com/science/article/pii/S0140673683919062.
Cady, E. B., Iwata, O., Bainbridge, A., Wyatt, J. S., and Robertson, N. J.
Phosphorus magnetic resonance spectroscopy 2 h after perinatal cerebral
hypoxia-ischemia prognosticates outcome in the newborn piglet. Journal
of neurochemistry, 107(4):1027–35, November 2008. ISSN 1471-4159. doi:
10.1111/j.1471-4159.2008.05662.x. URL http://www.ncbi.nlm.nih.gov/
pubmed/18786177.
391
Caldwell, M., Hapuarachchi, T., Highton, D., Elwell, C., Smith,
M., and Tachtsidis, I. BrainSignals Revisited: Simplifying a
Computational Model of Cerebral Physiology. PloS one, 10(5):
e0126695, January 2015. ISSN 1932-6203. doi: 10.1371/journal.pone.
0126695. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=4427507&tool=pmcentrez&rendertype=abstract.
Casey, J. R., Grinstein, S., and Orlowski, J. Sensors and regulators of intracel-
lular pH. Nature reviews. Molecular cell biology, 11(1):50–61, January 2010.
ISSN 1471-0080. doi: 10.1038/nrm2820. URL http://www.ncbi.nlm.nih.
gov/pubmed/19997129.
Cavaglia, M., Dombrowski, S. M., Drazba, J., Vasanji, a., Bokesch, P. M.,
and Janigro, D. Regional variation in brain capillary density and vascular
response to ischemia. Brain research, 910(1-2):81–93, August 2001. ISSN
0006-8993. URL http://www.ncbi.nlm.nih.gov/pubmed/11489257.
Chudler, E. Brain Facts and Figures. URL http://faculty.washington.
edu/chudler/facts.html.
Cloutier, M., Bolger, F. B., Lowry, J. P., and Wellstead, P. An integrative
dynamic model of brain energy metabolism using in vivo neurochem-
ical measurements. Journal of computational neuroscience, 27(3):391–414,
December 2009. ISSN 1573-6873. doi: 10.1007/s10827-009-0152-8. URL
http://www.ncbi.nlm.nih.gov/pubmed/19396534.
Cooper, C. E. and Springett, R. Measurement of cytochrome oxidase
and mitochondrial energetics by near-infrared spectroscopy. Philosophi-
cal transactions of the Royal Society of London. Series B, Biological sciences,
352(1354):669–76, June 1997. ISSN 0962-8436. doi: 10.1098/rstb.1997.
0048. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=1691958&tool=pmcentrez&rendertype=abstract.
Cooper, C. E., Cope, M., Quaresima, V., Ferrari, M., Nemoto, E.,
Springett, R., Matcher, S., Amess, P., Penrice, J., Tyszczuk, L., Wy-
att, J., and Delpy, D. T. Measurement of cytochrome oxidase re-
dox state by near infrared spectroscopy. Advances in experimental
medicine and biology, 413:63–73, January 1997. ISSN 0065-2598. URL
http://www.medphys.ucl.ac.uk/research/borg/pdf/cooper_aemb_
1997.pdfhttp://www.ncbi.nlm.nih.gov/pubmed/9238486.
392
Cooper, C. E. Nitric oxide and cytochrome oxidase: substrate, inhibitor or
effector? Trends in biochemical sciences, 27(1):33–9, January 2002. ISSN
0968-0004. URL http://www.ncbi.nlm.nih.gov/pubmed/11796222.
Cooper, R. J., Hebden, J. C., O’Reilly, H., Mitra, S., Michell, a. W., Everdell,
N. L., Gibson, a. P., and Austin, T. Transient haemodynamic events in neu-
rologically compromised infants: a simultaneous EEG and diffuse optical
imaging study. NeuroImage, 55(4):1610–6, April 2011. ISSN 1095-9572. doi:
10.1016/j.neuroimage.2011.01.022. URL http://www.ncbi.nlm.nih.gov/
pubmed/21255658.
Corbett, R. J., Laptook, a. R., and Nunnally, R. L. The use of the chemical
shift of the phosphomonoester P-31 magnetic resonance peak for the de-
termination of intracellular pH in the brains of neonates., November 1987.
ISSN 0028-3878. URL http://www.ncbi.nlm.nih.gov/pubmed/3670615.
Courchesne, E., Pierce, K., Schumann, C. M., Redcay, E., Buckwalter, J. a.,
Kennedy, D. P., and Morgan, J. Mapping early brain development in
autism. Neuron, 56(2):399–413, October 2007. ISSN 0896-6273. doi: 10.
1016/j.neuron.2007.10.016. URL http://www.ncbi.nlm.nih.gov/pubmed/
17964254.
Crambert, G., Hasler, U., Beggah, a. T., Yu, C., Modyanov, N. N., Horis-
berger, J. D., Lelie`vre, L., and Geering, K. Transport and pharmacological
properties of nine different human Na, K-ATPase isozymes. The Journal
of biological chemistry, 275(3):1976–86, January 2000. ISSN 0021-9258. URL
http://www.ncbi.nlm.nih.gov/pubmed/10636900.
Cuellar, A. A., Lloyd, C. M., Nielsen, P. F., Bullivant, D. P., Nicker-
son, D. P., and Hunter, P. J. An Overview of CellML 1.1, a Biolog-
ical Model Description Language. SIMULATION, 79(12):740–747, De-
cember 2003. ISSN 0037-5497. doi: 10.1177/0037549703040939. URL
http://sim.sagepub.com/cgi/doi/10.1177/0037549703040939.
Currie, S., Hadjivassiliou, M., Craven, I. J., Wilkinson, I. D., Griffiths, P. D.,
and Hoggard, N. Magnetic resonance spectroscopy of the brain. Post-
graduate medical journal, 89(1048):94–106, February 2013. ISSN 1469-0756.
doi: 10.1136/postgradmedj-2011-130471. URL http://www.ncbi.nlm.
nih.gov/pubmed/23014671.
393
Czosnyka, M., Harris, N. G., Pickard, J. D., and Piechnik, S. CO2 cerebrovas-
cular reactivity as a function of perfusion pressure a modelling study.
Acta Neurochirurgica, 121(3-4):159–165, September 1993. ISSN 0001-6268.
doi: 10.1007/BF01809269. URL http://link.springer.com/article/
10.1007/BF01809269http://link.springer.com/10.1007/BF01809269.
de Lima Santos, H. and Ciancaglini, P. Kinetic characterization of Na,K-
ATPase from rabbit outer renal medulla: properties of the (αβ)2 dimer.
Comparative Biochemistry and Physiology Part B: Biochemistry and Molec-
ular Biology, 135(3):539–549, July 2003. ISSN 10964959. doi: 10.
1016/S1096-4959(03)00139-8. URL http://linkinghub.elsevier.com/
retrieve/pii/S1096495903001398.
DeCharms, R. C. Applications of real-time fMRI. Nature reviews. Neu-
roscience, 9(9):720–9, September 2008. ISSN 1471-003X. doi: 10.1038/
nrn2414. URL http://www.ncbi.nlm.nih.gov/pubmed/18714327.
Easa, D. Noninvasive Intracranial Pressure Measurement in the New-
born. American Journal of Diseases of Children, 137(4):332, April
1983. ISSN 0002-922X. doi: 10.1001/archpedi.1983.02140300014004.
URL http://archpedi.jamanetwork.com/article.aspx?doi=10.1001/
archpedi.1983.02140300014004.
Edvinsson, L., Mackenzie, E. T., and McCulloch, J. Cerebral blood flow and
metabolism. Raven Press, 1992. ISBN 0-88167-918-6.
Edwards, A. D., Wyatt, J. S., Richardson, C., Delpy, D. T.,
Cope, M., and Reynolds, E. O. Cotside measurement of cere-
bral blood flow in ill newborn infants by near infrared spec-
troscopy. Lancet, 2(8614):770–1, October 1988. ISSN 0140-
6736. URL http://www.sciencedirect.com/science/article/pii/
S014067368892418Xhttp://www.ncbi.nlm.nih.gov/pubmed/2901613.
Edwards, A. D., Wyatt, J. S., and Thoresen, M. Treatment of hypoxic-
ischaemic brain damage by moderate hypothermia. Archives of disease in
childhood. Fetal and neonatal edition, 78(2):F85–8, March 1998. ISSN 1359-
2998. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=1720772&tool=pmcentrez&rendertype=abstract.
394
Edwards, A., Yue, X., Squier, M., Thoresen, M., Cady, E., Penrice, J., Cooper,
C., Wyatt, J., Reynolds, E., and Mehmet, H. Specific Inhibition of Apop-
tosis after Cerebral Hypoxia-Ischemia by Moderate Post-Insult Hypother-
mia. Biochemical and Biophysical Research Communications, 217(3):1193–1199,
December 1995. ISSN 0006291X. doi: 10.1006/bbrc.1995.2895. URL
http://linkinghub.elsevier.com/retrieve/pii/S0006291X85728951.
Ellsworth, M. a., Lang, T. R., Pickering, B. W., and Herasevich, V. Clinical
data needs in the neonatal intensive care unit electronic medical record.
BMC medical informatics and decision making, 14(1):92, January 2014. ISSN
1472-6947. doi: 10.1186/1472-6947-14-92. URL http://www.ncbi.nlm.
nih.gov/pubmed/25341847.
Elwell, C. E., Cope, M., Edwards, A. D., Wyatt, J. S., Delpy, D. T., and
Reynolds, E. O. Quantification of adult cerebral hemodynamics by near-
infrared spectroscopy. Journal of applied physiology (Bethesda, Md. : 1985),
77(6):2753–60, December 1994. ISSN 8750-7587. URL http://www.ncbi.
nlm.nih.gov/pubmed/7896617.
Elwell, C. E., Owen-Reece, H., Wyatt, J. S., Cope, M., Reynolds, E. O., and
Delpy, D. T. Influence of respiration and changes in expiratory pressure
on cerebral haemoglobin concentration measured by near infrared spec-
troscopy. Journal of cerebral blood flow and metabolism : official journal of
the International Society of Cerebral Blood Flow and Metabolism, 16(2):353–7,
March 1996. ISSN 0271-678X. doi: 10.1097/00004647-199603000-00022.
URL http://www.ncbi.nlm.nih.gov/pubmed/8594069.
Elwell, C. E., Henty, J. R., Leung, T. S., Austin, T., Meek, J. H.,
Delpy, D. T., and Wyatt, J. S. Measurement of CMRO2 in neonates
undergoing intensive care using near infrared spectroscopy. Ad-
vances in experimental medicine and biology, 566:263–8, January
2005. ISSN 0065-2598. doi: 10.1007/0-387-26206-7\ 35. URL
http://link.springer.com/chapter/10.1007/0-387-26206-7_35http:
//www.ncbi.nlm.nih.gov/pubmed/16594161.
Fuster, D., Moe, O. W., and Hilgemann, D. W. Steady-state function of
the ubiquitous mammalian Na/H exchanger (NHE1) in relation to dimer
coupling models with 2Na/2H stoichiometry. The Journal of general phys-
iology, 132(4):465–80, October 2008. ISSN 1540-7748. doi: 10.1085/jgp.
395
200810016. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=2553392&tool=pmcentrez&rendertype=abstract.
Gavaghan, D., Coveney, P. V., and Kohl, P. The virtual physiological human:
tools and applications I. Philosophical transactions. Series A, Mathematical,
physical, and engineering sciences, 367(1895):1817–21, May 2009. ISSN 1364-
503X. doi: 10.1098/rsta.2009.0070. URL http://www.ncbi.nlm.nih.gov/
pubmed/19380313.
Gjedde, A. Cerebral Blood Flow Change in Arterial Hypoxemia Is Consis-
tent with Negligible Oxygen Tension in Brain Mitochondria. NeuroIm-
age, 17(4):1876–1881, December 2002. ISSN 10538119. doi: 10.1006/
nimg.2002.1272. URL http://linkinghub.elsevier.com/retrieve/
pii/S1053811902912723.
Grant, P. E., Roche-Labarbe, N., Surova, A., Themelis, G., Selb, J., War-
ren, E. K., Krishnamoorthy, K. S., Boas, D. A., and Franceschini, M. A.
Increased cerebral blood volume and oxygen consumption in neonatal
brain injury. Journal of cerebral blood flow and metabolism : official jour-
nal of the International Society of Cerebral Blood Flow and Metabolism, 29
(10):1704–13, October 2009. ISSN 1559-7016. doi: 10.1038/jcbfm.2009.
90. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=2762197&tool=pmcentrez&rendertype=abstract.
Greisen, G. Cerebral blood flow in preterm infants during the first week of
life. Acta paediatrica Scandinavica, 75(1):43–51, January 1986. ISSN 0001-
656X. URL http://www.ncbi.nlm.nih.gov/pubmed/2420149.
Greisen, G. Autoregulation of cerebral blood flow in newborn ba-
bies. Early human development, 2005. doi: 10.1016/j.earlhumdev.2005.
03.005. URL http://www.sciencedirect.com/science/article/pii/
S0378378205000630.
Gujar, S. Magnetic resonance spectroscopy. Journal of neuro-
opthamology, 25(3):217–226, 2005. URL http://journals.lww.com/
jneuro-ophthalmology/Abstract/2005/09000/Magnetic_Resonance_
Spectroscopy.15.aspx.
Gunawardena, J. Models in biology: ’accurate descriptions of our pathetic
thinking’. BMC biology, 12:29, January 2014. ISSN 1741-7007. doi:
396
10.1186/1741-7007-12-29. URL http://www.pubmedcentral.nih.gov/
articlerender.fcgi?artid=4005397&tool=pmcentrez&rendertype=
abstract.
Gutenkunst, R. N., Waterfall, J. J., Casey, F. P., Brown, K. S., My-
ers, C. R., and Sethna, J. P. Universally sloppy parameter sensi-
tivities in systems biology models. PLoS computational biology, 3(10):
1871–78, October 2007. ISSN 1553-7358. doi: 10.1371/journal.pcbi.
0030189. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=2000971&tool=pmcentrez&rendertype=abstract.
Haefner, J. W. Modeling Biological Systems Principles and Applications. Springer
Science+Business Media, Inc., 2005. ISBN 9780387250120.
Hairer, E. and Wanner, G. Solving Ordinary Differential Equations II, vol-
ume 14 of Springer Series in Computational Mathematics. Springer Berlin
Heidelberg, Berlin, Heidelberg, 1996. ISBN 978-3-642-05220-0. doi:
10.1007/978-3-642-05221-7. URL http://link.springer.com/10.1007/
978-3-642-05221-7.
Hartwig, V., Giovannetti, G., Vanello, N., Lombardi, M., Landini, L., and
Simi, S. Biological effects and safety in magnetic resonance imaging: a
review. International journal of environmental research and public health, 6(6):
1778–98, June 2009. ISSN 1660-4601. doi: 10.3390/ijerph6061778. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2705217&tool=pmcentrez&rendertype=abstract.
Heep, A., Scheef, L., Jankowski, J., Born, M., Zimmermann, N., Sival, D.,
Bos, A., Gieseke, J., Bartmann, P., Schild, H., and Boecker, H. Func-
tional magnetic resonance imaging of the sensorimotor system in preterm
infants. Pediatrics, 123(1):294–300, January 2009. ISSN 1098-4275. doi:
10.1542/peds.2007-3475. URL http://www.ncbi.nlm.nih.gov/pubmed/
19117895.
Helbig, H., Korbmacher, C., Berweck, S., Ku¨hner, D., and Wiederholt, M.
Kinetic properties of Na+/H+ exchange in cultured bovine pigmented
ciliary epithelial cells. Pflu¨gers Archiv : European journal of physiology, 412
(1-2):80–5, July 1988. ISSN 0031-6768. doi: 10.1007/BF00583734. URL
http://www.ncbi.nlm.nih.gov/pubmed/3174387.
397
Helmy, M. M., Tolner, E. a., Vanhatalo, S., Voipio, J., and Kaila, K. Brain
alkalosis causes birth asphyxia seizures, suggesting therapeutic strategy.
Annals of neurology, 69(3):493–500, March 2011. ISSN 1531-8249. doi: 10.
1002/ana.22223. URL http://www.ncbi.nlm.nih.gov/pubmed/21337602.
Helmy, M. M., Ruusuvuori, E., Watkins, P. V., Voipio, J., Kanold, P. O., and
Kaila, K. Acid extrusion via blood-brain barrier causes brain alkalosis
and seizures after neonatal asphyxia. Brain : a journal of neurology, 135
(Pt 11):3311–9, November 2012. ISSN 1460-2156. doi: 10.1093/brain/
aws257. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=3501974&tool=pmcentrez&rendertype=abstract.
Hucka, M., Finney, A., Sauro, H. M., Bolouri, H., Doyle, J. C., Kitano,
H., Arkin, A. P., Bornstein, B. J., Bray, D., Cornish-Bowden, A., Cuel-
lar, A. A., Dronov, S., Gilles, E. D., Ginkel, M., Gor, V., Goryanin, I. I.,
Hedley, W. J., Hodgman, T. C., Hofmeyr, J.-H., Hunter, P. J., Juty, N. S.,
Kasberger, J. L., Kremling, A., Kummer, U., Le Nove`re, N., Loew, L. M.,
Lucio, D., Mendes, P., Minch, E., Mjolsness, E. D., Nakayama, Y., Nelson,
M. R., Nielsen, P. F., Sakurada, T., Schaff, J. C., Shapiro, B. E., Shimizu,
T. S., Spence, H. D., Stelling, J., Takahashi, K., Tomita, M., Wagner, J.,
and Wang, J. The systems biology markup language (SBML): a medium
for representation and exchange of biochemical network models. Bioinfor-
matics (Oxford, England), 19(4):524–31, March 2003. ISSN 1367-4803. URL
http://www.ncbi.nlm.nih.gov/pubmed/12611808.
Hunter, P. J. and Borg, T. K. Integration from proteins to organs: the Phys-
iome Project. Nature reviews. Molecular cell biology, 4(3):237–43, March 2003.
ISSN 1471-0072. doi: 10.1038/nrm1054. URL http://www.ncbi.nlm.nih.
gov/pubmed/12612642.
Huwaldt, J. A. and Steinhorst, S. Plot Digitizer. URL http://
plotdigitizer.sourceforge.net/.
Hyder, F., Kida, I., Behar, K. L., Kennan, R. P., Maciejewski, P. K., and
Rothman, D. L. Quantitative functional imaging of the brain: towards
mapping neuronal activity by BOLD fMRI. NMR in biomedicine, 14(7-
8):413–31, 2001. ISSN 0952-3480. doi: 10.1002/nbm.733. URL http:
//www.ncbi.nlm.nih.gov/pubmed/11746934.
398
Hyder, F., Shulman, R. G., and Rothman, D. L. A model for the regulation of
cerebral oxygen delivery. Journal of applied physiology (Bethesda, Md. : 1985),
85(2):554–64, August 1998. ISSN 8750-7587. URL http://www.ncbi.nlm.
nih.gov/pubmed/9688733.
Iliff, J. J., Wang, M., Zeppenfeld, D. M., Venkataraman, A., Plog, B. a., Liao,
Y., Deane, R., and Nedergaard, M. Cerebral arterial pulsation drives par-
avascular CSF-interstitial fluid exchange in the murine brain. The Journal of
neuroscience : the official journal of the Society for Neuroscience, 33(46):18190–
9, November 2013. ISSN 1529-2401. doi: 10.1523/JNEUROSCI.1592-13.
2013. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=3866416&tool=pmcentrez&rendertype=abstract.
Jelfs, B., Banaji, M., Tachtsidis, I., Cooper, C. E., and Elwell, C. E.
Modelling noninvasively measured cerebral signals during a hypox-
emia challenge: steps towards individualised modelling. PloS one, 7
(6):e38297, January 2012. ISSN 1932-6203. doi: 10.1371/journal.pone.
0038297. URL http://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=3367969&tool=pmcentrez&rendertype=abstract.
Jessen, N. A., Munk, A. S. F., Lundgaard, I., and Nedergaard, M. The
Glymphatic System: A Beginner’s Guide. Neurochemical research, May
2015. ISSN 1573-6903. doi: 10.1007/s11064-015-1581-6. URL http:
//www.ncbi.nlm.nih.gov/pubmed/25947369.
Jones, E., Oliphant, T., Peterson, P., and ... SciPy: Open Source Scientific
Tools for Python. URL http://www.scipy.org/.
Jopling, J., Henry, E., Wiedmeier, S. E., and Christensen, R. D. Reference
ranges for hematocrit and blood hemoglobin concentration during the
neonatal period: data from a multihospital health care system. Pedi-
atrics, 123(2):e333–7, February 2009. ISSN 1098-4275. doi: 10.1542/peds.
2008-2654. URL http://www.ncbi.nlm.nih.gov/pubmed/19171584.
Jung, A., Faltermeier, R., Rothoerl, R., and Brawanski, A. A mathemat-
ical model of cerebral circulation and oxygen supply. Journal of mathe-
matical biology, 51(5):491–507, November 2005. ISSN 0303-6812. doi: 10.
1007/s00285-005-0343-5. URL http://www.ncbi.nlm.nih.gov/pubmed/
16195926.
399
Karen, T., Morren, G., Haensse, D., Bauschatz, A. S., Bucher, H. U., and
Wolf, M. Hemodynamic response to visual stimulation in newborn infants
using functional near-infrared spectroscopy. Human brain mapping, 29(4):
453–60, April 2008. ISSN 1065-9471. doi: 10.1002/hbm.20411. URL http:
//www.ncbi.nlm.nih.gov/pubmed/17525986.
Kendall, G. S., Hristova, M., Zbarsky, V., Clements, A., Peebles, D. M.,
Robertson, N. J., and Raivich, G. Distribution of pH changes in mouse
neonatal hypoxic-ischaemic insult. Developmental neuroscience, 33(6):505–
18, January 2011. ISSN 1421-9859. doi: 10.1159/000333850. URL http:
//www.ncbi.nlm.nih.gov/pubmed/22343485.
Kirilina, E., Jelzow, A., Heine, A., Niessing, M., Wabnitz, H., Bru¨hl,
R., Ittermann, B., Jacobs, A. M., and Tachtsidis, I. The phys-
iological origin of task-evoked systemic artefacts in functional
near infrared spectroscopy. NeuroImage, 61(1):70–81, May 2012.
ISSN 1095-9572. doi: 10.1016/j.neuroimage.2012.02.074. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3348501&tool=pmcentrez&rendertype=abstract.
Kodali, B. S. Capnography outside the operating rooms. Anesthesiol-
ogy, 118(1):192–201, January 2013. ISSN 1528-1175. doi: 10.1097/
ALN.0b013e318278c8b6. URL http://www.ncbi.nlm.nih.gov/pubmed/
23221867.
Korzeniewski, B. Regulation of ATP supply during muscle contraction:
theoretical studies. The Biochemical journal, 330 ( Pt 3:1189–95, March 1998.
ISSN 0264-6021. URL http://www.biochemj.org/bj/330/bj3301189.
htmhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1219260&tool=pmcentrez&rendertype=abstract.
Korzeniewski, B. and Froncisz, W. An extended dynamic model of oxida-
tive phosphorylation. Biochimica et biophysica acta, 1060(2):210–23, Octo-
ber 1991. ISSN 0006-3002. URL http://www.ncbi.nlm.nih.gov/pubmed/
1657162.
Korzeniewski, B. and Zoladz, J. a. A model of oxidative phosphorylation
in mammalian skeletal muscle. Biophysical chemistry, 92(1-2):17–34, Au-
gust 2001. ISSN 0301-4622. URL http://www.ncbi.nlm.nih.gov/pubmed/
11527576.
400
Kozberg, M. G., Chen, B. R., DeLeo, S. E., Bouchard, M. B., and Hillman,
E. M. C. Resolving the transition from negative to positive blood
oxygen level-dependent responses in the developing brain. Proceedings
of the National Academy of Sciences of the United States of America, 110(11):
4380–5, March 2013. ISSN 1091-6490. doi: 10.1073/pnas.1212785110.
URL http://www.pnas.org/content/110/11/4380.shorthttp://www.
pubmedcentral.nih.gov/articlerender.fcgi?artid=3600493&tool=
pmcentrez&rendertype=abstract.
Lawn, J., Shibuya, K., and Stein, C. No cry at birth: global esti-
mates of intrapartum stillbirths and intrapartum-related neonatal
deaths. Bulletin of the World Health Organization, 83(6):409–17, June
2005. ISSN 0042-9686. doi: /S0042-96862005000600008. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2626256&tool=pmcentrez&rendertype=abstract.
Lawn, J. E., Lee, A. C. C., Kinney, M., Sibley, L., Carlo, W. a., Paul, V. K.,
Pattinson, R., and Darmstadt, G. L. Two million intrapartum-related still-
births and neonatal deaths: where, why, and what can be done? In-
ternational journal of gynaecology and obstetrics: the official organ of the In-
ternational Federation of Gynaecology and Obstetrics, 107 Suppl:S5–18, S19,
October 2009. ISSN 1879-3479. doi: 10.1016/j.ijgo.2009.07.016. URL
http://www.ncbi.nlm.nih.gov/pubmed/19815202.
Lee, J.-m., Grabb, M. C., Zipfel, G. J., and Choi, D. W. Tissue responses to
ischemia Brain tissue responses to ischemia. The Journal of Clinical Investi-
gation, 106(6):723–731, 2000.
Levene, M. I. Cool treatment for birth asphyxia, but what’s next? Archives of
disease in childhood. Fetal and neonatal edition, 95(3):F154–7, May 2010. ISSN
1468-2052. doi: 10.1136/adc.2009.165738. URL http://www.ncbi.nlm.
nih.gov/pubmed/20444808.
Lind, N. M., Moustgaard, A., Jelsing, J., Vajta, G., Cumming, P., and Hansen,
A. K. The use of pigs in neuroscience: modeling brain disorders. Neu-
roscience and biobehavioral reviews, 31(5):728–51, January 2007. ISSN 0149-
7634. doi: 10.1016/j.neubiorev.2007.02.003. URL http://www.ncbi.nlm.
nih.gov/pubmed/17445892.
401
Linninger, A. A., Xenos, M., Sweetman, B., Ponkshe, S., Guo, X., and Penn, R.
A mathematical model of blood, cerebrospinal fluid and brain dynamics.
Journal of mathematical biology, 59(6):729–59, December 2009. ISSN 1432-
1416. doi: 10.1007/s00285-009-0250-2. URL http://www.ncbi.nlm.nih.
gov/pubmed/19219605.
Lloyd-Fox, S., Blasi, a., and Elwell, C. E. Illuminating the developing brain:
the past, present and future of functional near infrared spectroscopy. Neu-
roscience and biobehavioral reviews, 34(3):269–84, March 2010. ISSN 1873-
7528. doi: 10.1016/j.neubiorev.2009.07.008. URL http://www.ncbi.nlm.
nih.gov/pubmed/19632270.
Lloyd-Fox, S., Blasi, A., Elwell, C. E., Charman, T., Murphy, D., and John-
son, M. H. Reduced neural sensitivity to social stimuli in infants at
risk for autism. Proceedings. Biological sciences / The Royal Society, 280
(1758):20123026, May 2013. ISSN 1471-2954. doi: 10.1098/rspb.2012.
3026. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=3619456&tool=pmcentrez&rendertype=abstract.
Lo, C.-J., Leake, M. C., and Berry, R. M. Fluorescence mea-
surement of intracellular sodium concentration in single Es-
cherichia coli cells. Biophysical journal, 90(1):357–65, January
2006. ISSN 0006-3495. doi: 10.1529/biophysj.105.071332. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
1367033&tool=pmcentrez&rendertype=abstract.
Lobo, N., Yang, B., Rizvi, M., and Ma, D. Hypothermia and xenon: novel no-
ble guardians in hypoxic-ischemic encephalopathy? Journal of neuroscience
research, 91(4):473–8, April 2013. ISSN 1097-4547. doi: 10.1002/jnr.23178.
URL http://www.ncbi.nlm.nih.gov/pubmed/23335252.
Lodygensky, G. A., Inder, T. E., and Neil, J. J. Application of mag-
netic resonance imaging in animal models of perinatal hypoxic-
ischemic cerebral injury. International journal of developmental neu-
roscience : the official journal of the International Society for Devel-
opmental Neuroscience, 26(1):13–25, February 2008. ISSN 0736-
5748. doi: 10.1016/j.ijdevneu.2007.08.018. URL http://www.
sciencedirect.com/science/article/pii/S0736574807001189http:
402
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2277321&tool=pmcentrez&rendertype=abstract.
Logothetis, N. K. What we can do and what we cannot do with fMRI. Nature,
453(7197):869–78, June 2008. ISSN 1476-4687. doi: 10.1038/nature06976.
URL http://www.ncbi.nlm.nih.gov/pubmed/18548064.
Longo, L. D. and Packianathan, S. Hypoxia-ischaemia and the develop-
ing brain: hypotheses regarding the pathophysiology of fetal-neonatal
brain damage. British journal of obstetrics and gynaecology, 104(6):652–62,
June 1997. ISSN 0306-5456. URL http://www.ncbi.nlm.nih.gov/pubmed/
9197867.
Lorek, a., Takei, Y., Cady, E. B., Wyatt, J. S., Penrice, J., Edwards, a. D.,
Peebles, D., Wylezinska, M., Owen-Reece, H., and Kirkbride, V. Delayed
(”secondary”) cerebral energy failure after acute hypoxia-ischemia in the
newborn piglet: continuous 48-hour studies by phosphorus magnetic res-
onance spectroscopy. Pediatric research, 36(6):699–706, December 1994.
ISSN 0031-3998. URL http://www.ncbi.nlm.nih.gov/pubmed/7898977.
Lossec, G., Lebreton, Y., Hulin, J. C., Fillaut, M., and Herpin, P. Age-
related changes in oxygen and nutrient uptake by hindquarters in new-
born pigs during cold-induced shivering. Experimental physiology, 83(6):
793–807, November 1998. ISSN 0958-0670. URL http://www.ncbi.nlm.
nih.gov/pubmed/9782189.
Lou, H. C., Lassen, N. A., and Friis-Hansen, B. Impaired autoregulation
of cerebral blood flow in the distressed newborn infant. The Journal of
pediatrics, 94(1):118–21, January 1979. ISSN 0022-3476. URL http://www.
ncbi.nlm.nih.gov/pubmed/758388.
Malamateniou, C., Adams, M. E., Srinivasan, L., Allsop, J. M., Counsell, S. J.,
Cowan, F. M., Hajnal, J. V., and Rutherford, M. a. The anatomic variations
of the circle of Willis in preterm-at-term and term-born infants: an MR
angiography study at 3T. AJNR. American journal of neuroradiology, 30(10):
1955–62, November 2009. ISSN 1936-959X. doi: 10.3174/ajnr.A1724. URL
http://www.ncbi.nlm.nih.gov/pubmed/19643922.
Meek, J. H., Tyszczuk, L., Elwell, C. E., and Wyatt, J. S. Low cerebral blood
flow is a risk factor for severe intraventricular haemorrhage. Archives of
403
Disease in Childhood - Fetal and Neonatal Edition, 81(1):F15–F18, July 1999.
ISSN 1359-2998. doi: 10.1136/fn.81.1.F15. URL http://fn.bmj.com/cgi/
doi/10.1136/fn.81.1.F15.
Meek, J. H., Firbank, M., Elwell, C. E., Atkinson, J., Braddick,
O., and Wyatt, J. S. Regional hemodynamic responses to visual
stimulation in awake infants. Pediatric research, 43(6):840–3, June
1998. ISSN 0031-3998. doi: 10.1203/00006450-199806000-00019.
URL http://dx.doi.org/10.1203/00006450-199806000-00019http://
www.ncbi.nlm.nih.gov/pubmed/9621996.
Mehmet, H., Yue, X., Squier, M., and Lorek, A. Increased apoptosis in the
cingulate sulcus of newborn piglets following transient hypoxia-ischaemia
is related to the degree of high energy phosphate depletion. Neuroscience
. . . , 181:121–125, 1994. URL http://www.sciencedirect.com/science/
article/pii/0304394094905746.
Mitra, S., Bale, G., Meek, J., Mathieson, S., Kendall, G., Robertson, N. J., and
Tachtsidis, I. In vivo Measurement of Cerebral Mitochondrial Metabolism
using Broadband Near Infrared Spectroscopy following Neonatal Stroke.
Advances in experimental medicine and biology (Accepted for publication), 2015.
Moroz, T., Banaji, M., Robertson, N. J., Cooper, C. E., and Tachtsidis, I.
Computational modelling of the piglet brain to simulate near-infrared
spectroscopy and magnetic resonance spectroscopy data collected dur-
ing oxygen deprivation. Journal of the Royal Society, Interface / the Royal
Society, January 2012. ISSN 1742-5662. doi: 10.1098/rsif.2011.0766. URL
http://www.ncbi.nlm.nih.gov/pubmed/22279158.
Moroz, T., Hapuarachchi, T., Bainbridge, A., Price, D., Cady, E., Baer, E.,
Tachtsidis, I., Broad, K., Ezzati, M., Robertson, N. J., Thomas, D., Golay,
X., and Cooper, C. E. Modelling blood flow and metabolism in the piglet
brain during hypoxia-ischaemia: simulating brain energetics. Advances
in experimental medicine and biology, 789:339–44, January 2013. ISSN 0065-
2598. doi: 10.1007/978-1-4614-7411-1\ 45. URL http://www.ncbi.nlm.
nih.gov/pubmed/23852513.
Morris, M. D. Factorial Sampling Plans for Preliminary Computational Ex-
periments. Technometrics, 33(2):161, May 1991. ISSN 00401706. doi: 10.
404
2307/1269043. URL http://www.jstor.org/stable/1269043?origin=
crossref.
Narins, S. C., Park, E. H., Ramakrishnan, R., Garcia, F. U., Diven, J. N.,
Balin, B. J., Hammond, C. J., Sodam, B. R., Smith, P. R., and Abedin,
M. Z. Functional characterization of Na(+)/H(+) exchangers in primary
cultures of prairie dog gallbladder. The Journal of membrane biology, 197(2):
123–34, January 2004. ISSN 0022-2631. doi: 10.1007/s00232-003-0647-6.
URL http://www.ncbi.nlm.nih.gov/pubmed/15014914.
Nascimento, M. C. V. A., Xavier, C. C., and Goulart, E. M. A. Arterial blood
pressure of term newborns during the first week of life. Brazilian jour-
nal of medical and biological research = Revista brasileira de pesquisas me´dicas e
biolo´gicas / Sociedade Brasileira de Biofı´sica ... [et al.], 35(8):905–11, August
2002. ISSN 0100-879X. URL http://www.ncbi.nlm.nih.gov/pubmed/
12185382.
Northington, F. J. Brief update on animal models of hypoxic-ischemic en-
cephalopathy and neonatal stroke. ILAR journal / National Research Coun-
cil, Institute of Laboratory Animal Resources, 47(1):32–8, January 2006. ISSN
1084-2020. URL http://www.ncbi.nlm.nih.gov/pubmed/16391429.
Orlowski, P., Chappell, M., Park, C. S., Grau, V., and Payne, S. Mod-
elling of pH dynamics in brain cells after stroke. Interface Focus, 1
(3):408–416, March 2011. ISSN 2042-8898. doi: 10.1098/rsfs.2010.
0025. URL http://rsfs.royalsocietypublishing.org/cgi/doi/10.
1098/rsfs.2010.0025.
Orlowski, P., O’Neill, D., Grau, V., Ventikos, Y., and Payne, S. Modelling of
the physiological response of the brain to ischaemic stroke. Interface focus,
3(2):20120079, April 2013. ISSN 2042-8898. doi: 10.1098/rsfs.2012.0079.
URL http://rsfs.royalsocietypublishing.org/content/3/2/
20120079.shorthttp://www.pubmedcentral.nih.gov/articlerender.
fcgi?artid=3638479&tool=pmcentrez&rendertype=abstract.
Paus, T., Collins, D. L., Evans, a. C., Leonard, G., Pike, B., and Zijdenbos, a.
Maturation of white matter in the human brain: a review of magnetic res-
onance studies. Brain research bulletin, 54(3):255–66, February 2001. ISSN
0361-9230. URL http://www.ncbi.nlm.nih.gov/pubmed/11287130.
405
Pejovic, B., Peco-Antic, A., and Marinkovic-Eric, J. Blood pressure in
non-critically ill preterm and full-term neonates. Pediatric nephrology
(Berlin, Germany), 22(2):249–57, February 2007. ISSN 0931-041X. doi: 10.
1007/s00467-006-0311-3. URL http://www.ncbi.nlm.nih.gov/pubmed/
17053885.
Penrice, J., Lorek, A., Cady, E. B., Amess, P. N., Wylezinska, M., Cooper,
C. E., D’Souza, P., Brown, G. C., Kirkbride, V., Edwards, A. D., Wyatt,
J. S., and Reynolds, E. O. Proton magnetic resonance spectroscopy of the
brain during acute hypoxia-ischemia and delayed cerebral energy failure
in the newborn piglet. Pediatric research, 41(6):795–802, June 1997. ISSN
0031-3998. doi: 10.1203/00006450-199706000-00001. URL http://www.
ncbi.nlm.nih.gov/pubmed/9167191.
Perlman, J. M. Summary proceedings from the neurology group on hypoxic-
ischemic encephalopathy. Pediatrics, 117(3 Pt 2):S28–33, March 2006. ISSN
1098-4275. doi: 10.1542/peds.2005-0620E. URL http://www.ncbi.nlm.
nih.gov/pubmed/16777819.
Petroff, O. a., Prichard, J. W., Behar, K. L., Alger, J. R., den Hollander, J. a.,
and Shulman, R. G. Cerebral intracellular pH by 31P nuclear magnetic
resonance spectroscopy., June 1985. ISSN 0028-3878. URL http://www.
ncbi.nlm.nih.gov/pubmed/7816318.
Pettegrew, J. and Withers, G. Considerations for brain pH assessment by
31 P NMR. Magnetic resonance . . . , 6:135–142, 1988. URL http://www.
sciencedirect.com/science/article/pii/0730725X88904432.
Plog, B. a., Dashnaw, M. L., Hitomi, E., Peng, W., Liao, Y., Lou, N., Deane,
R., and Nedergaard, M. Biomarkers of Traumatic Injury Are Trans-
ported from Brain to Blood via the Glymphatic System. Journal of Neu-
roscience, 35(2):518–526, January 2015. ISSN 0270-6474. doi: 10.1523/
JNEUROSCI.3742-14.2015. URL http://www.jneurosci.org/cgi/doi/
10.1523/JNEUROSCI.3742-14.2015.
Polin, R. A., Fox, W. W., and Abman, S. H. Fetal and Neonatal Physiology, 4th
edition, volume 41. Saunders, fourth edition, January 2010. ISBN 978-1-
4160-3479-7.
406
Powell, M. J. D. An efficient method for finding the minimum of a function
of several variables without calculating derivatives. The Computer Journal,
7(2):155–162, February 1964. ISSN 0010-4620. doi: 10.1093/comjnl/7.2.155.
URL http://comjnl.oxfordjournals.org/content/7/2/155.abstract.
Rehncrona, S., Rose´n, I., and Siesjo¨, B. K. Excessive cellular aci-
dosis: an important mechanism of neuronal damage in the
brain? Acta physiologica Scandinavica, 110(4):435–7, December 1980.
ISSN 0001-6772. doi: 10.1111/j.1748-1716.1980.tb06692.x. URL
http://onlinelibrary.wiley.com/doi/10.1111/j.1748-1716.1980.
tb06692.x/abstracthttp://www.ncbi.nlm.nih.gov/pubmed/7234448.
Robertson, N. J. and Wyatt, J. S. The magnetic resonance revolution in
brain imaging: impact on neonatal intensive care. Archives of disease in
childhood. Fetal and neonatal edition, 89(3):F193–7, May 2004. ISSN 1359-
2998. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=1721681&tool=pmcentrez&rendertype=abstract.
Robertson, N. J., Cox, I. J., Cowan, F. M., Counsell, S. J., Azzopardi, D., and
Edwards, A. D. Cerebral intracellular lactic alkalosis persisting months
after neonatal encephalopathy measured by magnetic resonance spec-
troscopy. Pediatric research, 46(3):287–96, September 1999. ISSN 0031-
3998. doi: 10.1203/00006450-199909000-00007. URL http://www.ncbi.
nlm.nih.gov/pubmed/10473043.
Robertson, N. J., Cowan, F. M., Cox, I. J., and Edwards, A. D. Brain alkaline
intracellular pH after neonatal encephalopathy. Annals of neurology, 52(6):
732–42, December 2002. ISSN 0364-5134. doi: 10.1002/ana.10365. URL
http://www.ncbi.nlm.nih.gov/pubmed/12447926.
Robertson, N. J., Kato, T., Bainbridge, A., Chandrasekaran, M., Iwata, O.,
Kapetanakis, A., Faulkner, S., Cheong, J., Iwata, S., Hristova, M., Cady, E.,
and Raivich, G. Methyl-isobutyl amiloride reduces brain Lac/NAA, cell
death and microglial activation in a perinatal asphyxia model. Journal of
neurochemistry, 124(5):645–57, March 2013. ISSN 1471-4159. doi: 10.1111/
jnc.12097. URL http://www.ncbi.nlm.nih.gov/pubmed/23171224.
Robertson, N., Nakakeeto, M., and Hagmann, C. Therapeutic hypothermia
for birth asphyxia in low-resource settings: a pilot randomised controlled
407
trial. The Lancet, pages 801–803, 2008. URL http://www.thelancet.com/
journals/lancet/article/PIIS0140-6736(08)61329-X.
Roche-Labarbe, N., Fenoglio, A., Radhakrishnan, H., Kocienski-Filip, M.,
Carp, S. a., Dubb, J., Boas, D. a., Grant, P. E., and Franceschini, M. A. So-
matosensory evoked changes in cerebral oxygen consumption measured
non-invasively in premature neonates. NeuroImage, 85 Pt 1:279–86, Jan-
uary 2014. ISSN 1095-9572. doi: 10.1016/j.neuroimage.2013.01.035. URL
http://www.ncbi.nlm.nih.gov/pubmed/23370052.
Rosenberg, A. A. Cerebral blood flow and O2 metabolism after asphyxia in
neonatal lambs. Pediatric research, 20(8):778–82, August 1986. ISSN 0031-
3998. doi: 10.1203/00006450-198608000-00016. URL http://www.ncbi.
nlm.nih.gov/pubmed/3737291.
Roth, S. C., Edwards, a. D., Cady, E. B., Delpy, D. T., Wyatt, J. S., Azzopardi,
D., Baudin, J., Townsend, J., Stewart, a. L., and Reynolds, E. O. Rela-
tion between cerebral oxidative metabolism following birth asphyxia, and
neurodevelopmental outcome and brain growth at one year. Developmen-
tal medicine and child neurology, 34(4):285–95, April 1992. ISSN 0012-1622.
URL http://www.ncbi.nlm.nih.gov/pubmed/1572514.
Rutherford, M. MRI of the Neonatal Brain. MRI of the NEonatal Brain,
9:1–18, 2002. URL http://scholar.google.com/scholar?hl=en&btnG=
Search&q=intitle:MRI+of+the+neonatal+brain#0.
Saltelli, A., Tarantola, S., and Chan, K. P.-S. A Quantitative Model-
Independent Method for Global Sensitivity Analysis of Model Out-
put. Technometrics, 41(1):39, February 1999. ISSN 00401706. doi: 10.
2307/1270993. URL http://www.jstor.org/stable/1270993?origin=
crossref.
Saltelli, A., Tarantola, S., Campolongo, F., and Ratto, M. Sen-
sitivity analysis in practice: a guide to assessing scientific mod-
els. John Wiley and Sons, 2004. ISBN 0470870931. URL
http://books.google.com/books?hl=en&lr=&id=NsAVmohPNpQC&oi=
fnd&pg=PR5&dq=Sensitivity+Analysis+in+Practice:+A+Guide+
to+Assessing+Scientific+Models&ots=0QqASZT0AV&sig=
Xy3xzRvvtHZJq-BGDPP_TFy5QIEhttp://books.google.com/books?hl=
en&lr=&id=NsAVmohPNpQC&oi=fnd&pg=PR5&dq=Sensitivity+analysis+
408
in+practice:+a+guide+to+assessing+scientific+models&ots=
0QqASZT1sW&sig=EGQQMaYO-k6xOP4LqUS0mOAnFf0.
Scholkmann, F. Figure. (reproduced with permission), 2014.
Scholkmann, F., Kleiser, S., Metz, A. J., Zimmermann, R., Mata Pavia,
J., Wolf, U., and Wolf, M. A review on continuous wave functional
near-infrared spectroscopy and imaging instrumentation and methodol-
ogy. NeuroImage, 85 Pt 1:6–27, January 2014. ISSN 1095-9572. doi:
10.1016/j.neuroimage.2013.05.004. URL http://www.ncbi.nlm.nih.gov/
pubmed/23684868.
Seghier, M. L., Lazeyras, F., Zimine, S., Maier, S. E., Hanquinet, S.,
Delavelle, J., Volpe, J. J., and Huppi, P. S. Combination of event-
related fMRI and diffusion tensor imaging in an infant with perinatal
stroke. NeuroImage, 21(1):463–472, January 2004. ISSN 10538119. doi:
10.1016/j.neuroimage.2003.09.015. URL http://linkinghub.elsevier.
com/retrieve/pii/S1053811903005640.
Shadid, M., Moison, R., Steendijk, P., Hiltermann, L., Berger, H. M., and van
Bel, F. The effect of antioxidative combination therapy on post hypoxic-
ischemic perfusion, metabolism, and electrical activity of the newborn
brain. Pediatric research, 44(1):119–24, July 1998. ISSN 0031-3998. doi: 10.
1203/00006450-199807000-00019. URL http://www.ncbi.nlm.nih.gov/
pubmed/9667381.
Shah, P., Ohlsson, A., and Perlman, M. Hypothermia to treat neona-
tal hypoxic ischemic encephalopathy: systematic review. Archives
of pediatrics & adolescent medicine, 161(10):951–958, 2007. URL http:
//aapgrandrounds.aappublications.org/content/19/1/3.shorthttp:
//archpedi.ama-assn.org/cgi/reprint/161/10/951.pdf.
Siesjo, B. Brain Energy Metabolism. {John Wiley and Sons Ltd},
1978. ISBN 0471995150. URL http://www.citeulike.org/group/160/
article/1473537.
Simpson, I., Carruthers, A., and Vannucci, S. Supply and demand in cerebral
energy metabolism: the role of nutrient transporters. . . . Blood Flow &
Metabolism, 27(11):1766–1791, 2007. URL http://www.nature.com/jcbfm/
journal/v27/n11/abs/9600521a.html.
409
Singh, H., Cooper, R. J., Wai Lee, C., Dempsey, L., Edwards, A., Brigadoi,
S., Airantzis, D., Everdell, N., Michell, A., Holder, D., Hebden, J. C., and
Austin, T. Mapping cortical haemodynamics during neonatal seizures
using diffuse optical tomography: a case study. NeuroImage. Clinical,
5:256–65, January 2014. ISSN 2213-1582. doi: 10.1016/j.nicl.2014.06.
012. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=4141980&tool=pmcentrez&rendertype=abstract.
Smye, S. W. and Clayton, R. H. Mathematical modelling for the new mille-
nium: medicine by numbers. Medical engineering & physics, 24(9):565–74,
November 2002. ISSN 1350-4533. URL http://www.ncbi.nlm.nih.gov/
pubmed/12376043.
Soares, D. P. and Law, M. Magnetic resonance spectroscopy of the brain:
review of metabolites and clinical applications. Clinical radiology, 64(1):
12–21, January 2009. ISSN 1365-229X. doi: 10.1016/j.crad.2008.07.002.
URL http://www.ncbi.nlm.nih.gov/pubmed/19070693.
Solas, A.-B., Munkeby, B. H., and Saugstad, O. D. Comparison of short-
and long-duration oxygen treatment after cerebral asphyxia in newborn
piglets. Pediatric research, 56(1):125–31, July 2004. ISSN 0031-3998. doi:
10.1203/01.PDR.0000128978.90201.1D. URL http://www.ncbi.nlm.nih.
gov/pubmed/15128930.
Soul, J. S., Taylor, G. a., Wypij, D., Duplessis, a. J., and Volpe, J. J. Nonin-
vasive detection of changes in cerebral blood flow by near-infrared spec-
troscopy in a piglet model of hydrocephalus. Pediatric research, 48(4):445–9,
October 2000. ISSN 0031-3998. doi: 10.1203/00006450-200010000-00005.
URL http://www.ncbi.nlm.nih.gov/pubmed/11004233.
Springett, R., Newman, J., Cope, M., and Delpy, D. T. Oxygen dependency
and precision of cytochrome oxidase signal from full spectral NIRS of the
piglet brain. American journal of physiology. Heart and circulatory physiology,
279(5):H2202–9, November 2000. ISSN 0363-6135. URL http://www.ncbi.
nlm.nih.gov/pubmed/11045954.
Springett, R., Sakata, Y., and Delpy, D. T. Precise measurement of cerebral
blood flow in newborn piglets from the bolus passage of indocyanine
green. Physics in medicine and biology, 46(8):2209–25, August 2001. ISSN
0031-9155. URL http://www.ncbi.nlm.nih.gov/pubmed/11512620.
410
Steiner, L. A. and Andrews, P. J. D. Monitoring the injured brain: ICP and
CBF. British journal of anaesthesia, 97(1):26–38, July 2006. ISSN 0007-0912.
doi: 10.1093/bja/ael110. URL http://www.ncbi.nlm.nih.gov/pubmed/
16698860.
Sturmfels, B. Can biology lead to new theorems? Annual report of the
Clay Mathematics Institute, 2005. URL http://www2.maths.ox.ac.uk/cmi/
library/annual_report/ar2005/05report_featurearticle.pdf.
Tachtsidis, I., Bainbridge, A., Faulkner, S., Price, D., Powell, E., Thomas,
D., Cady, E., Robertson, N., and Golay, X. In-Vivo Measurements of
Brain Haemodynamics and Energetics using Multimodal Spectroscopy
in Perinatal Hypoxia-Ischaemia. In Biomedical Optics and 3-D Imaging,
page JM3A.27, Washington, D.C., 2012. OSA. ISBN 978-1-55752-942-8.
doi: 10.1364/BIOMED.2012.JM3A.27. URL http://www.opticsinfobase.
org/abstract.cfm?URI=BIOMED-2012-JM3A.27.
Thayyil, S., Chandrasekaran, M., Taylor, A., Bainbridge, A., Cady, E. B.,
Chong, W. K. K., Murad, S., Omar, R. Z., and Robertson, N. J. Cere-
bral magnetic resonance biomarkers in neonatal encephalopathy: a meta-
analysis. Pediatrics, 125(2):e382–95, February 2010. ISSN 1098-4275. doi:
10.1542/peds.2009-1046. URL http://www.ncbi.nlm.nih.gov/pubmed/
20083516.
Thompson, R. F. The Brain: A Neuroscience Primer. W. H. Freeman and
Company, third edition, 2000. ISBN 978-0716732266.
Thoresen, M., Penrice, J., Lorek, a., Cady, E. B., Wylezinska, M., Kirkbride,
V., Cooper, C. E., Brown, G. C., Edwards, a. D., and Wyatt, J. S. Mild
hypothermia after severe transient hypoxia-ischemia ameliorates delayed
cerebral energy failure in the newborn piglet. Pediatric research, 37(5):667–
70, May 1995. ISSN 0031-3998. doi: 10.1203/00006450-199505000-00019.
URL http://www.ncbi.nlm.nih.gov/pubmed/7603788.
Tichauer, K. M., Brown, D. W., Hadway, J., Lee, T.-Y., and St Lawrence,
K. Near-infrared spectroscopy measurements of cerebral blood flow
and oxygen consumption following hypoxia-ischemia in newborn piglets.
Journal of applied physiology (Bethesda, Md. : 1985), 100(3):850–7, March
2006. ISSN 8750-7587. doi: 10.1152/japplphysiol.00830.2005. URL
http://www.ncbi.nlm.nih.gov/pubmed/16293704.
411
Tisdall, M., Tachtsidis, I., Leung, T., Elwell, C. E., and Smith, M. Near in-
frared spectroscopic quantification of changes in hte concentration of oxi-
dized cytochrome oxidase in the healthy human brain. Journal of Biomedi-
cal Optics, 2007.
Tisdall, M. M. and Smith, M. Multimodal monitoring in traumatic brain
injury: current status and future directions. British journal of anaesthesia,
99(1):61–7, July 2007. ISSN 0007-0912. doi: 10.1093/bja/aem143. URL
http://www.ncbi.nlm.nih.gov/pubmed/17548431.
Transtrum, M. K., Machta, B. B., and Sethna, J. P. Why are Nonlinear Fits
to Data so Challenging? Physical Review Letters, 104(6):060201, February
2010. ISSN 0031-9007. doi: 10.1103/PhysRevLett.104.060201. URL http:
//link.aps.org/doi/10.1103/PhysRevLett.104.060201.
Transtrum, M. K., Machta, B. B., and Sethna, J. P. Geometry of non-
linear least squares with applications to sloppy models and optimiza-
tion. Physical Review E, 83(3):036701, March 2011. ISSN 1539-3755. doi:
10.1103/PhysRevE.83.036701. URL http://link.aps.org/doi/10.1103/
PhysRevE.83.036701.
Trescher, W. H., Ishiwa, S., and Johnston, M. V. Brief post-hypoxic-ischemic
hypothermia markedly delays neonatal brain injury. Brain & development,
19(5):326–38, July 1997. ISSN 0387-7604. URL http://www.ncbi.nlm.nih.
gov/pubmed/9253485.
Tsuji, M., Naruse, H., Volpe, J., and Holtzman, D. Reduction of cytochrome
aa3 measured by near-infrared spectroscopy predicts cerebral energy loss
in hypoxic piglets. Pediatric research, 37(3):253–9, March 1995. ISSN 0031-
3998. doi: 10.1203/00006450-199503000-00001. URL http://www.ncbi.
nlm.nih.gov/pubmed/7784131.
Tyszczuk, L., Meek, J., Elwell, C., and Wyatt, J. S. Cerebral blood flow is in-
dependent of mean arterial blood pressure in preterm infants undergoing
intensive care. Pediatrics, 102(2 Pt 1):337–41, August 1998. ISSN 0031-4005.
URL http://www.ncbi.nlm.nih.gov/pubmed/9685435.
Uria-Avellanal, C. and Robertson, N. J. Na(+)/H (+) Exchangers and
Intracellular pH in Perinatal Brain Injury. Translational stroke research, 5(1):
79–98, February 2014. ISSN 1868-601X. doi: 10.1007/s12975-013-0322-x.
412
URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=3913853&tool=pmcentrez&rendertype=abstract.
Ursino, M. and Lodi, C. a. A simple mathematical model of the interac-
tion between intracranial pressure and cerebral hemodynamics. Journal of
applied physiology (Bethesda, Md. : 1985), 82(4):1256–69, April 1997. ISSN
8750-7587. URL http://www.ncbi.nlm.nih.gov/pubmed/9104864.
Ursino, M. and Lodi, C. Interaction among autoregulation, CO2 reactiv-
ity, and intracranial pressure: a mathematical model. American Journal
of Physiology-Heart . . . , 1998. URL http://ajpheart.physiology.org/
content/274/5/H1715.short.
van Kooij, B. J. M., Hendrikse, J., Benders, M. J. N. L., de Vries, L. S., and
Groenendaal, F. Anatomy of the circle of Willis and blood flow in the
brain-feeding vasculature in prematurely born infants. Neonatology, 97
(3):235–41, January 2010. ISSN 1661-7819. doi: 10.1159/000253754. URL
http://www.ncbi.nlm.nih.gov/pubmed/19887852.
Vatov, L., Kizner, Z., Ruppin, E., Meilin, S., Manor, T., and Mayevsky,
A. Modeling brain energy metabolism and function: a multiparamet-
ric monitoring approach. Bulletin of mathematical biology, 68(2):275–91,
February 2006. ISSN 0092-8240. doi: 10.1007/s11538-005-9008-1. URL
http://www.ncbi.nlm.nih.gov/pubmed/16794931.
Vaz, A. I. F. and Vicente, L. N. A particle swarm pattern search
method for bound constrained global optimization. Journal of Global
Optimization, 39(2):197–219, February 2007. ISSN 0925-5001. doi:
10.1007/s10898-007-9133-5. URL http://link.springer.com/10.1007/
s10898-007-9133-5.
Vaz, A. and Vicente, L. PSwarm: A hybrid solver for linearly constrained
global derivative-free optimization. Optimization Methods & Software,
pages 1–22, 2009. URL http://www.tandfonline.com/doi/abs/10.1080/
10556780902909948.
Verhagen, E. a., Van Braeckel, K. N. J. a., van der Veere, C. N., Groen,
H., Dijk, P. H., Hulzebos, C. V., and Bos, A. F. Cerebral oxygenation
is associated with neurodevelopmental outcome of preterm children at
age 2 to 3years. Developmental medicine and child neurology, (May 2006):
413
1–7, November 2014. ISSN 1469-8749. doi: 10.1111/dmcn.12622. URL
http://www.ncbi.nlm.nih.gov/pubmed/25382744.
Verma, P. K., Panerai, R. B., Rennie, J. M., and Evans, D. H. Grading of
cerebral autoregulation in preterm and term neonates. Pediatric neurology,
23(3):236–42, September 2000. ISSN 0887-8994. URL http://www.ncbi.
nlm.nih.gov/pubmed/11033287.
Volpe, J. Neurology of the Newborn, volume 1. Saunders, fifth edit edi-
tion, 2008. URL http://books.google.com/books?hl=en&lr=&id=
RiPpqyaH7DIC&oi=fnd&pg=PP1&dq=Neurology+of+the+Newborn&ots=
DNPmnhqDgi&sig=r9sh3QNh5Usy6mEd2PV0E-sSl2s.
Vutskits, L. Cerebral blood flow in the neonate. Paediatric anaesthesia, 24
(1):22–9, January 2014. ISSN 1460-9592. doi: 10.1111/pan.12307. URL
http://www.ncbi.nlm.nih.gov/pubmed/24238074.
Wakabayashi, S., Fafournoux, P., Sardet, C., and Pouysse´gur, J. The
Na+/H+ antiporter cytoplasmic domain mediates growth factor signals
and controls ”H(+)-sensing”. Proceedings of the National Academy of Sci-
ences of the United States of America, 89(6):2424–8, March 1992. ISSN 0027-
8424. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=48670&tool=pmcentrez&rendertype=abstract.
Ward, K. R. and Yealy, D. M. End-tidal carbon dioxide monitoring in emer-
gency medicine, Part 1: Basic principles. Academic emergency medicine :
official journal of the Society for Academic Emergency Medicine, 5(6):628–36,
June 1998. ISSN 1069-6563. URL http://www.ncbi.nlm.nih.gov/pubmed/
9660292.
Waterfall, J., Casey, F., Gutenkunst, R., Brown, K., Myers, C., Brouwer,
P., Elser, V., and Sethna, J. Sloppy-Model Universality Class and the
Vandermonde Matrix. Physical Review Letters, 97(15):150601, October
2006. ISSN 0031-9007. doi: 10.1103/PhysRevLett.97.150601. URL http:
//link.aps.org/doi/10.1103/PhysRevLett.97.150601.
Wigner, E. The unreasonable effectiveness of mathematics in the natural
sciences. Communications in Pure and Applied Mathematics, 13(1), 1960. URL
http://link.springer.com/chapter/10.1007/978-3-642-78374-6_41.
414
Williams, G. D. and Smith, M. B. Application of the accurate assessment of
intracellular magnesium and pH from the 31P shifts of ATP to cerebral
hypoxia-ischemia in neonatal rat. Magnetic resonance in medicine : official
journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic
Resonance in Medicine, 33(6):853–7, June 1995. ISSN 0740-3194. URL http:
//www.ncbi.nlm.nih.gov/pubmed/7651125.
Williamson, D. H., Lund, P., and Krebs, H. a. The redox state of free
nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of
rat liver. The Biochemical journal, 103(2):514–27, May 1967. ISSN 0264-
6021. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=1270436&tool=pmcentrez&rendertype=abstract.
Wong, F. Y., Leung, T. S., Austin, T., Wilkinson, M., Meek, J. H., Wyatt, J. S.,
and Walker, A. M. Impaired autoregulation in preterm infants identified
by using spatially resolved spectroscopy. Pediatrics, 121(3):e604–11, March
2008. ISSN 1098-4275. doi: 10.1542/peds.2007-1487. URL http://www.
ncbi.nlm.nih.gov/pubmed/18250118.
Worley, A., Fabrizi, L., Boyd, S., and Slater, R. Multi-modal pain
measurements in infants. Journal of neuroscience methods, 205(2):252–
7, April 2012. ISSN 1872-678X. doi: 10.1016/j.jneumeth.2012.01.
009. URL http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=3465552&tool=pmcentrez&rendertype=abstract.
Wray, S., Cope, M., Delpy, D. T., Wyatt, J. S., and Reynolds, E. O. Char-
acterization of the near infrared absorption spectra of cytochrome aa3
and haemoglobin for the non-invasive monitoring of cerebral oxygena-
tion. Biochimica et biophysica acta, 933(1):184–92, March 1988. ISSN 0006-
3002. URL http://www.ncbi.nlm.nih.gov/pubmed/2831976.
Wyatt, J. S., Cope, M., Delpy, D. T., Richardson, C. E., Edwards, a. D., Wray,
S., and Reynolds, E. O. Quantitation of cerebral blood volume in human
infants by near-infrared spectroscopy. Journal of applied physiology (Bethesda,
Md. : 1985), 68(3):1086–91, March 1990. ISSN 8750-7587. URL http://www.
ncbi.nlm.nih.gov/pubmed/2341336.
Yager, J. Y. and Ashwal, S. Animal models of perinatal hypoxic-ischemic
brain damage. Pediatric neurology, 40(3):156–67, March 2009. ISSN 0887-
415
8994. doi: 10.1016/j.pediatrneurol.2008.10.025. URL http://www.ncbi.
nlm.nih.gov/pubmed/19218028.
Yu, T., Lloyd, C. M., Nickerson, D. P., Cooling, M. T., Miller, A. K., Garny,
A., Terkildsen, J. R., Lawson, J., Britten, R. D., Hunter, P. J., and Nielsen, P.
M. F. The Physiome Model Repository 2. Bioinformatics (Oxford, England),
27(5):743–4, March 2011. ISSN 1367-4811. doi: 10.1093/bioinformatics/
btq723. URL http://www.ncbi.nlm.nih.gov/pubmed/21216774.
Zahler, R., Zhang, Z. T., Manor, M., and Boron, W. F. Sodium ki-
netics of Na,K-ATPase alpha isoforms in intact transfected HeLa
cells. The Journal of general physiology, 110(2):201–13, August
1997. ISSN 0022-1295. doi: 0022-1295/97/08/201/13. URL
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
2233788&tool=pmcentrez&rendertype=abstract.
Zaramella, P., Freato, F., Amigoni, a., Salvadori, S., Marangoni, P., Sup-
piej, a., Suppjei, a., Schiavo, B., and Chiandetti, L. Brain auditory acti-
vation measured by near-infrared spectroscopy (NIRS) in neonates. Pe-
diatric research, 49(2):213–9, February 2001. ISSN 0031-3998. doi: 10.
1203/00006450-200102000-00014. URL http://www.ncbi.nlm.nih.gov/
pubmed/11158516.
Zimmermann, B. B., Roche-Labarbe, N., Surova, A., Boas, D. A., Wolf,
M., Grant, P. E., and Franceschini, M. A. The confounding effect
of systemic physiology on the hemodynamic response in new-
borns. Advances in experimental medicine and biology, 737:103–9, Jan-
uary 2012. ISSN 0065-2598. doi: 10.1007/978-1-4614-1566-4\ 16.
URL http://link.springer.com/10.1007/978-1-4614-1566-4http:
//www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3386795&tool=pmcentrez&rendertype=abstract.
416
